VNDA NASDAQ
Vanda Pharmaceuticals Inc.
1W: -0.2%
1M: -20.5%
3M: -22.8%
YTD: -51.5%
1Y: -28.7%
3Y: -5.7%
5Y: -77.5%
$4.00
+0.01 (+0.25%)
Weekly Expected Move ±5.0%
$4
$4
$4
$4
$4
Credit Risk of going bust: higher than 65% of companies Debt: 8.6% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.06 (down 99%), Vanda Pharmaceuticals Inc. would be worth roughly what it owes.
Total debt $22.8M against a stock market value of $241.9M.
Distance to default 3.81 (Merton model): prices to 2026-10-28, balance sheet 2026-06-30, debt counted $11.4M (short-term plus half of long-term), stock volatility 78.5%; Altman Z'' -4.18. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.06 (down 99%), Vanda Pharmaceuticals Inc. would be worth roughly what it owes.
Total debt $22.8M against a stock market value of $241.9M.
Distance to default 3.81 (Merton model): prices to 2026-10-28, balance sheet 2026-06-30, debt counted $11.4M (short-term plus half of long-term), stock volatility 78.5%; Altman Z'' -4.18. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
#349
of 1062
Biotechnology
Technical Signal Map
167 Bullish
48 Neutral
564 Bearish
VNDA
$240M
Vanda Pharmaceuticals Inc.
BEARISH
-66
SEPN
$1.9B
Septerna Inc
BULLISH
+100
KLRA
$1.7B
Kailera Therapeutics, Inc.
BULLISH
+100
COAG
$1.6B
Hemab Therapeutics Holdings, Inc. Common Stock
BULLISH
+100
REPL
$1.1B
Replimune Group, Inc.
BULLISH
+100
RIGL
$900M
Rigel Pharmaceuticals, Inc.
BULLISH
+100
SOLTF
$770M
Nxera Pharma Co., Ltd.
BULLISH
+100
CRMD
$610M
CorMedix Inc.
BULLISH
+100
DMAC
$470M
DiaMedica Therapeutics Inc.
BULLISH
+100
SGMT
$310M
Sagimet Biosciences Inc.
BULLISH
+100
DTIL
$180M
Precision BioSciences, Inc.
BULLISH
+100
MXCT
$140M
MaxCyte, Inc.
BULLISH
+100
PYPD
$110M
PolyPid Ltd.
BULLISH
+100
ANIX
$100M
Anixa Biosciences, Inc.
BULLISH
+100
NNVC
$40M
NanoViricides, Inc.
BULLISH
+100
VIR
$1.8B
Vir Biotechnology, Inc.
BULLISH
+91
SGP
$950M
SpyGlass Pharma, Inc. Common Stock
BULLISH
+91
VSTM
$910M
Verastem, Inc.
BULLISH
+91
ATNM
$50M
Actinium Pharmaceuticals, Inc.
BULLISH
+91
GRDX
$40M
GridAI Technologies Corp.
BULLISH
+91
MAZE
$1.7B
Maze Therapeutics, Inc.
BULLISH
+87
PRME
$670M
Prime Medicine, Inc.
BULLISH
+87
XFOR
$320M
X4 Pharmaceuticals, Inc.
BULLISH
+87
LYEL
$230M
Lyell Immunopharma, Inc.
BULLISH
+87
ZIVO
$20M
ZIVO Bioscience, Inc.
BULLISH
+87
PVLA
$1.8B
Palvella Therapeutics, Inc.
BULLISH
+84
RARE
$1.5B
Ultragenyx Pharmaceutical Inc.
BULLISH
+84
OABIW
$1.1B
OmniAb, Inc.
BULLISH
+84
EDIT
$370M
Editas Medicine, Inc.
BULLISH
+84
INDP
$360M
Indaptus Therapeutics, Inc.
BULLISH
+84
KRRO
$180M
Korro Bio, Inc.
BULLISH
+84
PCSA
$10M
Processa Pharmaceuticals, Inc.
BULLISH
+84
IRLA
$30M
IRulya Therapeutics Inc.
BULLISH
+82
GENB
$1.6B
Generate Biomedicines, Inc.
BULLISH
+80
RXRX
$2.0B
Recursion Pharmaceuticals, Inc.
BULLISH
+78
CING
$70M
Cingulate Inc.
BULLISH
+78
ESLA
$40M
Estrella Immunopharma, Inc.
BULLISH
+78
ABSI
$1.6B
Absci Corporation
BULLISH
+75
TRAX
$1.6B
First Tracks Biotherapeutics Inc
BULLISH
+75
NTLA
$1.6B
Intellia Therapeutics, Inc.
BULLISH
+75
LBRX
$1.2B
LB Pharmaceuticals Inc Common Stock
BULLISH
+75
ENTX
$510M
Entera Bio Ltd.
BULLISH
+75
KROS
$220M
Keros Therapeutics, Inc.
BULLISH
+75
HURA
$140M
TuHURA Biosciences, Inc.
BULLISH
+75
NRXS
$90M
NeurAxis, Inc.
BULLISH
+75
HOWL
$50M
Werewolf Therapeutics, Inc.
BULLISH
+75
PRLD
$210M
Prelude Therapeutics Incorporated
BULLISH
+73
NAUT
$410M
Nautilus Biotechnolgy, Inc.
BULLISH
+69
PRTA
$420M
Prothena Corporation plc
BULLISH
+68
GLSI
$240M
Greenwich LifeSciences, Inc.
BULLISH
+68
SRPT
$1.9B
Sarepta Therapeutics, Inc.
BULLISH
+66
XNCR
$1.9B
Xencor, Inc.
BULLISH
+66
XERS
$1.9B
Xeris Biopharma Holdings, Inc.
BULLISH
+66
SPTX
$1.1B
Seaport Therapeutics, Inc. Common Stock
BULLISH
+66
SLN
$930M
Silence Therapeutics plc
BULLISH
+66
ADCT
$180M
ADC Therapeutics S.A.
BULLISH
+66
ICCC
$90M
ImmuCell Corporation
BULLISH
+66
ADIL
$10M
Adial Pharmaceuticals, Inc.
BULLISH
+66
MBRX
$10M
Moleculin Biotech, Inc.
BULLISH
+66
ABPO
—
Abpro Holdings, Inc.
BULLISH
+66
PDSB
$60M
PDS Biotechnology Corporation
BULLISH
+65
AGTX
—
Agentix Corp.
BULLISH
+65
NBTX
$1.5B
Nanobiotix S.A.
BULLISH
+62
MLTX
$1.0B
MoonLake Immunotherapeutics
BULLISH
+62
PLUR
$10M
Pluri Inc.
BULLISH
+62
BOLT
$10M
Bolt Biotherapeutics, Inc.
BULLISH
+62
BDRX
—
Biodexa Pharmaceuticals Plc
BULLISH
+62
CBDG
—
THC Farmaceuticals, Inc.
BULLISH
+60
KNBIF
—
Kane Biotech Inc.
BULLISH
+60
STOK
$1.6B
Stoke Therapeutics, Inc.
BULLISH
+59
PHAR
$710M
Pharming Group N.V.
BULLISH
+59
CCCC
$380M
C4 Therapeutics, Inc.
BULLISH
+59
NGNE
$370M
Neurogene Inc.
BULLISH
+59
FENC
$350M
Fennec Pharmaceuticals Inc.
BULLISH
+59
ALEC
$200M
Alector, Inc.
BULLISH
+59
OKYO
$70M
OKYO Pharma Limited
BULLISH
+59
PBYI
$570M
Puma Biotechnology, Inc.
BULLISH
+58
AZTR
—
Azitra, Inc.
BULLISH
+58
BCYC
$250M
Bicycle Therapeutics plc
BULLISH
+52
LCTX
$250M
Lineage Cell Therapeutics, Inc.
BULLISH
+52
IMCR
$1.6B
Immunocore Holdings plc
BULLISH
+50
JANX
$1.0B
Janux Therapeutics, Inc.
BULLISH
+50
ACOG
$130M
Alpha Cognition Inc
BULLISH
+50
SCNLF
$170M
Scancell Holdings plc
BULLISH
+49
PULM
$10M
Pulmatrix, Inc.
BULLISH
+47
TCRT
$10M
Alaunos Therapeutics, Inc.
BULLISH
+44
CLGN
—
CollPlant Biotechnologies Ltd.
BULLISH
+44
ZBIO
$1.8B
Zenas BioPharma, Inc.
BULLISH
+43
VOR
$990M
Vor Biopharma Inc.
BULLISH
+43
DRUG
$520M
Bright Minds Biosciences Inc.
BULLISH
+43
ELDN
$190M
Eledon Pharmaceuticals, Inc.
BULLISH
+43
ABOS
$140M
Acumen Pharmaceuticals, Inc.
BULLISH
+43
PMN
$70M
ProMIS Neurosciences, Inc.
BULLISH
+43
HEPA
—
Hepion Pharmaceuticals, Inc.
BULLISH
+43
ACUT
—
Accustem Sciences Inc.
BULLISH
+43
NXTC
$20M
NextCure, Inc.
BULLISH
+42
KPTI
$10M
Karyopharm Therapeutics Inc.
BULLISH
+42
HALB
—
Halberd Corporation
BULLISH
+42
BRVE
$1.5B
Braveheart Bio, Inc.
BULLISH
+40
DMRA
$1.3B
Damora Therapeutics, Inc.
BULLISH
+40
PTCHF
$390M
PureTech Health plc
BULLISH
+40
IPIX
—
Innovation Pharmaceuticals Inc.
BULLISH
+38
TYRA
$1.2B
Tyra Biosciences, Inc.
BULLISH
+36
ARVN
$470M
Arvinas, Inc.
BULLISH
+36
DBVT
$230M
DBV Technologies S.A.
BULLISH
+35
TIL
$40M
Instil Bio, Inc.
BULLISH
+35
MDNAF
$20M
Medicenna Therapeutics Corp.
BULLISH
+35
OBX
$10M
Obsidian Therapeutics Inc.
BULLISH
+35
CALC
—
CalciMedica, Inc.
BULLISH
+35
KURA
$850M
Kura Oncology, Inc.
BULLISH
+34
RZLT
$370M
Rezolute, Inc.
BULLISH
+34
OBIO
$340M
Orchestra BioMed Holdings, Inc.
BULLISH
+34
PEPG
$170M
PepGen Inc.
BULLISH
+33
DNA
$670M
Ginkgo Bioworks Holdings, Inc.
BULLISH
+32
QURE
$1.6B
uniQure N.V.
LEAN BULL
+29
BCRX
$1.9B
BioCryst Pharmaceuticals, Inc.
LEAN BULL
+27
CMPS
$1.6B
COMPASS Pathways plc
LEAN BULL
+27
OVID
$420M
Ovid Therapeutics Inc.
LEAN BULL
+27
SABS
$260M
SAB Biotherapeutics, Inc.
LEAN BULL
+27
CLNN
$60M
Clene Inc.
LEAN BULL
+27
BIVI
$10M
BioVie Inc.
LEAN BULL
+27
INFIQ
—
Infinity Pharmaceuticals, Inc.
LEAN BULL
+27
ARDS
—
Aridis Pharmaceuticals, Inc.
LEAN BULL
+27
BSSP
—
Baseline Productions, Inc.
LEAN BULL
+27
VCRE
$260M
Vicore Pharma Holding AB
LEAN BULL
+26
INKT
$50M
MiNK Therapeutics, Inc.
LEAN BULL
+26
CKDXF
$10M
Ceryvyn Therapeutics Ltd
LEAN BULL
+26
CYYNF
—
Cynata Therapeutics Limited
LEAN BULL
+26
VAXX
—
Vaxxinity, Inc.
LEAN BULL
+26
ANAB
$1.5B
AnaptysBio, Inc.
LEAN BULL
+22
IMRX
$240M
Immuneering Corporation
LEAN BULL
+22
INVA
$1.5B
Innoviva, Inc.
LEAN BULL
+18
YDES
$350M
YD Bio Limited Ordinary Shares
LEAN BULL
+18
ZURA
$320M
Zura Bio Limited
LEAN BULL
+18
FATE
$250M
Fate Therapeutics, Inc.
LEAN BULL
+18
MDWD
$150M
MediWound Ltd.
LEAN BULL
+18
RNXT
$60M
RenovoRx, Inc.
LEAN BULL
+18
VSBC
$10M
VitaSpring Biomedical Co. Ltd.
LEAN BULL
+18
LOBEF
$10M
Lobe Sciences Ltd.
LEAN BULL
+18
PXMD
—
PaxMedica, Inc. Common Stock
LEAN BULL
+18
SCPX
—
Scorpius Holdings, Inc.
LEAN BULL
+18
REVB
—
Revelation Biosciences, Inc.
LEAN BULL
+18
IUGNF
$30M
Imugene Limited
LEAN BULL
+17
CURX
$10M
Curanex Pharmaceuticals Inc Common Stock
LEAN BULL
+17
ACRS
$550M
Aclaris Therapeutics, Inc.
LEAN BULL
+16
RNA
$140M
Atrium Therapeutics, Inc.
LEAN BULL
+16
TXTM
$90M
ProText Mobility, Inc.
LEAN BULL
+16
CLCS
$40M
Cell Source, Inc.
LEAN BULL
+16
SRZN
$190M
Surrozen, Inc.
LEAN BULL
+15
ANTX
$130M
AN2 Therapeutics, Inc.
LEAN BULL
+15
PBLA
—
Panbela Therapeutics, Inc.
LEAN BULL
+15
NMAD
$50M
NOMAD Power Solutions, Inc.
LEAN BULL
+14
WVE
$630M
Wave Life Sciences Ltd.
LEAN BULL
+13
SPRB
$130M
Spruce Biosciences, Inc.
LEAN BULL
+13
ZEOX
$10M
Zeo ScientifiX, Inc.
LEAN BULL
+13
ENSC
$10M
Ensysce Biosciences, Inc.
LEAN BULL
+12
NWBO
$260M
Northwest Biotherapeutics, Inc.
LEAN BULL
+11
CHRS
$160M
Coherus Oncology, Inc.
LEAN BULL
+11
OKUR
$100M
OnKure Therapeutics, Inc.
LEAN BULL
+11
EHOS
—
Ehouse Global, Inc.
LEAN BULL
+11
BETRF
$110M
BetterLife Pharma Inc.
LEAN BULL
+10
LITS
$40M
Lite Strategy, Inc.
LEAN BULL
+10
LEXX
$10M
Lexaria Bioscience Corp.
LEAN BULL
+10
ENVB
$10M
Enveric Biosciences, Inc.
LEAN BULL
+10
NMTRQ
—
9 Meters Biopharma, Inc.
LEAN BULL
+10
CMRA
—
Comera Life Sciences Holdings, Inc.
LEAN BULL
+10
DNAG
—
DNAPrint Genomics, Inc.
LEAN BULL
+10
ONCSQ
—
OncoSec Medical Incorporated
LEAN BULL
+10
ABVC
$30M
ABVC BioPharma, Inc.
NEUTRAL
+9
IFRX
$230M
InflaRx N.V.
NEUTRAL
+8
LONA
$20M
LeonaBio, Inc.
NEUTRAL
+8
ADXN
—
Addex Therapeutics Ltd
NEUTRAL
+7
CYDY
$380M
CytoDyn Inc.
NEUTRAL
+5
CGEM
$880M
Cullinan Therapeutics, Inc.
NEUTRAL
+4
QTTB
$260M
Q32 Bio Inc.
NEUTRAL
+4
EVMN
$190M
Evommune, Inc.
NEUTRAL
+4
GBIM
—
GlobeImmune, Inc.
NEUTRAL
+4
OCEA
—
Ocean Biomedical, Inc.
NEUTRAL
+4
BPTH
—
Bio-Path Holdings, Inc.
NEUTRAL
+3
CARM
—
Carisma Therapeutics, Inc.
NEUTRAL
+3
FULC
$280M
Fulcrum Therapeutics, Inc.
NEUTRAL
+2
FHTX
$120M
Foghorn Therapeutics Inc.
NEUTRAL
+2
RNTX
$50M
Rein Therapeutics Inc.
NEUTRAL
+2
GDTC
$10M
CytoMed Therapeutics Limited
NEUTRAL
+2
ONCO
—
Onconetix, Inc.
NEUTRAL
+2
HESG
—
Health Sciences Group, Inc.
NEUTRAL
+2
NTRR
—
Neutra Corp.
NEUTRAL
+2
STTK
$550M
Shattuck Labs, Inc.
NEUTRAL
+1
ARCT
$280M
Arcturus Therapeutics Holdings Inc.
NEUTRAL
+1
CTXR
$10M
Citius Pharmaceuticals, Inc.
NEUTRAL
+1
NKGN
—
NKGen Biotech, Inc.
NEUTRAL
+1
YDESW
—
YD Bio Limited Warrants
NEUTRAL
+1
CFRXQ
—
ContraFect Corp.
NEUTRAL
+1
RBSH
—
Rebus Holdings, Inc.
NEUTRAL
+1
LYCA
$1.6B
Lycia Therapeutics Inc.
N/A
0
CTY
$200M
City Therapeutics Inc.
N/A
0
IAM
$130M
Iambic Therapeutics Inc.
N/A
0
ACHFF
$40M
Arch Biopartners Inc.
NEUTRAL
0
ATOS
$30M
Atossa Therapeutics, Inc.
NEUTRAL
0
ODTX
$940M
Odyssey Therapeutics, Inc.
NEUTRAL
-2
JBIO
$930M
Jade Biosciences, Inc.
NEUTRAL
-2
SVRA
$870M
Savara Inc.
NEUTRAL
-5
SNGX
$10M
Soligenix, Inc.
NEUTRAL
-5
KLDO
—
Kaleido Biosciences, Inc.
NEUTRAL
-5
ALMS
$880M
Alumis Inc.
NEUTRAL
-6
YARW
$180M
Yarrow Bioscience Inc
NEUTRAL
-6
EQ
$80M
Equillium, Inc.
NEUTRAL
-6
ELTX
$40M
Elicio Therapeutics, Inc.
NEUTRAL
-6
NYMXF
$10M
Nymox Pharmaceutical Corporation
NEUTRAL
-6
RVLPQ
—
RVL Pharmaceuticals plc
NEUTRAL
-7
WHWK
$180M
Whitehawk Therapeutics Inc
NEUTRAL
-9
PYXS
$110M
Pyxis Oncology, Inc.
NEUTRAL
-9
ELUT
$40M
Elutia Inc
NEUTRAL
-9
EVAX
$20M
Evaxion Biotech A/S
NEUTRAL
-9
LADX
—
LadRx Corporation
NEUTRAL
-9
MRPI
—
Mera Pharmaceuticals, Inc.
NEUTRAL
-9
MBXBF
$30M
Microbix Biosystems Inc.
LEAN BEAR
-10
XBIO
—
Xenetic Biosciences, Inc.
LEAN BEAR
-10
MLLCF
$150M
Molecular Partners AG
LEAN BEAR
-12
POLBF
$70M
Poolbeg Pharma PLC
LEAN BEAR
-12
CLYYF
$10M
Celyad Oncology S.A.
LEAN BEAR
-12
QPTFF
$10M
Quest PharmaTech Inc.
LEAN BEAR
-12
CAMP
$210M
CAMP4 Therapeutics Corporation
LEAN BEAR
-14
ENTA
$340M
Enanta Pharmaceuticals, Inc.
LEAN BEAR
-15
AGEN
$290M
Agenus Inc.
LEAN BEAR
-15
BIOA
$190M
BioAge Labs Inc.
LEAN BEAR
-15
ALXO
$160M
ALX Oncology Holdings Inc.
LEAN BEAR
-15
AURX
$60M
Nuo Therapeutics, Inc.
LEAN BEAR
-15
JSPR
$20M
Jasper Therapeutics, Inc.
LEAN BEAR
-15
CNBX
—
CNBX Pharmaceuticals Inc.
LEAN BEAR
-15
GYRE
$620M
Gyre Therapeutics, Inc.
LEAN BEAR
-16
NTRB
$70M
Nutriband Inc.
LEAN BEAR
-16
BOLD
$50M
Boundless Bio, Inc.
LEAN BEAR
-16
AEON
$10M
AEON Biopharma, Inc.
LEAN BEAR
-16
SRBCF
—
Sirona Biochem Corp.
LEAN BEAR
-16
SNNAQ
—
Sienna Biopharmaceuticals, Inc.
LEAN BEAR
-16
PPCB
—
Propanc Biopharma, Inc.
LEAN BEAR
-16
IMVIF
—
IMV Inc.
LEAN BEAR
-16
MCET
—
MultiCell Technologies, Inc.
LEAN BEAR
-16
TRVI
$1.8B
Trevi Therapeutics, Inc.
LEAN BEAR
-17
AURA
$650M
Aura Biosciences, Inc.
LEAN BEAR
-17
TTRX
$310M
Turn Therapeutics Inc.
LEAN BEAR
-17
MMIRF
$30M
MedMira Inc.
LEAN BEAR
-17
SLDB
$630M
Solid Biosciences Inc.
LEAN BEAR
-18
XTLB
—
XTL Biopharmaceuticals Ltd.
LEAN BEAR
-18
LYRA
—
Lyra Therapeutics, Inc.
LEAN BEAR
-18
PARD
—
Poniard Pharmaceuticals, Inc.
LEAN BEAR
-18
STAB
—
Statera Biopharma, Inc.
LEAN BEAR
-18
AOBI
—
American Oriental Bioengineering, Inc.
LEAN BEAR
-20
HSTC
$210M
HST Global, Inc.
LEAN BEAR
-21
TSHA
$1.3B
Taysha Gene Therapies, Inc.
LEAN BEAR
-22
CLLS
$100M
Cellectis S.A.
LEAN BEAR
-22
IMUX
$100M
Immunic, Inc.
LEAN BEAR
-22
GRCE
$30M
Grace Therapeutics, Inc.
LEAN BEAR
-22
PBIGF
$10M
Paradigm Biopharmaceuticals Limited
LEAN BEAR
-22
PREDQ
—
Predictive Discovery Limited
LEAN BEAR
-22
MNKD
$1.0B
MannKind Corporation
LEAN BEAR
-23
RCKT
$250M
Rocket Pharmaceuticals, Inc.
LEAN BEAR
-23
CSBR
$70M
Champions Oncology, Inc.
LEAN BEAR
-23
GOSS
$60M
Gossamer Bio, Inc.
LEAN BEAR
-23
KARD
$1.1B
Kardigan, Inc.
LEAN BEAR
-24
FDMT
$600M
4D Molecular Therapeutics, Inc.
LEAN BEAR
-24
RNAC
$190M
Cartesian Therapeutics, Inc.
LEAN BEAR
-24
CGEN
$180M
Compugen Ltd.
LEAN BEAR
-24
TRDA
$170M
Entrada Therapeutics, Inc.
LEAN BEAR
-24
BDTX
$110M
Black Diamond Therapeutics, Inc.
LEAN BEAR
-24
NTHI
$90M
Neonc Technologies Holdings, Inc.
LEAN BEAR
-24
SGMOQ
$50M
Sangamo Therapeutics, Inc.
LEAN BEAR
-24
PZRXQ
—
PhaseRx, Inc.
LEAN BEAR
-24
RNAZ
—
TransCode Therapeutics, Inc.
LEAN BEAR
-24
REPCF
—
RepliCel Life Sciences Inc.
LEAN BEAR
-24
NNBP
—
Nanobac Pharmaceuticals, Incorporated
LEAN BEAR
-24
NNLX
—
NanoLogix, Inc.
LEAN BEAR
-24
CLAZF
—
Claritas Pharmaceuticals, Inc.
LEAN BEAR
-24
GWIN
$360M
Glorywin Entertainment Group, Inc.
LEAN BEAR
-25
FGHQF
$360M
Frontage Holdings Corporation
LEAN BEAR
-25
KNTPF
$120M
Kintor Pharmaceutical Limited
LEAN BEAR
-25
HUMA
$120M
Humacyte, Inc.
LEAN BEAR
-25
LVCLF
$20M
Algorae Pharmaceuticals Limited
LEAN BEAR
-25
BCLI
$10M
Brainstorm Cell Therapeutics Inc.
LEAN BEAR
-25
ENGNW
$10M
enGene Holdings Inc. Warrants
LEAN BEAR
-25
FORU
—
ForU Holdings, Inc.
LEAN BEAR
-25
CHNXF
—
ChitogenX Inc.
LEAN BEAR
-25
HLSQ
—
Tessera Defense and Homeland Security Inc
LEAN BEAR
-25
JUNS
—
Jupiter Neurosciences, Inc.
LEAN BEAR
-25
CMND
—
Clearmind Medicine Inc.
LEAN BEAR
-25
VINC
—
Vincerx Pharma, Inc.
LEAN BEAR
-25
NURPF
$1.8B
Neuren Pharmaceuticals Limited
LEAN BEAR
-26
CUBT
—
Curative Biotechnology, Inc.
LEAN BEAR
-26
NRXP
$110M
NRx Pharmaceuticals, Inc.
LEAN BEAR
-27
CNTN
$150M
Canton Strategic Holdings Inc
LEAN BEAR
-28
CNSP
$10M
CNS Pharmaceuticals, Inc.
LEAN BEAR
-28
ADRX
$1.9B
ADARx Pharmaceuticals, Inc.
LEAN BEAR
-29
ANNX
$610M
Annexon, Inc.
BEARISH
-30
IMA
$50M
ImageneBio Inc
BEARISH
-30
GLUE
$920M
Monte Rosa Therapeutics, Inc.
BEARISH
-31
SANA
$700M
Sana Biotechnology, Inc.
BEARISH
-31
OCS
$490M
Oculis Holding AG
BEARISH
-31
RLMD
$350M
Relmada Therapeutics, Inc.
BEARISH
-31
IBO
$30M
Impact BioMedical Inc.
BEARISH
-31
LTRN
$10M
Lantern Pharma Inc.
BEARISH
-31
KZIA
$10M
Kazia Therapeutics Ltd ADR
BEARISH
-31
ADAPY
$10M
Adaptimmune Therapeutics plc
BEARISH
-31
ALLR
$10M
Allarity Therapeutics, Inc.
BEARISH
-31
PBMWW
—
Psyence Biomedical Ltd. Warrant
BEARISH
-31
LIPO
—
Lipella Pharmaceuticals Inc.
BEARISH
-31
TRVN
—
Trevena, Inc.
BEARISH
-31
PKTX
—
ProtoKinetix, Incorporated
BEARISH
-31
IMMB
—
Immunotech Laboratories, Inc.
BEARISH
-31
ALLO
$430M
Allogene Therapeutics, Inc.
BEARISH
-32
PMVP
$70M
PMV Pharmaceuticals, Inc.
BEARISH
-32
SPRO
$60M
Spero Therapeutics, Inc.
BEARISH
-32
SNANF
$20M
Sona Nanotech Inc.
BEARISH
-32
SNTI
$10M
Senti Biosciences, Inc.
BEARISH
-32
IMUC
$10M
EOM Pharmaceuticals Holdings, Inc.
BEARISH
-32
HTDS
—
Hard to Treat Diseases Inc.
BEARISH
-32
AAPG
$1.4B
Ascentage Pharma Group International
BEARISH
-33
SNBIF
$1.3B
SanBio Company Limited
BEARISH
-33
SLGL
$230M
Sol-Gel Technologies Ltd.
BEARISH
-33
APLMW
$170M
Apollomics, Inc.
BEARISH
-33
MRKR
$20M
Marker Therapeutics, Inc.
BEARISH
-33
VRCI
—
Verde Science, Inc.
BEARISH
-33
NTII
—
Neurobiological Technologies, Inc.
BEARISH
-33
IBOGF
—
Universal Ibogaine Inc.
BEARISH
-33
RGIN
—
Regenicin, Inc.
BEARISH
-33
GLSHQ
—
Gelesis Holdings, Inc.
BEARISH
-33
HAVLF
—
HAVN Life Sciences Inc.
BEARISH
-33
TLOG
—
TetraLogic Pharmaceuticals Corporation
BEARISH
-33
PSYBF
—
PsyBio Therapeutics Corp
BEARISH
-33
MAJI
—
Nextel Medical Corp.
BEARISH
-33
GRI
—
GRI Bio, Inc.
BEARISH
-33
MRZM
—
Marizyme, Inc.
BEARISH
-33
BPMUF
$960M
Basilea Pharmaceutica AG
BEARISH
-34
AKBA
$160M
Akebia Therapeutics, Inc.
BEARISH
-34
ATRA
$90M
Atara Biotherapeutics, Inc.
BEARISH
-34
SYGGF
—
Synairgen plc
BEARISH
-34
BTAX
—
Biostax Corp.
BEARISH
-34
CLYM
$590M
Climb Bio, Inc.
BEARISH
-35
MNPR
$470M
Monopar Therapeutics Inc.
BEARISH
-35
ATGGF
$140M
Actinogen Medical Limited
BEARISH
-35
BVAXF
—
BioVaxys Technology Corp.
BEARISH
-35
SQZB
—
SQZ Biotechnologies Company
BEARISH
-35
VOGX
$260M
Vogenx Inc.
BEARISH
-36
MEOBF
$2.0B
Mesoblast Limited
BEARISH
-37
MLYS
$1.8B
Mineralys Therapeutics, Inc.
BEARISH
-40
IMTX
$1.1B
Immatics N.V.
BEARISH
-40
AKTS
$850M
Aktis Oncology, Inc.
BEARISH
-40
ATTO
$630M
Attovia Therapeutics, Inc.
BEARISH
-40
OLMA
$560M
Olema Pharmaceuticals, Inc.
BEARISH
-40
BNTC
$300M
Benitec Biopharma Inc.
BEARISH
-40
TARA
$140M
Protara Therapeutics, Inc.
BEARISH
-40
OTLK
$130M
Outlook Therapeutics, Inc.
BEARISH
-40
AKTX
$20M
Akari Therapeutics, Plc
BEARISH
-40
NCNA
$10M
NuCana plc
BEARISH
-40
LIFS
—
Life Stem Genetics Inc.
BEARISH
-40
RLFTY
—
MindMaze Therapeutics Holding S.A.
BEARISH
-40
LGVN
—
Longeveron Inc.
BEARISH
-40
JAGX
—
Jaguar Health, Inc.
BEARISH
-40
DRMA
—
Dermata Therapeutics, Inc.
BEARISH
-40
ITMC
—
Itoco Inc.
BEARISH
-40
GBLX
—
GB Sciences, Inc.
BEARISH
-40
GNLX
$90M
Genelux Corporation
BEARISH
-41
ERNA
—
Ernexa Therapeutics Inc.
BEARISH
-41
AAGH
—
America Great Health
BEARISH
-41
MRES
—
Institute of Biomedical Research Corp.
BEARISH
-41
CSPHF
$1.4B
CStone Pharmaceuticals
BEARISH
-42
DRTSW
$1.2B
Alpha Tau Medical Ltd.
BEARISH
-42
XCUR
$10M
Exicure, Inc.
BEARISH
-42
PRVCF
$10M
PreveCeutical Medical Inc.
BEARISH
-42
LSTA
$10M
Lisata Therapeutics, Inc.
BEARISH
-42
ERNAW
—
Ernexa Therapeutics Inc. Warrants
BEARISH
-42
PROT
—
Proteonomix, Inc.
BEARISH
-42
NBIO
—
Nascent Biotech, Inc.
BEARISH
-42
RNUGF
—
ReNeuron Group plc
BEARISH
-42
PFND
—
Pathfinder Cell Therapy, Inc.
BEARISH
-42
CDXI
—
Cardax, Inc.
BEARISH
-42
ADYX
—
Adynxx, Inc.
BEARISH
-42
PANC
—
Panacos Pharmaceuticals, Inc.
BEARISH
-42
SYVC
—
Synovics Pharmaceuticals, Inc.
BEARISH
-42
GHRS
$1.2B
GH Research PLC
BEARISH
-43
DSGN
$640M
Design Therapeutics, Inc.
BEARISH
-43
TENX
$50M
Tenax Therapeutics, Inc.
BEARISH
-43
HNSBF
$330M
Hansa Biopharma AB (publ)
BEARISH
-44
VICP
$10M
Vicapsys Life Sciences, Inc.
BEARISH
-44
ANTH
—
Anthera Pharmaceuticals, Inc.
BEARISH
-44
PLYX
$90M
Polaryx Therapeutics, Inc. Common Stock
BEARISH
-46
CASIF
—
CASI Pharmaceuticals, Inc.
BEARISH
-46
IDRSF
$1.4B
Idorsia Ltd
BEARISH
-47
VBIZF
$400M
Viva Biotech Holdings
BEARISH
-47
SYRS
—
Syros Pharmaceuticals, Inc.
BEARISH
-47
FPMI
—
FluoroPharma Medical, Inc.
BEARISH
-47
CASBF
$1.4B
CanSino Biologics Inc.
BEARISH
-48
CRVS
$890M
Corvus Pharmaceuticals, Inc.
BEARISH
-48
NKTR
$1.1B
Nektar Therapeutics
BEARISH
-49
RGNX
$440M
REGENXBIO Inc.
BEARISH
-49
BLSM
$430M
BlossomHill Therapeutics, Inc.
BEARISH
-49
TECX
$390M
Tectonic Therapeutic, Inc.
BEARISH
-49
IPSC
$260M
Century Therapeutics, Inc.
BEARISH
-49
NAGE
$190M
Niagen Bioscience Inc
BEARISH
-49
MAIA
$70M
MAIA Biotechnology, Inc.
BEARISH
-49
HMTXF
$10M
Hemostemix Inc.
BEARISH
-49
SCPS
—
Scopus BioPharma Inc.
BEARISH
-49
BITRF
—
Biotron Limited
BEARISH
-49
THER
—
Theralink Technologies, Inc.
BEARISH
-49
CVKD
—
Cadrenal Therapeutics, Inc. Common Stock
BEARISH
-49
MLECW
—
Moolec Science S.A.
BEARISH
-49
VIVS
—
VivoSim Labs, Inc.
BEARISH
-49
PPTDF
$870M
PeptiDream Inc.
BEARISH
-50
SPHRY
$220M
Starpharma Holdings Limited
BEARISH
-50
HRGN
$30M
Harvard Apparatus Regenerative Technology Inc.
BEARISH
-50
LPCN
$10M
Lipocine Inc.
BEARISH
-50
BRAXF
—
Braxia Scientific Corp.
BEARISH
-50
SIGY
—
Sigyn Therapeutics, Inc.
BEARISH
-50
VRPX
—
Virpax Pharmaceuticals, Inc.
BEARISH
-50
VRAX
—
Virax Biolabs Group Limited
BEARISH
-50
ATXI
—
Avenue Therapeutics, Inc.
BEARISH
-50
SCNI
—
Scinai Immunotherapeutics Ltd.
BEARISH
-50
CALA
—
Calithera Biosciences, Inc.
BEARISH
-51
ANRO
$860M
Alto Neuroscience, Inc.
BEARISH
-52
ABUS
$830M
Arbutus Biopharma Corp
BEARISH
-52
HOPHF
$20M
Hemogenyx Pharmaceuticals Plc
BEARISH
-52
NUVB
$1.6B
Nuvation Bio Inc.
BEARISH
-53
AUTL
$410M
Autolus Therapeutics plc
BEARISH
-53
PLX
$210M
Protalix BioTherapeutics, Inc.
BEARISH
-53
RLYB
$90M
Rallybio Corporation
BEARISH
-53
ALZN
$10M
Alzamend Neuro Inc
BEARISH
-53
AFFY
—
Affymax, Inc.
BEARISH
-53
OCUL
$1.4B
Ocular Therapeutix, Inc.
BEARISH
-56
LRMR
$240M
Larimar Therapeutics, Inc.
BEARISH
-56
LXEO
$230M
Lexeo Therapeutics, Inc. Common Stock
BEARISH
-56
MENS
$130M
Jyong Biotech Ltd. Ordinary Shares
BEARISH
-56
ADAG
$90M
Adagene Inc.
BEARISH
-56
WINT
—
Windtree Therapeutics, Inc.
BEARISH
-56
SILO
—
Silo Pharma, Inc.
BEARISH
-56
OMER
$1.2B
Omeros Corporation
BEARISH
-58
AVBP
$1.0B
ArriVent BioPharma, Inc.
BEARISH
-58
EPRX
$450M
Eupraxia Pharmaceuticals Inc.
BEARISH
-58
CABA
$250M
Cabaletta Bio, Inc.
BEARISH
-58
ARMP
$140M
Armata Pharmaceuticals, Inc.
BEARISH
-58
VRXA
$140M
Veraxa Biotech Holding AG
BEARISH
-58
UNCY
$110M
Unicycive Therapeutics, Inc.
BEARISH
-58
INO
$60M
Inovio Pharmaceuticals, Inc.
BEARISH
-58
VERU
$40M
Veru Inc.
BEARISH
-58
ANVS
$40M
Annovis Bio, Inc.
BEARISH
-58
SEOVF
$30M
Sernova Corp.
BEARISH
-58
DVHGF
$20M
Devonian Health Group, Inc.
BEARISH
-58
DYAI
$20M
Dyadic International, Inc.
BEARISH
-58
BIORQ
—
Biora Therapeutics, Inc.
BEARISH
-58
ATRX
—
Adhera Therapeutics Inc
BEARISH
-58
SXTP
—
60 Degrees Pharmaceuticals, Inc.
BEARISH
-58
EVGN
—
Evogene Ltd.
BEARISH
-58
BLEG
—
Branded Legacy, Inc.
BEARISH
-58
CRIS
—
Curis, Inc.
BEARISH
-58
AMPE
—
Ampio Pharmaceuticals, Inc.
BEARISH
-58
ORIC
$1.4B
ORIC Pharmaceuticals, Inc.
BEARISH
-59
KPRX
$10M
Kiora Pharmaceuticals, Inc.
BEARISH
-59
BCTXZ
—
BriaCell Therapeutics Corp. Warrant
BEARISH
-59
RAPP
$1.2B
Rapport Therapeutics, Inc. Common Stock
BEARISH
-60
DRTS
$1.2B
Alpha Tau Medical Ltd
BEARISH
-60
MGTX
$880M
MeiraGTx Holdings plc
BEARISH
-60
ORMP
$170M
Oramed Pharmaceuticals Inc.
BEARISH
-60
BRIBF
$90M
Brii Biosciences Limited
BEARISH
-60
ELOX
$40M
Eloxx Pharmaceuticals, Inc.
BEARISH
-60
SYBX
$10M
Synlogic, Inc.
BEARISH
-60
FBIOP
$130M
Fortress Biotech, Inc.
BEARISH
-62
ORGS
—
Orgenesis Inc.
BEARISH
-62
AVLN
$1.1B
Avalyn Pharma Inc. Common Stock
BEARISH
-65
APMD
$790M
Apnimed, Inc.
BEARISH
-65
CBIO
$480M
Crescent Biopharma, Inc.
BEARISH
-65
KYTX
$330M
Kyverna Therapeutics, Inc.
BEARISH
-65
MIST
$80M
Milestone Pharmaceuticals Inc.
BEARISH
-65
RECEF
$70M
Recce Pharmaceuticals Ltd
BEARISH
-65
TELO
$70M
Telomir Pharmaceuticals, Inc. Common Stock
BEARISH
-65
NMRA
$70M
Neumora Therapeutics, Inc. Common Stock
BEARISH
-65
CNTB
$50M
Connect Biopharma Holdings Limited
BEARISH
-65
CVM
$30M
CEL-SCI Corporation
BEARISH
-65
ARTL
$10M
Artelo Biosciences, Inc.
BEARISH
-65
FNAM
—
Evolutionary Genomics, Inc.
BEARISH
-65
SYBE
—
SYBLEU Inc
BEARISH
-65
RGRX
—
RegeneRx Biopharmaceuticals, Inc.
BEARISH
-65
BICTF
—
Biocure Technology Inc.
BEARISH
-65
GERN
$720M
Geron Corporation
BEARISH
-66
ZVRA
$580M
Zevra Therapeutics, Inc.
BEARISH
-66
PHAT
$460M
Phathom Pharmaceuticals, Inc.
BEARISH
-66
FTH
$440M
Faeth Therapeutics, Inc.
BEARISH
-66
CLVLF
$250M
Clinuvel Pharmaceuticals Limited
BEARISH
-66
UPB
$150M
Upstream Bio, Inc.
BEARISH
-66
CUE
$140M
Cue Biopharma, Inc.
BEARISH
-66
LENZ
$100M
LENZ Therapeutics, Inc.
BEARISH
-66
ACRV
$70M
Acrivon Therapeutics, Inc. Common Stock
BEARISH
-66
NDTP
$50M
NDT Pharmaceuticals Inc.
BEARISH
-66
INNMF
$30M
Amplia Therapeutics Limited
BEARISH
-66
RVXCF
$20M
Resverlogix Corp.
BEARISH
-66
DTCFF
$20M
Defence Therapeutics Inc.
BEARISH
-66
OTLC
$10M
Oncotelic Therapeutics, Inc.
BEARISH
-66
ICU
$10M
SeaStar Medical Holding Corporation
BEARISH
-66
INTS
$10M
Intensity Therapeutics, Inc.
BEARISH
-66
PLRZ
$10M
Polyrizon Ltd.
BEARISH
-66
PHIO
$10M
Phio Pharmaceuticals Corp.
BEARISH
-66
CDT
—
CDT Equity Inc.
BEARISH
-66
APUS
—
Apimeds Pharmaceuticals US, Inc
BEARISH
-66
ADTX
—
Aditxt, Inc.
BEARISH
-66
AMBS
—
Amarantus BioScience Holdings, Inc.
BEARISH
-66
YECO
—
EV Biologics, Inc.
BEARISH
-66
BRTX
—
BioRestorative Therapies, Inc.
BEARISH
-66
AFMDQ
—
Affimed N.V.
BEARISH
-66
SPRC
—
SciSparc Ltd.
BEARISH
-66
MTNB
—
Matinas BioPharma Holdings, Inc.
BEARISH
-66
AGNPF
—
Grey Matters Health Inc.
BEARISH
-66
VBIO
—
Valion Bio, Inc.
BEARISH
-66
RGBPP
—
Regen BioPharma, Inc.
BEARISH
-66
NVAX
$1.6B
Novavax, Inc.
BEARISH
-69
PRQR
$180M
ProQR Therapeutics N.V.
BEARISH
-69
AMGXF
$140M
AnGes, Inc.
BEARISH
-69
BBIXF
$50M
Bonus BioGroup Ltd.
BEARISH
-69
INTI
$10M
Inhibitor Therapeutics, Inc.
BEARISH
-69
MYMX
—
Mymetics Corporation
BEARISH
-69
NWPHF
$410M
Newron Pharmaceuticals S.p.A.
BEARISH
-71
VRXAW
—
Veraxa Biotech AG
BEARISH
-71
SRNE
—
Sorrento Therapeutics, Inc.
BEARISH
-73
SNDX
$1.2B
Syndax Pharmaceuticals, Inc.
BEARISH
-74
CTMX
$510M
CytomX Therapeutics, Inc.
BEARISH
-74
ASMB
$400M
Assembly Biosciences, Inc.
BEARISH
-74
MPLT
$340M
MapLight Therapeutics, Inc.
BEARISH
-74
CTNM
$270M
Contineum Therapeutics, Inc.
BEARISH
-74
ABEO
$250M
Abeona Therapeutics Inc.
BEARISH
-74
CRBU
$60M
Caribou Biosciences, Inc.
BEARISH
-74
IBIO
$50M
iBio, Inc.
BEARISH
-74
CLRB
$10M
Cellectar Biosciences, Inc.
BEARISH
-74
AIM
$10M
AIM ImmunoTech Inc.
BEARISH
-74
BTAIQ
—
BioXcel Therapeutics, Inc.
BEARISH
-74
ASCLF
$770M
Ascletis Pharma Inc.
BEARISH
-75
ACHV
$670M
Achieve Life Sciences, Inc.
BEARISH
-75
NVCT
$650M
Nuvectis Pharma, Inc.
BEARISH
-75
IRD
$290M
Opus Genetics, Inc.
BEARISH
-75
PALI
$230M
Palisade Bio, Inc.
BEARISH
-75
GALT
$210M
Galectin Therapeutics Inc.
BEARISH
-75
MGNX
$140M
MacroGenics, Inc.
BEARISH
-75
SEER
$110M
Seer, Inc.
BEARISH
-75
COYA
$90M
Coya Therapeutics, Inc.
BEARISH
-75
MNOV
$70M
MediciNova, Inc.
BEARISH
-75
OSTX
$60M
OS Therapies Incorporated
BEARISH
-75
HRTX
$60M
Heron Therapeutics, Inc.
BEARISH
-75
XLO
$50M
Xilio Therapeutics, Inc.
BEARISH
-75
GANX
$50M
Gain Therapeutics, Inc.
BEARISH
-75
ALPS
$50M
Alps Group Inc
BEARISH
-75
MREO
$40M
Mereo BioPharma Group plc
BEARISH
-75
DWTX
$40M
Dogwood Therapeutics, Inc.
BEARISH
-75
PVCT
$20M
Provectus Biopharmaceuticals, Inc.
BEARISH
-75
COCP
$20M
Cocrystal Pharma, Inc.
BEARISH
-75
IMRN
$10M
Immuron Limited
BEARISH
-75
PHYOF
$10M
IXICO plc
BEARISH
-75
PASG
$10M
Passage Bio, Inc.
BEARISH
-75
GLWLF
$10M
Glow Lifetech Corp.
BEARISH
-75
EVLO
—
Evelo Biosciences, Inc.
BEARISH
-75
ISCO
—
International Stem Cell Corporation
BEARISH
-75
HMGN
—
Hemagen Diagnostics, Inc.
BEARISH
-75
RCAR
—
RenovaCare, Inc.
BEARISH
-75
ELAB
—
PMGC Holdings Inc.
BEARISH
-75
CHMMF
—
Chimeric Therapeutics Limited
BEARISH
-75
LIANY
—
LianMedical
BEARISH
-75
VCNX
—
Vaccinex, Inc.
BEARISH
-75
AXIM
—
AXIM Biotechnologies, Inc.
BEARISH
-75
LNAI
—
Lunai Bioworks Inc.
BEARISH
-75
IMMX
$680M
Immix Biopharma, Inc.
BEARISH
-78
LXRX
$630M
Lexicon Pharmaceuticals, Inc.
BEARISH
-78
CADL
$610M
Candel Therapeutics, Inc.
BEARISH
-78
MDXG
$570M
MiMedx Group, Inc.
BEARISH
-78
AVIR
$320M
Atea Pharmaceuticals, Inc.
BEARISH
-78
IKT
$220M
Inhibikase Therapeutics, Inc.
BEARISH
-78
INMB
$40M
INmune Bio, Inc.
BEARISH
-78
BMEA
$40M
Biomea Fusion, Inc.
BEARISH
-78
CELU
$30M
Celularity Inc.
BEARISH
-78
AVEFF
$20M
Avecho Biotechnology Limited
BEARISH
-78
SER
$20M
Serina Therapeutics, Inc.
BEARISH
-78
CMMB
$10M
Chemomab Therapeutics Ltd.
BEARISH
-78
CPMV
—
Mosaic ImmunoEngineering Inc.
BEARISH
-78
XRTX
—
XORTX Therapeutics Inc.
BEARISH
-78
OZYMF
—
Strategic Partners A/S
BEARISH
-78
GNLKQ
—
GeneLink, Inc.
BEARISH
-78
GLABF
—
Gemina Laboratories Ltd.
BEARISH
-78
PBM
—
Psyence Biomedical Ltd.
BEARISH
-78
HXBM
—
Helix BioMedix, Inc.
BEARISH
-78
KRSA
$150M
Korsana Biosciences, Inc.
BEARISH
-80
HBMHF
$1.3B
HBM Holdings Limited
BEARISH
-82
GPCR
$1.2B
Structure Therapeutics Inc.
BEARISH
-82
ARDX
$770M
Ardelyx, Inc.
BEARISH
-82
SLBT
$640M
SL Science Holding Ltd
BEARISH
-82
PROK
$470M
ProKidney Corp.
BEARISH
-82
ACIU
$250M
AC Immune S.A.
BEARISH
-82
BOVNF
$220M
BioInvent International AB (publ)
BEARISH
-82
BBOT
$210M
BridgeBio Oncology Therapeutics Inc.
BEARISH
-82
IVVD
$180M
Invivyd, Inc.
BEARISH
-82
SION
$160M
Sionna Therapeutics, Inc.
BEARISH
-82
CBUS
$110M
Cibus, Inc.
BEARISH
-82
VYGR
$110M
Voyager Therapeutics, Inc.
BEARISH
-82
VXRT
$100M
Vaxart, Inc.
BEARISH
-82
ENGN
$100M
enGene Holdings Inc.
BEARISH
-82
TNYA
$90M
Tenaya Therapeutics, Inc.
BEARISH
-82
HBPCF
$60M
Helix BioPharma Corp.
BEARISH
-82
PLRX
$50M
Pliant Therapeutics, Inc.
BEARISH
-82
KLRS
$40M
Kalaris Therapeutics Inc
BEARISH
-82
ALGS
$30M
Aligos Therapeutics, Inc.
BEARISH
-82
BYSI
$20M
BeyondSpring Inc.
BEARISH
-82
NEUP
$20M
Neuphoria Therapeutics Inc.
BEARISH
-82
PRRUF
$20M
Immutep Limited
BEARISH
-82
QNRX
$10M
Quoin Pharmaceuticals, Ltd.
BEARISH
-82
MSLE
$10M
Satellos Bioscience Inc.
BEARISH
-82
ANEB
$10M
Anebulo Pharmaceuticals, Inc.
BEARISH
-82
TCRX
$10M
TScan Therapeutics, Inc.
BEARISH
-82
FBLG
$10M
FibroBiologics, Inc. Common Stock
BEARISH
-82
CDIO
$10M
Cardio Diagnostics Holdings, Inc.
BEARISH
-82
APRE
$10M
Aprea Therapeutics, Inc.
BEARISH
-82
BCDA
$10M
BioCardia, Inc.
BEARISH
-82
HCWB
—
HCW Biologics Inc.
BEARISH
-82
USRM
—
U.S. Stem Cell, Inc.
BEARISH
-82
ARNI
—
Arno Therapeutics, Inc.
BEARISH
-82
ENZC
—
Enzolytics Inc.
BEARISH
-82
EVFM
—
Evofem Biosciences, Inc.
BEARISH
-82
BBLG
—
Bone Biologics Corporation
BEARISH
-82
MBIO
—
Mustang Bio, Inc.
BEARISH
-82
LIMN
—
Liminatus Pharma, Inc. Class A Common Stock
BEARISH
-82
BIOAF
—
Bioasis Technologies Inc.
BEARISH
-82
NCEL
—
NewcelX Ltd.
BEARISH
-82
SEPSF
—
Asep Medical Holdings Inc
BEARISH
-82
ENLV
—
Enlivex Therapeutics Ltd.
BEARISH
-82
ENDV
—
Endonovo Therapeutics, Inc.
BEARISH
-82
ARUXF
—
Acrux Limited
BEARISH
-82
MYNDF
—
MYND Life Sciences Inc.
BEARISH
-82
INBX
$1.4B
Inhibrx Biosciences Inc.
BEARISH
-84
SKYE
$10M
Skye Bioscience, Inc.
BEARISH
-84
PTIX
—
Protagenic Therapeutics, Inc.
BEARISH
-84
EMMA
—
Emmaus Life Sciences, Inc.
BEARISH
-84
PHRRF
—
PharmaTher Holdings Ltd.
BEARISH
-84
LIMNW
—
Liminatus Pharma, Inc. Warrants
BEARISH
-84
URGN
$1.7B
UroGen Pharma Ltd.
BEARISH
-87
MDCLF
$1.1B
MedinCell S.A.
BEARISH
-87
ANL
$560M
Adlai Nortye Ltd.
BEARISH
-87
GNFTF
$470M
Genfit S.A.
BEARISH
-87
ARTV
$300M
Artiva Biotherapeutics, Inc.
BEARISH
-87
TRGNF
$120M
Transgene S.A.
BEARISH
-87
PRNAF
$50M
Alterity Therapeutics Limited
BEARISH
-87
TVGN
$30M
Tevogen Bio Holdings Inc.
BEARISH
-87
BMNDF
$20M
Biomind Labs Inc.
BEARISH
-87
RMTG
—
Regenerative Medical Technology Group Inc.
BEARISH
-87
GENSF
$1.8B
Genus plc
BEARISH
-91
AGMB
$450M
AgomAb Therapeutics N.V. American Depositary Shares
BEARISH
-91
AVCTF
$420M
Avacta Group Plc
BEARISH
-91
ALT
$410M
Altimmune, Inc.
BEARISH
-91
AVTX
$370M
Avalo Therapeutics, Inc.
BEARISH
-91
CAPR
$340M
Capricor Therapeutics, Inc.
BEARISH
-91
SPHDF
$280M
Santhera Pharmaceuticals Holding AG
BEARISH
-91
ORYZF
$250M
Oryzon Genomics S.A.
BEARISH
-91
OCGN
$250M
Ocugen, Inc.
BEARISH
-91
SCTX
$250M
Scribe Therapeutics Inc.
BEARISH
-91
HLOSF
$240M
Healios K.K.
BEARISH
-91
IPHYF
$210M
Innate Pharma S.A.
BEARISH
-91
NBP
$160M
NovaBridge Biosciences
BEARISH
-91
ZNTL
$160M
Zentalis Pharmaceuticals, Inc.
BEARISH
-91
STRO
$150M
Sutro Biopharma, Inc.
BEARISH
-91
NGEN
$150M
NervGen Pharma Corp. Common stock
BEARISH
-91
CMPX
$140M
Compass Therapeutics, Inc.
BEARISH
-91
CDXS
$140M
Codexis, Inc.
BEARISH
-91
NKTX
$130M
Nkarta, Inc.
BEARISH
-91
AVXL
$120M
Anavex Life Sciences Corp.
BEARISH
-91
VTVT
$100M
vTv Therapeutics Inc.
BEARISH
-91
VANI
$100M
Vivani Medical, Inc.
BEARISH
-91
ORPOF
$100M
OSE Immunotherapeutics S.A.
BEARISH
-91
TNXP
$90M
Tonix Pharmaceuticals Holding Corp.
BEARISH
-91
CNXU
$90M
Conexeu Sciences Inc.
BEARISH
-91
JWCTF
$80M
JW (Cayman) Therapeutics Co. Ltd
BEARISH
-91
CRBP
$80M
Corbus Pharmaceuticals Holdings, Inc.
BEARISH
-91
CRDF
$70M
Cardiff Oncology, Inc.
BEARISH
-91
PTHS
$70M
Pelthos Therapeutics Inc.
BEARISH
-91
CGTX
$70M
Cognition Therapeutics, Inc.
BEARISH
-91
XBIT
$60M
XBiotech Inc.
BEARISH
-91
TLSA
$60M
Tiziana Life Sciences Ltd
BEARISH
-91
VTIAF
$50M
FamiCord AG
BEARISH
-91
HYFT
$50M
MindWalk Holdings Corp.
BEARISH
-91
EXOZ
$40M
eXoZymes, Inc.
BEARISH
-91
ACET
$40M
Adicet Bio, Inc.
BEARISH
-91
RANI
$40M
Rani Therapeutics Holdings, Inc.
BEARISH
-91
ALDX
$40M
Aldeyra The
BEARISH
-91
IXHL
$30M
Incannex Healthcare Limited
BEARISH
-91
AARD
$30M
Aardvark Therapeutics, Inc. Common Stock
BEARISH
-91
BCTX
$30M
BriaCell Therapeutics Corp.
BEARISH
-91
FLNA
$30M
Filana Therapeutics, Inc.
BEARISH
-91
MGX
$30M
Metagenomi, Inc. Common Stock
BEARISH
-91
KYNB
$20M
Kyntra Bio, Inc.
BEARISH
-91
MVMDF
$20M
More Life Company Corp.
BEARISH
-91
TELIF
$20M
Telescope Innovations Corp.
BEARISH
-91
MCRB
$20M
Seres Therapeutics, Inc.
BEARISH
-91
ATYR
$20M
aTyr Pharma, Inc.
BEARISH
-91
TRAW
$10M
Traws Pharma, Inc.
BEARISH
-91
TOVX
$10M
Theriva Biologics, Inc.
BEARISH
-91
PTN
$10M
Palatin Technologies, Inc.
BEARISH
-91
GUTS
$10M
Fractyl Health, Inc.
BEARISH
-91
VTGN
$10M
VistaGen Therapeutics, Inc.
BEARISH
-91
OPTBF
$10M
OptiBiotix Health Plc
BEARISH
-91
TPST
$10M
Tempest Therapeutics, Inc.
BEARISH
-91
INAB
$10M
IN8bio, Inc.
BEARISH
-91
QNTM
$10M
Quantum BioPharma Ltd.
BEARISH
-91
IMNN
$10M
Imunon, Inc.
BEARISH
-91
GTBP
$10M
GT Biopharma, Inc.
BEARISH
-91
TVRD
$10M
Tvardi Therapeutics, Inc.
BEARISH
-91
PXXLF
$10M
Poxel S.A.
BEARISH
-91
DARE
$10M
Dare Bioscience, Inc.
BEARISH
-91
HIND
$10M
Vyome Holdings, Inc.
BEARISH
-91
GSGTF
$10M
GenSight Biologics S.A.
BEARISH
-91
OGEN
—
Oragenics, Inc.
BEARISH
-91
GSTC
—
GlobeStar Therapeutics Corporation
BEARISH
-91
SUVZ
—
Suvanza Pharma, LLC
BEARISH
-91
LABT
—
Lakewood-Amedex Biotherapeutics, Inc.
BEARISH
-91
RADX
—
Radiopharm Theranostics Limited
BEARISH
-91
MBAI
—
MBody AI Ltd.
BEARISH
-91
EFTR
—
eFFECTOR Therapeutics, Inc.
BEARISH
-91
DCOY
—
Decoy Therapeutics Inc.
BEARISH
-91
RASP
—
Actavia Life Sciences, Inc.
BEARISH
-91
CLDI
—
Calidi Biotherapeutics, Inc.
BEARISH
-91
GNPX
—
Genprex, Inc.
BEARISH
-91
KALA
—
KALA BIO, Inc.
BEARISH
-91
TSOI
—
Therapeutic Solutions International, Inc.
BEARISH
-91
WSNAF
—
Wesana Health Holdings Inc.
BEARISH
-91
CEROW
—
CERo Therapeutics Holdings, Inc.
BEARISH
-91
NBRVF
—
Nabriva Therapeutics plc
BEARISH
-91
BNIGF
—
Beroni Group Limited
BEARISH
-91
SLXN
—
Silexion Therapeutics Ltd.
BEARISH
-91
ZVSA
—
ZyVersa Therapeutics, Inc.
BEARISH
-91
NIKI
—
Niki BioSolutions, Inc.
BEARISH
-91
BIXT
—
Bioxytran, Inc.
BEARISH
-91
GOVX
—
GeoVax Labs, Inc.
BEARISH
-91
TNGNQ
—
Tengion, Inc.
BEARISH
-91
XENO
—
Xeno Transplants Corporation
BEARISH
-91
ZHCLF
—
Zenith Capital Corp.
BEARISH
-91
MDCX
—
Medicus Pharma Ltd. Common Stock
BEARISH
-91
VPRO
—
Viropro Inc.
BEARISH
-91
PHMMF
$1.6B
Pharma Mar, S.A.
BEARISH
-100
BCAX
$1.1B
Bicara Therapeutics Inc. Common Stock
BEARISH
-100
IVEVF
$750M
Inventiva S.A.
BEARISH
-100
INRLF
$640M
Valneva SE
BEARISH
-100
SPRY
$400M
ARS Pharmaceuticals, Inc.
BEARISH
-100
EIKN
$390M
Eikon Therapeutics, Inc. Common Stock
BEARISH
-100
DMTRF
$310M
3-D Matrix, Ltd.
BEARISH
-100
NERV
$110M
Minerva Neurosciences, Inc.
BEARISH
-100
VRCA
$60M
Verrica Pharmaceuticals Inc.
BEARISH
-100
ONCY
$50M
Oncolytics Biotech Inc.
BEARISH
-100
EDSA
$30M
Edesa Biotech, Inc.
BEARISH
-100
EYPT
$30M
EyePoint Pharmaceuticals, Inc.
BEARISH
-100
NRXBF
$30M
NurExone Biologic Inc.
BEARISH
-100
IGC
$30M
IGC Pharma, Inc.
BEARISH
-100
CRVO
$30M
CervoMed Inc.
BEARISH
-100
BSEM
$30M
BioStem Technologies, Inc.
BEARISH
-100
CNTX
$20M
Context Therapeutics Inc.
BEARISH
-100
BXPHF
$20M
Botanix Pharmaceuticals Limited
BEARISH
-100
ACXP
$10M
Acurx Pharmaceuticals, Inc.
BEARISH
-100
RDTCF
$10M
Rapid Dose Therapeutics Corp.
BEARISH
-100
BLRX
$10M
BioLineRx Ltd.
BEARISH
-100
ACTU
$10M
Actuate Therapeutics Inc
BEARISH
-100
AIMD
$10M
Ainos, Inc.
BEARISH
-100
KTTA
$10M
Pasithea Therapeutics Corp.
BEARISH
-100
RVPH
$10M
Reviva Pharmaceuticals Holdings, Inc.
BEARISH
-100
MTVA
$10M
MetaVia Inc.
BEARISH
-100
CODX
—
Co-Diagnostics, Inc.
BEARISH
-100
NAVBQ
—
Navidea Biopharmaceuticals, Inc.
BEARISH
-100
HLUN
—
HEALTHeUNIVERSE, Inc.
BEARISH
-100
FAMDF
—
Futura Medical plc
BEARISH
-100
KAPA
—
Kairos Pharma, Ltd.
BEARISH
-100
APVO
—
Aptevo Therapeutics Inc.
BEARISH
-100
NSHSF
—
NanoSphere Health Sciences Inc.
BEARISH
-100
CANF
—
Can-Fite BioPharma Ltd.
BEARISH
-100
PPBT
—
Purple Biotech Ltd.
BEARISH
-100
BXRXQ
—
Baudax Bio, Inc.
BEARISH
-100
NRSN
—
NeuroSense Therapeutics Ltd.
BEARISH
-100
NMLSF
—
Restart Life Sciences Corp.
BEARISH
-100
ZLDAF
—
Zelira Therapeutics Limited
BEARISH
-100
PMCB
—
PharmaCyte Biotech, Inc.
BEARISH
-100
OXBOF
—
Oxford BioDynamics Plc
BEARISH
-100
CELZ
—
Creative Medical Technology Holdings, Inc.
BEARISH
-100
XSNX
—
NovAccess Global Inc.
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| VNDA Vanda Pharmaceuticals Inc. | $240M | -0.9 | -77.8 | -201.0 | -123.7 | 6.0 | 3 | BEARISH | -28.7 |
| SEPN Septerna Inc | $1.9B | -81.9 | -6.3 | -93.1 | -48.7 | 17878.5 | 5 | BULLISH | 95.6 |
| KLRA Kailera Therapeutics, Inc. | $1.7B | — | — | — | — | — | — | BULLISH | — |
| COAG Hemab Therapeutics Holdings, Inc. Common Stock | $1.6B | — | — | — | — | — | — | BULLISH | — |
| REPL Replimune Group, Inc. | $1.1B | -5.8 | -115.8 | -882.8 | — | — | 3 | BULLISH | 72.1 |
| RIGL Rigel Pharmaceuticals, Inc. | $900M | 2.9 | 126.9 | 88.5 | 22.0 | 3.3 | 4 | BULLISH | 71.5 |
| SOLTF Nxera Pharma Co., Ltd. | $770M | -16.4 | -12.0 | -1.7 | -2.6 | 7.5 | 4 | BULLISH | 38.2 |
| CRMD CorMedix Inc. | $610M | 3.4 | 54.9 | 57.2 | 25.5 | 280.5 | 5 | BULLISH | -25.8 |
| DMAC DiaMedica Therapeutics Inc. | $470M | -13.6 | -114.6 | 616.3 | — | — | 2 | BULLISH | 42.7 |
| SGMT Sagimet Biosciences Inc. | $310M | -8.4 | -24.4 | -231.4 | — | — | 3 | BULLISH | 24.9 |
| DTIL Precision BioSciences, Inc. | $180M | -2.7 | -135.1 | 203.1 | — | 3473.0 | 5 | BULLISH | 4.0 |
| MXCT MaxCyte, Inc. | $140M | -5.1 | -20.4 | -38.9 | -122.0 | -13.2 | 2 | BULLISH | 11.0 |
| PYPD PolyPid Ltd. | $110M | -3.9 | -1913.8 | 231.6 | — | — | 3 | BULLISH | 60.1 |
| ANIX Anixa Biosciences, Inc. | $100M | -11.0 | -67.1 | -1110.2 | — | — | 3 | BULLISH | -22.2 |
| NNVC NanoViricides, Inc. | $40M | -3.5 | -101.5 | -111.4 | — | — | 3 | BULLISH | -9.9 |
| VIR Vir Biotechnology, Inc. | $1.8B | -6.4 | -26.1 | -38.8 | 33.5 | 1495.9 | 5 | BULLISH | 92.7 |
| SGP SpyGlass Pharma, Inc. Common Stock | $950M | — | — | — | — | — | — | BULLISH | — |
| VSTM Verastem, Inc. | $910M | -4.0 | -471.2 | 6197.3 | -86.5 | 3995.7 | 4 | BULLISH | 12.8 |
| ATNM Actinium Pharmaceuticals, Inc. | $50M | 3.8 | 45.9 | -197.8 | 79.7 | — | 3 | BULLISH | -9.8 |
| GRDX GridAI Technologies Corp. | $40M | -1.3 | -55.6 | -51.7 | -14927.4 | 67.4 | 2 | BULLISH | 40.8 |
| MAZE Maze Therapeutics, Inc. | $1.7B | -11.6 | -37.3 | -112.3 | — | — | 3 | BULLISH | 2.4 |
| PRME Prime Medicine, Inc. | $670M | -4.9 | -373.3 | -271.3 | -3649.0 | -17.9 | 3 | BULLISH | 4.1 |
| XFOR X4 Pharmaceuticals, Inc. | $320M | -2.8 | -113.1 | -281.1 | -183.5 | -51.6 | 4 | BULLISH | -10.4 |
| LYEL Lyell Immunopharma, Inc. | $230M | -0.7 | -93.3 | -227.7 | -1118875.0 | -55.0 | 3 | BULLISH | -36.6 |
| ZIVO ZIVO Bioscience, Inc. | $20M | -5.2 | 185.9 | 147.5 | — | -62.5 | 2 | BULLISH | -50.1 |
| PVLA Palvella Therapeutics, Inc. | $1.8B | -30.5 | -46.6 | 137.5 | — | — | 3 | BULLISH | 109.4 |
| RARE Ultragenyx Pharmaceutical Inc. | $1.5B | -2.9 | 839.4 | -67.5 | -43.0 | 17.5 | 2 | BULLISH | -51.3 |
| OABIW OmniAb, Inc. | $1.1B | -14.7 | -16.9 | -16.8 | -43.7 | 66.9 | 6 | BULLISH | -14.0 |
| EDIT Editas Medicine, Inc. | $370M | -3.9 | -118.8 | 71.4 | -153.3 | 20.8 | 4 | BULLISH | -9.2 |
| INDP Indaptus Therapeutics, Inc. | $360M | -0.5 | -318.0 | 6437.4 | — | — | 4 | BULLISH | -6.2 |
| KRRO Korro Bio, Inc. | $180M | -1.4 | -97.7 | -196.6 | — | -62.1 | 2 | BULLISH | -65.0 |
| PCSA Processa Pharmaceuticals, Inc. | $10M | -0.3 | -464.2 | 1977.5 | — | — | 2 | BULLISH | -76.2 |
| IRLA IRulya Therapeutics Inc. | $30M | — | — | — | — | — | — | BULLISH | — |
| GENB Generate Biomedicines, Inc. | $1.6B | -9.1 | -28.2 | -175.0 | -1065.2 | — | 1 | BULLISH | — |
| RXRX Recursion Pharmaceuticals, Inc. | $2.0B | -4.2 | -56.6 | -99.7 | -1708.0 | -14.9 | 4 | BULLISH | -30.9 |
| CING Cingulate Inc. | $70M | -1.0 | -198.7 | -1452.8 | — | — | 4 | BULLISH | 39.6 |
| ESLA Estrella Immunopharma, Inc. | $40M | -3.3 | 148.1 | 102.1 | — | — | 3 | BULLISH | -64.0 |
| ABSI Absci Corporation | $1.6B | -14.8 | -57.7 | -213.1 | -10443.4 | -62.3 | 5 | BULLISH | 164.0 |
| TRAX First Tracks Biotherapeutics Inc | $1.6B | — | — | — | — | — | — | BULLISH | — |
| NTLA Intellia Therapeutics, Inc. | $1.6B | -4.0 | -55.4 | -92.1 | -1392.3 | 12.6 | 5 | BULLISH | -10.0 |
| LBRX LB Pharmaceuticals Inc Common Stock | $1.2B | -13.4 | -25.8 | -768.9 | — | — | 2 | BULLISH | 138.5 |
| ENTX Entera Bio Ltd. | $510M | -8.9 | -138.9 | 314.4 | — | -100.0 | 1 | BULLISH | 33.0 |
| KROS Keros Therapeutics, Inc. | $220M | -3.1 | -17.2 | -392.2 | — | -93.6 | 3 | BULLISH | -22.8 |
| HURA TuHURA Biosciences, Inc. | $140M | -3.7 | -161.4 | -137.6 | — | — | 2 | BULLISH | -13.5 |
| NRXS NeurAxis, Inc. | $90M | -9.8 | -143.2 | 464.1 | -118.1 | 65.2 | 6 | BULLISH | 143.4 |
| HOWL Werewolf Therapeutics, Inc. | $50M | -1.4 | -119.9 | 354.7 | 17.5 | — | 4 | BULLISH | -36.1 |
| PRLD Prelude Therapeutics Incorporated | $210M | -5.2 | -57.7 | 14236.3 | -244.1 | 220.3 | 5 | BULLISH | 142.1 |
| NAUT Nautilus Biotechnolgy, Inc. | $410M | -7.0 | -41.0 | -89.2 | -6682.1 | — | 2 | BULLISH | 137.8 |
| PRTA Prothena Corporation plc | $420M | -11.0 | -14.4 | -871.5 | -1839.9 | 427.3 | 5 | BULLISH | -12.2 |
| GLSI Greenwich LifeSciences, Inc. | $240M | -11.9 | -951.6 | 299.9 | — | — | 2 | BULLISH | 87.0 |
| SRPT Sarepta Therapeutics, Inc. | $1.9B | -13.4 | -9.5 | -6.3 | -1.2 | -20.4 | 4 | BULLISH | -17.8 |
| XNCR Xencor, Inc. | $1.9B | -13.8 | -29.1 | -152.4 | -42.4 | -36.1 | 2 | BULLISH | 110.2 |
| XERS Xeris Biopharma Holdings, Inc. | $1.9B | -109.6 | 118.2 | 18.3 | -33.8 | 36.3 | 6 | BULLISH | 14.3 |
| SPTX Seaport Therapeutics, Inc. Common Stock | $1.1B | — | — | — | — | — | — | BULLISH | — |
| SLN Silence Therapeutics plc | $930M | -5.2 | -90.4 | 157.8 | — | -97.6 | 1 | BULLISH | 176.1 |
| ADCT ADC Therapeutics S.A. | $180M | -2.4 | 45.3 | 260.9 | -86.1 | 2.0 | 2 | BULLISH | -62.2 |
| ICCC ImmuCell Corporation | $90M | 125.5 | 2.6 | 10.2 | 25.5 | 8.5 | 6 | BULLISH | 70.2 |
| ADIL Adial Pharmaceuticals, Inc. | $10M | -0.3 | -2011.6 | 159.6 | — | — | 3 | BULLISH | -43.0 |
| MBRX Moleculin Biotech, Inc. | $10M | -0.0 | -1371.6 | -494.1 | — | — | 3 | BULLISH | -27.8 |
| ABPO Abpro Holdings, Inc. | — | — | — | — | — | — | — | BULLISH | — |
| PDSB PDS Biotechnology Corporation | $60M | -2.4 | -544.0 | 456.9 | — | — | 1 | BULLISH | 62.8 |
| AGTX Agentix Corp. | — | -5.1 | 12.0 | 8.1 | — | — | 3 | BULLISH | 6.0 |
| NBTX Nanobiotix S.A. | $1.5B | -27.6 | 104.2 | 62.0 | -626.0 | 49.1 | 4 | BULLISH | 125.3 |
| MLTX MoonLake Immunotherapeutics | $1.0B | -3.2 | -67.4 | 2902.7 | — | — | 1 | BULLISH | 22.2 |
| PLUR Pluri Inc. | $10M | -0.5 | 163.6 | -483.9 | -1755.2 | -24.0 | 2 | BULLISH | -68.5 |
| BOLT Bolt Biotherapeutics, Inc. | $10M | -0.4 | -111.6 | -138.8 | -154400.0 | 12.8 | 3 | BULLISH | 5.5 |
| BDRX Biodexa Pharmaceuticals Plc | — | -77.8 | -42.3 | -117.9 | — | — | 2 | BULLISH | -88.9 |
| CBDG THC Farmaceuticals, Inc. | — | -30.9 | 2.0 | -0.9 | — | 28.1 | 5 | BULLISH | -63.1 |
| KNBIF Kane Biotech Inc. | — | -2.4 | 439.7 | -2166.6 | -10238.1 | -97.9 | 2 | BULLISH | -22.4 |
| STOK Stoke Therapeutics, Inc. | $1.6B | -7.9 | -61.1 | -318.5 | -660.8 | -86.2 | 2 | BULLISH | -20.0 |
| PHAR Pharming Group N.V. | $710M | 34.4 | 3.6 | 3.2 | 1.8 | 7.8 | 7 | BULLISH | -8.0 |
| CCCC C4 Therapeutics, Inc. | $380M | -3.4 | -48.1 | -175.0 | -355.9 | 2.3 | 4 | BULLISH | 28.3 |
| NGNE Neurogene Inc. | $370M | -5.5 | -45.3 | -111469.0 | — | — | 2 | BULLISH | -5.1 |
| FENC Fennec Pharmaceuticals Inc. | $350M | -83.6 | -18.6 | -76.2 | 11.0 | 77.8 | 6 | BULLISH | 23.2 |
| ALEC Alector, Inc. | $200M | -2.0 | -385.1 | 66.8 | -692.5 | -82.9 | 1 | BULLISH | 50.0 |
| OKYO OKYO Pharma Limited | $70M | -6.2 | -263.8 | 88.0 | — | — | 3 | BULLISH | -43.8 |
| PBYI Puma Biotechnology, Inc. | $570M | 19.8 | 22.0 | 52.8 | 14.5 | -2.9 | 6 | BULLISH | 101.5 |
| AZTR Azitra, Inc. | — | -0.1 | -256.7 | -959.6 | — | — | 5 | BULLISH | 65.7 |
| BCYC Bicycle Therapeutics plc | $250M | -1.4 | -32.3 | -1197.0 | -8002.1 | 217.4 | 4 | BULLISH | -52.2 |
| LCTX Lineage Cell Therapeutics, Inc. | $250M | -7.4 | -59.0 | -171.3 | 138.6 | 19.9 | 5 | BULLISH | -41.1 |
| IMCR Immunocore Holdings plc | $1.6B | -180.9 | -2.3 | -472.0 | -0.7 | 13.4 | 4 | BULLISH | -2.5 |
| JANX Janux Therapeutics, Inc. | $1.0B | -10.9 | -10.7 | 516.9 | -214.0 | 7162.0 | 4 | BULLISH | -34.0 |
| ACOG Alpha Cognition Inc | $130M | -8.4 | -55.3 | -198.4 | -144.3 | 232.7 | 2 | BULLISH | 14.6 |
| SCNLF Scancell Holdings plc | $170M | -5.1 | 153.2 | 179.2 | — | -100.0 | 2 | BULLISH | 969.8 |
| PULM Pulmatrix, Inc. | $10M | -1.4 | -98.3 | -835.1 | — | -100.0 | 3 | BULLISH | -69.6 |
| TCRT Alaunos Therapeutics, Inc. | $10M | -1.1 | -185.9 | -607.2 | — | -50.0 | 1 | BULLISH | -27.3 |
| CLGN CollPlant Biotechnologies Ltd. | — | -0.4 | -162.0 | -369.3 | -2524.1 | -86.8 | 2 | BULLISH | -83.0 |
| ZBIO Zenas BioPharma, Inc. | $1.8B | -3.0 | -199.0 | 5842.1 | -11145.6 | -93.3 | 2 | BULLISH | -9.5 |
| VOR Vor Biopharma Inc. | $990M | 0.1 | -73.6 | 22.2 | — | — | 3 | BULLISH | -26.6 |
| DRUG Bright Minds Biosciences Inc. | $520M | -26.8 | -13.7 | -105758.3 | — | — | 3 | BULLISH | -5.9 |
| ELDN Eledon Pharmaceuticals, Inc. | $190M | -2.8 | -110.7 | 411.1 | — | — | 2 | BULLISH | -27.9 |
| ABOS Acumen Pharmaceuticals, Inc. | $140M | -1.5 | -162.7 | 466.8 | — | — | 2 | BULLISH | 8.2 |
| PMN ProMIS Neurosciences, Inc. | $70M | -0.7 | -172.3 | 844.3 | — | — | 2 | BULLISH | -3.4 |
| HEPA Hepion Pharmaceuticals, Inc. | — | -0.6 | -125.6 | 710.2 | — | — | 3 | BULLISH | 130.8 |
| ACUT Accustem Sciences Inc. | — | -1.4 | 49.7 | 34.0 | -256.7 | 2610.7 | 4 | BULLISH | -88.8 |
| NXTC NextCure, Inc. | $20M | -0.6 | -195.2 | 949.7 | — | — | 2 | BULLISH | -31.6 |
| KPTI Karyopharm Therapeutics Inc. | $10M | -0.0 | 79.0 | 36.3 | -200.5 | 6.8 | 2 | BULLISH | -87.0 |
| HALB Halberd Corporation | — | -25.4 | 11.6 | 12.4 | — | -52.1 | 1 | BULLISH | -18.6 |
| BRVE Braveheart Bio, Inc. | $1.5B | — | — | — | — | — | — | BULLISH | — |
| DMRA Damora Therapeutics, Inc. | $1.3B | — | — | — | — | — | — | BULLISH | — |
| PTCHF PureTech Health plc | $390M | 156.5 | 0.2 | 50.8 | 1890.6 | 7.7 | 4 | BULLISH | -5.4 |
| IPIX Innovation Pharmaceuticals Inc. | — | -0.2 | -115.7 | -377.9 | — | -133.3 | 3 | BULLISH | 25.0 |
| TYRA Tyra Biosciences, Inc. | $1.2B | -9.1 | -45.3 | -2390.9 | — | — | 2 | BULLISH | 46.6 |
| ARVN Arvinas, Inc. | $470M | 40.0 | 1.6 | -519.3 | 67.8 | -15.0 | 4 | BULLISH | -21.2 |
| DBVT DBV Technologies S.A. | $230M | -2.7 | -142.6 | -2201.5 | — | -100.0 | 2 | BULLISH | -33.4 |
| TIL Instil Bio, Inc. | $40M | -1.5 | -25.3 | -69.1 | — | — | 4 | BULLISH | -65.8 |
| MDNAF Medicenna Therapeutics Corp. | $20M | — | — | — | — | — | — | BULLISH | — |
| OBX Obsidian Therapeutics Inc. | $10M | — | — | — | — | — | — | BULLISH | — |
| CALC CalciMedica, Inc. | — | -0.2 | -365.7 | 118.3 | — | — | 4 | BULLISH | -89.0 |
| KURA Kura Oncology, Inc. | $850M | -3.2 | -167.7 | 56.3 | -327.3 | -7.3 | 1 | BULLISH | -2.9 |
| RZLT Rezolute, Inc. | $370M | -5.6 | -59.0 | 1060.6 | — | — | 2 | BULLISH | -55.2 |
| OBIO Orchestra BioMed Holdings, Inc. | $340M | -6.1 | -397.3 | 468.3 | -26994.3 | 986.1 | 4 | BULLISH | 51.6 |
| PEPG PepGen Inc. | $170M | -1.7 | -75.5 | -327.5 | — | — | 4 | BULLISH | -53.4 |
| DNA Ginkgo Bioworks Holdings, Inc. | $670M | -2.7 | -56.3 | -44.0 | -231.7 | -51.5 | 2 | BULLISH | -0.4 |
| QURE uniQure N.V. | $1.6B | -6.2 | -157.6 | 37.9 | -1387.8 | 30.2 | 4 | LEAN BULL | -63.2 |
| BCRX BioCryst Pharmaceuticals, Inc. | $1.9B | -5.8 | 87.8 | 62.3 | 35.9 | 68.7 | 5 | LEAN BULL | 14.5 |
| CMPS COMPASS Pathways plc | $1.6B | -2.2 | -319.1 | 48.8 | — | — | 2 | LEAN BULL | 87.8 |
| OVID Ovid Therapeutics Inc. | $420M | -5.1 | -26.0 | -43.7 | -2047.6 | -76.2 | 3 | LEAN BULL | 53.1 |
| SABS SAB Biotherapeutics, Inc. | $260M | 0.9 | -11.3 | -48.4 | — | -100.0 | 3 | LEAN BULL | 5.6 |
| CLNN Clene Inc. | $60M | -1.1 | 237.2 | 132.5 | -14915.6 | -31.1 | 2 | LEAN BULL | -52.6 |
| BIVI BioVie Inc. | $10M | -0.5 | -0.0 | -0.0 | — | — | 3 | LEAN BULL | -22.8 |
| INFIQ Infinity Pharmaceuticals, Inc. | — | -0.0 | 109.5 | 60.9 | -1707.7 | — | 2 | LEAN BULL | 0.0 |
| ARDS Aridis Pharmaceuticals, Inc. | — | -0.0 | 4.8 | 10.0 | -19.9 | 2227.6 | 4 | LEAN BULL | -86.2 |
| BSSP Baseline Productions, Inc. | — | -0.0 | 167.7 | 64.9 | — | — | 2 | LEAN BULL | 19900.0 |
| VCRE Vicore Pharma Holding AB | $260M | — | — | — | — | — | — | LEAN BULL | — |
| INKT MiNK Therapeutics, Inc. | $50M | -4.5 | 57.9 | 42.8 | — | — | 4 | LEAN BULL | -24.0 |
| CKDXF Ceryvyn Therapeutics Ltd | $10M | 0.1 | -243.9 | 2882.8 | — | -97.3 | 3 | LEAN BULL | -97.6 |
| CYYNF Cynata Therapeutics Limited | — | -0.3 | -326.4 | 584.9 | — | -100.0 | 1 | LEAN BULL | -93.9 |
| VAXX Vaxxinity, Inc. | — | -0.2 | -150.6 | 2534.7 | — | — | 0 | LEAN BULL | 2699900.0 |
| ANAB AnaptysBio, Inc. | $1.5B | 7.5 | -1146.3 | 466.0 | 668.9 | 92.9 | 5 | LEAN BULL | 109.4 |
| IMRX Immuneering Corporation | $240M | -3.8 | -52.1 | -112.8 | — | — | 4 | LEAN BULL | -36.7 |
| INVA Innoviva, Inc. | $1.5B | 4.3 | 36.7 | 15.0 | -69.8 | 19.8 | 7 | LEAN BULL | 19.2 |
| YDES YD Bio Limited Ordinary Shares | $350M | — | — | — | — | — | — | LEAN BULL | -62.1 |
| ZURA Zura Bio Limited | $320M | -3.9 | -65.4 | 806.5 | — | — | 2 | LEAN BULL | 10.7 |
| FATE Fate Therapeutics, Inc. | $250M | -2.1 | -60.7 | -140.1 | -1448.6 | -23.4 | 2 | LEAN BULL | 114.8 |
| MDWD MediWound Ltd. | $150M | -8.5 | -72.4 | -255.1 | -239.1 | -40.3 | 2 | LEAN BULL | -26.3 |
| RNXT RenovoRx, Inc. | $60M | -4.5 | -125.2 | 4391.9 | -320.2 | 198.5 | 3 | LEAN BULL | 24.4 |
| VSBC VitaSpring Biomedical Co. Ltd. | $10M | -13.8 | 10.3 | 15.9 | — | -100.0 | 4 | LEAN BULL | -96.8 |
| LOBEF Lobe Sciences Ltd. | $10M | -2.7 | 359.0 | 181.6 | — | — | 2 | LEAN BULL | 33.1 |
| PXMD PaxMedica, Inc. Common Stock | — | -0.0 | -7716.2 | 572.1 | — | — | 2 | LEAN BULL | 600.0 |
| SCPX Scorpius Holdings, Inc. | — | -0.0 | 0.0 | 0.0 | -428.3 | -75.5 | 0 | LEAN BULL | -45.5 |
| REVB Revelation Biosciences, Inc. | — | -0.1 | -154.8 | 1317.2 | — | — | 4 | LEAN BULL | 176.7 |
| IUGNF Imugene Limited | $30M | -0.1 | -389.5 | -458.5 | — | -100.0 | 1 | LEAN BULL | -82.1 |
| CURX Curanex Pharmaceuticals Inc Common Stock | $10M | -0.7 | -218.7 | -392.2 | — | — | 1 | LEAN BULL | -69.1 |
| ACRS Aclaris Therapeutics, Inc. | $550M | -6.8 | -59.1 | -206.5 | -1320.1 | -51.0 | 3 | LEAN BULL | 69.2 |
| RNA Atrium Therapeutics, Inc. | $140M | -2.2 | -36.9 | 455.9 | -672.0 | 235.3 | 5 | LEAN BULL | -82.9 |
| TXTM ProText Mobility, Inc. | $90M | 72.0 | -0.4 | -0.3 | — | -100.0 | 1 | LEAN BULL | 191.4 |
| CLCS Cell Source, Inc. | $40M | -5.3 | 27.7 | 34.5 | — | — | 4 | LEAN BULL | 41.3 |
| SRZN Surrozen, Inc. | $190M | -0.7 | 387.2 | 11.1 | 1003.5 | -8.8 | 2 | LEAN BULL | 117.9 |
| ANTX AN2 Therapeutics, Inc. | $130M | -4.2 | -50.1 | 1243.3 | — | — | 2 | LEAN BULL | 234.8 |
| PBLA Panbela Therapeutics, Inc. | — | -0.0 | 270.3 | 240.0 | — | 100.0 | 3 | LEAN BULL | 0.0 |
| NMAD NOMAD Power Solutions, Inc. | $50M | — | — | — | — | — | — | LEAN BULL | — |
| WVE Wave Life Sciences Ltd. | $630M | -3.4 | -80.0 | -1243.7 | -470.5 | -35.1 | 2 | LEAN BULL | -52.2 |
| SPRB Spruce Biosciences, Inc. | $130M | -1.1 | -106.0 | 772.2 | — | -100.0 | 4 | LEAN BULL | -61.8 |
| ZEOX Zeo ScientifiX, Inc. | $10M | -2.1 | -140.0 | 105.8 | -5.6 | — | 2 | LEAN BULL | — |
| ENSC Ensysce Biosciences, Inc. | $10M | -0.2 | -968.3 | 792.9 | -220.8 | -77.6 | 3 | LEAN BULL | -78.9 |
| NWBO Northwest Biotherapeutics, Inc. | $260M | -6.8 | 55.8 | -188.7 | -1142.6 | 98.6 | 3 | LEAN BULL | -34.9 |
| CHRS Coherus Oncology, Inc. | $160M | -1.1 | -145.4 | 1854.0 | -144.2 | -64.3 | 2 | LEAN BULL | -27.5 |
| OKUR OnKure Therapeutics, Inc. | $100M | -0.8 | -46.9 | 1464.5 | — | — | 4 | LEAN BULL | -26.3 |
| EHOS Ehouse Global, Inc. | — | -0.0 | 161.0 | 52.5 | — | — | 1 | LEAN BULL | 0.0 |
| BETRF BetterLife Pharma Inc. | $110M | -10.9 | 34.9 | 21.6 | — | — | 4 | LEAN BULL | 282.3 |
| LITS Lite Strategy, Inc. | $40M | -0.1 | -170.9 | -28.2 | — | — | 2 | LEAN BULL | -41.1 |
| LEXX Lexaria Bioscience Corp. | $10M | -0.6 | -150.3 | -504.2 | — | -68.5 | 4 | LEAN BULL | -78.0 |
| ENVB Enveric Biosciences, Inc. | $10M | -0.1 | -170.0 | 3225.6 | — | — | 4 | LEAN BULL | -80.1 |
| NMTRQ 9 Meters Biopharma, Inc. | — | — | — | — | — | — | — | LEAN BULL | 9900.0 |
| CMRA Comera Life Sciences Holdings, Inc. | — | -0.0 | 235.6 | 124.2 | -1580.0 | 81.8 | 4 | LEAN BULL | 0.0 |
| DNAG DNAPrint Genomics, Inc. | — | -0.0 | 63.1 | -156.0 | -826.7 | -15.2 | 3 | LEAN BULL | 100.0 |
| ONCSQ OncoSec Medical Incorporated | — | -0.0 | -410.2 | 452.1 | — | — | 2 | LEAN BULL | -90.0 |
| ABVC ABVC BioPharma, Inc. | $30M | -3.7 | -82.2 | -43.0 | — | -100.0 | 2 | NEUTRAL | -62.3 |
| IFRX InflaRx N.V. | $230M | -3.2 | -38.5 | 251.5 | — | -106.2 | 4 | NEUTRAL | 4.2 |
| LONA LeonaBio, Inc. | $20M | — | — | — | — | — | — | NEUTRAL | — |
| ADXN Addex Therapeutics Ltd | — | -0.4 | -150.5 | -168.4 | -17543.0 | -48.1 | 2 | NEUTRAL | -69.7 |
| CYDY CytoDyn Inc. | $380M | -4.8 | 57.8 | 24.6 | — | 100.0 | 4 | NEUTRAL | -16.7 |
| CGEM Cullinan Therapeutics, Inc. | $880M | -4.6 | -50.3 | 1635.6 | — | — | 1 | NEUTRAL | 93.0 |
| QTTB Q32 Bio Inc. | $260M | 3.2 | 72.1 | 435.2 | — | — | 5 | NEUTRAL | 223.6 |
| EVMN Evommune, Inc. | $190M | -1.9 | -29.6 | -82.4 | — | — | 2 | NEUTRAL | — |
| GBIM GlobeImmune, Inc. | — | -0.0 | -66.2 | 25.0 | -91.5 | 55.1 | 4 | NEUTRAL | 0.0 |
| OCEA Ocean Biomedical, Inc. | — | -0.0 | 36.5 | 0.3 | — | — | 1 | NEUTRAL | -20.0 |
| BPTH Bio-Path Holdings, Inc. | — | -0.0 | 49.0 | 15.2 | — | -100.0 | 1 | NEUTRAL | -99.7 |
| CARM Carisma Therapeutics, Inc. | — | 0.0 | -134.1 | -376.4 | 98.8 | 159.7 | 3 | NEUTRAL | -98.8 |
| FULC Fulcrum Therapeutics, Inc. | $280M | -3.1 | -32.4 | 2389.1 | — | — | 4 | NEUTRAL | -61.1 |
| FHTX Foghorn Therapeutics Inc. | $120M | -2.2 | 81.9 | 26.3 | -44.7 | 52.0 | 4 | NEUTRAL | -48.3 |
| RNTX Rein Therapeutics Inc. | $50M | -0.4 | -753.6 | 53.9 | — | — | 3 | NEUTRAL | -47.1 |
| GDTC CytoMed Therapeutics Limited | $10M | -2.7 | -66.1 | -87.8 | -1125.6 | -11.3 | 0 | NEUTRAL | -61.4 |
| ONCO Onconetix, Inc. | — | -0.1 | -105.2 | -83.7 | -16748.3 | -51.3 | 3 | NEUTRAL | -83.2 |
| HESG Health Sciences Group, Inc. | — | -0.0 | 69.4 | 44.6 | -19219.1 | 101.6 | 3 | NEUTRAL | 900.0 |
| NTRR Neutra Corp. | — | 2.0 | -139.6 | -802.5 | -3.8 | 142.2 | 7 | NEUTRAL | 0.0 |
| STTK Shattuck Labs, Inc. | $550M | -11.4 | -39.2 | -29.3 | — | -66.6 | 4 | NEUTRAL | 182.0 |
| ARCT Arcturus Therapeutics Holdings Inc. | $280M | -3.6 | -46.3 | -2501.0 | -803.8 | -79.1 | 1 | NEUTRAL | 14.0 |
| CTXR Citius Pharmaceuticals, Inc. | $10M | -0.3 | -70.3 | -85.4 | -593.3 | 4456.8 | 3 | NEUTRAL | -66.6 |
| NKGN NKGen Biotech, Inc. | — | -0.0 | 150.9 | — | -4511.3 | — | 3 | NEUTRAL | -45.0 |
| YDESW YD Bio Limited Warrants | — | — | — | — | — | — | — | NEUTRAL | -69.0 |
| CFRXQ ContraFect Corp. | — | -0.0 | 544.7 | 276.9 | — | — | 1 | NEUTRAL | -90.0 |
| RBSH Rebus Holdings, Inc. | — | -0.0 | -9.7 | 8.9 | — | — | 2 | NEUTRAL | 0.0 |
| LYCA Lycia Therapeutics Inc. | $1.6B | — | — | — | — | — | — | N/A | — |
| CTY City Therapeutics Inc. | $200M | — | — | — | — | — | — | N/A | — |
| IAM Iambic Therapeutics Inc. | $130M | — | — | — | — | — | — | N/A | — |
| ACHFF Arch Biopartners Inc. | $40M | -19.3 | 73.5 | 165.4 | — | 100.0 | 2 | NEUTRAL | -15.7 |
| ATOS Atossa Therapeutics, Inc. | $30M | -0.5 | -89.2 | -4213.1 | — | — | 2 | NEUTRAL | -83.2 |
| ODTX Odyssey Therapeutics, Inc. | $940M | — | — | — | — | — | — | NEUTRAL | — |
| JBIO Jade Biosciences, Inc. | $930M | -5.3 | -47.8 | 629.9 | — | — | 3 | NEUTRAL | 43.2 |
| SVRA Savara Inc. | $870M | -8.7 | -105.5 | -15438.9 | — | — | 2 | NEUTRAL | 14.6 |
| SNGX Soligenix, Inc. | $10M | -0.3 | -241.7 | 304.6 | — | — | 4 | NEUTRAL | -83.9 |
| KLDO Kaleido Biosciences, Inc. | — | -0.0 | -591.2 | 1121.9 | -4292.5 | 13.2 | 2 | NEUTRAL | 0.0 |
| ALMS Alumis Inc. | $880M | -1.9 | -93.6 | 2645.2 | -8557.2 | -63.1 | 2 | NEUTRAL | 48.2 |
| YARW Yarrow Bioscience Inc | $180M | — | — | — | — | — | — | NEUTRAL | — |
| EQ Equillium, Inc. | $80M | -5.5 | -59.0 | 2703.6 | — | -100.0 | 3 | NEUTRAL | 3.6 |
| ELTX Elicio Therapeutics, Inc. | $40M | -0.9 | -774.6 | 2147.3 | — | — | 4 | NEUTRAL | -80.9 |
| NYMXF Nymox Pharmaceutical Corporation | $10M | -0.7 | 193.9 | 89.4 | — | — | 2 | NEUTRAL | -70.0 |
| RVLPQ RVL Pharmaceuticals plc | — | -0.0 | -182.4 | -101.1 | -289.3 | 5.6 | 3 | NEUTRAL | 900.0 |
| WHWK Whitehawk Therapeutics Inc | $180M | -3.1 | -45.0 | 963.4 | — | -100.0 | 1 | NEUTRAL | 43.0 |
| PYXS Pyxis Oncology, Inc. | $110M | -1.4 | -179.1 | 1953.9 | — | 291.4 | 2 | NEUTRAL | -41.6 |
| ELUT Elutia Inc | $40M | 0.6 | -397.0 | -290.2 | -315.0 | -48.8 | 6 | NEUTRAL | -6.7 |
| EVAX Evaxion Biotech A/S | $20M | -0.5 | -109.8 | -260.4 | — | 135.9 | 6 | NEUTRAL | -49.3 |
| LADX LadRx Corporation | — | -0.0 | 278.9 | 118.4 | — | -61.0 | 1 | NEUTRAL | -99.0 |
| MRPI Mera Pharmaceuticals, Inc. | — | -10000.0 | 24.3 | 18.3 | -159.9 | 4.8 | 5 | NEUTRAL | 0.0 |
| MBXBF Microbix Biosystems Inc. | $30M | -8.2 | -16.4 | -14.6 | -19.9 | -27.1 | 3 | LEAN BEAR | 24.3 |
| XBIO Xenetic Biosciences, Inc. | — | -1.8 | -47.0 | 523.4 | -140.7 | 33.3 | 4 | LEAN BEAR | -44.0 |
| MLLCF Molecular Partners AG | $150M | -2.2 | -62.1 | 650.3 | — | -100.0 | 2 | LEAN BEAR | 14.6 |
| POLBF Poolbeg Pharma PLC | $70M | -8.5 | -58.8 | -255.9 | — | — | 1 | LEAN BEAR | 125.4 |
| CLYYF Celyad Oncology S.A. | $10M | 2.5 | -11.7 | -979.7 | 64360.6 | -88.7 | 5 | LEAN BEAR | 40.0 |
| QPTFF Quest PharmaTech Inc. | $10M | 1.6 | 3.9 | -1.7 | — | — | 4 | LEAN BEAR | 125.6 |
| CAMP CAMP4 Therapeutics Corporation | $210M | -1.6 | -545.9 | 48.4 | -1884.8 | 40.2 | 2 | LEAN BEAR | -6.4 |
| ENTA Enanta Pharmaceuticals, Inc. | $340M | -4.8 | -70.1 | 141.5 | -135.8 | 0.7 | 4 | LEAN BEAR | 10.0 |
| AGEN Agenus Inc. | $290M | 2.6 | -33.2 | -20.4 | -1.6 | 30.5 | 6 | LEAN BEAR | 71.8 |
| BIOA BioAge Labs Inc. | $190M | -2.5 | -28.2 | -142.3 | -1064.7 | 168.1 | 4 | LEAN BEAR | -22.1 |
| ALXO ALX Oncology Holdings Inc. | $160M | -1.0 | -80.6 | -851.1 | — | — | 4 | LEAN BEAR | -30.6 |
| AURX Nuo Therapeutics, Inc. | $60M | -31.1 | 170.6 | 280.3 | -15.7 | 166.6 | 3 | LEAN BEAR | -45.8 |
| JSPR Jasper Therapeutics, Inc. | $20M | -0.3 | -255.0 | 773.9 | — | — | 2 | LEAN BEAR | -76.9 |
| CNBX CNBX Pharmaceuticals Inc. | — | -0.5 | 17.8 | 13.3 | — | 100.0 | 3 | LEAN BEAR | -66.7 |
| GYRE Gyre Therapeutics, Inc. | $620M | -35.6 | -15.6 | -22.3 | -36.4 | 16.8 | 3 | LEAN BEAR | -11.6 |
| NTRB Nutriband Inc. | $70M | -11.2 | -100.7 | -264.9 | -201.3 | -37.3 | 3 | LEAN BEAR | -9.0 |
| BOLD Boundless Bio, Inc. | $50M | -0.9 | -67.9 | 807.9 | — | — | 2 | LEAN BEAR | 67.8 |
| AEON AEON Biopharma, Inc. | $10M | -0.1 | 350.0 | 98.0 | — | — | 2 | LEAN BEAR | -71.0 |
| SRBCF Sirona Biochem Corp. | — | -0.7 | 111.4 | 1025.7 | -34808.5 | -119.4 | 2 | LEAN BEAR | -50.5 |
| SNNAQ Sienna Biopharmaceuticals, Inc. | — | -0.0 | -140.9 | -331.4 | — | — | 2 | LEAN BEAR | 0.0 |
| PPCB Propanc Biopharma, Inc. | — | -0.1 | -161.9 | -166.7 | — | — | 4 | LEAN BEAR | 45.3 |
| IMVIF IMV Inc. | — | -0.2 | -503.3 | -2870.5 | — | — | 1 | LEAN BEAR | 1900.0 |
| MCET MultiCell Technologies, Inc. | — | -0.1 | 101.2 | 99.1 | -81.8 | 1532.7 | 5 | LEAN BEAR | 900.0 |
| TRVI Trevi Therapeutics, Inc. | $1.8B | -40.0 | -19.7 | -1451.7 | — | — | 3 | LEAN BEAR | 28.8 |
| AURA Aura Biosciences, Inc. | $650M | -3.6 | -53.5 | -1360.0 | — | — | 4 | LEAN BEAR | 4.9 |
| TTRX Turn Therapeutics Inc. | $310M | -38.2 | -952.4 | 115.0 | — | — | 2 | LEAN BEAR | 123.7 |
| MMIRF MedMira Inc. | $30M | -11.4 | 11.8 | 21.7 | -200.5 | 45.7 | 4 | LEAN BEAR | -20.4 |
| SLDB Solid Biosciences Inc. | $630M | -3.4 | -65.5 | -1012.6 | — | — | 3 | LEAN BEAR | 9.8 |
| XTLB XTL Biopharmaceuticals Ltd. | — | -0.6 | -26.8 | -38.7 | -88.2 | — | 3 | LEAN BEAR | 67.5 |
| LYRA Lyra Therapeutics, Inc. | — | -0.0 | -6595.0 | -671.6 | -99300.0 | -74.1 | 4 | LEAN BEAR | -97.6 |
| PARD Poniard Pharmaceuticals, Inc. | — | -0.0 | -210.4 | -442.5 | — | — | 3 | LEAN BEAR | 0.0 |
| STAB Statera Biopharma, Inc. | — | -0.0 | -298.8 | 2085.4 | -769.5 | 1459.1 | 3 | LEAN BEAR | -50.0 |
| AOBI American Oriental Bioengineering, Inc. | — | -0.0 | -28.2 | -16.5 | -118.1 | -10.2 | 3 | LEAN BEAR | 983.3 |
| HSTC HST Global, Inc. | $210M | -538.5 | -2.5 | -1.2 | -13.7 | 564.0 | 5 | LEAN BEAR | 349900.0 |
| TSHA Taysha Gene Therapies, Inc. | $1.3B | -10.0 | -47.1 | 961.0 | — | -32.3 | 3 | LEAN BEAR | -13.1 |
| CLLS Cellectis S.A. | $100M | -1.9 | -94.6 | 118.6 | -417.3 | 0.5 | 2 | LEAN BEAR | -65.3 |
| IMUX Immunic, Inc. | $100M | -1.7 | -138.2 | 345.6 | — | — | 5 | LEAN BEAR | -4.4 |
| GRCE Grace Therapeutics, Inc. | $30M | -1.6 | -38.4 | -58.9 | — | — | 2 | LEAN BEAR | -36.2 |
| PBIGF Paradigm Biopharmaceuticals Limited | $10M | -1.6 | -456.6 | 1081.8 | -60158.9 | 53.6 | 4 | LEAN BEAR | -96.1 |
| PREDQ Predictive Discovery Limited | — | — | — | — | — | — | — | LEAN BEAR | — |
| MNKD MannKind Corporation | $1.0B | -24.6 | 71.4 | 4.0 | -17.4 | 30.5 | 2 | LEAN BEAR | -36.7 |
| RCKT Rocket Pharmaceuticals, Inc. | $250M | -16.1 | -4.8 | -137.8 | — | — | 3 | LEAN BEAR | -34.5 |
| CSBR Champions Oncology, Inc. | $70M | -62.3 | -30.7 | -7.8 | -2.8 | 6.7 | 3 | LEAN BEAR | -27.9 |
| GOSS Gossamer Bio, Inc. | $60M | -0.2 | 178.7 | 117.2 | 182.9 | 32.4 | 3 | LEAN BEAR | -94.4 |
| KARD Kardigan, Inc. | $1.1B | — | — | — | — | — | — | LEAN BEAR | — |
| FDMT 4D Molecular Therapeutics, Inc. | $600M | -4.8 | -43.3 | -182.0 | -1929.0 | 278712.1 | 4 | LEAN BEAR | 5.4 |
| RNAC Cartesian Therapeutics, Inc. | $190M | -1.1 | 241.0 | 37.3 | — | 44.0 | 2 | LEAN BEAR | -24.4 |
| CGEN Compugen Ltd. | $180M | 5.4 | 49.6 | -90.2 | -269.3 | 886.7 | 5 | LEAN BEAR | 17.5 |
| TRDA Entrada Therapeutics, Inc. | $170M | -1.2 | -54.1 | -236.6 | -4762.0 | -94.1 | 1 | LEAN BEAR | -33.8 |
| BDTX Black Diamond Therapeutics, Inc. | $110M | -2.5 | -37.2 | -1604.9 | — | -100.0 | 1 | LEAN BEAR | -53.7 |
| NTHI Neonc Technologies Holdings, Inc. | $90M | — | — | — | — | — | — | LEAN BEAR | -63.2 |
| SGMOQ Sangamo Therapeutics, Inc. | $50M | — | — | — | — | — | — | LEAN BEAR | — |
| PZRXQ PhaseRx, Inc. | — | -0.0 | -228.2 | 8803.4 | — | — | 2 | LEAN BEAR | 0.0 |
| RNAZ TransCode Therapeutics, Inc. | — | -0.0 | -59.2 | -21.0 | — | — | 1 | LEAN BEAR | -86.5 |
| REPCF RepliCel Life Sciences Inc. | — | -9.4 | -248.8 | -13.9 | -80.9 | 200.0 | 6 | LEAN BEAR | 0.0 |
| NNBP Nanobac Pharmaceuticals, Incorporated | — | 0.0 | 358.0 | 221.2 | -26718.6 | -92.2 | 3 | LEAN BEAR | 0.0 |
| NNLX NanoLogix, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -20.0 |
| CLAZF Claritas Pharmaceuticals, Inc. | — | 0.0 | -170.1 | 15.9 | — | — | 3 | LEAN BEAR | 0.0 |
| GWIN Glorywin Entertainment Group, Inc. | $360M | -26081.4 | 11.7 | 5.1 | — | — | 1 | LEAN BEAR | 229.5 |
| FGHQF Frontage Holdings Corporation | $360M | 36.5 | 3.1 | 3.0 | 4.6 | 9.8 | 7 | LEAN BEAR | 16.8 |
| KNTPF Kintor Pharmaceutical Limited | $120M | -2.9 | -116.6 | -74.4 | -145.6 | 2237.9 | 3 | LEAN BEAR | -10.2 |
| HUMA Humacyte, Inc. | $120M | -0.9 | -547.9 | -500.7 | -9064.5 | -73.6 | 3 | LEAN BEAR | -72.0 |
| LVCLF Algorae Pharmaceuticals Limited | $20M | -5.7 | -47.4 | -24288.6 | — | -100.0 | 3 | LEAN BEAR | 51.6 |
| BCLI Brainstorm Cell Therapeutics Inc. | $10M | -0.8 | 119.2 | 76.7 | — | -100.0 | 1 | LEAN BEAR | 11.1 |
| ENGNW enGene Holdings Inc. Warrants | $10M | -5.6 | -2.3 | 134.1 | — | -100.0 | 2 | LEAN BEAR | -77.1 |
| FORU ForU Holdings, Inc. | — | -0.0 | 759.2 | -476.4 | — | -100.0 | 2 | LEAN BEAR | 100.0 |
| CHNXF ChitogenX Inc. | — | -0.2 | 23.2 | 36.2 | — | — | 2 | LEAN BEAR | 586.4 |
| HLSQ Tessera Defense and Homeland Security Inc | — | — | — | — | — | — | — | LEAN BEAR | — |
| JUNS Jupiter Neurosciences, Inc. | — | -0.1 | -1888.7 | 5586.0 | -9380.9 | — | 3 | LEAN BEAR | -98.0 |
| CMND Clearmind Medicine Inc. | — | -0.1 | -104.0 | 593.4 | — | — | 2 | LEAN BEAR | -99.8 |
| VINC Vincerx Pharma, Inc. | — | -0.0 | -3136.4 | 910.2 | — | -18.7 | 5 | LEAN BEAR | -53.1 |
| NURPF Neuren Pharmaceuticals Limited | $1.8B | 125.7 | 6.2 | 22.4 | 14.6 | -68.5 | 5 | LEAN BEAR | 20.8 |
| CUBT Curative Biotechnology, Inc. | — | -2.0 | 31.0 | 15.3 | — | — | 4 | LEAN BEAR | -26.6 |
| NRXP NRx Pharmaceuticals, Inc. | $110M | -3.6 | 131.2 | 61.3 | -1500.5 | — | 5 | LEAN BEAR | -14.3 |
| CNTN Canton Strategic Holdings Inc | $150M | -1.3 | -14.6 | -7.2 | -1287.2 | — | 2 | LEAN BEAR | — |
| CNSP CNS Pharmaceuticals, Inc. | $10M | -0.2 | -106.6 | 748.6 | — | — | 3 | LEAN BEAR | -46.0 |
| ADRX ADARx Pharmaceuticals, Inc. | $1.9B | — | — | — | — | — | — | LEAN BEAR | — |
| ANNX Annexon, Inc. | $610M | -3.5 | -105.3 | -11323.3 | — | — | 2 | BEARISH | 14.1 |
| IMA ImageneBio Inc | $50M | -0.8 | -40.7 | -594.7 | — | — | 3 | BEARISH | -49.7 |
| GLUE Monte Rosa Therapeutics, Inc. | $920M | -5.0 | -42.7 | 149.9 | -483.9 | -83.9 | 3 | BEARISH | -11.9 |
| SANA Sana Biotechnology, Inc. | $700M | -3.5 | -152.9 | -242.3 | — | — | 3 | BEARISH | -49.9 |
| OCS Oculis Holding AG | $490M | -4.7 | -44.0 | -31.0 | — | -6.9 | 3 | BEARISH | -63.0 |
| RLMD Relmada Therapeutics, Inc. | $350M | -3.6 | -55.7 | 460.5 | — | — | 3 | BEARISH | 43.8 |
| IBO Impact BioMedical Inc. | $30M | -3.2 | 10.8 | -30.4 | -23300.0 | — | 5 | BEARISH | -45.8 |
| LTRN Lantern Pharma Inc. | $10M | -0.5 | -400.9 | 115.9 | — | — | 2 | BEARISH | -80.9 |
| KZIA Kazia Therapeutics Ltd ADR | $10M | -1.1 | -104.5 | 62.7 | — | -99.2 | 4 | BEARISH | 14.1 |
| ADAPY Adaptimmune Therapeutics plc | $10M | -0.1 | -1341.1 | 268.4 | -221.8 | -54.0 | 0 | BEARISH | -47.7 |
| ALLR Allarity Therapeutics, Inc. | $10M | -1.2 | -157.1 | -96.5 | — | — | 2 | BEARISH | -30.8 |
| PBMWW Psyence Biomedical Ltd. Warrant | — | — | — | — | — | — | — | BEARISH | -63.9 |
| LIPO Lipella Pharmaceuticals Inc. | — | -0.0 | -361.8 | 4105.8 | — | -64.1 | 1 | BEARISH | -99.9 |
| TRVN Trevena, Inc. | — | -0.0 | 344.3 | -3198.4 | -1745.2 | -82.9 | 3 | BEARISH | -7.5 |
| PKTX ProtoKinetix, Incorporated | — | -1.0 | -117.2 | -115.0 | — | — | 2 | BEARISH | -94.6 |
| IMMB Immunotech Laboratories, Inc. | — | — | — | — | — | — | — | BEARISH | 100.0 |
| ALLO Allogene Therapeutics, Inc. | $430M | -1.9 | -42.4 | -81.9 | -919.8 | — | 5 | BEARISH | 5.7 |
| PMVP PMV Pharmaceuticals, Inc. | $70M | -1.0 | -70.9 | 815.8 | — | — | 2 | BEARISH | -12.7 |
| SPRO Spero Therapeutics, Inc. | $60M | 8.4 | 19.2 | -128.5 | — | -7.0 | 7 | BEARISH | -48.9 |
| SNANF Sona Nanotech Inc. | $20M | -13.1 | 526.4 | 252.2 | — | — | 1 | BEARISH | -58.9 |
| SNTI Senti Biosciences, Inc. | $10M | -0.1 | -466.5 | -430.9 | -75000.0 | — | 2 | BEARISH | -90.4 |
| IMUC EOM Pharmaceuticals Holdings, Inc. | $10M | -4.9 | 64.4 | 131.0 | — | — | 4 | BEARISH | -42.8 |
| HTDS Hard to Treat Diseases Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| AAPG Ascentage Pharma Group International | $1.4B | -6.3 | -236.8 | -144.8 | -270.2 | 170.9 | 3 | BEARISH | -56.5 |
| SNBIF SanBio Company Limited | $1.3B | -19.7 | -55.8 | -2935.2 | — | — | 3 | BEARISH | 0.0 |
| SLGL Sol-Gel Technologies Ltd. | $230M | -12.1 | -35.9 | -228.0 | 36.4 | 282.9 | 3 | BEARISH | 71.3 |
| APLMW Apollomics, Inc. | $170M | -2.6 | -233.7 | 845.7 | 1188.0 | -75.9 | 3 | BEARISH | -64.6 |
| MRKR Marker Therapeutics, Inc. | $20M | -2.1 | -76.9 | -1014.3 | — | -77.1 | 2 | BEARISH | -2.0 |
| VRCI Verde Science, Inc. | — | -0.0 | 72.3 | 23.0 | — | — | 5 | BEARISH | 100.0 |
| NTII Neurobiological Technologies, Inc. | — | 0.0 | 48.7 | 441.6 | 89.7 | 99.7 | 4 | BEARISH | 0.0 |
| IBOGF Universal Ibogaine Inc. | — | -0.5 | -94.8 | 5.5 | -9.4 | 208.2 | 4 | BEARISH | -98.6 |
| RGIN Regenicin, Inc. | — | -0.0 | 16.9 | 4.1 | — | — | 4 | BEARISH | 0.0 |
| GLSHQ Gelesis Holdings, Inc. | — | -0.0 | 391.0 | -233.6 | -693.9 | -45.8 | 3 | BEARISH | 0.0 |
| HAVLF HAVN Life Sciences Inc. | — | -0.0 | -275.3 | -163.4 | 5734.1 | 876.8 | 3 | BEARISH | 0.0 |
| TLOG TetraLogic Pharmaceuticals Corporation | — | -0.0 | 382.3 | 479.8 | — | — | 1 | BEARISH | 0.0 |
| PSYBF PsyBio Therapeutics Corp | — | -0.0 | 344.6 | 135.0 | — | — | 2 | BEARISH | -90.0 |
| MAJI Nextel Medical Corp. | — | 0.6 | -2.6 | 42.9 | — | — | 1 | BEARISH | — |
| GRI GRI Bio, Inc. | — | -0.0 | -142.0 | 1227.5 | — | — | 5 | BEARISH | -97.1 |
| MRZM Marizyme, Inc. | — | -0.0 | 117.5 | -190.1 | — | -69.0 | 3 | BEARISH | 0.0 |
| BPMUF Basilea Pharmaceutica AG | $960M | 17.2 | 39.5 | 75.9 | 23.5 | 4.5 | 7 | BEARISH | 27.1 |
| AKBA Akebia Therapeutics, Inc. | $160M | -7.1 | -109.4 | 15.6 | -18.1 | 7.5 | 6 | BEARISH | -75.9 |
| ATRA Atara Biotherapeutics, Inc. | $90M | -7.3 | 46.3 | 30.3 | -767.3 | -96.7 | 2 | BEARISH | -44.5 |
| SYGGF Synairgen plc | — | -0.2 | -71.9 | -381.4 | — | — | 1 | BEARISH | -50.0 |
| BTAX Biostax Corp. | — | -0.0 | 7.3 | 5.8 | — | — | 2 | BEARISH | 100.0 |
| CLYM Climb Bio, Inc. | $590M | -12.2 | -27.1 | -88.6 | — | — | 2 | BEARISH | 381.9 |
| MNPR Monopar Therapeutics Inc. | $470M | -31.4 | -19.5 | 523.8 | — | — | 2 | BEARISH | -9.7 |
| ATGGF Actinogen Medical Limited | $140M | -8.8 | -77.5 | -235.8 | — | -100.0 | 1 | BEARISH | 17.2 |
| BVAXF BioVaxys Technology Corp. | — | -0.9 | 310.6 | 48.4 | — | — | 1 | BEARISH | -52.0 |
| SQZB SQZ Biotechnologies Company | — | -0.0 | -203.4 | -410.2 | — | -44.6 | 0 | BEARISH | 4.3 |
| VOGX Vogenx Inc. | $260M | — | — | — | — | — | — | BEARISH | — |
| MEOBF Mesoblast Limited | $2.0B | -34.8 | -9.9 | -6.4 | -23.4 | 613.8 | 5 | BEARISH | -21.4 |
| MLYS Mineralys Therapeutics, Inc. | $1.8B | -5.0 | -80.9 | 2274.6 | — | — | 2 | BEARISH | -47.3 |
| IMTX Immatics N.V. | $1.1B | -4.2 | -47.8 | -858.3 | -683.4 | -68.0 | 2 | BEARISH | -30.5 |
| AKTS Aktis Oncology, Inc. | $850M | -16.0 | -29.9 | 276.4 | -713.5 | -36.1 | 5 | BEARISH | 365552.2 |
| ATTO Attovia Therapeutics, Inc. | $630M | -17.0 | -294.4 | -1137.2 | -4597.1 | -50.5 | 4 | BEARISH | 313.6 |
| OLMA Olema Pharmaceuticals, Inc. | $560M | -3.5 | -52.7 | 585.3 | — | — | 2 | BEARISH | -14.8 |
| BNTC Benitec Biopharma Inc. | $300M | -9.0 | -33.2 | 1840.8 | — | — | 3 | BEARISH | -34.9 |
| TARA Protara Therapeutics, Inc. | $140M | -1.8 | -45.8 | -41.3 | — | — | 2 | BEARISH | -51.4 |
| OTLK Outlook Therapeutics, Inc. | $130M | -0.5 | 256.9 | 1372.0 | -225766.7 | -169.4 | 3 | BEARISH | -59.3 |
| AKTX Akari Therapeutics, Plc | $20M | -0.0 | -139.9 | -175.8 | — | — | 3 | BEARISH | -73.2 |
| NCNA NuCana plc | $10M | -0.3 | -70.7 | -739.9 | — | — | 4 | BEARISH | -74.8 |
| LIFS Life Stem Genetics Inc. | — | -2.5 | -126.7 | -111.5 | — | — | 2 | BEARISH | -50.0 |
| RLFTY MindMaze Therapeutics Holding S.A. | — | -4.6 | -36.8 | -30.3 | -1182.3 | -95.8 | 2 | BEARISH | -95.4 |
| LGVN Longeveron Inc. | — | -0.2 | -203.6 | -2062.6 | -2116.0 | -42.7 | 4 | BEARISH | -80.6 |
| JAGX Jaguar Health, Inc. | — | -0.0 | -501.9 | -118.9 | -1035.3 | 135.5 | 4 | BEARISH | -99.8 |
| DRMA Dermata Therapeutics, Inc. | — | -0.2 | -183.9 | 734.5 | — | — | 2 | BEARISH | -78.5 |
| ITMC Itoco Inc. | — | -0.0 | 303.4 | 96.7 | — | — | 2 | BEARISH | 0.0 |
| GBLX GB Sciences, Inc. | — | -0.0 | 19.5 | 17.2 | -103.2 | — | 3 | BEARISH | -66.7 |
| GNLX Genelux Corporation | $90M | -2.5 | -168.9 | 20537.7 | — | — | 2 | BEARISH | -69.7 |
| ERNA Ernexa Therapeutics Inc. | — | -0.1 | -320.7 | 626.9 | — | -100.0 | 5 | BEARISH | -93.3 |
| AAGH America Great Health | — | 2.0 | -12.2 | 22.4 | -635.8 | -5.1 | 4 | BEARISH | 33.3 |
| MRES Institute of Biomedical Research Corp. | — | -2.3 | 301783.0 | -6062.7 | — | — | 1 | BEARISH | -81.2 |
| CSPHF CStone Pharmaceuticals | $1.4B | -15.0 | -51.4 | -340.2 | -123.0 | 135.6 | 5 | BEARISH | -15.4 |
| DRTSW Alpha Tau Medical Ltd. | $1.2B | -12.8 | -141.7 | -17.1 | — | — | 3 | BEARISH | 820.5 |
| XCUR Exicure, Inc. | $10M | -0.8 | -168.4 | 779.8 | — | — | 2 | BEARISH | -78.2 |
| PRVCF PreveCeutical Medical Inc. | $10M | -16.7 | 9.9 | 96.4 | — | — | 3 | BEARISH | -49.5 |
| LSTA Lisata Therapeutics, Inc. | $10M | -0.6 | -99.9 | 590.1 | — | -90.7 | 2 | BEARISH | -62.1 |
| ERNAW Ernexa Therapeutics Inc. Warrants | — | — | — | — | — | — | — | BEARISH | — |
| PROT Proteonomix, Inc. | — | -0.0 | 77.5 | -1239.4 | — | -63.1 | 4 | BEARISH | 0.0 |
| NBIO Nascent Biotech, Inc. | — | -0.0 | 230.6 | 328.8 | — | — | 5 | BEARISH | -77.8 |
| RNUGF ReNeuron Group plc | — | -0.0 | -106.8 | 210.1 | -1809.6 | -68.2 | 1 | BEARISH | 0.0 |
| PFND Pathfinder Cell Therapy, Inc. | — | -0.0 | 22.4 | 46.3 | — | — | 2 | BEARISH | 0.0 |
| CDXI Cardax, Inc. | — | -0.0 | 81.1 | 38.5 | -1740.8 | -27.3 | 2 | BEARISH | 0.0 |
| ADYX Adynxx, Inc. | — | -0.0 | 1148.3 | 259.7 | — | -95.1 | 2 | BEARISH | 0.0 |
| PANC Panacos Pharmaceuticals, Inc. | — | -0.0 | -168.8 | -792.8 | -33966.7 | -45.9 | 1 | BEARISH | 0.0 |
| SYVC Synovics Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| GHRS GH Research PLC | $1.2B | -20.7 | -18.8 | 2015.5 | — | — | 2 | BEARISH | 44.6 |
| DSGN Design Therapeutics, Inc. | $640M | -9.4 | -34.1 | 1787.8 | — | — | 1 | BEARISH | 59.0 |
| TENX Tenax Therapeutics, Inc. | $50M | -1.3 | -59.8 | 1235.8 | — | — | 1 | BEARISH | -74.9 |
| HNSBF Hansa Biopharma AB (publ) | $330M | -4.9 | 159.8 | 1182.7 | -541.7 | -3.7 | 2 | BEARISH | -28.2 |
| VICP Vicapsys Life Sciences, Inc. | $10M | -20.5 | 31.3 | 17.6 | — | — | 5 | BEARISH | -73.3 |
| ANTH Anthera Pharmaceuticals, Inc. | — | -0.0 | -251.4 | 1107.5 | — | — | 1 | BEARISH | 9900.0 |
| PLYX Polaryx Therapeutics, Inc. Common Stock | $90M | -15.5 | -35.9 | 437.3 | — | — | 2 | BEARISH | — |
| CASIF CASI Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| IDRSF Idorsia Ltd | $1.4B | -3.5 | 27.1 | -344.5 | -203.1 | -8.1 | 1 | BEARISH | 19.6 |
| VBIZF Viva Biotech Holdings | $400M | 13.9 | 4.5 | 4.2 | 8.0 | 2.9 | 7 | BEARISH | -35.1 |
| SYRS Syros Pharmaceuticals, Inc. | — | -0.0 | -777.0 | 960.6 | — | -90.5 | 0 | BEARISH | 0.0 |
| FPMI FluoroPharma Medical, Inc. | — | -0.0 | 22.7 | 39.7 | — | — | 2 | BEARISH | 100.0 |
| CASBF CanSino Biologics Inc. | $1.4B | 399.2 | 0.8 | -1.2 | 11.0 | 32.5 | 7 | BEARISH | -39.1 |
| CRVS Corvus Pharmaceuticals, Inc. | $890M | -16.4 | -35.4 | -415.6 | — | — | 4 | BEARISH | 33.8 |
| NKTR Nektar Therapeutics | $1.1B | -5.8 | -35.8 | -29.2 | -401.0 | -27.2 | 3 | BEARISH | -38.4 |
| RGNX REGENXBIO Inc. | $440M | -1.9 | -137.6 | -368.4 | 21.0 | 12.0 | 2 | BEARISH | -46.8 |
| BLSM BlossomHill Therapeutics, Inc. | $430M | — | — | — | — | — | — | BEARISH | — |
| TECX Tectonic Therapeutic, Inc. | $390M | -4.5 | -33.8 | -6371.3 | — | — | 1 | BEARISH | 10.4 |
| IPSC Century Therapeutics, Inc. | $260M | -1.4 | -49.7 | -60.0 | — | -100.0 | 2 | BEARISH | 150.0 |
| NAGE Niagen Bioscience Inc | $190M | 13.1 | 21.8 | 44.7 | 3.2 | 11.0 | 6 | BEARISH | -66.6 |
| MAIA MAIA Biotechnology, Inc. | $70M | -1.8 | -218.7 | 330.4 | — | — | 3 | BEARISH | -22.7 |
| HMTXF Hemostemix Inc. | $10M | -2.4 | 69.9 | 190.1 | — | — | 1 | BEARISH | -44.5 |
| SCPS Scopus BioPharma Inc. | — | -0.0 | 132.3 | 53.6 | — | — | 2 | BEARISH | 33.3 |
| BITRF Biotron Limited | — | -3.6 | -87.5 | -87.8 | -113.4 | -71.0 | 0 | BEARISH | -90.7 |
| THER Theralink Technologies, Inc. | — | -0.0 | 6.0 | -69.7 | 5363.6 | 32.8 | 2 | BEARISH | 0.0 |
| CVKD Cadrenal Therapeutics, Inc. Common Stock | — | -0.2 | -275.2 | -540.4 | — | — | 3 | BEARISH | -92.5 |
| MLECW Moolec Science S.A. | — | -0.0 | -174.7 | -31.5 | -91.8 | 170.4 | 3 | BEARISH | -3.8 |
| VIVS VivoSim Labs, Inc. | — | -0.0 | -343.1 | 241.9 | -7433.3 | 202.7 | 2 | BEARISH | -93.6 |
| PPTDF PeptiDream Inc. | $870M | -39.6 | -7.1 | -9.6 | -25.7 | 47.8 | 4 | BEARISH | -38.7 |
| SPHRY Starpharma Holdings Limited | $220M | -26.9 | -46.5 | -441.4 | -725.1 | 186.8 | 4 | BEARISH | 64.3 |
| HRGN Harvard Apparatus Regenerative Technology Inc. | $30M | -4.9 | 239.0 | 256.6 | -409.4 | — | 2 | BEARISH | — |
| LPCN Lipocine Inc. | $10M | -0.8 | -60.9 | 662.3 | -1379.6 | -62.7 | 2 | BEARISH | -46.5 |
| BRAXF Braxia Scientific Corp. | — | -0.1 | -254.6 | -2393.3 | -184.2 | 27.6 | 3 | BEARISH | 0.0 |
| SIGY Sigyn Therapeutics, Inc. | — | -0.0 | 61.7 | 32.8 | — | -100.0 | 1 | BEARISH | -99.0 |
| VRPX Virpax Pharmaceuticals, Inc. | — | -0.0 | 2.6 | 0.4 | — | — | 1 | BEARISH | -96.2 |
| VRAX Virax Biolabs Group Limited | — | -0.0 | -110.9 | -481.7 | -40439.1 | 121.6 | 4 | BEARISH | 105.4 |
| ATXI Avenue Therapeutics, Inc. | — | -0.4 | -120.0 | 178.4 | — | -100.0 | 2 | BEARISH | -47.1 |
| SCNI Scinai Immunotherapeutics Ltd. | — | -0.0 | -19.2 | -53.3 | -435.4 | 162.7 | 2 | BEARISH | -63.4 |
| CALA Calithera Biosciences, Inc. | — | -0.0 | -141.5 | 979.6 | — | -100.0 | 1 | BEARISH | -50.0 |
| ANRO Alto Neuroscience, Inc. | $860M | -9.4 | -49.2 | -201.4 | — | — | 3 | BEARISH | 90.5 |
| ABUS Arbutus Biopharma Corp | $830M | 5.5 | 89.6 | 86.7 | -507.2 | 1078.8 | 4 | BEARISH | -3.4 |
| HOPHF Hemogenyx Pharmaceuticals Plc | $20M | -3.7 | -628.5 | -474.6 | — | — | 4 | BEARISH | 0.0 |
| NUVB Nuvation Bio Inc. | $1.6B | -10.6 | -47.8 | 70.2 | -198.3 | 1083.6 | 4 | BEARISH | -8.7 |
| AUTL Autolus Therapeutics plc | $410M | -1.5 | -132.9 | 451.5 | -85.6 | 292.0 | 3 | BEARISH | -1.2 |
| PLX Protalix BioTherapeutics, Inc. | $210M | 10.7 | 31.2 | 47.1 | 19.0 | 30.1 | 5 | BEARISH | 8.8 |
| RLYB Rallybio Corporation | $90M | 3.5 | 34.5 | -1198.7 | — | -35.6 | 6 | BEARISH | 2462.0 |
| ALZN Alzamend Neuro Inc | $10M | -0.5 | -163.2 | 401.5 | — | — | 1 | BEARISH | -51.4 |
| AFFY Affymax, Inc. | — | -0.0 | 98.1 | -302.0 | 17164.3 | -99.9 | 5 | BEARISH | -11.1 |
| OCUL Ocular Therapeutix, Inc. | $1.4B | -5.1 | -73.0 | -31671.3 | -584.5 | -8.1 | 3 | BEARISH | -36.9 |
| LRMR Larimar Therapeutics, Inc. | $240M | -1.3 | -139.6 | 590.9 | — | — | 2 | BEARISH | -41.5 |
| LXEO Lexeo Therapeutics, Inc. Common Stock | $230M | -2.7 | -46.8 | -249.1 | — | — | 3 | BEARISH | -68.2 |
| MENS Jyong Biotech Ltd. Ordinary Shares | $130M | — | — | — | — | — | — | BEARISH | -95.9 |
| ADAG Adagene Inc. | $90M | -5.7 | -28.6 | 111.8 | -1011.1 | 8927.0 | 5 | BEARISH | 44.3 |
| WINT Windtree Therapeutics, Inc. | — | -0.0 | 1111.0 | -2375.5 | — | — | 3 | BEARISH | -99.7 |
| SILO Silo Pharma, Inc. | — | -0.3 | -91.2 | 645.1 | — | -25.0 | 3 | BEARISH | 135.4 |
| OMER Omeros Corporation | $1.2B | 9.4 | -89.2 | 71.8 | 46.4 | — | 5 | BEARISH | 131.9 |
| AVBP ArriVent BioPharma, Inc. | $1.0B | -4.3 | -53.1 | 2345.1 | — | — | 3 | BEARISH | -19.3 |
| EPRX Eupraxia Pharmaceuticals Inc. | $450M | -7.2 | -68.6 | 8742.2 | — | — | 3 | BEARISH | 33.5 |
| CABA Cabaletta Bio, Inc. | $250M | -1.0 | -93.2 | -1308.0 | — | — | 3 | BEARISH | -45.5 |
| ARMP Armata Pharmaceuticals, Inc. | $140M | -0.6 | 127.8 | -54.7 | 2953.8 | -35.1 | 2 | BEARISH | -37.6 |
| VRXA Veraxa Biotech Holding AG | $140M | — | — | — | — | — | — | BEARISH | — |
| UNCY Unicycive Therapeutics, Inc. | $110M | -2.2 | -101.1 | 349.9 | — | — | 4 | BEARISH | -28.2 |
| INO Inovio Pharmaceuticals, Inc. | $60M | -0.8 | -409.9 | 257.7 | — | -100.0 | 1 | BEARISH | -62.7 |
| VERU Veru Inc. | $40M | -3.8 | -62.3 | -211.2 | — | -100.0 | 3 | BEARISH | -40.3 |
| ANVS Annovis Bio, Inc. | $40M | -0.6 | -703.7 | 170.2 | — | — | 1 | BEARISH | -52.6 |
| SEOVF Sernova Corp. | $30M | -3.7 | 57.0 | 76.3 | — | — | 3 | BEARISH | -35.6 |
| DVHGF Devonian Health Group, Inc. | $20M | — | -76.1 | -75.1 | -1098.1 | -91.5 | 1 | BEARISH | 37.7 |
| DYAI Dyadic International, Inc. | $20M | -1.8 | 522.6 | 1288.0 | -221.0 | 1.5 | 3 | BEARISH | -66.6 |
| BIORQ Biora Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| ATRX Adhera Therapeutics Inc | — | -0.0 | 18.6 | 6.5 | — | — | 1 | BEARISH | 0.0 |
| SXTP 60 Degrees Pharmaceuticals, Inc. | — | -0.1 | -321.8 | -390.2 | -1089.2 | 68.0 | 3 | BEARISH | -43.8 |
| EVGN Evogene Ltd. | — | -0.4 | 265.3 | 101.3 | -509.5 | -80.4 | 3 | BEARISH | -70.5 |
| BLEG Branded Legacy, Inc. | — | -0.0 | 2011.7 | 147.0 | — | -29.4 | 2 | BEARISH | -98.7 |
| CRIS Curis, Inc. | — | -0.0 | 455.3 | -23281.0 | — | -62.2 | 3 | BEARISH | -98.5 |
| AMPE Ampio Pharmaceuticals, Inc. | — | -0.0 | -114.0 | 1652.6 | -838.4 | — | 4 | BEARISH | 5806.4 |
| ORIC ORIC Pharmaceuticals, Inc. | $1.4B | -6.9 | -39.8 | -102.9 | — | — | 3 | BEARISH | -30.6 |
| KPRX Kiora Pharmaceuticals, Inc. | $10M | -0.9 | -56.4 | -2884.1 | — | — | 2 | BEARISH | -6.7 |
| BCTXZ BriaCell Therapeutics Corp. Warrant | — | -0.3 | -168.1 | -2016.9 | — | — | 1 | BEARISH | -69.3 |
| RAPP Rapport Therapeutics, Inc. Common Stock | $1.2B | -7.4 | -40.0 | 3981.5 | — | — | 4 | BEARISH | -15.0 |
| DRTS Alpha Tau Medical Ltd | $1.2B | -12.8 | -141.7 | -17.1 | — | — | 3 | BEARISH | 220.9 |
| MGTX MeiraGTx Holdings plc | $880M | 12.8 | 72.3 | 96.7 | 50.0 | 948.3 | 7 | BEARISH | 9.9 |
| ORMP Oramed Pharmaceuticals Inc. | $170M | 1.0 | 74.1 | -4.3 | — | -100.0 | 4 | BEARISH | 75.5 |
| BRIBF Brii Biosciences Limited | $90M | -3.5 | -10.3 | -62.6 | — | 22.5 | 4 | BEARISH | -46.0 |
| ELOX Eloxx Pharmaceuticals, Inc. | $40M | -8.6 | -107.5 | 81.5 | — | — | 4 | BEARISH | 1311999900.0 |
| SYBX Synlogic, Inc. | $10M | -19.6 | -5.3 | 306.3 | — | — | 2 | BEARISH | -40.7 |
| FBIOP Fortress Biotech, Inc. | $130M | 0.6 | 107.5 | -87.8 | -2.5 | 15.5 | 6 | BEARISH | 118.1 |
| ORGS Orgenesis Inc. | — | -0.0 | 764.3 | 1083.0 | 2628.2 | -192.0 | 1 | BEARISH | -74.1 |
| AVLN Avalyn Pharma Inc. Common Stock | $1.1B | — | — | — | — | — | — | BEARISH | — |
| APMD Apnimed, Inc. | $790M | — | — | — | — | — | — | BEARISH | — |
| CBIO Crescent Biopharma, Inc. | $480M | -1.8 | -107.7 | 1928.6 | — | — | 5 | BEARISH | 3.9 |
| KYTX Kyverna Therapeutics, Inc. | $330M | -2.0 | -87.2 | 14267.8 | — | — | 2 | BEARISH | -24.6 |
| MIST Milestone Pharmaceuticals Inc. | $80M | -1.1 | -35522.6 | 587.8 | -5118.8 | — | 5 | BEARISH | -62.3 |
| RECEF Recce Pharmaceuticals Ltd | $70M | -6.3 | 151.4 | 200.5 | — | -100.0 | 2 | BEARISH | -56.0 |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | $70M | -0.7 | -213.1 | 3515.1 | — | — | 4 | BEARISH | -35.7 |
| NMRA Neumora Therapeutics, Inc. Common Stock | $70M | -0.3 | -187.1 | 231.9 | — | — | 2 | BEARISH | -77.6 |
| CNTB Connect Biopharma Holdings Limited | $50M | -1.0 | -105.5 | 1034.1 | -1249.0 | 49.8 | 2 | BEARISH | -47.2 |
| CVM CEL-SCI Corporation | $30M | -0.6 | -252.5 | -142.9 | — | -100.0 | 4 | BEARISH | -82.3 |
| ARTL Artelo Biosciences, Inc. | $10M | -0.0 | -705.7 | -1031.2 | — | — | 5 | BEARISH | -92.2 |
| FNAM Evolutionary Genomics, Inc. | — | -0.0 | 62.2 | -99.6 | — | — | 2 | BEARISH | 0.0 |
| SYBE SYBLEU Inc | — | -3.1 | 71.5 | -202.2 | -685.7 | — | 2 | BEARISH | 0.0 |
| RGRX RegeneRx Biopharmaceuticals, Inc. | — | -0.0 | 53.5 | 45.8 | -2006.3 | -0.0 | 3 | BEARISH | 450.0 |
| BICTF Biocure Technology Inc. | — | -0.1 | -889.9 | 60.0 | — | — | 1 | BEARISH | 0.0 |
| GERN Geron Corporation | $720M | -9.7 | -29.2 | -74.1 | -29.0 | 24.4 | 2 | BEARISH | -24.3 |
| ZVRA Zevra Therapeutics, Inc. | $580M | 10.7 | 34.8 | -1356.4 | 22.1 | 119.4 | 6 | BEARISH | -7.0 |
| PHAT Phathom Pharmaceuticals, Inc. | $460M | -4.9 | 26.4 | 8.9 | -23.7 | 110.2 | 4 | BEARISH | -54.5 |
| FTH Faeth Therapeutics, Inc. | $440M | — | — | — | — | — | — | BEARISH | — |
| CLVLF Clinuvel Pharmaceuticals Limited | $250M | 10.7 | 13.2 | 126.7 | 41.1 | -1.1 | 6 | BEARISH | -32.0 |
| UPB Upstream Bio, Inc. | $150M | -1.0 | -46.0 | -1266.4 | -5136.1 | 49.2 | 3 | BEARISH | -82.1 |
| CUE Cue Biopharma, Inc. | $140M | -0.8 | -1603.5 | 1241.9 | -1943.2 | 354.4 | 3 | BEARISH | -8.4 |
| LENZ LENZ Therapeutics, Inc. | $100M | -0.8 | -59.2 | 17313.3 | -581.8 | 329.5 | 3 | BEARISH | -89.7 |
| ACRV Acrivon Therapeutics, Inc. Common Stock | $70M | -1.0 | -64.6 | 5251.5 | — | — | 1 | BEARISH | -14.3 |
| NDTP NDT Pharmaceuticals Inc. | $50M | -29.4 | -3.8 | -1.5 | -458.3 | — | 4 | BEARISH | -87.3 |
| INNMF Amplia Therapeutics Limited | $30M | -5.1 | -24.9 | -86.9 | — | -100.0 | 2 | BEARISH | 10.2 |
| RVXCF Resverlogix Corp. | $20M | -1.5 | 11.5 | 25.3 | — | — | 4 | BEARISH | -30.1 |
| DTCFF Defence Therapeutics Inc. | $20M | -3.1 | -237.8 | -86.8 | — | — | 4 | BEARISH | -56.4 |
| OTLC Oncotelic Therapeutics, Inc. | $10M | 0.0 | 181.4 | -1.4 | 155.3 | — | 5 | BEARISH | -82.1 |
| ICU SeaStar Medical Holding Corporation | $10M | -0.6 | -356.9 | 415.0 | -606.5 | 123.6 | 4 | BEARISH | -58.3 |
| INTS Intensity Therapeutics, Inc. | $10M | -0.7 | -195.9 | 4123.4 | — | — | 5 | BEARISH | -44.7 |
| PLRZ Polyrizon Ltd. | $10M | -1.9 | -21.4 | -68.2 | — | — | 0 | BEARISH | 31.6 |
| PHIO Phio Pharmaceuticals Corp. | $10M | -0.7 | -113.7 | 2701.6 | — | — | 2 | BEARISH | -57.6 |
| CDT CDT Equity Inc. | — | -0.0 | 13.1 | 5.4 | 9.1 | — | 7 | BEARISH | -97.5 |
| APUS Apimeds Pharmaceuticals US, Inc | — | -0.1 | -100.1 | -12.6 | — | — | 2 | BEARISH | -84.5 |
| ADTX Aditxt, Inc. | — | -0.0 | 622.6 | 49.4 | -131159.8 | -74.1 | 1 | BEARISH | -100.0 |
| AMBS Amarantus BioScience Holdings, Inc. | — | -0.0 | 7.3 | 3.8 | -4080.5 | — | 3 | BEARISH | -66.7 |
| YECO EV Biologics, Inc. | — | -0.0 | 16.2 | 18.1 | 18.6 | 264.7 | 5 | BEARISH | -99.9 |
| BRTX BioRestorative Therapies, Inc. | — | -0.1 | -241.1 | 2112.9 | -9298.3 | -8.5 | 3 | BEARISH | -95.5 |
| AFMDQ Affimed N.V. | — | — | — | — | — | — | — | BEARISH | — |
| SPRC SciSparc Ltd. | — | -0.0 | -519.9 | -161.9 | -1891.2 | -26.8 | 5 | BEARISH | -78.1 |
| MTNB Matinas BioPharma Holdings, Inc. | — | -0.1 | -154.3 | -504.1 | — | — | 4 | BEARISH | -91.7 |
| AGNPF Grey Matters Health Inc. | — | — | -140.9 | -64.7 | — | — | 3 | BEARISH | -51.7 |
| VBIO Valion Bio, Inc. | — | -0.0 | -240.8 | -48.0 | — | -281.4 | 2 | BEARISH | — |
| RGBPP Regen BioPharma, Inc. | — | -0.0 | 20.3 | 12.8 | -1079.8 | 0.0 | 4 | BEARISH | -98.5 |
| NVAX Novavax, Inc. | $1.6B | -6.8 | 323.7 | 29.2 | -94.2 | -61.6 | 2 | BEARISH | 18.6 |
| PRQR ProQR Therapeutics N.V. | $180M | -3.2 | -57.9 | 139.7 | -99.6 | 12.7 | 2 | BEARISH | -50.7 |
| AMGXF AnGes, Inc. | $140M | -3.0 | -160.6 | -111.8 | -531.3 | -16.1 | 4 | BEARISH | 0.0 |
| BBIXF Bonus BioGroup Ltd. | $50M | -17.2 | 3245.0 | 2543.1 | — | — | 2 | BEARISH | 13233.3 |
| INTI Inhibitor Therapeutics, Inc. | $10M | -4.2 | 358.8 | 88.0 | — | — | 1 | BEARISH | 59.8 |
| MYMX Mymetics Corporation | — | -0.0 | 16.6 | 357.9 | -3012.0 | -62.8 | 2 | BEARISH | 0.0 |
| NWPHF Newron Pharmaceuticals S.p.A. | $410M | -6.6 | 83.9 | -32.1 | -513.4 | — | 1 | BEARISH | — |
| VRXAW Veraxa Biotech AG | — | — | — | — | — | — | — | BEARISH | — |
| SRNE Sorrento Therapeutics, Inc. | — | -0.0 | 1502.8 | 468.4 | -633.7 | 16.9 | 2 | BEARISH | -98.3 |
| SNDX Syndax Pharmaceuticals, Inc. | $1.2B | -5.7 | -255.9 | -270.9 | -67.8 | 222.3 | 4 | BEARISH | 9.2 |
| CTMX CytomX Therapeutics, Inc. | $510M | -5.2 | -37.8 | 305.9 | -1457.4 | -87.0 | 2 | BEARISH | -29.8 |
| ASMB Assembly Biosciences, Inc. | $400M | 37.4 | -0.0 | 56.2 | -28.8 | 125.1 | 4 | BEARISH | -31.0 |
| MPLT MapLight Therapeutics, Inc. | $340M | -1.5 | -57.5 | -366.6 | — | — | 2 | BEARISH | -56.5 |
| CTNM Contineum Therapeutics, Inc. | $270M | -5.3 | -28.0 | -541.6 | — | — | 4 | BEARISH | -18.4 |
| ABEO Abeona Therapeutics Inc. | $250M | -4.0 | -43.1 | -5983.3 | -177.4 | 6280.0 | 2 | BEARISH | -17.9 |
| CRBU Caribou Biosciences, Inc. | $60M | -0.5 | -78.3 | -695.0 | -1619.9 | 10.0 | 3 | BEARISH | -80.0 |
| IBIO iBio, Inc. | $50M | -2.5 | -65.7 | 21688.6 | — | -75.0 | 4 | BEARISH | -37.2 |
| CLRB Cellectar Biosciences, Inc. | $10M | -0.3 | -119.6 | 717.6 | — | — | 3 | BEARISH | -65.5 |
| AIM AIM ImmunoTech Inc. | $10M | -0.0 | -2382.3 | -513.5 | -14569.2 | -21.5 | 5 | BEARISH | -93.3 |
| BTAIQ BioXcel Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| ASCLF Ascletis Pharma Inc. | $770M | -7.8 | -28.4 | -7144.0 | — | -60.6 | 2 | BEARISH | -40.0 |
| ACHV Achieve Life Sciences, Inc. | $670M | -4.4 | -845.0 | 24.6 | — | — | 2 | BEARISH | 46.4 |
| NVCT Nuvectis Pharma, Inc. | $650M | -14.0 | -214.6 | 174.4 | — | — | 1 | BEARISH | 180.3 |
| IRD Opus Genetics, Inc. | $290M | -2.9 | -4796.5 | 59.8 | -1072.6 | -36.1 | 3 | BEARISH | 84.0 |
| PALI Palisade Bio, Inc. | $230M | -2.2 | -51.4 | 815.6 | -2114.8 | — | 5 | BEARISH | -28.3 |
| GALT Galectin Therapeutics Inc. | $210M | -8.3 | 21.9 | 99.4 | — | — | 2 | BEARISH | -30.6 |
| MGNX MacroGenics, Inc. | $140M | -11.2 | -32.6 | 33.8 | 59.4 | 2.3 | 2 | BEARISH | 29.3 |
| SEER Seer, Inc. | $110M | -1.6 | -26.4 | -58.8 | -544.8 | -13.3 | 3 | BEARISH | -16.0 |
| COYA Coya Therapeutics, Inc. | $90M | -3.8 | -60.5 | -18820.6 | -2723.4 | 1793.8 | 4 | BEARISH | -37.2 |
| MNOV MediciNova, Inc. | $70M | -6.8 | -25.6 | -78.2 | -504.8 | 583.9 | 3 | BEARISH | 21.5 |
| OSTX OS Therapies Incorporated | $60M | -1.1 | 1924.5 | 268.9 | — | — | 1 | BEARISH | -35.2 |
| HRTX Heron Therapeutics, Inc. | $60M | -1.7 | 334.6 | -7.6 | -14.6 | 1.0 | 3 | BEARISH | -73.8 |
| XLO Xilio Therapeutics, Inc. | $50M | -5.4 | -55.0 | 43.1 | -34.1 | 327.3 | 6 | BEARISH | 864.5 |
| GANX Gain Therapeutics, Inc. | $50M | -2.4 | -268.3 | 1288.8 | — | — | 4 | BEARISH | -38.5 |
| ALPS Alps Group Inc | $50M | — | — | — | — | — | — | BEARISH | — |
| MREO Mereo BioPharma Group plc | $40M | -1.6 | -67.8 | 6194.3 | — | -100.0 | 2 | BEARISH | -85.2 |
| DWTX Dogwood Therapeutics, Inc. | $40M | -0.1 | -47.8 | -39.7 | — | — | 2 | BEARISH | -79.9 |
| PVCT Provectus Biopharmaceuticals, Inc. | $20M | -3.9 | 78.1 | 83.4 | — | -100.0 | 5 | BEARISH | -37.8 |
| COCP Cocrystal Pharma, Inc. | $20M | -1.2 | -311.7 | -3697.6 | -3013.3 | — | 2 | BEARISH | -18.7 |
| IMRN Immuron Limited | $10M | -2.5 | -40.2 | -187.8 | -54.4 | -29.7 | 5 | BEARISH | -59.1 |
| PHYOF IXICO plc | $10M | -6.0 | -15.8 | -23.6 | -28.5 | 13.2 | 2 | BEARISH | 0.0 |
| PASG Passage Bio, Inc. | $10M | -0.3 | -169.1 | 159.0 | — | — | 3 | BEARISH | -53.2 |
| GLWLF Glow Lifetech Corp. | $10M | -50.0 | -11.1 | -21.1 | -26.6 | 59.2 | 5 | BEARISH | -16.1 |
| EVLO Evelo Biosciences, Inc. | — | -0.0 | 948.0 | 605.0 | — | — | 2 | BEARISH | -80.0 |
| ISCO International Stem Cell Corporation | — | -2.7 | 30.4 | -10.8 | -2.7 | 3.4 | 6 | BEARISH | 16.0 |
| HMGN Hemagen Diagnostics, Inc. | — | -0.0 | 29.1 | -24.6 | -18.6 | -21.4 | 2 | BEARISH | 100.0 |
| RCAR RenovaCare, Inc. | — | -0.0 | -436.6 | 812.3 | — | — | 2 | BEARISH | -99.0 |
| ELAB PMGC Holdings Inc. | — | -0.0 | -73.0 | -66.6 | -225.1 | 408.6 | 3 | BEARISH | -100.0 |
| CHMMF Chimeric Therapeutics Limited | — | -0.0 | 655.2 | 80.8 | — | -100.0 | 2 | BEARISH | 0.0 |
| LIANY LianMedical | — | 1.0 | 74.7 | -612.1 | — | — | 6 | BEARISH | -35.6 |
| VCNX Vaccinex, Inc. | — | -0.4 | 776.6 | 414.6 | -1584.0 | 226.6 | 3 | BEARISH | 4.2 |
| AXIM AXIM Biotechnologies, Inc. | — | -1.6 | 3.0 | 24.9 | -90.9 | 2142.6 | 5 | BEARISH | -62.7 |
| LNAI Lunai Bioworks Inc. | — | -0.3 | -21.6 | 30.2 | — | — | 2 | BEARISH | -97.2 |
| IMMX Immix Biopharma, Inc. | $680M | -9.2 | -34.2 | 1509.2 | — | — | 4 | BEARISH | 139.8 |
| LXRX Lexicon Pharmaceuticals, Inc. | $630M | -9.9 | -40.2 | -99.7 | -4591.8 | -29.0 | 3 | BEARISH | 28.4 |
| CADL Candel Therapeutics, Inc. | $610M | -6.1 | -81.8 | 219.4 | — | — | 2 | BEARISH | 60.6 |
| MDXG MiMedx Group, Inc. | $570M | -30.4 | 2.9 | 5.8 | -23.1 | -2.4 | 6 | BEARISH | -41.3 |
| AVIR Atea Pharmaceuticals, Inc. | $320M | -2.1 | -58.1 | 974.6 | — | — | 3 | BEARISH | 31.4 |
| IKT Inhibikase Therapeutics, Inc. | $220M | -3.4 | -52.0 | 920.5 | — | — | 3 | BEARISH | 3.9 |
| INMB INmune Bio, Inc. | $40M | -2.2 | -74.8 | -475.4 | — | -100.0 | 2 | BEARISH | -16.9 |
| BMEA Biomea Fusion, Inc. | $40M | -1.3 | -164.1 | 210.3 | — | — | 2 | BEARISH | -54.4 |
| CELU Celularity Inc. | $30M | -0.5 | 150.9 | 40592.8 | 13.0 | -58.1 | 4 | BEARISH | -55.0 |
| AVEFF Avecho Biotechnology Limited | $20M | -9.3 | -268.2 | 103.4 | -3227.5 | -46.6 | 3 | BEARISH | 0.0 |
| SER Serina Therapeutics, Inc. | $20M | -0.9 | -206.3 | 1868.6 | — | -100.0 | 3 | BEARISH | -67.7 |
| CMMB Chemomab Therapeutics Ltd. | $10M | -1.1 | -82.7 | -314.7 | — | — | 1 | BEARISH | -63.9 |
| CPMV Mosaic ImmunoEngineering Inc. | — | -2.8 | 9.2 | 7.5 | — | — | 2 | BEARISH | -73.2 |
| XRTX XORTX Therapeutics Inc. | — | -0.4 | -99.1 | -68.5 | — | — | 3 | BEARISH | 63.0 |
| OZYMF Strategic Partners A/S | — | 20.1 | 0.8 | -117.5 | 1019.0 | — | 6 | BEARISH | 0.0 |
| GNLKQ GeneLink, Inc. | — | -0.0 | 73.0 | 82.1 | -183.0 | -33.6 | 3 | BEARISH | 0.0 |
| GLABF Gemina Laboratories Ltd. | — | -3.0 | 42.7 | 32.4 | -7838.5 | — | 5 | BEARISH | -78.3 |
| PBM Psyence Biomedical Ltd. | — | — | — | — | — | — | — | BEARISH | 4.3 |
| HXBM Helix BioMedix, Inc. | — | — | — | — | — | — | — | BEARISH | -6.0 |
| KRSA Korsana Biosciences, Inc. | $150M | — | — | — | — | — | — | BEARISH | — |
| HBMHF HBM Holdings Limited | $1.3B | 12.7 | 24.1 | 53.0 | 53.0 | 54.6 | 4 | BEARISH | -38.1 |
| GPCR Structure Therapeutics Inc. | $1.2B | -7.1 | -20.2 | -1134.3 | — | — | 3 | BEARISH | -25.0 |
| ARDX Ardelyx, Inc. | $770M | -13.7 | -38.6 | -22.7 | -13.8 | 16.8 | 4 | BEARISH | -39.2 |
| SLBT SL Science Holding Ltd | $640M | — | — | — | — | — | — | BEARISH | — |
| PROK ProKidney Corp. | $470M | -2.7 | 9.2 | 13.2 | -18948.0 | 55.2 | 1 | BEARISH | -52.8 |
| ACIU AC Immune S.A. | $250M | -4.6 | -78.5 | 96.7 | 12.4 | -39.5 | 2 | BEARISH | -34.0 |
| BOVNF BioInvent International AB (publ) | $220M | -2.7 | -88.2 | 19958.5 | -964.0 | -87.2 | 1 | BEARISH | 0.0 |
| BBOT BridgeBio Oncology Therapeutics Inc. | $210M | -0.0 | -56.4 | -157.3 | — | — | 1 | BEARISH | -75.2 |
| IVVD Invivyd, Inc. | $180M | -1.6 | -95.9 | -302.5 | -310.8 | 26.3 | 2 | BEARISH | -71.3 |
| SION Sionna Therapeutics, Inc. | $160M | -1.9 | -32.3 | -137.7 | — | — | 0 | BEARISH | -89.5 |
| CBUS Cibus, Inc. | $110M | -0.9 | -225.9 | -157.2 | -2227.9 | -10.3 | 2 | BEARISH | -14.6 |
| VYGR Voyager Therapeutics, Inc. | $110M | -1.0 | -54.1 | -131.1 | -773.2 | -19.1 | 2 | BEARISH | -61.8 |
| VXRT Vaxart, Inc. | $100M | 2.7 | 67.0 | 149.6 | -49.6 | 201.1 | 6 | BEARISH | 13.3 |
| ENGN enGene Holdings Inc. | $100M | -5.6 | -2.3 | 134.1 | — | -100.0 | 2 | BEARISH | -80.2 |
| TNYA Tenaya Therapeutics, Inc. | $90M | -0.8 | -121.9 | 1769.3 | -3909.3 | — | 3 | BEARISH | -75.7 |
| HBPCF Helix BioPharma Corp. | $60M | -22.5 | -50.8 | -21.5 | — | — | 3 | BEARISH | -55.5 |
| PLRX Pliant Therapeutics, Inc. | $50M | -0.6 | -50.3 | -438.3 | — | — | 3 | BEARISH | -50.6 |
| KLRS Kalaris Therapeutics Inc | $40M | -1.0 | -79.9 | 109.5 | — | — | 0 | BEARISH | -58.6 |
| ALGS Aligos Therapeutics, Inc. | $30M | -0.7 | -113.6 | -1246.4 | -5.4 | 893.0 | 2 | BEARISH | -47.1 |
| BYSI BeyondSpring Inc. | $20M | -3.2 | 20.3 | 15.7 | — | 100.0 | 2 | BEARISH | -70.7 |
| NEUP Neuphoria Therapeutics Inc. | $20M | -0.5 | -0.2 | -0.2 | -417.7 | -91.9 | 4 | BEARISH | -25.8 |
| PRRUF Immutep Limited | $20M | -0.5 | -77.3 | 1092.5 | -328.8 | 255.0 | 3 | BEARISH | -89.5 |
| QNRX Quoin Pharmaceuticals, Ltd. | $10M | -0.3 | -578.6 | 221.3 | — | — | 1 | BEARISH | -68.9 |
| MSLE Satellos Bioscience Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| ANEB Anebulo Pharmaceuticals, Inc. | $10M | -1.8 | -69.7 | 650.7 | — | — | 1 | BEARISH | -89.8 |
| TCRX TScan Therapeutics, Inc. | $10M | -0.2 | -95.8 | -159.4 | -2888.6 | 2.2 | 2 | BEARISH | -91.3 |
| FBLG FibroBiologics, Inc. Common Stock | $10M | -0.2 | -660.1 | -511.6 | — | — | 4 | BEARISH | -88.8 |
| CDIO Cardio Diagnostics Holdings, Inc. | $10M | -0.6 | -75.4 | -230.9 | -28012.5 | -25.9 | 3 | BEARISH | -56.5 |
| APRE Aprea Therapeutics, Inc. | $10M | -0.5 | -47.4 | 378.1 | — | -99.8 | 2 | BEARISH | -59.7 |
| BCDA BioCardia, Inc. | $10M | -1.2 | -1803.2 | 519.4 | — | — | 3 | BEARISH | -27.5 |
| HCWB HCW Biologics Inc. | — | -0.0 | -133.5 | -36.8 | -3849.9 | 707.0 | 3 | BEARISH | -94.7 |
| USRM U.S. Stem Cell, Inc. | — | -0.0 | 20.8 | 23.4 | -2836.8 | -59.1 | 5 | BEARISH | -99.0 |
| ARNI Arno Therapeutics, Inc. | — | -0.0 | 250.7 | 111.6 | — | — | 3 | BEARISH | 0.0 |
| ENZC Enzolytics Inc. | — | -14.9 | 105.9 | 1.4 | — | — | 7 | BEARISH | 0.0 |
| EVFM Evofem Biosciences, Inc. | — | -0.1 | 20.1 | 26.0 | -419.1 | 4.5 | 2 | BEARISH | -45.6 |
| BBLG Bone Biologics Corporation | — | -0.2 | -47.5 | 1744.6 | — | — | 2 | BEARISH | -81.8 |
| MBIO Mustang Bio, Inc. | — | -0.8 | -58.1 | 36.6 | — | — | 2 | BEARISH | -76.4 |
| LIMN Liminatus Pharma, Inc. Class A Common Stock | — | -0.1 | 294.4 | 252.1 | — | — | 4 | BEARISH | -95.4 |
| BIOAF Bioasis Technologies Inc. | — | -0.1 | 135.1 | 538.8 | -661.8 | 614.1 | 2 | BEARISH | -50.0 |
| NCEL NewcelX Ltd. | — | 8.2 | -48.0 | -39.1 | — | — | 2 | BEARISH | -79.0 |
| SEPSF Asep Medical Holdings Inc | — | -0.3 | -36.4 | -75.5 | -844.8 | 208.8 | 5 | BEARISH | -97.2 |
| ENLV Enlivex Therapeutics Ltd. | — | 0.0 | 209.7 | -0.4 | — | — | 5 | BEARISH | -99.0 |
| ENDV Endonovo Therapeutics, Inc. | — | -0.1 | 9.2 | 4.5 | — | -100.0 | 3 | BEARISH | -50.0 |
| ARUXF Acrux Limited | — | -7.1 | -48.5 | -74.2 | -26.5 | 289.9 | 7 | BEARISH | -90.0 |
| MYNDF MYND Life Sciences Inc. | — | -2.2 | 9.5 | 34.0 | — | — | 5 | BEARISH | -41.3 |
| INBX Inhibrx Biosciences Inc. | $1.4B | -8.3 | -1773.6 | 55.8 | — | -100.0 | 4 | BEARISH | 24.5 |
| SKYE Skye Bioscience, Inc. | $10M | -0.1 | -233.9 | 389.5 | — | — | 3 | BEARISH | -3.1 |
| PTIX Protagenic Therapeutics, Inc. | — | 0.2 | -485.4 | -367.8 | — | 100.0 | 6 | BEARISH | -78.7 |
| EMMA Emmaus Life Sciences, Inc. | — | -0.4 | 9.9 | -9.3 | 21.2 | 11.0 | 4 | BEARISH | 299.0 |
| PHRRF PharmaTher Holdings Ltd. | — | -8.3 | -76.9 | 234.4 | — | — | 2 | BEARISH | -54.3 |
| LIMNW Liminatus Pharma, Inc. Warrants | — | -0.1 | -4165.9 | 252.1 | — | — | 2 | BEARISH | -75.0 |
| URGN UroGen Pharma Ltd. | $1.7B | -17.0 | 86.5 | 119.0 | -19.8 | 169.5 | 2 | BEARISH | 61.9 |
| MDCLF MedinCell S.A. | $1.1B | -29.2 | 472.2 | 81.6 | -152.1 | -14.8 | 3 | BEARISH | 333.5 |
| ANL Adlai Nortye Ltd. | $560M | -5.2 | -22.4 | -317.5 | -36.3 | 223.4 | 4 | BEARISH | 575.5 |
| GNFTF Genfit S.A. | $470M | -5.6 | -5084.0 | -322.7 | -124.0 | 27.5 | 3 | BEARISH | 153.5 |
| ARTV Artiva Biotherapeutics, Inc. | $300M | -1.3 | -36.6 | -954.6 | — | — | 3 | BEARISH | -15.1 |
| TRGNF Transgene S.A. | $120M | -4.4 | -64.1 | -184.9 | -5760.7 | -185.8 | 4 | BEARISH | -53.1 |
| PRNAF Alterity Therapeutics Limited | $50M | -2.3 | -55.0 | -401.1 | — | -100.0 | 2 | BEARISH | 8233.3 |
| TVGN Tevogen Bio Holdings Inc. | $30M | -1.1 | 235.3 | 244.1 | — | — | 5 | BEARISH | 860.5 |
| BMNDF Biomind Labs Inc. | $20M | -13.3 | 85.8 | 101.7 | — | — | 2 | BEARISH | 1483.5 |
| RMTG Regenerative Medical Technology Group Inc. | — | -0.0 | 9.6 | -3.3 | -72.2 | — | 3 | BEARISH | — |
| GENSF Genus plc | $1.8B | 5.4 | 45.4 | 9.0 | 80.4 | -3.8 | 5 | BEARISH | -19.4 |
| AGMB AgomAb Therapeutics N.V. American Depositary Shares | $450M | — | — | — | — | — | — | BEARISH | — |
| AVCTF Avacta Group Plc | $420M | -6.7 | -2083.2 | -753.6 | -33970.3 | -99.7 | 5 | BEARISH | -18.7 |
| ALT Altimmune, Inc. | $410M | -2.7 | -28.9 | -43.1 | — | 55.0 | 4 | BEARISH | -47.0 |
| AVTX Avalo Therapeutics, Inc. | $370M | -1.5 | -36.3 | -148.4 | — | -86.6 | 4 | BEARISH | -60.4 |
| CAPR Capricor Therapeutics, Inc. | $340M | -2.5 | -73.7 | -107.5 | — | -100.0 | 3 | BEARISH | 0.8 |
| SPHDF Santhera Pharmaceuticals Holding AG | $280M | -6.6 | 729.6 | 111.3 | -44.5 | 106.3 | 7 | BEARISH | 49.1 |
| ORYZF Oryzon Genomics S.A. | $250M | -79.9 | -3.0 | -7.2 | -1.6 | 12.6 | 4 | BEARISH | -14.1 |
| OCGN Ocugen, Inc. | $250M | -3.1 | 1211.7 | 190.2 | -1671.8 | -3.7 | 2 | BEARISH | -50.2 |
| SCTX Scribe Therapeutics Inc. | $250M | — | — | — | — | — | — | BEARISH | — |
| HLOSF Healios K.K. | $240M | 57.1 | 3.7 | -129.2 | 17028.6 | -47.1 | 4 | BEARISH | -48.6 |
| IPHYF Innate Pharma S.A. | $210M | -2.5 | 267.9 | 125.3 | -343.8 | 32.0 | 3 | BEARISH | -24.5 |
| NBP NovaBridge Biosciences | $160M | -2.2 | -45.7 | -617.8 | — | — | 1 | BEARISH | -73.2 |
| ZNTL Zentalis Pharmaceuticals, Inc. | $160M | -0.8 | -83.7 | -2245.4 | — | -100.0 | 2 | BEARISH | 19.8 |
| STRO Sutro Biopharma, Inc. | $150M | -0.5 | 266.8 | 43.6 | -391.6 | -56.3 | 4 | BEARISH | -19.9 |
| NGEN NervGen Pharma Corp. Common stock | $150M | — | — | — | — | — | — | BEARISH | — |
| CMPX Compass Therapeutics, Inc. | $140M | -1.8 | -56.7 | 1526.3 | — | — | 4 | BEARISH | -81.2 |
| CDXS Codexis, Inc. | $140M | -3.8 | -69.4 | -37.8 | -80.5 | 35.9 | 3 | BEARISH | -51.5 |
| NKTX Nkarta, Inc. | $130M | -1.1 | -38.8 | -75.4 | — | — | 1 | BEARISH | -18.1 |
| AVXL Anavex Life Sciences Corp. | $120M | -5.0 | -23.6 | 411.7 | — | — | 2 | BEARISH | -84.7 |
| VTVT vTv Therapeutics Inc. | $100M | -233.8 | -11.7 | 91.2 | — | 216600.0 | 4 | BEARISH | 21.4 |
| VANI Vivani Medical, Inc. | $100M | -3.3 | -220.4 | -127.1 | — | — | 4 | BEARISH | -29.6 |
| ORPOF OSE Immunotherapeutics S.A. | $100M | — | — | — | — | — | — | BEARISH | — |
| TNXP Tonix Pharmaceuticals Holding Corp. | $90M | -0.4 | -81.8 | -276.2 | -299.4 | 196.0 | 3 | BEARISH | -73.6 |
| CNXU Conexeu Sciences Inc. | $90M | — | — | — | — | — | — | BEARISH | — |
| JWCTF JW (Cayman) Therapeutics Co. Ltd | $80M | -2.4 | -49.0 | -68.1 | -45.3 | 60.7 | 3 | BEARISH | -55.3 |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | $80M | -0.7 | -95.6 | 738.2 | — | — | 1 | BEARISH | -75.0 |
| CRDF Cardiff Oncology, Inc. | $70M | -1.5 | -94.1 | 443.4 | -8876.9 | -7.0 | 3 | BEARISH | -60.8 |
| PTHS Pelthos Therapeutics Inc. | $70M | -0.4 | 4767.3 | -97.0 | -150.1 | — | 2 | BEARISH | -49.1 |
| CGTX Cognition Therapeutics, Inc. | $70M | -3.9 | -83.8 | 6061.8 | — | — | 3 | BEARISH | -55.4 |
| XBIT XBiotech Inc. | $60M | -1.3 | -29.9 | -201.2 | — | — | 2 | BEARISH | -22.6 |
| TLSA Tiziana Life Sciences Ltd | $60M | -4.6 | -780.6 | 375.0 | — | — | 1 | BEARISH | -49.7 |
| VTIAF FamiCord AG | $50M | -6.4 | -84.3 | -13.6 | -5.1 | 0.1 | 5 | BEARISH | -55.7 |
| HYFT MindWalk Holdings Corp. | $50M | -4.5 | -123.5 | -481.3 | -158.7 | -15.9 | 4 | BEARISH | -31.8 |
| EXOZ eXoZymes, Inc. | $40M | -3.5 | -187.2 | 913.0 | — | — | 2 | BEARISH | -65.9 |
| ACET Adicet Bio, Inc. | $40M | -0.3 | -78.1 | -553.5 | — | — | 4 | BEARISH | -73.6 |
| RANI Rani Therapeutics Holdings, Inc. | $40M | -2.3 | -179.1 | 245.5 | -432.7 | 306.4 | 5 | BEARISH | -65.4 |
| ALDX Aldeyra The | $40M | -1.8 | -49.5 | 269.3 | — | — | 4 | BEARISH | -86.9 |
| IXHL Incannex Healthcare Limited | $30M | -2.4 | -31.9 | 5284.2 | — | -100.0 | 4 | BEARISH | -74.2 |
| AARD Aardvark Therapeutics, Inc. Common Stock | $30M | -0.5 | -66.0 | -3642.4 | — | — | 1 | BEARISH | -87.1 |
| BCTX BriaCell Therapeutics Corp. | $30M | -0.3 | -179.9 | -2435.2 | — | — | 2 | BEARISH | -73.9 |
| FLNA Filana Therapeutics, Inc. | $30M | -0.7 | -13.5 | 38.9 | — | — | 2 | BEARISH | — |
| MGX Metagenomi, Inc. Common Stock | $30M | -0.3 | -60.6 | -268.2 | 10693.4 | -59.8 | 1 | BEARISH | -70.0 |
| KYNB Kyntra Bio, Inc. | $20M | 0.1 | -115.2 | 29.6 | -812.3 | — | 2 | BEARISH | — |
| MVMDF More Life Company Corp. | $20M | -5.2 | -167.0 | -602.2 | -5006.5 | 43.0 | 4 | BEARISH | 115.8 |
| TELIF Telescope Innovations Corp. | $20M | 5.5 | -229.2 | -80.7 | -116.8 | 66.3 | 2 | BEARISH | -19.4 |
| MCRB Seres Therapeutics, Inc. | $20M | -0.8 | -66.6 | -87.8 | 622.4 | — | 3 | BEARISH | -89.6 |
| ATYR aTyr Pharma, Inc. | $20M | -0.2 | -98.4 | -1890.1 | — | — | 2 | BEARISH | -86.8 |
| TRAW Traws Pharma, Inc. | $10M | -0.7 | -711.4 | 133.9 | — | -100.0 | 1 | BEARISH | -86.2 |
| TOVX Theriva Biologics, Inc. | $10M | -0.3 | -101.9 | -213.5 | — | — | 2 | BEARISH | -42.0 |
| PTN Palatin Technologies, Inc. | $10M | -1.0 | -877.5 | 1176.9 | -1449.1 | — | 5 | BEARISH | -12.7 |
| GUTS Fractyl Health, Inc. | $10M | -0.1 | 1063.0 | -568.7 | — | -100.0 | 5 | BEARISH | -94.3 |
| VTGN VistaGen Therapeutics, Inc. | $10M | -0.1 | -166.5 | 851.1 | -882.8 | 287.3 | 4 | BEARISH | -95.6 |
| OPTBF OptiBiotix Health Plc | $10M | -1.4 | -102.1 | -102.1 | -231.5 | -12.9 | 4 | BEARISH | 109900.0 |
| TPST Tempest Therapeutics, Inc. | $10M | -0.1 | -931.1 | -564.2 | — | — | 1 | BEARISH | -95.1 |
| INAB IN8bio, Inc. | $10M | -0.5 | -111.1 | -576.1 | — | — | 4 | BEARISH | -53.3 |
| QNTM Quantum BioPharma Ltd. | $10M | -0.4 | -425.3 | 175.1 | — | — | 4 | BEARISH | -82.3 |
| IMNN Imunon, Inc. | $10M | -0.2 | -429.7 | -226.7 | — | — | 2 | BEARISH | -82.4 |
| GTBP GT Biopharma, Inc. | $10M | -0.1 | -798.9 | 927.8 | — | — | 2 | BEARISH | -68.3 |
| TVRD Tvardi Therapeutics, Inc. | $10M | -0.3 | -126.2 | 296.9 | — | — | 1 | BEARISH | -81.8 |
| PXXLF Poxel S.A. | $10M | -0.4 | 34.8 | 129.6 | -624.6 | 41.5 | 4 | BEARISH | -12.0 |
| DARE Dare Bioscience, Inc. | $10M | -0.9 | 165.3 | 136.8 | -1590.4 | 7816.7 | 3 | BEARISH | -66.5 |
| HIND Vyome Holdings, Inc. | $10M | -0.1 | -193.1 | 516.3 | -2543.3 | -98.0 | 4 | BEARISH | -68.8 |
| GSGTF GenSight Biologics S.A. | $10M | -1.0 | 46.5 | 47.3 | 1190.6 | -401.7 | 3 | BEARISH | -57.9 |
| OGEN Oragenics, Inc. | — | -0.1 | -1307.1 | 4273.7 | — | — | 3 | BEARISH | -71.9 |
| GSTC GlobeStar Therapeutics Corporation | — | -0.0 | 60.9 | 49.1 | — | — | 4 | BEARISH | -99.0 |
| SUVZ Suvanza Pharma, LLC | — | — | — | — | — | — | — | BEARISH | 0.0 |
| LABT Lakewood-Amedex Biotherapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| RADX Radiopharm Theranostics Limited | — | — | — | — | — | — | — | BEARISH | -82.0 |
| MBAI MBody AI Ltd. | — | — | — | — | — | — | — | BEARISH | — |
| EFTR eFFECTOR Therapeutics, Inc. | — | -0.0 | 1737.6 | 607.9 | — | -91.9 | 4 | BEARISH | 0.0 |
| DCOY Decoy Therapeutics Inc. | — | — | — | — | — | — | — | BEARISH | — |
| RASP Actavia Life Sciences, Inc. | — | -0.1 | 20.1 | 14.5 | — | — | 2 | BEARISH | -87.5 |
| CLDI Calidi Biotherapeutics, Inc. | — | -0.0 | -713.6 | -1404.6 | — | — | 4 | BEARISH | -97.2 |
| GNPX Genprex, Inc. | — | -0.0 | -203.9 | 3484.8 | — | — | 4 | BEARISH | -99.0 |
| KALA KALA BIO, Inc. | — | -0.0 | -345.3 | -913.5 | — | -100.0 | 4 | BEARISH | -99.5 |
| TSOI Therapeutic Solutions International, Inc. | — | -0.1 | -187.6 | -130.3 | -5123.0 | -99.7 | 4 | BEARISH | 0.0 |
| WSNAF Wesana Health Holdings Inc. | — | -0.1 | 1113.6 | 90.8 | — | — | 3 | BEARISH | -80.1 |
| CEROW CERo Therapeutics Holdings, Inc. | — | -0.0 | 101.5 | 60.5 | — | -100.0 | 1 | BEARISH | -84.2 |
| NBRVF Nabriva Therapeutics plc | — | — | — | — | — | — | — | BEARISH | -0.0 |
| BNIGF Beroni Group Limited | — | -0.1 | -1153.4 | -274.8 | -15945.7 | 40.9 | 5 | BEARISH | 0.0 |
| SLXN Silexion Therapeutics Ltd. | — | -0.0 | -17022.0 | -931.4 | — | — | 3 | BEARISH | -95.6 |
| ZVSA ZyVersa Therapeutics, Inc. | — | -0.0 | 817.1 | 242.0 | — | -100.0 | 1 | BEARISH | -99.3 |
| NIKI Niki BioSolutions, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| BIXT Bioxytran, Inc. | — | -0.7 | 92.2 | 68.7 | — | — | 4 | BEARISH | -54.0 |
| GOVX GeoVax Labs, Inc. | — | -0.0 | -891.6 | 1530.7 | — | -100.0 | 3 | BEARISH | -98.6 |
| TNGNQ Tengion, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| XENO Xeno Transplants Corporation | — | -0.0 | -286.5 | 78.1 | — | — | 1 | BEARISH | 0.0 |
| ZHCLF Zenith Capital Corp. | — | -0.2 | 35107.2 | 37766.2 | -360.0 | — | 3 | BEARISH | 3233.3 |
| MDCX Medicus Pharma Ltd. Common Stock | — | -0.0 | -3904.0 | -693.1 | — | — | 3 | BEARISH | -97.9 |
| VPRO Viropro Inc. | — | -0.0 | -19.7 | -4.8 | -269.7 | 155.0 | 2 | BEARISH | 0.0 |
| PHMMF Pharma Mar, S.A. | $1.6B | 21.0 | 24.9 | 35.9 | -2.0 | 15.5 | 7 | BEARISH | -16.4 |
| BCAX Bicara Therapeutics Inc. Common Stock | $1.1B | -3.1 | -41.0 | 583.9 | — | — | 2 | BEARISH | -42.6 |
| IVEVF Inventiva S.A. | $750M | -6.2 | -988.4 | -371.6 | -347346.6 | -99.7 | 3 | BEARISH | -22.8 |
| INRLF Valneva SE | $640M | -2.8 | -118.0 | -54.8 | -89.3 | -27.2 | 1 | BEARISH | -44.9 |
| SPRY ARS Pharmaceuticals, Inc. | $400M | -1.7 | -210.3 | -424.3 | -185.2 | 4.1 | 2 | BEARISH | -61.8 |
| EIKN Eikon Therapeutics, Inc. Common Stock | $390M | — | — | — | — | — | — | BEARISH | — |
| DMTRF 3-D Matrix, Ltd. | $310M | 12.4 | 75.0 | 31.1 | 9.4 | 57.0 | 6 | BEARISH | 61.3 |
| NERV Minerva Neurosciences, Inc. | $110M | -0.1 | 337.5 | 10.0 | — | — | 1 | BEARISH | -51.2 |
| VRCA Verrica Pharmaceuticals Inc. | $60M | -2.0 | 473.3 | 437.4 | -224.4 | 106.2 | 5 | BEARISH | -7.5 |
| ONCY Oncolytics Biotech Inc. | $50M | -1.8 | 90135.4 | 285.1 | — | — | 1 | BEARISH | -63.5 |
| EDSA Edesa Biotech, Inc. | $30M | -1.5 | -122.9 | 759.6 | — | — | 1 | BEARISH | -2.7 |
| EYPT EyePoint Pharmaceuticals, Inc. | $30M | -0.1 | -148.7 | -3014.8 | -18633.1 | -94.6 | 2 | BEARISH | -96.9 |
| NRXBF NurExone Biologic Inc. | $30M | — | — | — | — | — | — | BEARISH | — |
| IGC IGC Pharma, Inc. | $30M | -2.9 | -129.2 | -127.6 | -1107.9 | -15.4 | 1 | BEARISH | -43.1 |
| CRVO CervoMed Inc. | $30M | -0.7 | -107.6 | 1244.8 | — | — | 2 | BEARISH | -68.5 |
| BSEM BioStem Technologies, Inc. | $30M | -0.9 | -74.7 | -84.3 | -113.6 | -119.6 | 2 | BEARISH | -67.9 |
| CNTX Context Therapeutics Inc. | $20M | -0.4 | -76.1 | 841.7 | — | — | 2 | BEARISH | -82.8 |
| BXPHF Botanix Pharmaceuticals Limited | $20M | -0.3 | -96.3 | -131.6 | -203.1 | 495.6 | 4 | BEARISH | -92.5 |
| ACXP Acurx Pharmaceuticals, Inc. | $10M | -0.3 | -128.1 | 241.9 | — | — | 3 | BEARISH | -83.8 |
| RDTCF Rapid Dose Therapeutics Corp. | $10M | -4.2 | 49.3 | 80.2 | -86.2 | 4.3 | 4 | BEARISH | -58.4 |
| BLRX BioLineRx Ltd. | $10M | -1.1 | -63.5 | -113.0 | -1029.3 | -94.3 | 3 | BEARISH | -46.8 |
| ACTU Actuate Therapeutics Inc | $10M | -0.4 | 2457.6 | 541.3 | — | — | 3 | BEARISH | -94.7 |
| AIMD Ainos, Inc. | $10M | -0.3 | -196.3 | -69.4 | -3022849.3 | -87.7 | 1 | BEARISH | -77.2 |
| KTTA Pasithea Therapeutics Corp. | $10M | -0.2 | -65.5 | -453.2 | — | — | 4 | BEARISH | -45.8 |
| RVPH Reviva Pharmaceuticals Holdings, Inc. | $10M | -0.1 | -32.2 | 45.6 | — | — | 4 | BEARISH | -29.9 |
| MTVA MetaVia Inc. | $10M | -0.3 | -175.7 | 209.3 | — | — | 0 | BEARISH | -89.3 |
| CODX Co-Diagnostics, Inc. | — | -0.0 | -174.8 | -218.8 | -3782.4 | -28.1 | 3 | BEARISH | -98.8 |
| NAVBQ Navidea Biopharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| HLUN HEALTHeUNIVERSE, Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| FAMDF Futura Medical plc | — | -0.3 | -145.8 | -370.5 | -72.8 | -70.7 | 2 | BEARISH | -86.7 |
| KAPA Kairos Pharma, Ltd. | — | -0.3 | -114.0 | -301.0 | — | — | 3 | BEARISH | -93.5 |
| APVO Aptevo Therapeutics Inc. | — | -0.0 | -420.3 | -4688.7 | — | — | 1 | BEARISH | -95.2 |
| NSHSF NanoSphere Health Sciences Inc. | — | 9.5 | 4.6 | 11.1 | — | — | 0 | BEARISH | 0.0 |
| CANF Can-Fite BioPharma Ltd. | — | -0.2 | -184.2 | 353.7 | -2277.7 | -40.1 | 2 | BEARISH | -82.5 |
| PPBT Purple Biotech Ltd. | — | -0.0 | -111.3 | -99.1 | — | — | 2 | BEARISH | 60.8 |
| BXRXQ Baudax Bio, Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| NRSN NeuroSense Therapeutics Ltd. | — | -0.3 | 779.3 | 571.3 | — | — | 3 | BEARISH | -89.7 |
| NMLSF Restart Life Sciences Corp. | — | -1.7 | -214.3 | -153.9 | -307.0 | — | 2 | BEARISH | -63.3 |
| ZLDAF Zelira Therapeutics Limited | — | -1.6 | 80.8 | 147.8 | -185107971.7 | -99.3 | 1 | BEARISH | -7.8 |
| PMCB PharmaCyte Biotech, Inc. | — | -0.1 | -44.0 | 793.8 | — | — | 2 | BEARISH | -66.1 |
| OXBOF Oxford BioDynamics Plc | — | -0.3 | -214.9 | -155.8 | -649.8 | 33.6 | 3 | BEARISH | -81.1 |
| CELZ Creative Medical Technology Holdings, Inc. | — | -0.4 | -78.0 | 8335.2 | — | -50.0 | 2 | BEARISH | -86.0 |
| XSNX NovAccess Global Inc. | — | -0.0 | 27.7 | 18.0 | — | — | 3 | BEARISH | 0.0 |
| VNDA Vanda Pharmaceuticals Inc. | $240M | -0.9 | -77.8 | -201.0 | -123.7 | 6.0 | 3 | BEARISH | -28.7 |
| AMWL American Well Corporation | $230M | -3.0 | -31.0 | -215.3 | -19.1 | -19.0 | 4 | BULLISH | 155.8 |
| CBWTF Auxly Cannabis Group Inc. | $250M | 10.8 | 16.6 | 2.2 | 16.8 | 10.8 | 7 | BULLISH | 70.5 |
| AMRN Amarin Corporation plc | $240M | -12.0 | -4.2 | -15.1 | 0.6 | -22.4 | 4 | BULLISH | -33.7 |
| HITI High Tide Inc. | $230M | -10.0 | -27.0 | 0.8 | 5.7 | 26.8 | 3 | LEAN BULL | -17.2 |
| SIGA SIGA Technologies, Inc. | $220M | -75.9 | -1.5 | -18.3 | 30.4 | -70.1 | 1 | LEAN BULL | -60.7 |
| LFCR Lifecore Biomedical, Inc. | $240M | -5.9 | 202.6 | 0.1 | -18.0 | -4.1 | 5 | LEAN BULL | -3.3 |
| KJFI Comjoyful International Company | $210M | -98.4 | 171.5 | -1549.9 | 44.3 | 38.8 | 6 | LEAN BULL | 459.8 |
| ACB Aurora Cannabis Inc. | $250M | -3.0 | -20.5 | -17.0 | -6.0 | -16.6 | 3 | LEAN BEAR | -19.8 |
| IMPZY Implanet S.A. | $230M | -5.2 | 275.6 | -110.9 | -30.0 | 24.3 | 5 | BEARISH | 0.2 |
| BHCCF Benchmark Holdings plc | $230M | -4.1 | 16.4 | -17.9 | 377.4 | -62.6 | 6 | BEARISH | 0.0 |
| CPHRF Cipher Pharmaceuticals Inc. | $240M | 8.5 | 23.5 | 24.9 | 33.3 | 3.7 | 6 | BEARISH | -8.3 |
| TLSI TriSalus Life Sciences, Inc. | $220M | -3.0 | 438.3 | 453.7 | -80.5 | 25.2 | 4 | BEARISH | -21.7 |
| ELMD Electromed, Inc. | $220M | 19.9 | 23.3 | 32.5 | 17.5 | 15.3 | 8 | BEARISH | 10.7 |
| RXST RxSight, Inc. | $210M | -4.3 | -17.3 | -66.9 | -35.9 | -18.8 | 3 | BEARISH | -43.4 |
| CELG-RI Bristol-Myers Squibb Company Ce | $250M | 0.0 | 46.7 | 22.0 | 25.6 | 3.1 | 8 | BEARISH | 232.3 |
| CRLBF Cresco Labs Inc. | $210M | -2.0 | -25.8 | 5.5 | 9.7 | -4.5 | 2 | BEARISH | -50.6 |
| CUVL Clinuvel Pharmaceuticals Ltd. | $250M | — | — | — | — | — | — | BEARISH | — |
| UTMD Utah Medical Products, Inc. | $240M | 20.6 | 8.8 | 22.4 | 32.3 | -9.6 | 6 | BEARISH | 16.9 |
| LAB Standard BioTools Inc. | $240M | -2.7 | -18.1 | -69.4 | -133.1 | -45.2 | 5 | BEARISH | -53.3 |
| SPOK Spok Holdings, Inc. | $220M | 11.4 | 8.4 | 10.0 | 11.8 | -3.4 | 5 | BEARISH | -36.3 |
| VNDA Vanda Pharmaceuticals Inc. | $240M | -0.9 | -77.8 | -201.0 | -123.7 | 6.0 | 3 | BEARISH | -28.7 |
| SEPN Septerna Inc | $1.9B | -81.9 | -6.3 | -93.1 | -48.7 | 17878.5 | 5 | BULLISH | 95.6 |
| KLRA Kailera Therapeutics, Inc. | $1.7B | — | — | — | — | — | — | BULLISH | — |
| COAG Hemab Therapeutics Holdings, Inc. Common Stock | $1.6B | — | — | — | — | — | — | BULLISH | — |
| MRCHF H.U. Group Holdings, Inc. | $1.3B | 21.9 | 7.2 | 3.3 | 2.5 | 1.8 | 9 | BULLISH | -7.4 |
| REPL Replimune Group, Inc. | $1.1B | -5.8 | -115.8 | -882.8 | — | — | 3 | BULLISH | 72.1 |
| SIBN SI-BONE, Inc. | $960M | -64.2 | -8.3 | -32.2 | -7.3 | 15.3 | 6 | BULLISH | 39.4 |
| RIGL Rigel Pharmaceuticals, Inc. | $900M | 2.9 | 126.9 | 88.5 | 22.0 | 3.3 | 4 | BULLISH | 71.5 |
| SOLTF Nxera Pharma Co., Ltd. | $770M | -16.4 | -12.0 | -1.7 | -2.6 | 7.5 | 4 | BULLISH | 38.2 |
| CTKB Cytek Biosciences, Inc. | $730M | -9.9 | -23.0 | -40.8 | -25.3 | 5.4 | 3 | BULLISH | 48.0 |
| CRMD CorMedix Inc. | $610M | 3.4 | 54.9 | 57.2 | 25.5 | 280.5 | 5 | BULLISH | -25.8 |
| DMAC DiaMedica Therapeutics Inc. | $470M | -13.6 | -114.6 | 616.3 | — | — | 2 | BULLISH | 42.7 |
| RCEL Avita Medical Inc. | $390M | -11.4 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | BULLISH | 335.4 |
| MOBI Mobia Medical, Inc. Common Stock | $350M | — | — | — | — | — | — | BULLISH | — |
| SGMT Sagimet Biosciences Inc. | $310M | -8.4 | -24.4 | -231.4 | — | — | 3 | BULLISH | 24.9 |
| QSI Quantum-Si incorporated | $280M | -3.7 | -49.1 | -121.8 | -6841.3 | -53.0 | 3 | BULLISH | -26.1 |
| TMCI Treace Medical Concepts, Inc. | $280M | -5.2 | -72.0 | -44.8 | -35.0 | -4.0 | 2 | BULLISH | -29.5 |
| AMWL American Well Corporation | $230M | -3.0 | -31.0 | -215.3 | -19.1 | -19.0 | 4 | BULLISH | 155.8 |
| DTIL Precision BioSciences, Inc. | $180M | -2.7 | -135.1 | 203.1 | — | 3473.0 | 5 | BULLISH | 4.0 |
| MXCT MaxCyte, Inc. | $140M | -5.1 | -20.4 | -38.9 | -122.0 | -13.2 | 2 | BULLISH | 11.0 |
| PYPD PolyPid Ltd. | $110M | -3.9 | -1913.8 | 231.6 | — | — | 3 | BULLISH | 60.1 |
| ANIX Anixa Biosciences, Inc. | $100M | -11.0 | -67.1 | -1110.2 | — | — | 3 | BULLISH | -22.2 |
| NNVC NanoViricides, Inc. | $40M | -3.5 | -101.5 | -111.4 | — | — | 3 | BULLISH | -9.9 |
| AMN AMN Healthcare Services, Inc. | $1.9B | 17.3 | 15.6 | 8.9 | 3.1 | 24.0 | 8 | BULLISH | 122.4 |
| VIR Vir Biotechnology, Inc. | $1.8B | -6.4 | -26.1 | -38.8 | 33.5 | 1495.9 | 5 | BULLISH | 92.7 |
| HCSG Healthcare Services Group, Inc. | $1.7B | 15.9 | 20.4 | 27.0 | 5.2 | 4.0 | 7 | BULLISH | 27.0 |
| CERT Certara, Inc. | $1.6B | -25.9 | -6.7 | 0.6 | -59.3 | 0.7 | 6 | BULLISH | -8.2 |
| LTGHY Life Healthcare Group Holdings Limited | $1.1B | 2.7 | 68.5 | 10.7 | 6.2 | -3.0 | 4 | BULLISH | 12.6 |
| CBLL CeriBell, Inc. | $1.0B | -15.5 | -43.9 | -263.7 | -68.6 | 69.3 | 3 | BULLISH | 111.2 |
| BVS Bioventus Inc. | $1.0B | 18.2 | 28.0 | 21.3 | 21.8 | 3.1 | 7 | BULLISH | 118.3 |
| SGP SpyGlass Pharma, Inc. Common Stock | $950M | — | — | — | — | — | — | BULLISH | — |
| VSTM Verastem, Inc. | $910M | -4.0 | -471.2 | 6197.3 | -86.5 | 3995.7 | 4 | BULLISH | 12.8 |
| PHR Phreesia, Inc. | $790M | 71.8 | 3.1 | 16.7 | 1.5 | 12.9 | 4 | BULLISH | -47.2 |
| PACB Pacific Biosciences of California, Inc. | $660M | -6.6 | -929.3 | -29.4 | -114.7 | 2.0 | 2 | BULLISH | 35.4 |
| AONC American Oncology Network, Inc. | $640M | -30.1 | 5.6 | -14.7 | 0.3 | 37.5 | 6 | BULLISH | 135.6 |
| KIDS OrthoPediatrics Corp. | $640M | -21.5 | -9.8 | -4.4 | -8.2 | 16.1 | 6 | BULLISH | 81.6 |
| NRC NRC Health | $490M | 77.6 | 248.1 | 10.8 | 12.3 | 3.4 | 6 | BULLISH | 55.5 |
| MASS 908 Devices Inc. | $470M | -13.8 | -25.1 | -103.8 | -74.0 | 4.6 | 5 | BULLISH | 54.5 |
| CV CapsoVision, Inc. | $370M | -11.2 | -226.6 | -73.0 | -205.4 | — | 2 | BULLISH | 45.3 |
| ANIK Anika Therapeutics, Inc. | $290M | -80.0 | -2.7 | -3.3 | 10.1 | 31.4 | 7 | BULLISH | 122.2 |
| INFU InfuSystem Holdings, Inc. | $280M | 34.1 | 15.0 | 11.4 | 8.7 | 2.5 | 9 | BULLISH | 43.1 |
| BIOYF BioSyent Inc. | $140M | 19.3 | 23.7 | 23.8 | 14.3 | 41.0 | 5 | BULLISH | 51.1 |
| ATNM Actinium Pharmaceuticals, Inc. | $50M | 3.8 | 45.9 | -197.8 | 79.7 | — | 3 | BULLISH | -9.8 |
| GRDX GridAI Technologies Corp. | $40M | -1.3 | -55.6 | -51.7 | -14927.4 | 67.4 | 2 | BULLISH | 40.8 |
| HBIO Harvard Bioscience, Inc. | $40M | -3.6 | -89.9 | 1.8 | -12.8 | -1.1 | 7 | BULLISH | 110.7 |
| MCUJF Medicure Inc. | $30M | -6.1 | -49.9 | -54.9 | -19.2 | 38.3 | 4 | BULLISH | 290.6 |
| BIOE Bio Essence Corporation | $20M | 11.3 | -392.9 | 38.8 | 34.0 | 416.6 | 5 | BULLISH | 508.7 |
| MAZE Maze Therapeutics, Inc. | $1.7B | -11.6 | -37.3 | -112.3 | — | — | 3 | BULLISH | 2.4 |
| AZTA Azenta, Inc. | $1.6B | -14.8 | -7.7 | -1.4 | 1.5 | 1.5 | 4 | BULLISH | 27.4 |
| ENOV Enovis Corporation | $1.2B | -1.1 | -54.3 | -13.5 | -0.2 | 4.9 | 4 | BULLISH | -33.3 |
| QDEL QuidelOrtho Corporation | $940M | -0.9 | -45.9 | -13.7 | -14.7 | 0.1 | 4 | BULLISH | -52.5 |
| PRME Prime Medicine, Inc. | $670M | -4.9 | -373.3 | -271.3 | -3649.0 | -17.9 | 3 | BULLISH | 4.1 |
| MYGN Myriad Genetics, Inc. | $560M | -5.5 | -32.5 | -19.5 | -22.7 | -3.2 | 4 | BULLISH | -18.1 |
| XFOR X4 Pharmaceuticals, Inc. | $320M | -2.8 | -113.1 | -281.1 | -183.5 | -51.6 | 4 | BULLISH | -10.4 |
| LYEL Lyell Immunopharma, Inc. | $230M | -0.7 | -93.3 | -227.7 | -1118875.0 | -55.0 | 3 | BULLISH | -36.6 |
| INGN Inogen, Inc. | $190M | -8.1 | -13.1 | -27.8 | -4.0 | 3.2 | 5 | BULLISH | -16.3 |
| OM Outset Medical, Inc. | $80M | -1.1 | -59.2 | -97.3 | -56.8 | -1.3 | 4 | BULLISH | -69.8 |
| ZIVO ZIVO Bioscience, Inc. | $20M | -5.2 | 185.9 | 147.5 | — | -62.5 | 2 | BULLISH | -50.1 |
| NUWE Nuwellis, Inc. | — | -0.0 | 202.0 | 173.3 | -245.2 | 8.4 | 5 | BULLISH | 75.2 |
| PVLA Palvella Therapeutics, Inc. | $1.8B | -30.5 | -46.6 | 137.5 | — | — | 3 | BULLISH | 109.4 |
| RARE Ultragenyx Pharmaceutical Inc. | $1.5B | -2.9 | 839.4 | -67.5 | -43.0 | 17.5 | 2 | BULLISH | -51.3 |
| AGL Agilon Health, Inc. | $1.5B | -5.9 | -78.9 | -273.7 | 1.2 | 0.3 | 6 | BULLISH | 286.2 |
| TNDM Tandem Diabetes Care, Inc. | $1.2B | -21.2 | -48.0 | -8.2 | -8.3 | -7.1 | 4 | BULLISH | 31.7 |
| TDOC Teladoc Health, Inc. | $1.1B | -8.0 | -13.0 | -8.7 | -6.4 | -2.1 | 5 | BULLISH | -23.6 |
| STAA STAAR Surgical Company | $1.1B | 307.6 | 1.1 | 3.5 | 8.6 | 51.3 | 5 | BULLISH | -11.4 |
| OABIW OmniAb, Inc. | $1.1B | -14.7 | -16.9 | -16.8 | -43.7 | 66.9 | 6 | BULLISH | -14.0 |
| VMD Viemed Healthcare, Inc. | $370M | 26.5 | 10.2 | 11.8 | 3.5 | 25.2 | 4 | BULLISH | 43.7 |
| EDIT Editas Medicine, Inc. | $370M | -3.9 | -118.8 | 71.4 | -153.3 | 20.8 | 4 | BULLISH | -9.2 |
| INDP Indaptus Therapeutics, Inc. | $360M | -0.5 | -318.0 | 6437.4 | — | — | 4 | BULLISH | -6.2 |
| KRRO Korro Bio, Inc. | $180M | -1.4 | -97.7 | -196.6 | — | -62.1 | 2 | BULLISH | -65.0 |
| PCSA Processa Pharmaceuticals, Inc. | $10M | -0.3 | -464.2 | 1977.5 | — | — | 2 | BULLISH | -76.2 |
| ARDT Ardent Health Inc. | $1.7B | 21.7 | 6.0 | 13.5 | 1.0 | 3.3 | 5 | BULLISH | -21.1 |
| GDRX GoodRx Holdings, Inc. | $1.2B | 66.0 | 2.5 | 3.5 | 4.3 | -1.8 | 6 | BULLISH | -8.0 |
| AVHHL AVITA Medical, Inc. | $360M | -11.4 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | BULLISH | 149.1 |
| IRLA IRulya Therapeutics Inc. | $30M | — | — | — | — | — | — | BULLISH | — |
| GENB Generate Biomedicines, Inc. | $1.6B | -9.1 | -28.2 | -175.0 | -1065.2 | — | 1 | BULLISH | — |
| RXRX Recursion Pharmaceuticals, Inc. | $2.0B | -4.2 | -56.6 | -99.7 | -1708.0 | -14.9 | 4 | BULLISH | -30.9 |
| XRAY DENTSPLY SIRONA Inc. | $1.9B | -3.4 | -33.0 | 9.9 | 4.1 | -0.8 | 5 | BULLISH | -26.8 |
| GRRMF Gerresheimer AG | $1.2B | -2.8 | 1.6 | 2.2 | -2.3 | 11.8 | 4 | BULLISH | -27.1 |
| CING Cingulate Inc. | $70M | -1.0 | -198.7 | -1452.8 | — | — | 4 | BULLISH | 39.6 |
| ESLA Estrella Immunopharma, Inc. | $40M | -3.3 | 148.1 | 102.1 | — | — | 3 | BULLISH | -64.0 |
| CTSO Cytosorbents Corporation | $20M | -0.9 | -336.2 | -46.3 | -45.9 | 3.1 | 4 | BULLISH | -68.0 |
| SAEYY Redcare Pharmacy N.V. | $1.7B | -37.9 | -8.7 | -1.2 | 0.6 | 20.5 | 2 | BULLISH | -5.2 |
| TGLVY Top Glove Corporation Bhd. | $1.7B | 25.3 | 6.3 | 8.5 | 12.6 | 21.4 | 8 | BULLISH | 56.4 |
| KMTS Kestra Medical Technologies, Ltd. | $1.7B | -11.2 | -73.7 | -113.5 | -142.3 | 191.6 | 3 | BULLISH | 10.3 |
| ABSI Absci Corporation | $1.6B | -14.8 | -57.7 | -213.1 | -10443.4 | -62.3 | 5 | BULLISH | 164.0 |
| TRAX First Tracks Biotherapeutics Inc | $1.6B | — | — | — | — | — | — | BULLISH | — |
| NTLA Intellia Therapeutics, Inc. | $1.6B | -4.0 | -55.4 | -92.1 | -1392.3 | 12.6 | 5 | BULLISH | -10.0 |
| NWKHY Netcare Limited | $1.4B | 12.3 | 16.9 | 8.1 | 6.7 | 5.0 | 7 | BULLISH | 59.5 |
| LBRX LB Pharmaceuticals Inc Common Stock | $1.2B | -13.4 | -25.8 | -768.9 | — | — | 2 | BULLISH | 138.5 |
| PRCT PROCEPT BioRobotics Corporation | $1.1B | -10.4 | -30.2 | -47.6 | -28.4 | 22.7 | 2 | BULLISH | -44.4 |
| LMRI Lumexa Imaging Holdings, Inc. Common Stock | $1.1B | -30.9 | -3.9 | 0.1 | 1.0 | — | 3 | BULLISH | — |
| CSTL Castle Biosciences, Inc. | $1.0B | -55.6 | -4.2 | -10.6 | -2.0 | 3.2 | 4 | BULLISH | 53.1 |
| ARRJF Arjo AB (publ) | $920M | 25.4 | 4.6 | 4.4 | 2.0 | -2.0 | 6 | BULLISH | 3.1 |
| ENTX Entera Bio Ltd. | $510M | -8.9 | -138.9 | 314.4 | — | -100.0 | 1 | BULLISH | 33.0 |
| KROS Keros Therapeutics, Inc. | $220M | -3.1 | -17.2 | -392.2 | — | -93.6 | 3 | BULLISH | -22.8 |
| OPRX OptimizeRx Corp. | $170M | 38.2 | 3.7 | 6.1 | -3.4 | -5.8 | 8 | BULLISH | -55.5 |
| HURA TuHURA Biosciences, Inc. | $140M | -3.7 | -161.4 | -137.6 | — | — | 2 | BULLISH | -13.5 |
| NRXS NeurAxis, Inc. | $90M | -9.8 | -143.2 | 464.1 | -118.1 | 65.2 | 6 | BULLISH | 143.4 |
| LUNG Pulmonx Corporation | $80M | -2.5 | -88.9 | -92.5 | -44.3 | -3.4 | 4 | BULLISH | 61.5 |
| HOWL Werewolf Therapeutics, Inc. | $50M | -1.4 | -119.9 | 354.7 | 17.5 | — | 4 | BULLISH | -36.1 |
| CCEL Cryo-Cell International, Inc. | $40M | -23.1 | 18.1 | -0.7 | 16.2 | -2.0 | 6 | BULLISH | 13.1 |
| INM InMed Pharmaceuticals Inc. | $10M | -0.5 | -129.6 | 732.1 | -0.2 | 37942.8 | 3 | BULLISH | -21.6 |
| HSTM HealthStream, Inc. | $1.1B | 47.1 | 6.0 | 6.5 | 8.0 | 8.8 | 8 | BULLISH | 30.0 |
| PRLD Prelude Therapeutics Incorporated | $210M | -5.2 | -57.7 | 14236.3 | -244.1 | 220.3 | 5 | BULLISH | 142.1 |
| NAUT Nautilus Biotechnolgy, Inc. | $410M | -7.0 | -41.0 | -89.2 | -6682.1 | — | 2 | BULLISH | 137.8 |
| PRTA Prothena Corporation plc | $420M | -11.0 | -14.4 | -871.5 | -1839.9 | 427.3 | 5 | BULLISH | -12.2 |
| CBWTF Auxly Cannabis Group Inc. | $250M | 10.8 | 16.6 | 2.2 | 16.8 | 10.8 | 7 | BULLISH | 70.5 |
| GLSI Greenwich LifeSciences, Inc. | $240M | -11.9 | -951.6 | 299.9 | — | — | 2 | BULLISH | 87.0 |
| BMGL Basel Medical Group Ltd Ordinary Shares | $10M | — | — | — | — | — | — | BULLISH | -75.4 |
| GCTK GlucoTrack, Inc. | — | -0.0 | -620.6 | 427.4 | — | — | 2 | BULLISH | -97.9 |
| SRPT Sarepta Therapeutics, Inc. | $1.9B | -13.4 | -9.5 | -6.3 | -1.2 | -20.4 | 4 | BULLISH | -17.8 |
| XNCR Xencor, Inc. | $1.9B | -13.8 | -29.1 | -152.4 | -42.4 | -36.1 | 2 | BULLISH | 110.2 |
| XERS Xeris Biopharma Holdings, Inc. | $1.9B | -109.6 | 118.2 | 18.3 | -33.8 | 36.3 | 6 | BULLISH | 14.3 |
| PNTG The Pennant Group, Inc. | $1.5B | 44.9 | 9.6 | 5.5 | 3.0 | 37.9 | 6 | BULLISH | 71.5 |
| SPTX Seaport Therapeutics, Inc. Common Stock | $1.1B | — | — | — | — | — | — | BULLISH | — |
| AMPH Amphastar Pharmaceuticals, Inc. | $1.1B | 15.1 | 10.3 | 7.5 | 16.5 | 1.4 | 6 | BULLISH | 9.5 |
| SLN Silence Therapeutics plc | $930M | -5.2 | -90.4 | 157.8 | — | -97.6 | 1 | BULLISH | 176.1 |
| OSUR OraSure Technologies, Inc. | $280M | -5.9 | -14.1 | -23.5 | 20.4 | -18.9 | 4 | BULLISH | 41.9 |
| ADCT ADC Therapeutics S.A. | $180M | -2.4 | 45.3 | 260.9 | -86.1 | 2.0 | 2 | BULLISH | -62.2 |
| ICCC ImmuCell Corporation | $90M | 125.5 | 2.6 | 10.2 | 25.5 | 8.5 | 6 | BULLISH | 70.2 |
| RAPH Raphael Pharmaceutical Inc. | $30M | -30.7 | 59.9 | 47.0 | — | — | 2 | BULLISH | 277.5 |
| ADIL Adial Pharmaceuticals, Inc. | $10M | -0.3 | -2011.6 | 159.6 | — | — | 3 | BULLISH | -43.0 |
| MBRX Moleculin Biotech, Inc. | $10M | -0.0 | -1371.6 | -494.1 | — | — | 3 | BULLISH | -27.8 |
| ABPO Abpro Holdings, Inc. | — | — | — | — | — | — | — | BULLISH | — |
| IDGXF Integrated Diagnostics Holdings plc | $340M | 9.9 | 41.4 | 38.4 | 13.8 | 46.8 | 8 | BULLISH | 10.8 |
| PDSB PDS Biotechnology Corporation | $60M | -2.4 | -544.0 | 456.9 | — | — | 1 | BULLISH | 62.8 |
| TBIO Telesis Bio, Inc. | — | -0.0 | -180.9 | -154.3 | -424.1 | -54.9 | 3 | BULLISH | 250.9 |
| AGTX Agentix Corp. | — | -5.1 | 12.0 | 8.1 | — | — | 3 | BULLISH | 6.0 |
| ESTA Establishment Labs Holdings Inc. | $1.9B | -52.7 | -175.3 | -6.9 | -17.4 | 38.6 | 5 | BULLISH | 35.7 |
| NBTX Nanobiotix S.A. | $1.5B | -27.6 | 104.2 | 62.0 | -626.0 | 49.1 | 4 | BULLISH | 125.3 |
| CMOPF Cosmo N.V. | $1.1B | -158.1 | -1.2 | -2.9 | -9.5 | -43.8 | 1 | BULLISH | -16.0 |
| MLTX MoonLake Immunotherapeutics | $1.0B | -3.2 | -67.4 | 2902.7 | — | — | 1 | BULLISH | 22.2 |
| DH Definitive Healthcare Corp. | $120M | -0.7 | -75.0 | 96.7 | -9.8 | -5.0 | 6 | BULLISH | -61.6 |
| PLUR Pluri Inc. | $10M | -0.5 | 163.6 | -483.9 | -1755.2 | -24.0 | 2 | BULLISH | -68.5 |
| BOLT Bolt Biotherapeutics, Inc. | $10M | -0.4 | -111.6 | -138.8 | -154400.0 | 12.8 | 3 | BULLISH | 5.5 |
| BDRX Biodexa Pharmaceuticals Plc | — | -77.8 | -42.3 | -117.9 | — | — | 2 | BULLISH | -88.9 |
| POM Pomdoctor Limited | $10M | -0.2 | 48.5 | 554.8 | -124.2 | — | 3 | BULLISH | -61.7 |
| MBCI MabCure Inc. | — | -0.0 | -127.0 | -14.0 | -2239.0 | — | 3 | BULLISH | 400.0 |
| CBDG THC Farmaceuticals, Inc. | — | -30.9 | 2.0 | -0.9 | — | 28.1 | 5 | BULLISH | -63.1 |
| KNBIF Kane Biotech Inc. | — | -2.4 | 439.7 | -2166.6 | -10238.1 | -97.9 | 2 | BULLISH | -22.4 |
| STOK Stoke Therapeutics, Inc. | $1.6B | -7.9 | -61.1 | -318.5 | -660.8 | -86.2 | 2 | BULLISH | -20.0 |
| PHAR Pharming Group N.V. | $710M | 34.4 | 3.6 | 3.2 | 1.8 | 7.8 | 7 | BULLISH | -8.0 |
| TCMD Tactile Systems Technology, Inc. | $540M | 21.9 | 11.9 | 13.8 | 9.1 | 17.2 | 8 | BULLISH | 59.4 |
| SGHT Sight Sciences, Inc. | $500M | -16.5 | -48.4 | -145.7 | -19.0 | 9.3 | 4 | BULLISH | 78.7 |
| CARL Carlsmed, Inc. | $400M | -11.3 | -43.8 | -122.7 | -55.5 | — | 2 | BULLISH | 13.1 |
| CCCC C4 Therapeutics, Inc. | $380M | -3.4 | -48.1 | -175.0 | -355.9 | 2.3 | 4 | BULLISH | 28.3 |
| NGNE Neurogene Inc. | $370M | -5.5 | -45.3 | -111469.0 | — | — | 2 | BULLISH | -5.1 |
| FENC Fennec Pharmaceuticals Inc. | $350M | -83.6 | -18.6 | -76.2 | 11.0 | 77.8 | 6 | BULLISH | 23.2 |
| ALEC Alector, Inc. | $200M | -2.0 | -385.1 | 66.8 | -692.5 | -82.9 | 1 | BULLISH | 50.0 |
| KRMD KORU Medical Systems, Inc. | $150M | -82.1 | -10.5 | -8.8 | 2.1 | 22.4 | 6 | BULLISH | -22.0 |
| HLTRF HLS Therapeutics Inc. | $90M | -12.0 | -14.1 | -4.2 | -7.0 | -0.2 | 5 | BULLISH | -20.4 |
| PARK Park Dental Partners, Inc. Common Stock | $90M | -24.9 | -16.0 | 0.0 | 2.0 | — | 3 | BULLISH | — |
| OKYO OKYO Pharma Limited | $70M | -6.2 | -263.8 | 88.0 | — | — | 3 | BULLISH | -43.8 |
| NSYS Nortech Systems Incorporated | $30M | 30.6 | 3.0 | 3.2 | 0.9 | 6.0 | 7 | BULLISH | 14.9 |
| HYEX Healthy Extracts Inc. | $10M | -8.1 | -7.7 | -2.8 | -6.3 | 84.1 | 5 | BULLISH | -42.1 |
| SYRA Syra Health Corp. Class A Common Stock | $10M | 98.9 | 5.2 | 11.3 | 10.5 | 0.3 | 4 | BULLISH | 1071.0 |
| KHTRF Knight Therapeutics Inc. | $810M | 76.9 | 1.9 | 2.6 | -2.3 | 42.4 | 8 | BULLISH | 97.6 |
| STLN Starling Oncology, Inc. | $670M | — | — | — | — | — | — | BULLISH | — |
| PBYI Puma Biotechnology, Inc. | $570M | 19.8 | 22.0 | 52.8 | 14.5 | -2.9 | 6 | BULLISH | 101.5 |
| SUSRF Surgical Science Sweden AB (publ) | $280M | 32.6 | 2.1 | 2.7 | 8.2 | 8.1 | 6 | BULLISH | -37.8 |
| AZTR Azitra, Inc. | — | -0.1 | -256.7 | -959.6 | — | — | 5 | BULLISH | 65.7 |
| VTRLY Vitrolife AB (publ) | $1.4B | -3.1 | -46.2 | -41.3 | 14.3 | -2.0 | 5 | BULLISH | -34.0 |
| OPK OPKO Health, Inc. | $1.2B | -17.0 | -5.9 | -3.0 | -5.1 | -11.5 | 2 | BULLISH | 11.7 |
| CVALF Covalon Technologies Ltd. | $80M | 28.6 | 14.3 | 28.5 | 28.0 | 4.2 | 8 | BULLISH | 114.2 |
| CCM Concord Medical Services Holdings Limited | — | -0.0 | 7.5 | -26.9 | -13.5 | -22.5 | 2 | BULLISH | -30.2 |
| VIBEF Vibe Growth Corporation | — | -0.2 | 40.9 | -1.4 | -8.6 | 24.4 | 6 | BULLISH | 696.8 |
| EOLS Evolus, Inc. | $460M | -14.7 | 138.6 | -20.7 | -9.6 | 13.9 | 5 | BULLISH | 5.8 |
| KMDA Kamada Ltd. | $450M | 20.9 | 8.4 | 11.0 | 16.9 | 13.2 | 7 | BULLISH | 13.8 |
| BCYC Bicycle Therapeutics plc | $250M | -1.4 | -32.3 | -1197.0 | -8002.1 | 217.4 | 4 | BULLISH | -52.2 |
| LCTX Lineage Cell Therapeutics, Inc. | $250M | -7.4 | -59.0 | -171.3 | 138.6 | 19.9 | 5 | BULLISH | -41.1 |
| ACUR Acura Pharmaceuticals, Inc. | — | -0.0 | 30.8 | -306.4 | 80.6 | -56.2 | 4 | BULLISH | 0.0 |
| UMCN UMC, Inc. | $50M | -93.7 | -840.4 | -95.6 | -590.7 | 2325.0 | 4 | BULLISH | 115.4 |
| FZMD Fuse Medical, Inc. | — | 15.0 | -177.1 | -13.7 | 6.2 | -5.8 | 5 | BULLISH | -60.9 |
| HADV Health Advance Inc. | — | -4.4 | 77.3 | -29.9 | — | — | 1 | BULLISH | -25.0 |
| IMCR Immunocore Holdings plc | $1.6B | -180.9 | -2.3 | -472.0 | -0.7 | 13.4 | 4 | BULLISH | -2.5 |
| CRON Cronos Group Inc. | $1.2B | 17.9 | 6.5 | 5.4 | 60.5 | 72.9 | 7 | BULLISH | 35.6 |
| JANX Janux Therapeutics, Inc. | $1.0B | -10.9 | -10.7 | 516.9 | -214.0 | 7162.0 | 4 | BULLISH | -34.0 |
| MLAB Mesa Laboratories, Inc. | $720M | 152.7 | 2.7 | 4.4 | 4.7 | 3.0 | 8 | BULLISH | 71.1 |
| IOBCF Ion Beam Applications S.A. | $550M | 19.7 | 20.6 | 14.0 | 2.9 | 7.0 | 5 | BULLISH | 39.5 |
| ACOG Alpha Cognition Inc | $130M | -8.4 | -55.3 | -198.4 | -144.3 | 232.7 | 2 | BULLISH | 14.6 |
| BGMS Bio Green Med Solution, Inc. | $10M | -0.3 | -30.7 | -64.2 | -120.5 | — | 2 | BULLISH | -52.8 |
| PCRX Pacira BioSciences, Inc. | $1.4B | 103.4 | 2.0 | 1.8 | 2.4 | 5.7 | 8 | BULLISH | 70.6 |
| SCNLF Scancell Holdings plc | $170M | -5.1 | 153.2 | 179.2 | — | -100.0 | 2 | BULLISH | 969.8 |
| ZYBT Zhengye Biotechnology Holding Limited | $70M | — | — | — | — | — | — | BULLISH | -36.6 |
| SNWV SANUWAVE Health Inc. | $40M | 3.2 | -238.8 | 4.8 | -7.0 | 12.0 | 7 | BULLISH | -83.0 |
| BEAT HeartBeam, Inc. | $20M | -1.0 | -328.4 | 2958.2 | — | — | 3 | BULLISH | -67.0 |
| VRSEF Verisante Technology Inc. | — | 5.4 | 124.9 | 102.2 | — | — | 3 | BULLISH | 354.6 |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. | $20M | -0.2 | -90.1 | -46.0 | — | — | 4 | BULLISH | 67.4 |
| PULM Pulmatrix, Inc. | $10M | -1.4 | -98.3 | -835.1 | — | -100.0 | 3 | BULLISH | -69.6 |
| YUKA Yuka Group, Inc. | — | -2.8 | 24.0 | 81.8 | -50.7 | -8.2 | 5 | BULLISH | 157.8 |
| AHG Akso Health Group | $1.1B | -19.3 | -50.1 | -44.9 | -546.5 | 22.7 | 4 | BULLISH | -15.8 |
| TCRT Alaunos Therapeutics, Inc. | $10M | -1.1 | -185.9 | -607.2 | — | -50.0 | 1 | BULLISH | -27.3 |
| CLGN CollPlant Biotechnologies Ltd. | — | -0.4 | -162.0 | -369.3 | -2524.1 | -86.8 | 2 | BULLISH | -83.0 |
| EBYH Strainsforpains, Inc. | — | -22.6 | -3.4 | 16.3 | -603.3 | 1679.9 | 5 | BULLISH | 49.5 |
| IDTA IDenta Corp. | — | 9.8 | 13.8 | 25.0 | -9.1 | 57.3 | 8 | BULLISH | 95.5 |
| ZBIO Zenas BioPharma, Inc. | $1.8B | -3.0 | -199.0 | 5842.1 | -11145.6 | -93.3 | 2 | BULLISH | -9.5 |
| VOR Vor Biopharma Inc. | $990M | 0.1 | -73.6 | 22.2 | — | — | 3 | BULLISH | -26.6 |
| FLGT Fulgent Genetics, Inc. | $550M | -7.6 | -8.0 | -12.6 | -34.6 | 6.8 | 4 | BULLISH | -7.7 |
| DRUG Bright Minds Biosciences Inc. | $520M | -26.8 | -13.7 | -105758.3 | — | — | 3 | BULLISH | -5.9 |
| ELDN Eledon Pharmaceuticals, Inc. | $190M | -2.8 | -110.7 | 411.1 | — | — | 2 | BULLISH | -27.9 |
| ABOS Acumen Pharmaceuticals, Inc. | $140M | -1.5 | -162.7 | 466.8 | — | — | 2 | BULLISH | 8.2 |
| MEDXF Medexus Pharmaceuticals Inc. | $110M | -46.3 | -4.7 | 8.1 | 1.9 | -2.9 | 5 | BULLISH | 69.7 |
| PMN ProMIS Neurosciences, Inc. | $70M | -0.7 | -172.3 | 844.3 | — | — | 2 | BULLISH | -3.4 |
| IGPK Integrated Cannabis Solutions, Inc. | $10M | 6.8 | -3.2 | -5.2 | 0.6 | 2762.5 | 5 | BULLISH | -66.7 |
| HDVY Health Discovery Corporation | — | -0.1 | -3852.6 | 357.6 | — | -100.0 | 1 | BULLISH | 100.0 |
| HEPA Hepion Pharmaceuticals, Inc. | — | -0.6 | -125.6 | 710.2 | — | — | 3 | BULLISH | 130.8 |
| ACUT Accustem Sciences Inc. | — | -1.4 | 49.7 | 34.0 | -256.7 | 2610.7 | 4 | BULLISH | -88.8 |
| OMCL Omnicell, Inc. | $1.7B | 42.1 | 3.1 | 3.2 | 7.8 | 8.5 | 9 | BULLISH | 17.7 |
| NEGXF NexgenRx Inc. | $30M | — | 30.1 | -9.7 | 19.7 | 12.0 | 4 | BULLISH | 120.0 |
| NXTC NextCure, Inc. | $20M | -0.6 | -195.2 | 949.7 | — | — | 2 | BULLISH | -31.6 |
| KPTI Karyopharm Therapeutics Inc. | $10M | -0.0 | 79.0 | 36.3 | -200.5 | 6.8 | 2 | BULLISH | -87.0 |
| CNNC Cannonau Corp. | — | 0.0 | -96.5 | -93.3 | — | -100.0 | 2 | BULLISH | -33.3 |
| HALB Halberd Corporation | — | -25.4 | 11.6 | 12.4 | — | -52.1 | 1 | BULLISH | -18.6 |
| BRVE Braveheart Bio, Inc. | $1.5B | — | — | — | — | — | — | BULLISH | — |
| DMRA Damora Therapeutics, Inc. | $1.3B | — | — | — | — | — | — | BULLISH | — |
| PTCHF PureTech Health plc | $390M | 156.5 | 0.2 | 50.8 | 1890.6 | 7.7 | 4 | BULLISH | -5.4 |
| TNPH Tian'an Pharmaceutical Co., Ltd. | $20M | -1961.1 | 0.3 | 33.0 | — | -100.0 | 3 | BULLISH | 1150.0 |
| AIBT Aibotics Inc. | — | — | — | — | — | — | — | BULLISH | — |
| IPIX Innovation Pharmaceuticals Inc. | — | -0.2 | -115.7 | -377.9 | — | -133.3 | 3 | BULLISH | 25.0 |
| RDGT Ridgetech, Inc. | — | -0.0 | -3.6 | -5.9 | -1.7 | 170.8 | 4 | BULLISH | -51.1 |
| TYRA Tyra Biosciences, Inc. | $1.2B | -9.1 | -45.3 | -2390.9 | — | — | 2 | BULLISH | 46.6 |
| ARVN Arvinas, Inc. | $470M | 40.0 | 1.6 | -519.3 | 67.8 | -15.0 | 4 | BULLISH | -21.2 |
| SHWGF Shandong Weigao Group Medical Polymer Company Limited | $1.9B | 9.4 | 5.6 | 7.4 | 11.3 | 2.2 | 6 | BULLISH | -39.1 |
| EBOSY EBOS Group Limited | $1.0B | 15.0 | 5.0 | 4.4 | 1.7 | -8.1 | 6 | BULLISH | -39.5 |
| JCRRF JCR Pharmaceuticals Co., Ltd. | $460M | 76.2 | 1.9 | -0.5 | -19.7 | 66.6 | 4 | BULLISH | -17.1 |
| AMRN Amarin Corporation plc | $240M | -12.0 | -4.2 | -15.1 | 0.6 | -22.4 | 4 | BULLISH | -33.7 |
| DBVT DBV Technologies S.A. | $230M | -2.7 | -142.6 | -2201.5 | — | -100.0 | 2 | BULLISH | -33.4 |
| STIM Neuronetics, Inc. | $160M | -5.3 | -135.3 | -21.3 | -8.3 | 39.6 | 4 | BULLISH | -26.9 |
| MBOT Microbot Medical Inc. | $70M | -4.3 | -32.9 | -600.2 | -2334.9 | — | 3 | BULLISH | -53.1 |
| TIL Instil Bio, Inc. | $40M | -1.5 | -25.3 | -69.1 | — | — | 4 | BULLISH | -65.8 |
| MDNAF Medicenna Therapeutics Corp. | $20M | — | — | — | — | — | — | BULLISH | — |
| OBX Obsidian Therapeutics Inc. | $10M | — | — | — | — | — | — | BULLISH | — |
| CNHC China Health Management Corp. | — | 13.7 | 3.2 | 3.3 | 29.8 | -1.0 | 6 | BULLISH | 53.4 |
| YBGJ Yubo International Biotech Limited | — | -1.7 | 28.2 | 30.1 | — | 9417.8 | 5 | BULLISH | -20.6 |
| RLBD Real Brands, Inc. | — | -0.2 | 62.2 | 111.8 | — | 204.2 | 5 | BULLISH | 900.0 |
| CALC CalciMedica, Inc. | — | -0.2 | -365.7 | 118.3 | — | — | 4 | BULLISH | -89.0 |
| CDXQ China De Xiao Quan Care Group Co., Ltd | — | 0.1 | -136.1 | -277.5 | — | — | 4 | BULLISH | 2000.0 |
| APLIF Appili Therapeutics Inc. | — | — | 27.8 | 79.4 | -1441.5 | 277.2 | 2 | BULLISH | -63.2 |
| UPHL UpHealth, Inc. | — | -0.0 | -84.2 | -4.7 | — | -46.7 | 3 | BULLISH | 50.0 |
| NUTX Nutex Health, Inc. | $1.4B | 8.1 | 49.2 | 53.9 | 31.2 | 6.9 | 7 | BULLISH | 64.2 |
| KURA Kura Oncology, Inc. | $850M | -3.2 | -167.7 | 56.3 | -327.3 | -7.3 | 1 | BULLISH | -2.9 |
| RZLT Rezolute, Inc. | $370M | -5.6 | -59.0 | 1060.6 | — | — | 2 | BULLISH | -55.2 |
| OBIO Orchestra BioMed Holdings, Inc. | $340M | -6.1 | -397.3 | 468.3 | -26994.3 | 986.1 | 4 | BULLISH | 51.6 |
| EBS Emergent BioSolutions Inc. | $320M | -2.1 | -40.3 | -5.5 | -76.9 | -9.6 | 5 | BULLISH | -26.8 |
| PROCF Sofgen Pharma S.A. | $60M | — | — | — | — | — | — | BULLISH | — |
| VASO Vaso Corporation | $50M | 17.9 | 10.0 | -3055.8 | 7.5 | -8.0 | 8 | BULLISH | 159.9 |
| AIMV AI Maverick Intel, Inc. | $10M | — | — | — | — | — | — | BULLISH | — |
| SNNC Sibannac, Inc. | — | -2.0 | 44.4 | 105.9 | — | -14.2 | 3 | BULLISH | -69.6 |
| CSWYF China Shineway Pharmaceutical Group Limited | $760M | 5.9 | 19.9 | 46.7 | 21.6 | 1081.8 | 8 | BULLISH | 0.0 |
| PEPG PepGen Inc. | $170M | -1.7 | -75.5 | -327.5 | — | — | 4 | BULLISH | -53.4 |
| CPIVF Captiva Verde Wellness Corp. | $30M | -40.6 | -49.0 | -123.3 | — | — | 2 | BULLISH | 500.0 |
| GSAC GelStat Corporation | — | -3.7 | 25.1 | 80.4 | -124.9 | 62.9 | 6 | BULLISH | 0.0 |
| DNA Ginkgo Bioworks Holdings, Inc. | $670M | -2.7 | -56.3 | -44.0 | -231.7 | -51.5 | 2 | BULLISH | -0.4 |
| BCCOY BICO Group AB (publ) | $190M | -2.0 | -41.5 | -8.4 | -11.1 | -19.8 | 6 | BULLISH | -9.6 |
| GMRS GMR Solutions Inc. | $580M | — | — | — | — | — | — | BULLISH | — |
| EVH Evolent Health, Inc. | $540M | -1.0 | -79.0 | -1.8 | -4.3 | -4.5 | 5 | BULLISH | -43.3 |
| QURE uniQure N.V. | $1.6B | -6.2 | -157.6 | 37.9 | -1387.8 | 30.2 | 4 | LEAN BULL | -63.2 |
| ATEC Alphatec Holdings, Inc. | $1.7B | -15.9 | -623.1 | -7.6 | -12.1 | 19.5 | 5 | LEAN BULL | -30.9 |
| VREX Varex Imaging Corporation | $780M | 35.1 | 4.6 | 7.6 | 7.5 | 5.3 | 6 | LEAN BULL | 54.8 |
| EMBC Embecta Corp. | $380M | 4.3 | -13.6 | 26.3 | 7.8 | -7.6 | 5 | LEAN BULL | -53.5 |
| BCRX BioCryst Pharmaceuticals, Inc. | $1.9B | -5.8 | 87.8 | 62.3 | 35.9 | 68.7 | 5 | LEAN BULL | 14.5 |
| CMPS COMPASS Pathways plc | $1.6B | -2.2 | -319.1 | 48.8 | — | — | 2 | LEAN BULL | 87.8 |
| COLL Collegium Pharmaceutical, Inc. | $750M | 15.2 | 17.6 | 9.4 | -7.5 | 14.3 | 6 | LEAN BULL | -33.3 |
| SOPH SOPHiA GENETICS S.A. | $630M | -6.8 | -101.2 | -155.2 | -95.9 | 23.6 | 3 | LEAN BULL | 87.4 |
| CERS Cerus Corporation | $470M | -66.9 | -10.8 | -7.4 | -5.1 | 15.1 | 5 | LEAN BULL | 57.1 |
| OVID Ovid Therapeutics Inc. | $420M | -5.1 | -26.0 | -43.7 | -2047.6 | -76.2 | 3 | LEAN BULL | 53.1 |
| SABS SAB Biotherapeutics, Inc. | $260M | 0.9 | -11.3 | -48.4 | — | -100.0 | 3 | LEAN BULL | 5.6 |
| CLNN Clene Inc. | $60M | -1.1 | 237.2 | 132.5 | -14915.6 | -31.1 | 2 | LEAN BULL | -52.6 |
| HCTI Healthcare Triangle, Inc. | $10M | -0.0 | -57.4 | -19.3 | -48.0 | 116.4 | 3 | LEAN BULL | -95.9 |
| BIVI BioVie Inc. | $10M | -0.5 | -0.0 | -0.0 | — | — | 3 | LEAN BULL | -22.8 |
| AGFAF Digicann Ventures Inc. | — | -0.0 | 30.8 | 63.6 | — | — | 2 | LEAN BULL | 47.7 |
| INFIQ Infinity Pharmaceuticals, Inc. | — | -0.0 | 109.5 | 60.9 | -1707.7 | — | 2 | LEAN BULL | 0.0 |
| ARDS Aridis Pharmaceuticals, Inc. | — | -0.0 | 4.8 | 10.0 | -19.9 | 2227.6 | 4 | LEAN BULL | -86.2 |
| PMEDF Qscreen Ai Inc. | — | -13.1 | 145.2 | 82.8 | — | — | 3 | LEAN BULL | -16.7 |
| MICR Micron Solutions, Inc. | — | -0.1 | -32.9 | -10.2 | -16.0 | 19.3 | 3 | LEAN BULL | 25450.0 |
| BSSP Baseline Productions, Inc. | — | -0.0 | 167.7 | 64.9 | — | — | 2 | LEAN BULL | 19900.0 |
| MOTS Motus GI Holdings, Inc. | — | -0.0 | -1069.0 | -1348.2 | -3301.6 | -47.9 | 4 | LEAN BULL | 5350.0 |
| SENS Senseonics Holdings, Inc. | $400M | -4.1 | -118.2 | -901.4 | -253.4 | 79.0 | 3 | LEAN BULL | 25.5 |
| VCRE Vicore Pharma Holding AB | $260M | — | — | — | — | — | — | LEAN BULL | — |
| HITI High Tide Inc. | $230M | -10.0 | -27.0 | 0.8 | 5.7 | 26.8 | 3 | LEAN BULL | -17.2 |
| SERA Sera Prognostics, Inc. | $80M | -3.0 | -45.0 | -184.9 | -30463.3 | -35.2 | 3 | LEAN BULL | -44.4 |
| INKT MiNK Therapeutics, Inc. | $50M | -4.5 | 57.9 | 42.8 | — | — | 4 | LEAN BULL | -24.0 |
| EVGRF China Evergrande New Energy Vehicle Group Limited | $20M | -12.9 | 104.0 | 16.8 | -766929.9 | 284.5 | 4 | LEAN BULL | 185.7 |
| CKDXF Ceryvyn Therapeutics Ltd | $10M | 0.1 | -243.9 | 2882.8 | — | -97.3 | 3 | LEAN BULL | -97.6 |
| BIEI Premier Graphene, Inc. | — | -28.3 | 9.8 | 7.4 | — | -100.0 | 5 | LEAN BULL | 28.6 |
| CYYNF Cynata Therapeutics Limited | — | -0.3 | -326.4 | 584.9 | — | -100.0 | 1 | LEAN BULL | -93.9 |
| MSGP MedSmart Group Inc. | — | -0.6 | 33.6 | 85.8 | — | -100.0 | 1 | LEAN BULL | 2000.0 |
| THCT THC Therapeutics, Inc. | — | -0.0 | 16.8 | 16.9 | — | — | 2 | LEAN BULL | 300.0 |
| MSTH Mystic Holdings, Inc. | — | -0.2 | -35.2 | -19.8 | -27.1 | 24.7 | 5 | LEAN BULL | -79.2 |
| VAXX Vaxxinity, Inc. | — | -0.2 | -150.6 | 2534.7 | — | — | 0 | LEAN BULL | 2699900.0 |
| AFIB Acutus Medical, Inc. | — | -0.0 | 153.1 | -0.4 | -19.7 | 375.7 | 2 | LEAN BULL | -66.7 |
| LMAT LeMaitre Vascular, Inc. | $1.9B | 28.6 | 16.8 | 25.6 | 24.2 | 11.8 | 8 | LEAN BULL | -7.8 |
| SI Shoulder Innovations, Inc. | $410M | -11.4 | -28.2 | -69.1 | -59.1 | — | 1 | LEAN BULL | 58.1 |
| OFIX Orthofix Medical Inc. | $400M | -6.5 | -13.9 | -3.6 | -7.5 | 3.0 | 6 | LEAN BULL | -37.6 |
| COCH Envoy Medical, Inc. | $50M | -1.0 | 176.2 | 119.9 | -11729.4 | -6.8 | 5 | LEAN BULL | -17.8 |
| DBCCF Decibel Cannabis Company Inc. | $50M | -118.1 | -1.0 | -3.0 | 11.7 | 26.5 | 3 | LEAN BULL | -1.5 |
| ADMT ADM Tronics Unlimited, Inc. | — | -6.5 | -49.5 | -22.1 | 3.7 | -2.2 | 3 | LEAN BULL | -39.1 |
| TSMRF Tsumura & Co. | $1.7B | 9.2 | 9.9 | 6.6 | 13.0 | 10.7 | 4 | LEAN BULL | 0.0 |
| SWGHF Sawai Group Holdings Co., Ltd. | $1.3B | 22.2 | 4.3 | 4.6 | 4.7 | 11.4 | 4 | LEAN BULL | 0.0 |
| TWAPF Towa Pharmaceutical Co., Ltd. | $1.3B | 20.8 | 4.7 | 3.2 | 7.7 | 7.1 | 7 | LEAN BULL | 54.4 |
| KKPCF Kaken Pharmaceutical Co., Ltd. | $980M | 13.9 | 6.9 | 7.9 | 28.0 | -6.6 | 4 | LEAN BULL | 8.3 |
| ANAB AnaptysBio, Inc. | $1.5B | 7.5 | -1146.3 | 466.0 | 668.9 | 92.9 | 5 | LEAN BULL | 109.4 |
| TKNO Alpha Teknova, Inc. | $340M | -25.0 | -24.2 | -17.2 | -26.0 | 12.3 | 4 | LEAN BULL | 44.2 |
| IMRX Immuneering Corporation | $240M | -3.8 | -52.1 | -112.8 | — | — | 4 | LEAN BULL | -36.7 |
| BFRGW Bullfrog AI Holdings, Inc. Warrants | — | -1.0 | -130.7 | -3026.9 | -636.8 | 798.5 | 6 | LEAN BULL | -91.8 |
| BGM BGM Group Ltd. | $100M | -2.0 | -0.5 | -0.2 | -8.7 | — | 3 | LEAN BULL | -96.5 |
| INVA Innoviva, Inc. | $1.5B | 4.3 | 36.7 | 15.0 | -69.8 | 19.8 | 7 | LEAN BULL | 19.2 |
| YDES YD Bio Limited Ordinary Shares | $350M | — | — | — | — | — | — | LEAN BULL | -62.1 |
| ZURA Zura Bio Limited | $320M | -3.9 | -65.4 | 806.5 | — | — | 2 | LEAN BULL | 10.7 |
| FATE Fate Therapeutics, Inc. | $250M | -2.1 | -60.7 | -140.1 | -1448.6 | -23.4 | 2 | LEAN BULL | 114.8 |
| SIGA SIGA Technologies, Inc. | $220M | -75.9 | -1.5 | -18.3 | 30.4 | -70.1 | 1 | LEAN BULL | -60.7 |
| MDWD MediWound Ltd. | $150M | -8.5 | -72.4 | -255.1 | -239.1 | -40.3 | 2 | LEAN BULL | -26.3 |
| EKDHF EKF Diagnostics Holdings plc | $140M | 40.2 | 3.5 | 5.2 | 9.3 | 2.5 | 7 | LEAN BULL | -17.8 |
| RNXT RenovoRx, Inc. | $60M | -4.5 | -125.2 | 4391.9 | -320.2 | 198.5 | 3 | LEAN BULL | 24.4 |
| TLTFF Theralase Technologies Inc. | $50M | -14.1 | -93.5 | -173.9 | -646.5 | -24.8 | 4 | LEAN BULL | -2.6 |
| VSBC VitaSpring Biomedical Co. Ltd. | $10M | -13.8 | 10.3 | 15.9 | — | -100.0 | 4 | LEAN BULL | -96.8 |
| NUMIF Numinus Wellness Inc. | $10M | -0.8 | 57.6 | 40.6 | -18.7 | 429.3 | 5 | LEAN BULL | -51.9 |
| LOBEF Lobe Sciences Ltd. | $10M | -2.7 | 359.0 | 181.6 | — | — | 2 | LEAN BULL | 33.1 |
| ERGO Entia Biosciences, Inc. | — | -0.0 | 106.8 | 92.5 | -1021.5 | -23.5 | 5 | LEAN BULL | 900.0 |
| BGXXQ Bright Green Corporation | — | — | — | — | — | — | — | LEAN BULL | — |
| PXMD PaxMedica, Inc. Common Stock | — | -0.0 | -7716.2 | 572.1 | — | — | 2 | LEAN BULL | 600.0 |
| ESMC Escalon Medical Corp. | — | 0.7 | 102.3 | -0.0 | 46.1 | 5.7 | 7 | LEAN BULL | 18.1 |
| BTTX Better Therapeutics, Inc. | — | -0.0 | 2351.8 | 1050.0 | — | -100.0 | 1 | LEAN BULL | 0.0 |
| SONX Sonendo, Inc. | — | -0.4 | -166.8 | -185.6 | -76.7 | -27.7 | 5 | LEAN BULL | 212.2 |
| NEWUF Newtopia Inc. | — | -0.1 | 75.4 | 107.5 | -166.7 | -36.4 | 2 | LEAN BULL | 0.0 |
| TGIFF 1933 Industries Inc. | — | 6.2 | -14.6 | -33.1 | 8.9 | -11.8 | 5 | LEAN BULL | -24.7 |
| VSEED VSee Health, Inc. | — | — | — | — | — | — | — | LEAN BULL | — |
| SCPX Scorpius Holdings, Inc. | — | -0.0 | 0.0 | 0.0 | -428.3 | -75.5 | 0 | LEAN BULL | -45.5 |
| OTRKQ Ontrak, Inc. | — | -0.0 | -215.7 | -149.5 | -341.6 | -21.0 | 1 | LEAN BULL | -0.0 |
| PBIO Pressure BioSciences, Inc. | — | -0.0 | 100.6 | 84.5 | -1687.2 | -25.3 | 3 | LEAN BULL | -98.7 |
| REVB Revelation Biosciences, Inc. | — | -0.1 | -154.8 | 1317.2 | — | — | 4 | LEAN BULL | 176.7 |
| INNV Innovage Holding Corp. | $1.3B | -439.6 | -1.1 | -89.6 | 3.2 | 16.4 | 6 | LEAN BULL | 81.3 |
| XGN Exagen Inc. | $180M | -10.2 | -113.8 | -79.2 | -16.0 | 20.8 | 3 | LEAN BULL | -29.5 |
| IUGNF Imugene Limited | $30M | -0.1 | -389.5 | -458.5 | — | -100.0 | 1 | LEAN BULL | -82.1 |
| CURX Curanex Pharmaceuticals Inc Common Stock | $10M | -0.7 | -218.7 | -392.2 | — | — | 1 | LEAN BULL | -69.1 |
| ACRS Aclaris Therapeutics, Inc. | $550M | -6.8 | -59.1 | -206.5 | -1320.1 | -51.0 | 3 | LEAN BULL | 69.2 |
| RNA Atrium Therapeutics, Inc. | $140M | -2.2 | -36.9 | 455.9 | -672.0 | 235.3 | 5 | LEAN BULL | -82.9 |
| TXTM ProText Mobility, Inc. | $90M | 72.0 | -0.4 | -0.3 | — | -100.0 | 1 | LEAN BULL | 191.4 |
| CLCS Cell Source, Inc. | $40M | -5.3 | 27.7 | 34.5 | — | — | 4 | LEAN BULL | 41.3 |
| KOAN Resonate Blends, Inc. | — | -0.0 | 46.5 | -991.9 | -399.0 | -32.1 | 4 | LEAN BULL | -97.5 |
| HRAL Hear AtLast Holdings, Inc. | — | -0.3 | 16.3 | 89.4 | — | — | 3 | LEAN BULL | -20.0 |
| PAHC Phibro Animal Health Corporation | $1.6B | 15.4 | 29.7 | 13.2 | 5.5 | 17.1 | 7 | LEAN BULL | -8.9 |
| LFCR Lifecore Biomedical, Inc. | $240M | -5.9 | 202.6 | 0.1 | -18.0 | -4.1 | 5 | LEAN BULL | -3.3 |
| SRZN Surrozen, Inc. | $190M | -0.7 | 387.2 | 11.1 | 1003.5 | -8.8 | 2 | LEAN BULL | 117.9 |
| ANTX AN2 Therapeutics, Inc. | $130M | -4.2 | -50.1 | 1243.3 | — | — | 2 | LEAN BULL | 234.8 |
| PBLA Panbela Therapeutics, Inc. | — | -0.0 | 270.3 | 240.0 | — | 100.0 | 3 | LEAN BULL | 0.0 |
| NMAD NOMAD Power Solutions, Inc. | $50M | — | — | — | — | — | — | LEAN BULL | — |
| WVE Wave Life Sciences Ltd. | $630M | -3.4 | -80.0 | -1243.7 | -470.5 | -35.1 | 2 | LEAN BULL | -52.2 |
| SPRB Spruce Biosciences, Inc. | $130M | -1.1 | -106.0 | 772.2 | — | -100.0 | 4 | LEAN BULL | -61.8 |
| PIIIW P3 Health Partners Inc. | $20M | -0.1 | -168.8 | -64.8 | 1.9 | 2.8 | 4 | LEAN BULL | -17.5 |
| ZEOX Zeo ScientifiX, Inc. | $10M | -2.1 | -140.0 | 105.8 | -5.6 | — | 2 | LEAN BULL | — |
| ENSC Ensysce Biosciences, Inc. | $10M | -0.2 | -968.3 | 792.9 | -220.8 | -77.6 | 3 | LEAN BULL | -78.9 |
| IRIX IRIDEX Corporation | $10M | -3.7 | -73.1 | -73.9 | -10.1 | 3.7 | 5 | LEAN BULL | -29.6 |
| NWBO Northwest Biotherapeutics, Inc. | $260M | -6.8 | 55.8 | -188.7 | -1142.6 | 98.6 | 3 | LEAN BULL | -34.9 |
| CHRS Coherus Oncology, Inc. | $160M | -1.1 | -145.4 | 1854.0 | -144.2 | -64.3 | 2 | LEAN BULL | -27.5 |
| OKUR OnKure Therapeutics, Inc. | $100M | -0.8 | -46.9 | 1464.5 | — | — | 4 | LEAN BULL | -26.3 |
| POSC Positron Corporation | $60M | -5.5 | 1961.0 | -1406.8 | -734.6 | -22.9 | 2 | LEAN BULL | 11.0 |
| EXMT Anything Technologies Media, Inc. | — | -11.1 | 27.0 | -24.5 | — | -100.0 | 2 | LEAN BULL | 11.1 |
| TRCNF Transnational Cannabis Ltd. | — | -0.0 | -178.2 | -75.5 | — | — | 1 | LEAN BULL | -96.0 |
| ECGS Eco-Growth Strategies Inc. | — | -2.2 | 15.4 | 46.1 | — | — | 3 | LEAN BULL | -86.3 |
| EHOS Ehouse Global, Inc. | — | -0.0 | 161.0 | 52.5 | — | — | 1 | LEAN BULL | 0.0 |
| DOGP Dogecoin Cash, Inc. | — | -2.1 | 30.1 | 16.3 | -76.3 | 0.2 | 3 | LEAN BULL | -73.4 |
| PSNL Personalis, Inc. | $1.7B | -14.7 | -50.3 | -149.3 | -141.7 | -13.3 | 2 | LEAN BULL | 65.3 |
| IUSDF AS ONE Corporation | $1.0B | 18.8 | 12.2 | 13.4 | 8.1 | 5.7 | 6 | LEAN BULL | -39.5 |
| KJFI Comjoyful International Company | $210M | -98.4 | 171.5 | -1549.9 | 44.3 | 38.8 | 6 | LEAN BULL | 459.8 |
| FOCL EDAP TMS S.A. American Depositary Shares | $160M | — | — | — | — | — | — | LEAN BULL | — |
| BETRF BetterLife Pharma Inc. | $110M | -10.9 | 34.9 | 21.6 | — | — | 4 | LEAN BULL | 282.3 |
| LITS Lite Strategy, Inc. | $40M | -0.1 | -170.9 | -28.2 | — | — | 2 | LEAN BULL | -41.1 |
| LEXX Lexaria Bioscience Corp. | $10M | -0.6 | -150.3 | -504.2 | — | -68.5 | 4 | LEAN BULL | -78.0 |
| ENVB Enveric Biosciences, Inc. | $10M | -0.1 | -170.0 | 3225.6 | — | — | 4 | LEAN BULL | -80.1 |
| ETBI Eastgate Biotech Corp. | $10M | -2.6 | 93.4 | 134.9 | -7057.2 | -53.0 | 3 | LEAN BULL | 66.7 |
| HPMM Hemp Naturals, Inc. | — | -0.0 | -141.5 | -78.5 | — | — | 3 | LEAN BULL | -80.0 |
| PMHS Polomar Health Services, Inc. | — | — | — | — | — | — | — | LEAN BULL | — |
| DVLP Golden Developing Solutions, Inc. | — | -0.0 | 450.9 | 46.1 | -166.7 | — | 6 | LEAN BULL | -90.0 |
| BIOIF Biome Grow Inc. | — | -0.0 | 56.7 | 86.9 | — | — | 3 | LEAN BULL | 0.0 |
| MSPR MSP Recovery, Inc. | — | -0.0 | 127.6 | -506.2 | -84750.5 | — | 2 | LEAN BULL | -100.0 |
| ALGWF Alliance Growers Corp. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| CNGGF Cann Group Limited | — | 0.3 | 157.4 | -25.1 | -150.3 | -35.4 | 5 | LEAN BULL | -40.8 |
| NMTRQ 9 Meters Biopharma, Inc. | — | — | — | — | — | — | — | LEAN BULL | 9900.0 |
| MHTX Manhattan Scientifics, Inc. | — | -0.0 | 45.1 | 23.3 | — | 104.9 | 3 | LEAN BULL | 0.0 |
| CMRA Comera Life Sciences Holdings, Inc. | — | -0.0 | 235.6 | 124.2 | -1580.0 | 81.8 | 4 | LEAN BULL | 0.0 |
| ELIXF Elixxer Ltd. | — | -0.2 | 27.1 | 280.4 | — | — | 2 | LEAN BULL | -58.1 |
| RBII Rising Biosciences, Inc. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| DNAG DNAPrint Genomics, Inc. | — | -0.0 | 63.1 | -156.0 | -826.7 | -15.2 | 3 | LEAN BULL | 100.0 |
| GRCU Global Roundtable Corporation | — | -2.9 | 28.1 | 25.5 | -673.8 | 35.7 | 7 | LEAN BULL | 0.0 |
| WHSI Wearable Health Solutions, Inc. | — | -0.1 | 37.4 | 155.3 | 98.4 | -29.7 | 2 | LEAN BULL | 0.0 |
| PXYN Praxsyn Corporation | — | -0.0 | 159.9 | 101.7 | 14.5 | 14.7 | 4 | LEAN BULL | 0.0 |
| INLB Item 9 Labs Corp. | — | -0.0 | -47.3 | -18.4 | -117.7 | -17.4 | 2 | LEAN BULL | 0.0 |
| OMHE OMNI Health, Inc. | — | 0.0 | 30.4 | -8.8 | -6.1 | 2046.4 | 4 | LEAN BULL | 233.3 |
| KHRNF Khiron Life Sciences Corp. | — | -0.2 | -74.7 | -41.4 | -105.6 | 76.2 | 2 | LEAN BULL | 900.0 |
| CNFHF CanaFarma Hemp Products Corp. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| REFG Medical Cannabis Payment Solutions | — | -3.0 | 1.2 | 1.5 | — | — | 2 | LEAN BULL | 200.0 |
| ONCSQ OncoSec Medical Incorporated | — | -0.0 | -410.2 | 452.1 | — | — | 2 | LEAN BULL | -90.0 |
| SVSO SheerVision, Inc. | — | -0.0 | 31.8 | -24.5 | 42.2 | -32.8 | 3 | LEAN BULL | 0.0 |
| XBRAF Xebra Brands Ltd. | — | -0.1 | -542.1 | -2373.1 | — | -100.0 | 1 | LEAN BULL | -98.9 |
| ABVC ABVC BioPharma, Inc. | $30M | -3.7 | -82.2 | -43.0 | — | -100.0 | 2 | NEUTRAL | -62.3 |
| PJET Priority Aviation, Inc. | — | -0.1 | 19.5 | 31.9 | — | -83.3 | 2 | NEUTRAL | 0.0 |
| AEMD Aethlon Medical, Inc. | — | -0.5 | -160.9 | -883.2 | — | — | 3 | NEUTRAL | -78.7 |
| REZNF Street Capital Inc. | — | -3.3 | 20.7 | 15.0 | — | -44.3 | 5 | NEUTRAL | 566.7 |
| SLDX Stella Diagnostics Inc. | — | -0.7 | 18.1 | 21.7 | -195.2 | — | 4 | NEUTRAL | -33.3 |
| BGMD BG Medicine, Inc. | — | -0.0 | 747.3 | 104.5 | -311.0 | -43.8 | 5 | NEUTRAL | 0.0 |
| NPNKF Nippon Shinyaku Co., Ltd. | $1.6B | 7.2 | 11.6 | 12.5 | 20.6 | 12.8 | 4 | NEUTRAL | -1.1 |
| BBNX Beta Bionics, Inc. | $860M | -9.5 | -23.9 | -43.7 | -68.6 | 86.8 | 4 | NEUTRAL | -24.8 |
| AHCO AdaptHealth Corp. | $820M | -3.6 | -15.5 | -0.2 | -18.1 | 22.9 | 6 | NEUTRAL | -35.9 |
| IFRX InflaRx N.V. | $230M | -3.2 | -38.5 | 251.5 | — | -106.2 | 4 | NEUTRAL | 4.2 |
| LONA LeonaBio, Inc. | $20M | — | — | — | — | — | — | NEUTRAL | — |
| BIEL Bioelectronics Corporation | $10M | -13.9 | 6.3 | 24.0 | -132.4 | -63.1 | 1 | NEUTRAL | -33.3 |
| LWSCF Sienna Senior Living Inc. | $1.6B | 38.2 | 6.7 | 3.9 | 4.4 | 16.2 | 7 | NEUTRAL | 1.6 |
| THMO ThermoGenesis Holdings, Inc. | — | -0.0 | -417.9 | -71.5 | -67.8 | -7.5 | 3 | NEUTRAL | 9900.0 |
| ADXN Addex Therapeutics Ltd | — | -0.4 | -150.5 | -168.4 | -17543.0 | -48.1 | 2 | NEUTRAL | -69.7 |
| CYDY CytoDyn Inc. | $380M | -4.8 | 57.8 | 24.6 | — | 100.0 | 4 | NEUTRAL | -16.7 |
| CGEM Cullinan Therapeutics, Inc. | $880M | -4.6 | -50.3 | 1635.6 | — | — | 1 | NEUTRAL | 93.0 |
| QTTB Q32 Bio Inc. | $260M | 3.2 | 72.1 | 435.2 | — | — | 5 | NEUTRAL | 223.6 |
| EVMN Evommune, Inc. | $190M | -1.9 | -29.6 | -82.4 | — | — | 2 | NEUTRAL | — |
| NVLPF Nova Leap Health Corp. | $30M | 23.5 | 7.0 | 5.6 | 6.9 | 20.3 | 5 | NEUTRAL | 80.0 |
| SETO SETO Holdings, Inc. | — | -13.8 | -22.5 | -8.5 | -32.2 | 9760.2 | 6 | NEUTRAL | 103.7 |
| GBIM GlobeImmune, Inc. | — | -0.0 | -66.2 | 25.0 | -91.5 | 55.1 | 4 | NEUTRAL | 0.0 |
| OCEA Ocean Biomedical, Inc. | — | -0.0 | 36.5 | 0.3 | — | — | 1 | NEUTRAL | -20.0 |
| OWCP OWC Pharmaceutical Research Corp. | — | -0.0 | -34.4 | 1662.7 | — | — | 2 | NEUTRAL | 0.0 |
| PMI Picard Medical, Inc. | $730M | -0.4 | -1631.2 | -469.0 | -191.6 | — | 2 | NEUTRAL | 50.5 |
| BPTH Bio-Path Holdings, Inc. | — | -0.0 | 49.0 | 15.2 | — | -100.0 | 1 | NEUTRAL | -99.7 |
| CARM Carisma Therapeutics, Inc. | — | 0.0 | -134.1 | -376.4 | 98.8 | 159.7 | 3 | NEUTRAL | -98.8 |
| OSSFF Embla Medical hf. | $1.9B | 18.3 | 10.4 | 7.7 | 10.5 | 9.9 | 7 | NEUTRAL | -5.6 |
| CSSPF NIOX Group Plc | $380M | 40.7 | 10.8 | 13.0 | 24.6 | 3.5 | 7 | NEUTRAL | -2.3 |
| FULC Fulcrum Therapeutics, Inc. | $280M | -3.1 | -32.4 | 2389.1 | — | — | 4 | NEUTRAL | -61.1 |
| CAIHF CPBIO Holding Company Limited | $270M | 10.0 | 10.0 | 8.1 | 3.4 | 73.4 | 8 | NEUTRAL | 282.1 |
| DIUXF Diaceutics PLC | $200M | -635.9 | -0.8 | -2.3 | -15.9 | 20.4 | 4 | NEUTRAL | 68.6 |
| HCAT Health Catalyst, Inc. | $130M | -0.5 | -118.1 | -27.1 | -57.5 | -7.5 | 5 | NEUTRAL | -48.0 |
| FHTX Foghorn Therapeutics Inc. | $120M | -2.2 | 81.9 | 26.3 | -44.7 | 52.0 | 4 | NEUTRAL | -48.3 |
| RNTX Rein Therapeutics Inc. | $50M | -0.4 | -753.6 | 53.9 | — | — | 3 | NEUTRAL | -47.1 |
| EXHI Exlites Holdings International, Inc. | $20M | -750.0 | -66.7 | -65.8 | -35.4 | 283.9 | 4 | NEUTRAL | 97.4 |
| GDTC CytoMed Therapeutics Limited | $10M | -2.7 | -66.1 | -87.8 | -1125.6 | -11.3 | 0 | NEUTRAL | -61.4 |
| NEPTF Neptune Wellness Solutions Inc. | — | -2.8 | 606.5 | 1351.5 | -233.6 | -24.7 | 2 | NEUTRAL | -96.0 |
| ADVT Advantis Corp. | — | -0.4 | -8.4 | -3.2 | -1775.1 | — | 1 | NEUTRAL | 0.0 |
| SFWJ Software Effective Solutions Corp. | — | -1.3 | -21.8 | -12.6 | -51.5 | 26679.3 | 6 | NEUTRAL | 31.8 |
| BTCY Biotricity, Inc. | — | -0.4 | 8.3 | -17.1 | -22.4 | 13.4 | 6 | NEUTRAL | -91.1 |
| STHZF StateHouse Holdings Inc. | — | -0.1 | 36.1 | 3.8 | 0.8 | -2.6 | 4 | NEUTRAL | -99.3 |
| FCGD First Colombia Gold Corp. | — | -95.6 | 23.1 | 122.7 | — | -93.9 | 2 | NEUTRAL | 100.0 |
| STEK Stemtech Corporation | — | -0.0 | 58.2 | 37.1 | -46.5 | -38.6 | 2 | NEUTRAL | -97.9 |
| ONCO Onconetix, Inc. | — | -0.1 | -105.2 | -83.7 | -16748.3 | -51.3 | 3 | NEUTRAL | -83.2 |
| MPXOF MPX International Corp. | — | -0.0 | -179.4 | -42.1 | -411.8 | 14.3 | 4 | NEUTRAL | -0.0 |
| PAOG PAO Group, Inc. | — | -5.8 | -20.2 | 11.2 | — | — | 4 | NEUTRAL | 200.0 |
| NSTM NovelStem International Corp. | — | -1.5 | 15.3 | 31.5 | — | -100.0 | 3 | NEUTRAL | -44.4 |
| FLWPF The Flowr Corporation | — | — | -335.3 | 207.1 | -1827.8 | 38.5 | 3 | NEUTRAL | 0.0 |
| HESG Health Sciences Group, Inc. | — | -0.0 | 69.4 | 44.6 | -19219.1 | 101.6 | 3 | NEUTRAL | 900.0 |
| CRYM Cryomass Technologies Inc. | — | -0.0 | 137.2 | 57.9 | -22040.0 | -96.0 | 2 | NEUTRAL | 19900.0 |
| NTRR Neutra Corp. | — | 2.0 | -139.6 | -802.5 | -3.8 | 142.2 | 7 | NEUTRAL | 0.0 |
| STTK Shattuck Labs, Inc. | $550M | -11.4 | -39.2 | -29.3 | — | -66.6 | 4 | NEUTRAL | 182.0 |
| VHIBF Vitalhub Corp. | $340M | 63.5 | 3.3 | 10.7 | 6.1 | 53.9 | 7 | NEUTRAL | -34.9 |
| HUMDF Hua Medicine (Shanghai) Ltd. | $300M | -18.4 | -10.3 | -30.2 | -8.0 | 73.9 | 3 | NEUTRAL | -26.1 |
| ARCT Arcturus Therapeutics Holdings Inc. | $280M | -3.6 | -46.3 | -2501.0 | -803.8 | -79.1 | 1 | NEUTRAL | 14.0 |
| CTXR Citius Pharmaceuticals, Inc. | $10M | -0.3 | -70.3 | -85.4 | -593.3 | 4456.8 | 3 | NEUTRAL | -66.6 |
| WMGR Wellness Matrix Group, Inc. | — | -0.0 | 24.4 | 19.3 | — | — | 2 | NEUTRAL | 0.0 |
| SPBBF Speakeasy Cannabis Club Ltd. | — | -0.0 | -55.1 | -4.0 | -803.2 | 16129.5 | 3 | NEUTRAL | 0.0 |
| NKGN NKGen Biotech, Inc. | — | -0.0 | 150.9 | — | -4511.3 | — | 3 | NEUTRAL | -45.0 |
| LPTI Longport, Inc. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| RVVQF RavenQuest BioMed Inc. | — | -0.0 | -112.5 | -40.6 | -440.2 | 93.6 | 2 | NEUTRAL | 0.0 |
| YDESW YD Bio Limited Warrants | — | — | — | — | — | — | — | NEUTRAL | -69.0 |
| JWCAF James E. Wagner Cultivation Corporation | — | -0.0 | -50.3 | -16.2 | -493.1 | 315.1 | 2 | NEUTRAL | 0.0 |
| CLVR Clever Leaves Holdings Inc. | — | -0.0 | -55.4 | -63.3 | -109.6 | 3.6 | 4 | NEUTRAL | 11100.0 |
| BMGP Biomagnetics Diagnostics Corp. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| HEWA HealthWarehouse.com, Inc. | — | -4.8 | 24.7 | 44.2 | -6.8 | -42.5 | 3 | NEUTRAL | -9.1 |
| VRSYF VMS Rehab Systems, Inc. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| FRLI Frélii, Inc. | — | -0.0 | -671.6 | -265.5 | -10546.4 | 378.8 | 4 | NEUTRAL | 0.0 |
| CFRXQ ContraFect Corp. | — | -0.0 | 544.7 | 276.9 | — | — | 1 | NEUTRAL | -90.0 |
| AUSAF Australis Capital Inc. | — | -0.0 | -52.8 | -42.1 | -1022.3 | 1388076.3 | 3 | NEUTRAL | -90.0 |
| RDDTF Radient Technologies Inc. | — | — | 98.9 | 263.2 | -131.7 | -20.4 | 3 | NEUTRAL | 0.0 |
| MHUAF Meihua International Medical Technologies Co., Ltd. | — | — | — | — | — | — | — | NEUTRAL | — |
| RBSH Rebus Holdings, Inc. | — | -0.0 | -9.7 | 8.9 | — | — | 2 | NEUTRAL | 0.0 |
| LYCA Lycia Therapeutics Inc. | $1.6B | — | — | — | — | — | — | N/A | — |
| CTEV Claritev Corporation | $400M | -1.4 | 169.3 | 0.9 | -23.0 | 110.3 | 4 | NEUTRAL | -67.8 |
| CTY City Therapeutics Inc. | $200M | — | — | — | — | — | — | N/A | — |
| DAVI Davion Healthcare Plc | $150M | — | — | — | — | — | — | N/A | — |
| IAM Iambic Therapeutics Inc. | $130M | — | — | — | — | — | — | N/A | — |
| TRXB TRex Bio Inc. | $120M | — | — | — | — | — | — | N/A | — |
| RTSN Retension Pharmaceuticals Inc. | $60M | — | — | — | — | — | — | N/A | — |
| ACHFF Arch Biopartners Inc. | $40M | -19.3 | 73.5 | 165.4 | — | 100.0 | 2 | NEUTRAL | -15.7 |
| ATOS Atossa Therapeutics, Inc. | $30M | -0.5 | -89.2 | -4213.1 | — | — | 2 | NEUTRAL | -83.2 |
| NRTSF Nobilis Health Corp. | — | 0.0 | 1.1 | 2.8 | 1.3 | -11.1 | 3 | N/A | -100.0 |
| ODYY Odyssey Health, Inc. | — | -0.2 | 43.4 | 10.0 | — | -100.0 | 4 | NEUTRAL | -90.3 |
| ASBP Aspire Biopharma Holdings, Inc. | — | -1.1 | -1032.1 | 1368.4 | -2009.6 | — | 6 | NEUTRAL | -97.9 |
| MDVLQ MedAvail Holdings, Inc. | — | -0.0 | -164.8 | -243.8 | -1429.9 | -28.6 | 4 | NEUTRAL | 0.0 |
| INDR Indie Ranch Media, Inc. | — | — | — | — | — | — | — | N/A | -90.0 |
| ODTX Odyssey Therapeutics, Inc. | $940M | — | — | — | — | — | — | NEUTRAL | — |
| JBIO Jade Biosciences, Inc. | $930M | -5.3 | -47.8 | 629.9 | — | — | 3 | NEUTRAL | 43.2 |
| CNSY Cerenome, Inc. | $10M | — | — | — | — | — | — | NEUTRAL | — |
| EDVA Endovia Health Sciences, Inc. | — | — | — | — | — | — | — | NEUTRAL | — |
| RKAGY RHÃN-KLINIKUM Aktiengesellschaft | $1.1B | 22.3 | 2.8 | 3.1 | 2.1 | 2.5 | 6 | NEUTRAL | 10.7 |
| NVYTF Novacyt S.A. | $40M | -0.8 | -59.6 | -45.1 | -50.1 | -44.9 | 3 | NEUTRAL | 14.0 |
| AJYG AJ1G, Inc. | — | — | — | — | — | — | — | NEUTRAL | 380.1 |
| LGNDZ Ligand Pharmaceuticals, Inc. | — | 0.0 | 20.4 | 11.3 | 76.2 | — | 3 | NEUTRAL | — |
| SVRA Savara Inc. | $870M | -8.7 | -105.5 | -15438.9 | — | — | 2 | NEUTRAL | 14.6 |
| MDRX Veradigm Inc. | $830M | -7.5 | 4.3 | 7.0 | 6.2 | -39.7 | 5 | NEUTRAL | 6.4 |
| SNGX Soligenix, Inc. | $10M | -0.3 | -241.7 | 304.6 | — | — | 4 | NEUTRAL | -83.9 |
| KLDO Kaleido Biosciences, Inc. | — | -0.0 | -591.2 | 1121.9 | -4292.5 | 13.2 | 2 | NEUTRAL | 0.0 |
| EDXC Endexx Corporation | — | -0.0 | 51.8 | 0.5 | — | -125.6 | 2 | NEUTRAL | -95.5 |
| CNNA Cann American Corp. | — | 0.4 | -312.1 | -287.6 | -7986.6 | -64.9 | 3 | NEUTRAL | 120.0 |
| ALMS Alumis Inc. | $880M | -1.9 | -93.6 | 2645.2 | -8557.2 | -63.1 | 2 | NEUTRAL | 48.2 |
| YARW Yarrow Bioscience Inc | $180M | — | — | — | — | — | — | NEUTRAL | — |
| QTRX Quanterix Corporation | $140M | -1.2 | -46.5 | -59.0 | -148.7 | 23.4 | 2 | NEUTRAL | -45.1 |
| EQ Equillium, Inc. | $80M | -5.5 | -59.0 | 2703.6 | — | -100.0 | 3 | NEUTRAL | 3.6 |
| ELTX Elicio Therapeutics, Inc. | $40M | -0.9 | -774.6 | 2147.3 | — | — | 4 | NEUTRAL | -80.9 |
| NYMXF Nymox Pharmaceutical Corporation | $10M | -0.7 | 193.9 | 89.4 | — | — | 2 | NEUTRAL | -70.0 |
| ISCNF Isracann Biosciences Inc. | — | -0.5 | -252.3 | 2640.8 | — | — | 2 | NEUTRAL | 0.0 |
| MDCE Medical Care Technologies Inc. | — | 1.0 | 28.0 | 28.7 | 23.9 | 0.6 | 7 | NEUTRAL | -66.7 |
| FWDG FutureWorld Corp. | — | -0.1 | -1.2 | -0.5 | -507.1 | 153.6 | 5 | NEUTRAL | 0.0 |
| LOWLF Lowell Farms Inc. | — | -0.0 | -146.8 | -63.3 | -111.9 | -35.7 | 5 | NEUTRAL | -88.0 |
| NXGL NEXGEL, Inc. | — | -0.0 | -128.6 | -35.8 | -98.6 | 3.4 | 2 | NEUTRAL | -92.2 |
| BBBT Black Bird Biotech, Inc. | — | -0.0 | 129.1 | 137.7 | -3333.2 | -61.0 | 2 | NEUTRAL | 0.0 |
| TUTH Standard Dental Labs Inc. | — | -3.0 | 22.6 | 1394.1 | -117.5 | -7.5 | 6 | NEUTRAL | 26.4 |
| IDCN Indocan Resources Inc. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| ARYC Arrayit Corporation | — | -0.0 | 116.8 | 89.8 | -513.1 | -30.5 | 2 | NEUTRAL | -90.0 |
| RVLPQ RVL Pharmaceuticals plc | — | -0.0 | -182.4 | -101.1 | -289.3 | 5.6 | 3 | NEUTRAL | 900.0 |
| GRPS Trans American Aquaculture, Inc. | — | -0.5 | 114.2 | 17.8 | — | -96.0 | 3 | NEUTRAL | -66.7 |
| VRAYQ ViewRay, Inc. | — | -0.0 | -108.9 | -146.1 | -128.1 | 44.1 | 1 | NEUTRAL | 900.0 |
| USPH U.S. Physical Therapy, Inc. | $1.3B | 501.9 | -1.3 | 7.7 | 0.7 | 17.1 | 5 | NEUTRAL | -4.0 |
| AORT Artivion, Inc. | $1.1B | -384.6 | -0.7 | -3.4 | -10.7 | 16.4 | 4 | NEUTRAL | -48.8 |
| HSCS HeartSciences Inc. | $20M | -1.1 | -1851.9 | 26.8 | -151064.0 | -27.7 | 1 | NEUTRAL | 1.9 |
| EGRX Eagle Pharmaceuticals, Inc. | $10M | 0.3 | 6.4 | 3.6 | 8.0 | -5.4 | 3 | NEUTRAL | -5.0 |
| VPTDF VentriPoint Diagnostics Ltd. | $10M | -6.5 | 58.8 | 122.3 | -3487.7 | 8.8 | 4 | NEUTRAL | -18.5 |
| BIOCQ Biocept, Inc. | — | -0.0 | -13593.8 | -631.8 | -616.5 | — | 2 | NEUTRAL | 200.0 |
| VLXC Veltex Corporation | — | -2.6 | 49.0 | -433.9 | -89.4 | 3.2 | 3 | NEUTRAL | -45.8 |
| SPLM Sentry Petroleum Ltd | — | -0.1 | -184.2 | -129.4 | — | — | 1 | NEUTRAL | 0.0 |
| SESI SES Solar Inc. | — | -0.5 | 16.7 | 1.7 | 28.0 | 324.6 | 7 | NEUTRAL | 9900.0 |
| RMSL REMSleep Holdings, Inc. | — | -0.0 | 4286484750.6 | 1769.6 | -702.2 | -27.1 | 2 | NEUTRAL | -43.1 |
| WHWK Whitehawk Therapeutics Inc | $180M | -3.1 | -45.0 | 963.4 | — | -100.0 | 1 | NEUTRAL | 43.0 |
| PYXS Pyxis Oncology, Inc. | $110M | -1.4 | -179.1 | 1953.9 | — | 291.4 | 2 | NEUTRAL | -41.6 |
| EAPIF Euroapi S.A. | $80M | -0.2 | -39.9 | 2.1 | -39.7 | -10.3 | 3 | NEUTRAL | -75.2 |
| ELUT Elutia Inc | $40M | 0.6 | -397.0 | -290.2 | -315.0 | -48.8 | 6 | NEUTRAL | -6.7 |
| EVAX Evaxion Biotech A/S | $20M | -0.5 | -109.8 | -260.4 | — | 135.9 | 6 | NEUTRAL | -49.3 |
| CSCIF COSCIENS Biopharma Inc. | $10M | -0.5 | -19.9 | -18.7 | -6.4 | — | 1 | NEUTRAL | -17.7 |
| CANN Trees Corporation | — | -2.5 | 284.2 | -3.9 | -15.1 | -24.7 | 4 | NEUTRAL | -59.6 |
| VDRM ViaDerma, Inc. | — | 28.7 | 133.1 | -25.3 | -214.1 | 5.3 | 3 | NEUTRAL | -50.0 |
| LADX LadRx Corporation | — | -0.0 | 278.9 | 118.4 | — | -61.0 | 1 | NEUTRAL | -99.0 |
| CBIH Cannabis Bioscience International Holdings, Inc. | — | -0.0 | 48.2 | 34.0 | -341.5 | -58.2 | 1 | NEUTRAL | -66.7 |
| CBDY Target Group Inc. | — | -0.3 | 23.2 | -10.4 | -17.4 | -30.4 | 2 | NEUTRAL | -44.4 |
| MRPI Mera Pharmaceuticals, Inc. | — | -10000.0 | 24.3 | 18.3 | -159.9 | 4.8 | 5 | NEUTRAL | 0.0 |
| MCTA Charming Medical Limited Class A Ordinary Shares | $450M | — | — | — | — | — | — | LEAN BEAR | — |
| TRIB Trinity Biotech plc | $150M | -0.1 | 69.8 | -14.6 | -157.8 | -28.8 | 2 | LEAN BEAR | 584.3 |
| MBXBF Microbix Biosystems Inc. | $30M | -8.2 | -16.4 | -14.6 | -19.9 | -27.1 | 3 | LEAN BEAR | 24.3 |
| DYNTQ Dynatronics Corporation | — | — | — | — | — | — | — | LEAN BEAR | — |
| XBIO Xenetic Biosciences, Inc. | — | -1.8 | -47.0 | 523.4 | -140.7 | 33.3 | 4 | LEAN BEAR | -44.0 |
| STSEY Stratec SE | $1.7B | -572.5 | -0.2 | -0.2 | 7.0 | -4.8 | 4 | LEAN BEAR | -17.8 |
| SAFLY Safilo Group S.p.A. | $1.4B | 15.2 | 12.0 | 10.0 | 8.7 | -3.4 | 7 | LEAN BEAR | 40.1 |
| AGYTF Allergy Therapeutics plc | $760M | -4.0 | 3372.3 | -97.9 | -54.9 | 19.9 | 3 | LEAN BEAR | 36.4 |
| MLLCF Molecular Partners AG | $150M | -2.2 | -62.1 | 650.3 | — | -100.0 | 2 | LEAN BEAR | 14.6 |
| OPORF hVIVO plc | $80M | -3.1 | -32.7 | -34.7 | -39.7 | -23.6 | 2 | LEAN BEAR | -54.3 |
| POLBF Poolbeg Pharma PLC | $70M | -8.5 | -58.8 | -255.9 | — | — | 1 | LEAN BEAR | 125.4 |
| CLYYF Celyad Oncology S.A. | $10M | 2.5 | -11.7 | -979.7 | 64360.6 | -88.7 | 5 | LEAN BEAR | 40.0 |
| QPTFF Quest PharmaTech Inc. | $10M | 1.6 | 3.9 | -1.7 | — | — | 4 | LEAN BEAR | 125.6 |
| CAMP CAMP4 Therapeutics Corporation | $210M | -1.6 | -545.9 | 48.4 | -1884.8 | 40.2 | 2 | LEAN BEAR | -6.4 |
| EMED Electromedical Technologies, Inc. | — | -0.2 | 44.6 | 29.8 | -8153.1 | -66.6 | 2 | LEAN BEAR | 0.0 |
| INND InnerScope Hearing Technologies, Inc. | — | -0.0 | -1.4 | -0.4 | — | -56.8 | 4 | LEAN BEAR | -95.2 |
| ENTA Enanta Pharmaceuticals, Inc. | $340M | -4.8 | -70.1 | 141.5 | -135.8 | 0.7 | 4 | LEAN BEAR | 10.0 |
| AGEN Agenus Inc. | $290M | 2.6 | -33.2 | -20.4 | -1.6 | 30.5 | 6 | LEAN BEAR | 71.8 |
| BIOA BioAge Labs Inc. | $190M | -2.5 | -28.2 | -142.3 | -1064.7 | 168.1 | 4 | LEAN BEAR | -22.1 |
| ALXO ALX Oncology Holdings Inc. | $160M | -1.0 | -80.6 | -851.1 | — | — | 4 | LEAN BEAR | -30.6 |
| AURX Nuo Therapeutics, Inc. | $60M | -31.1 | 170.6 | 280.3 | -15.7 | 166.6 | 3 | LEAN BEAR | -45.8 |
| JSPR Jasper Therapeutics, Inc. | $20M | -0.3 | -255.0 | 773.9 | — | — | 2 | LEAN BEAR | -76.9 |
| CNBX CNBX Pharmaceuticals Inc. | — | -0.5 | 17.8 | 13.3 | — | 100.0 | 3 | LEAN BEAR | -66.7 |
| VIVE Viveve Medical, Inc. | — | -0.0 | -222.0 | -1442.3 | -314.1 | 2.4 | 3 | LEAN BEAR | 19900.0 |
| FFNTF 4Front Ventures Corp. | — | -0.0 | 73.3 | -15.3 | -37.4 | -34.7 | 3 | LEAN BEAR | 900.0 |
| GYRE Gyre Therapeutics, Inc. | $620M | -35.6 | -15.6 | -22.3 | -36.4 | 16.8 | 3 | LEAN BEAR | -11.6 |
| NTRB Nutriband Inc. | $70M | -11.2 | -100.7 | -264.9 | -201.3 | -37.3 | 3 | LEAN BEAR | -9.0 |
| BOLD Boundless Bio, Inc. | $50M | -0.9 | -67.9 | 807.9 | — | — | 2 | LEAN BEAR | 67.8 |
| DROR Dror Ortho-Design, Inc. | $10M | -0.0 | 15.8 | 36.4 | — | — | 1 | LEAN BEAR | — |
| AEON AEON Biopharma, Inc. | $10M | -0.1 | 350.0 | 98.0 | — | — | 2 | LEAN BEAR | -71.0 |
| SRBCF Sirona Biochem Corp. | — | -0.7 | 111.4 | 1025.7 | -34808.5 | -119.4 | 2 | LEAN BEAR | -50.5 |
| HCANF Halo Collective Inc. | — | -0.0 | -132.7 | -43.7 | -192.0 | -43.0 | 2 | LEAN BEAR | 0.0 |
| SNNAQ Sienna Biopharmaceuticals, Inc. | — | -0.0 | -140.9 | -331.4 | — | — | 2 | LEAN BEAR | 0.0 |
| CHOOF Choom Holdings Inc. | — | -0.0 | 3772.9 | -35.1 | -140.0 | 4.6 | 4 | LEAN BEAR | 0.0 |
| PPJE PPJ Healthcare Enterprises, Inc. | — | 56.8 | -0.0 | -0.0 | 0.0 | -1.2 | 4 | LEAN BEAR | 4900.0 |
| PPCB Propanc Biopharma, Inc. | — | -0.1 | -161.9 | -166.7 | — | — | 4 | LEAN BEAR | 45.3 |
| LFCOF Lift & Co. Corp. | — | -0.0 | 149.0 | -666.2 | -170.0 | — | 2 | LEAN BEAR | 0.0 |
| EVRRF Molecule Holdings Inc. | — | -0.1 | 97.7 | -3110.1 | -110.2 | 11.6 | 4 | LEAN BEAR | 0.0 |
| RAFA Rafarma Pharmaceuticals, Inc. | — | 10.8 | 2.9 | 3.4 | 26.6 | -66.0 | 3 | LEAN BEAR | -37.2 |
| IMVIF IMV Inc. | — | -0.2 | -503.3 | -2870.5 | — | — | 1 | LEAN BEAR | 1900.0 |
| IMRSQ IMRIS Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| CBDD CBD of Denver, Inc. | — | -5.1 | -0.1 | -28.9 | -2.7 | 19.0 | 3 | LEAN BEAR | 9900.0 |
| MEDVF Medivolve Inc. | — | -0.2 | 149.7 | 23.5 | -322.7 | -93.6 | 3 | LEAN BEAR | -95.0 |
| MCET MultiCell Technologies, Inc. | — | -0.1 | 101.2 | 99.1 | -81.8 | 1532.7 | 5 | LEAN BEAR | 900.0 |
| THCBF THC Biomed Intl Ltd. | — | -1.1 | -56.5 | -34.0 | -196.4 | -17.5 | 2 | LEAN BEAR | 0.0 |
| NSVGF Nass Valley Gateway Ltd. | — | -3.7 | 12.1 | 2.9 | — | -95.8 | 1 | LEAN BEAR | 0.0 |
| DRWN Quantum Medical Transport, Inc. | — | 0.3 | 25.7 | 20.8 | 2.2 | -96.3 | 4 | LEAN BEAR | 0.0 |
| MDIN MedGen, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| TRVI Trevi Therapeutics, Inc. | $1.8B | -40.0 | -19.7 | -1451.7 | — | — | 3 | LEAN BEAR | 28.8 |
| AURA Aura Biosciences, Inc. | $650M | -3.6 | -53.5 | -1360.0 | — | — | 4 | LEAN BEAR | 4.9 |
| RSLBF RaySearch Laboratories AB (publ) | $510M | 31.9 | 26.1 | 21.8 | 7.2 | 1.2 | 6 | LEAN BEAR | -35.8 |
| TTRX Turn Therapeutics Inc. | $310M | -38.2 | -952.4 | 115.0 | — | — | 2 | LEAN BEAR | 123.7 |
| MMIRF MedMira Inc. | $30M | -11.4 | 11.8 | 21.7 | -200.5 | 45.7 | 4 | LEAN BEAR | -20.4 |
| GMVDF G Medical Innovations Holdings Ltd | — | -0.0 | 5665.0 | 622.9 | -585.5 | 49.0 | 1 | LEAN BEAR | -0.0 |
| LITH BioELife Corp. | — | -0.0 | -598.1 | 467.7 | — | — | 2 | LEAN BEAR | 0.0 |
| SLDB Solid Biosciences Inc. | $630M | -3.4 | -65.5 | -1012.6 | — | — | 3 | LEAN BEAR | 9.8 |
| ANGO AngioDynamics, Inc. | $520M | -15.4 | -19.2 | -20.5 | -8.8 | 8.2 | 5 | LEAN BEAR | -1.3 |
| SRTA Strata Critical Medical, Inc. | $410M | 9.5 | 16.0 | -6.2 | -14.5 | 0.6 | 3 | LEAN BEAR | -5.0 |
| GBCS Selectis Health, Inc. | $20M | 1.2 | 1850.1 | -22.2 | 171.7 | -21.3 | 4 | LEAN BEAR | 172.9 |
| XTLB XTL Biopharmaceuticals Ltd. | — | -0.6 | -26.8 | -38.7 | -88.2 | — | 3 | LEAN BEAR | 67.5 |
| MJNA Medical Marijuana, Inc. | — | -1.3 | -1.3 | -2.2 | -0.9 | -22.1 | 2 | LEAN BEAR | -50.0 |
| NIVF NewGenIvf Group Limited | — | -0.0 | 50.6 | -147.7 | -8.5 | — | 2 | LEAN BEAR | -100.0 |
| LYRA Lyra Therapeutics, Inc. | — | -0.0 | -6595.0 | -671.6 | -99300.0 | -74.1 | 4 | LEAN BEAR | -97.6 |
| PARD Poniard Pharmaceuticals, Inc. | — | -0.0 | -210.4 | -442.5 | — | — | 3 | LEAN BEAR | 0.0 |
| STAB Statera Biopharma, Inc. | — | -0.0 | -298.8 | 2085.4 | -769.5 | 1459.1 | 3 | LEAN BEAR | -50.0 |
| PAIYY Aesthetic Medical International Holdings Group Limited | — | — | — | — | — | — | — | LEAN BEAR | -94.1 |
| CSDX CS Diagnostics Corp. | — | — | — | — | — | — | — | LEAN BEAR | — |
| BACK IMAC Holdings, Inc. | — | -0.0 | 109.1 | 67.3 | -14505.6 | 100.5 | 2 | LEAN BEAR | -99.3 |
| JNDOF JINS HOLDINGS Inc. | $810M | 17.6 | 22.7 | 27.1 | 5.1 | 15.0 | 6 | LEAN BEAR | 51.6 |
| MDRSF Medartis Holding AG | $1.4B | 79.4 | 5.5 | 0.7 | 3.2 | 29.6 | 6 | LEAN BEAR | 72.5 |
| JMDMF Japan Medical Dynamic Marketing, Inc. | $130M | — | — | — | — | — | — | LEAN BEAR | 49.7 |
| TCLIF Theraclion S.A. | $40M | -6.7 | -342.1 | 1171.9 | -543.9 | 61.2 | 2 | LEAN BEAR | 312841.2 |
| LANZ Lancer Orthodontics, Inc. | — | 4.0 | 3.3 | 2.5 | -4.3 | 4.5 | 4 | LEAN BEAR | 2566.7 |
| AOBI American Oriental Bioengineering, Inc. | — | -0.0 | -28.2 | -16.5 | -118.1 | -10.2 | 3 | LEAN BEAR | 983.3 |
| NDATF nDatalyze Corp. | — | -16.7 | -61.8 | 1180.9 | — | -100.0 | 3 | LEAN BEAR | 633.9 |
| HDRPF Epsilon Healthcare Limited | — | 70.0 | -33.3 | -22.6 | -9.6 | 161.1 | 5 | LEAN BEAR | 614.3 |
| HSTC HST Global, Inc. | $210M | -538.5 | -2.5 | -1.2 | -13.7 | 564.0 | 5 | LEAN BEAR | 349900.0 |
| TSHA Taysha Gene Therapies, Inc. | $1.3B | -10.0 | -47.1 | 961.0 | — | -32.3 | 3 | LEAN BEAR | -13.1 |
| MAYNF Mayne Pharma Group Limited | $150M | 8.4 | 6.4 | -13.8 | 23.0 | -6.1 | 3 | LEAN BEAR | -53.8 |
| CLLS Cellectis S.A. | $100M | -1.9 | -94.6 | 118.6 | -417.3 | 0.5 | 2 | LEAN BEAR | -65.3 |
| IMUX Immunic, Inc. | $100M | -1.7 | -138.2 | 345.6 | — | — | 5 | LEAN BEAR | -4.4 |
| GRCE Grace Therapeutics, Inc. | $30M | -1.6 | -38.4 | -58.9 | — | — | 2 | LEAN BEAR | -36.2 |
| PBIGF Paradigm Biopharmaceuticals Limited | $10M | -1.6 | -456.6 | 1081.8 | -60158.9 | 53.6 | 4 | LEAN BEAR | -96.1 |
| NEXI NexImmune, Inc. | — | -0.0 | -230.1 | 1048.5 | — | — | 4 | LEAN BEAR | 0.0 |
| MNDR Mobile-health Network Solutions Class A Ordinary Shares | — | -0.0 | -43.7 | -41.6 | -21.7 | -42.3 | 4 | LEAN BEAR | -99.1 |
| DECN Decision Diagnostics Corp. | — | -0.0 | -8643.1 | -51.3 | -107.0 | -2.7 | 4 | LEAN BEAR | 0.0 |
| CBDL CBD Life Sciences Inc. | — | -115.1 | -79.7 | -382.6 | 45.8 | -47.8 | 3 | LEAN BEAR | -20.0 |
| GELS Gelteq Limited Ordinary Shares | — | — | — | — | — | — | — | LEAN BEAR | -60.3 |
| PREDQ Predictive Discovery Limited | — | — | — | — | — | — | — | LEAN BEAR | — |
| MNKD MannKind Corporation | $1.0B | -24.6 | 71.4 | 4.0 | -17.4 | 30.5 | 2 | LEAN BEAR | -36.7 |
| RCKT Rocket Pharmaceuticals, Inc. | $250M | -16.1 | -4.8 | -137.8 | — | — | 3 | LEAN BEAR | -34.5 |
| PDEX Pro-Dex, Inc. | $200M | 15.0 | 32.4 | 17.5 | 14.0 | 16.4 | 8 | LEAN BEAR | 118.9 |
| CSBR Champions Oncology, Inc. | $70M | -62.3 | -30.7 | -7.8 | -2.8 | 6.7 | 3 | LEAN BEAR | -27.9 |
| GOSS Gossamer Bio, Inc. | $60M | -0.2 | 178.7 | 117.2 | 182.9 | 32.4 | 3 | LEAN BEAR | -94.4 |
| RNVA Rennova Health, Inc. | — | -0.5 | 23.5 | -4.3 | -241.1 | 43.3 | 5 | LEAN BEAR | -0.0 |
| FITX Creative Edge Nutrition, Inc. | — | -0.0 | 242.9 | 120.2 | -98.6 | — | 3 | LEAN BEAR | 0.0 |
| MRRCF Wayland Group Corp. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| BFLY Butterfly Network, Inc. | $1.8B | -27.0 | -35.5 | -74.8 | -39.6 | 28.1 | 4 | LEAN BEAR | 255.9 |
| LJUIF SSY Group Limited | $1.2B | 15.0 | 6.7 | 4.6 | 13.6 | -4.4 | 5 | LEAN BEAR | 0.0 |
| KARD Kardigan, Inc. | $1.1B | — | — | — | — | — | — | LEAN BEAR | — |
| SHEZF Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | $690M | 66.0 | 2.8 | 2.7 | 7.0 | -0.3 | 6 | LEAN BEAR | 0.0 |
| FDMT 4D Molecular Therapeutics, Inc. | $600M | -4.8 | -43.3 | -182.0 | -1929.0 | 278712.1 | 4 | LEAN BEAR | 5.4 |
| RNAC Cartesian Therapeutics, Inc. | $190M | -1.1 | 241.0 | 37.3 | — | 44.0 | 2 | LEAN BEAR | -24.4 |
| CGEN Compugen Ltd. | $180M | 5.4 | 49.6 | -90.2 | -269.3 | 886.7 | 5 | LEAN BEAR | 17.5 |
| TRDA Entrada Therapeutics, Inc. | $170M | -1.2 | -54.1 | -236.6 | -4762.0 | -94.1 | 1 | LEAN BEAR | -33.8 |
| BDTX Black Diamond Therapeutics, Inc. | $110M | -2.5 | -37.2 | -1604.9 | — | -100.0 | 1 | LEAN BEAR | -53.7 |
| NTHI Neonc Technologies Holdings, Inc. | $90M | — | — | — | — | — | — | LEAN BEAR | -63.2 |
| SGMOQ Sangamo Therapeutics, Inc. | $50M | — | — | — | — | — | — | LEAN BEAR | — |
| TDSGF Telo Genomics Corp. | $10M | -2.1 | -2858.5 | 258.3 | — | — | 2 | LEAN BEAR | -10.2 |
| PFHO Pacific Health Care Organization, Inc. | $10M | 12.3 | 7.5 | 60.8 | 18.4 | -2.6 | 4 | LEAN BEAR | -18.3 |
| ADGM Adagio Medical Holdings, Inc. | — | -0.1 | -657.8 | -87.8 | — | -100.0 | 2 | LEAN BEAR | -91.8 |
| TRLFF Maven Brands Inc. | — | -0.3 | 54.0 | -28.1 | — | -200.0 | 3 | LEAN BEAR | 0.0 |
| SKTO SK3 Group, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| PZRXQ PhaseRx, Inc. | — | -0.0 | -228.2 | 8803.4 | — | — | 2 | LEAN BEAR | 0.0 |
| GEATF Radiko Holdings Corp | — | -0.0 | 178.7 | -374.3 | -40.1 | -30.5 | 3 | LEAN BEAR | 0.0 |
| EWPI Emerging World Pharma, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| CGNSF Cognetivity Neurosciences Ltd. | — | -0.1 | 78.7 | 25.2 | -6985.2 | — | 2 | LEAN BEAR | 0.0 |
| RNAZ TransCode Therapeutics, Inc. | — | -0.0 | -59.2 | -21.0 | — | — | 1 | LEAN BEAR | -86.5 |
| SKYI Sky Century Investment, Inc. | — | -2.5 | 26.2 | 61.1 | -11.3 | 180.9 | 3 | LEAN BEAR | 5086.8 |
| GEGP Gold Entertainment Group, Inc. | — | -2.5 | 39.4 | 1402.0 | -16.8 | 39.5 | 6 | LEAN BEAR | -90.0 |
| NOBDF North Bud Farms Inc. | — | -0.0 | -30.5 | -29.8 | — | — | 2 | LEAN BEAR | 0.0 |
| TCNAF TransCanna Holdings Inc. | — | -0.0 | -246.6 | -38.8 | -338.7 | 90.3 | 3 | LEAN BEAR | 0.0 |
| ASFX American Scientific Resources, Incorporated | — | — | — | — | — | — | — | LEAN BEAR | -25.0 |
| ULGX Urologix, Inc. | — | -0.0 | 80.8 | 96.5 | -12.5 | -19.4 | 3 | LEAN BEAR | 0.0 |
| BNYN Banyan Corp. | — | -0.0 | 719.9 | -36.9 | -121.9 | -37.7 | 3 | LEAN BEAR | 0.0 |
| OWPC One World Products, Inc. | — | 0.0 | -124.8 | -16.4 | 10538.7 | 1987.1 | 5 | LEAN BEAR | -98.4 |
| HENC Hero Technologies Inc. | — | -0.1 | -10112.1 | 3310.9 | — | 100.0 | 4 | LEAN BEAR | 0.0 |
| AHGIF Alternate Health Corp. | — | -0.0 | -611.4 | -2862.3 | -21.3 | 171.0 | 4 | LEAN BEAR | 0.0 |
| OMRX Orthometrix, Inc. | — | 0.0 | 30.7 | -48.6 | -238.0 | -29.6 | 2 | LEAN BEAR | 0.0 |
| REPCF RepliCel Life Sciences Inc. | — | -9.4 | -248.8 | -13.9 | -80.9 | 200.0 | 6 | LEAN BEAR | 0.0 |
| WIBFF West Island Brands Inc. | — | -0.3 | -99.5 | -95.1 | -40.3 | 165.1 | 4 | LEAN BEAR | 0.0 |
| ELLXF Elixinol Wellness Limited | — | -0.7 | -52.3 | -22.6 | -14.9 | -4.8 | 1 | LEAN BEAR | -56.2 |
| NMRD Nemaura Medical Inc. | — | -0.0 | 45.5 | -457.0 | — | -491.0 | 1 | LEAN BEAR | 9900.0 |
| CRFTF BC Craft Supply Co. Ltd. | — | -0.0 | 152.6 | 13.1 | — | -82.0 | 2 | LEAN BEAR | 0.0 |
| DXBRF BellRock Brands Inc. | — | — | — | — | — | — | — | LEAN BEAR | -50.0 |
| RLLVF Relevium Technologies Inc. | — | -0.3 | 969.5 | 2839.9 | -218.6 | — | 1 | LEAN BEAR | 0.0 |
| BHNGF Bhang Inc. | — | -0.0 | 782.7 | 270.1 | -248.2 | 78.7 | 3 | LEAN BEAR | 0.0 |
| SPPH Spencer Pharmaceutical Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| CNNXF CannAmerica Brands Corp. | — | -0.0 | 53.3 | 23.6 | -127.3 | 39.6 | 4 | LEAN BEAR | 0.0 |
| NNBP Nanobac Pharmaceuticals, Incorporated | — | 0.0 | 358.0 | 221.2 | -26718.6 | -92.2 | 3 | LEAN BEAR | 0.0 |
| PEMTF Thoughtful Brands Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| VRTHF Indigenous Bloom Hemp Corp. | — | -0.3 | 77.3 | 21.2 | — | — | 3 | LEAN BEAR | 0.0 |
| MJARF MJardin Group, Inc. | — | -0.0 | 59.5 | -11.0 | -1614.6 | -42.3 | 3 | LEAN BEAR | 0.0 |
| NNLX NanoLogix, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -20.0 |
| CLAZF Claritas Pharmaceuticals, Inc. | — | 0.0 | -170.1 | 15.9 | — | — | 3 | LEAN BEAR | 0.0 |
| CXBS Corix Bioscience, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| PRPH ProPhase Labs, Inc. | — | -0.0 | -544.0 | -207.6 | -301.8 | -5.5 | 3 | LEAN BEAR | -99.8 |
| EVARF Lombard Medical, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| JXFGF Jinxin Fertility Group Limited | $730M | 26.6 | 1.9 | 1.8 | 7.8 | 1.4 | 7 | LEAN BEAR | 3.6 |
| GWIN Glorywin Entertainment Group, Inc. | $360M | -26081.4 | 11.7 | 5.1 | — | — | 1 | LEAN BEAR | 229.5 |
| FGHQF Frontage Holdings Corporation | $360M | 36.5 | 3.1 | 3.0 | 4.6 | 9.8 | 7 | LEAN BEAR | 16.8 |
| CLVSF CellaVision AB (publ) | $330M | 32.3 | 15.1 | 17.1 | 16.3 | -1.9 | 6 | LEAN BEAR | -27.4 |
| KNTPF Kintor Pharmaceutical Limited | $120M | -2.9 | -116.6 | -74.4 | -145.6 | 2237.9 | 3 | LEAN BEAR | -10.2 |
| HUMA Humacyte, Inc. | $120M | -0.9 | -547.9 | -500.7 | -9064.5 | -73.6 | 3 | LEAN BEAR | -72.0 |
| HYPR Hyperfine, Inc. | $70M | -2.0 | -97.0 | -395.6 | -238.2 | 53.2 | 5 | LEAN BEAR | -37.2 |
| HSTI High Sierra Technologies, Inc. | $30M | -22.8 | 225.7 | 189.7 | — | — | 4 | LEAN BEAR | 0.0 |
| MILFF 1CM Inc. | $30M | 4.5 | 15.1 | 7.4 | 2.5 | 7.3 | 7 | LEAN BEAR | 42.7 |
| ZJYL Jin Medical International Ltd. | $20M | 13.0 | 4.0 | 1.9 | -1.2 | -13.6 | 3 | LEAN BEAR | 540.6 |
| LVCLF Algorae Pharmaceuticals Limited | $20M | -5.7 | -47.4 | -24288.6 | — | -100.0 | 3 | LEAN BEAR | 51.6 |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $10M | -1.0 | -130.7 | -3026.9 | -636.8 | 798.5 | 6 | LEAN BEAR | -65.0 |
| PLLWF Polarean Imaging plc | $10M | -0.1 | -83.4 | -772.7 | -852.0 | 39.1 | 2 | LEAN BEAR | -40.0 |
| BCLI Brainstorm Cell Therapeutics Inc. | $10M | -0.8 | 119.2 | 76.7 | — | -100.0 | 1 | LEAN BEAR | 11.1 |
| ENGNW enGene Holdings Inc. Warrants | $10M | -5.6 | -2.3 | 134.1 | — | -100.0 | 2 | LEAN BEAR | -77.1 |
| FORU ForU Holdings, Inc. | — | -0.0 | 759.2 | -476.4 | — | -100.0 | 2 | LEAN BEAR | 100.0 |
| CHNXF ChitogenX Inc. | — | -0.2 | 23.2 | 36.2 | — | — | 2 | LEAN BEAR | 586.4 |
| ELXMF Nova Eye Medical Limited | — | -9.5 | -26.1 | -22.0 | -5.3 | 19.0 | 5 | LEAN BEAR | -85.7 |
| NMSCA Nutrition Management Services Company | — | 0.0 | 4.0 | 6.5 | -0.5 | -7.8 | 5 | LEAN BEAR | 200.0 |
| OMWS Omnia Wellness Inc. | — | -0.0 | 91.7 | -520.4 | -2231.0 | -14.0 | 1 | LEAN BEAR | 100.0 |
| REMI Remedent, Inc. | — | -0.1 | -11.3 | -4.3 | -86.4 | 14.2 | 6 | LEAN BEAR | 300.0 |
| HYHY Hydrogen Hybrid Technologies, Inc. | — | -0.0 | -138.6 | -342.9 | — | 16.1 | 4 | LEAN BEAR | 0.0 |
| HLSQ Tessera Defense and Homeland Security Inc | — | — | — | — | — | — | — | LEAN BEAR | — |
| RTSL Rapid Therapeutic Science Laboratories, Inc. | — | -0.0 | -3.4 | 35.5 | — | -100.0 | 2 | LEAN BEAR | -86.7 |
| AIDA Aida Pharmaceuticals, Inc. | — | 0.0 | -20.7 | 25.4 | 19.3 | 40.9 | 6 | LEAN BEAR | 50.0 |
| GRHY Green Hygienics, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -93.0 |
| LCDX Caliber Imaging & Diagnostics, Inc. | — | -0.0 | 54.6 | 46.8 | -212.5 | 20.6 | 3 | LEAN BEAR | 50.0 |
| JUNS Jupiter Neurosciences, Inc. | — | -0.1 | -1888.7 | 5586.0 | -9380.9 | — | 3 | LEAN BEAR | -98.0 |
| BRSF Brain Scientific Inc. | — | -0.0 | -633.9 | -94.8 | -77714.6 | -19.3 | 3 | LEAN BEAR | 500.0 |
| BLMS Bloomios, Inc. | — | -0.0 | 221.4 | 58.3 | -3817.0 | 46.5 | 2 | LEAN BEAR | 200.0 |
| CMND Clearmind Medicine Inc. | — | -0.1 | -104.0 | 593.4 | — | — | 2 | LEAN BEAR | -99.8 |
| VINC Vincerx Pharma, Inc. | — | -0.0 | -3136.4 | 910.2 | — | -18.7 | 5 | LEAN BEAR | -53.1 |
| XSVT Xsovt Brands, Inc. | — | -0.0 | 241.0 | 189.8 | -134.3 | 300584.1 | 4 | LEAN BEAR | 233.3 |
| NURPF Neuren Pharmaceuticals Limited | $1.8B | 125.7 | 6.2 | 22.4 | 14.6 | -68.5 | 5 | LEAN BEAR | 20.8 |
| CNMD CONMED Corporation | $1.5B | 18.9 | 5.5 | 5.2 | 6.7 | 3.4 | 7 | LEAN BEAR | -3.5 |
| BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited | $540M | 10.1 | 20.8 | 23.4 | 32.9 | 697.9 | 9 | LEAN BEAR | 0.0 |
| COGZF Cogstate Limited | $410M | 35.1 | 22.4 | 37.3 | 22.4 | -14.8 | 3 | LEAN BEAR | 44.2 |
| ACB Aurora Cannabis Inc. | $250M | -3.0 | -20.5 | -17.0 | -6.0 | -16.6 | 3 | LEAN BEAR | -19.8 |
| MEDS DataMEDS AI, Inc. | $10M | -0.0 | -142327.8 | -322403.1 | -1031.7 | 339160.3 | 4 | LEAN BEAR | -15.1 |
| CUBT Curative Biotechnology, Inc. | — | -2.0 | 31.0 | 15.3 | — | — | 4 | LEAN BEAR | -26.6 |
| EMYSF Easy Technologies Inc. | — | -0.3 | 192.7 | 227.8 | — | -100.0 | 1 | LEAN BEAR | 0.0 |
| ASTH Astrana Health, Inc. | $1.9B | 44.3 | 5.1 | 4.7 | 2.0 | 58.9 | 5 | LEAN BEAR | 10.9 |
| CLHLF COLTENE Holding AG | $330M | 19.5 | 16.1 | 12.5 | 3.6 | -2.5 | 5 | LEAN BEAR | -8.4 |
| NRXP NRx Pharmaceuticals, Inc. | $110M | -3.6 | 131.2 | 61.3 | -1500.5 | — | 5 | LEAN BEAR | -14.3 |
| CGNH CardioGenics Holdings Inc | — | -0.0 | 58.8 | 40.3 | — | — | 3 | LEAN BEAR | 0.0 |
| WUHN Wuhan General Group (China), Inc. | — | -0.0 | 106.5 | 1.0 | -155074.0 | — | 2 | LEAN BEAR | -0.0 |
| CNTN Canton Strategic Holdings Inc | $150M | -1.3 | -14.6 | -7.2 | -1287.2 | — | 2 | LEAN BEAR | — |
| CWBHF Charlotte's Web Holdings, Inc. | $70M | -1.1 | -97.1 | -27.9 | -38.0 | -6.9 | 5 | LEAN BEAR | 48.9 |
| CNSP CNS Pharmaceuticals, Inc. | $10M | -0.2 | -106.6 | 748.6 | — | — | 3 | LEAN BEAR | -46.0 |
| ITNS Itonis, Inc. | — | -51.2 | 2.9 | 16.1 | -299.0 | -55.8 | 3 | LEAN BEAR | 0.0 |
| STME Stimcell Energetics, Inc. | — | -6.8 | 24.8 | 29.2 | — | — | 2 | LEAN BEAR | — |
| ADRX ADARx Pharmaceuticals, Inc. | $1.9B | — | — | — | — | — | — | LEAN BEAR | — |
| SXTC China SXT Pharmaceuticals, Inc. | — | -0.0 | -32.7 | -254.3 | 13.7 | 42.5 | 6 | LEAN BEAR | -100.0 |
| EOCN Eocene Ltd. | — | — | — | — | — | — | — | LEAN BEAR | — |
| ANNX Annexon, Inc. | $610M | -3.5 | -105.3 | -11323.3 | — | — | 2 | BEARISH | 14.1 |
| CLPT ClearPoint Neuro, Inc. | $280M | -8.7 | -226.5 | -54.1 | -104.2 | 25.9 | 3 | BEARISH | -58.5 |
| BTMD biote Corp. | $50M | 6.8 | -7.8 | 19.7 | -14.8 | -7.8 | 5 | BEARISH | -60.3 |
| IMA ImageneBio Inc | $50M | -0.8 | -40.7 | -594.7 | — | — | 3 | BEARISH | -49.7 |
| PLSH Panacea Life Sciences Holdings, Inc. | — | -0.8 | 128.5 | -48.4 | -1581.6 | -90.2 | 5 | BEARISH | 14.0 |
| SWNM Southwestern Medical Solutions, Inc. | — | — | — | — | — | — | — | BEARISH | -70.0 |
| ETON Eton Pharmaceuticals, Inc. | $1.4B | 111.4 | 36.0 | 33.3 | 30.8 | 81.5 | 7 | BEARISH | 180.3 |
| HROW Harrow Health, Inc. | $1.1B | -29.6 | -114.8 | 1.9 | -24.4 | 21.1 | 5 | BEARISH | -23.1 |
| GLUE Monte Rosa Therapeutics, Inc. | $920M | -5.0 | -42.7 | 149.9 | -483.9 | -83.9 | 3 | BEARISH | -11.9 |
| LTGO Latigo Biotherapeutics Inc. | $900M | — | — | — | — | — | — | BEARISH | — |
| SANA Sana Biotechnology, Inc. | $700M | -3.5 | -152.9 | -242.3 | — | — | 3 | BEARISH | -49.9 |
| OCS Oculis Holding AG | $490M | -4.7 | -44.0 | -31.0 | — | -6.9 | 3 | BEARISH | -63.0 |
| RLMD Relmada Therapeutics, Inc. | $350M | -3.6 | -55.7 | 460.5 | — | — | 3 | BEARISH | 43.8 |
| QTI QT Imaging Holdings, Inc. | $30M | -1.5 | -1915.2 | 88.4 | -148.9 | -99.4 | 5 | BEARISH | 407.2 |
| IBO Impact BioMedical Inc. | $30M | -3.2 | 10.8 | -30.4 | -23300.0 | — | 5 | BEARISH | -45.8 |
| LTRN Lantern Pharma Inc. | $10M | -0.5 | -400.9 | 115.9 | — | — | 2 | BEARISH | -80.9 |
| KZIA Kazia Therapeutics Ltd ADR | $10M | -1.1 | -104.5 | 62.7 | — | -99.2 | 4 | BEARISH | 14.1 |
| ADAPY Adaptimmune Therapeutics plc | $10M | -0.1 | -1341.1 | 268.4 | -221.8 | -54.0 | 0 | BEARISH | -47.7 |
| XCRT Xcelerate Inc. | $10M | -11.0 | 71.8 | 24.0 | — | -142.3 | 2 | BEARISH | 106.9 |
| ALLR Allarity Therapeutics, Inc. | $10M | -1.2 | -157.1 | -96.5 | — | — | 2 | BEARISH | -30.8 |
| HKPD Cellyan Biotechnology Co., Ltd | — | -5.0 | -15.6 | -7.4 | -20.5 | 45.7 | 6 | BEARISH | -91.9 |
| PBMWW Psyence Biomedical Ltd. Warrant | — | — | — | — | — | — | — | BEARISH | -63.9 |
| DHBUF Delivra Health Brands Inc. | — | -2.8 | -19.4 | -34.1 | -82.4 | -10.7 | 2 | BEARISH | -71.4 |
| LIPO Lipella Pharmaceuticals Inc. | — | -0.0 | -361.8 | 4105.8 | — | -64.1 | 1 | BEARISH | -99.9 |
| TRVN Trevena, Inc. | — | -0.0 | 344.3 | -3198.4 | -1745.2 | -82.9 | 3 | BEARISH | -7.5 |
| CTTH CTT Pharmaceutical Holdings, Inc. | — | -45.3 | -272.8 | -210.7 | — | — | 2 | BEARISH | -0.2 |
| PKTX ProtoKinetix, Incorporated | — | -1.0 | -117.2 | -115.0 | — | — | 2 | BEARISH | -94.6 |
| IMMB Immunotech Laboratories, Inc. | — | — | — | — | — | — | — | BEARISH | 100.0 |
| ALLO Allogene Therapeutics, Inc. | $430M | -1.9 | -42.4 | -81.9 | -919.8 | — | 5 | BEARISH | 5.7 |
| EBRCZ EBR Systems, Inc. | $80M | -0.9 | -102.2 | 22812.5 | -661.9 | 305113.7 | 3 | BEARISH | -87.9 |
| PMVP PMV Pharmaceuticals, Inc. | $70M | -1.0 | -70.9 | 815.8 | — | — | 2 | BEARISH | -12.7 |
| SPRO Spero Therapeutics, Inc. | $60M | 8.4 | 19.2 | -128.5 | — | -7.0 | 7 | BEARISH | -48.9 |
| BMKDF BioMark Diagnostics Inc. | $40M | -34.8 | -149.8 | -103.7 | -5198.4 | -82.1 | 2 | BEARISH | 40.8 |
| VEXTF Vext Science, Inc. | $40M | -2.3 | -23.2 | -8.7 | -2.6 | 14.2 | 5 | BEARISH | -9.3 |
| PETV PetVivo Holdings, Inc. | $30M | -2.2 | -384.4 | -353.6 | -478.1 | -9.5 | 4 | BEARISH | -54.1 |
| SNANF Sona Nanotech Inc. | $20M | -13.1 | 526.4 | 252.2 | — | — | 1 | BEARISH | -58.9 |
| LFWD Lifeward Ltd. | $10M | -0.3 | -225.6 | -129.9 | -173.9 | -10.7 | 4 | BEARISH | -26.2 |
| SNTI Senti Biosciences, Inc. | $10M | -0.1 | -466.5 | -430.9 | -75000.0 | — | 2 | BEARISH | -90.4 |
| IMUC EOM Pharmaceuticals Holdings, Inc. | $10M | -4.9 | 64.4 | 131.0 | — | — | 4 | BEARISH | -42.8 |
| RQHTF Reliq Health Technologies Inc. | — | -5.4 | -4.5 | -8.2 | 15.4 | 119.4 | 5 | BEARISH | -33.3 |
| KGET CaliPharms, Inc. | — | -0.4 | 72.6 | 7.6 | -6979.1 | — | 2 | BEARISH | 3900.0 |
| HTDS Hard to Treat Diseases Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PHRX Pharmagen, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| VVOS Vivos Therapeutics, Inc. | — | -0.1 | -6663.0 | -267.4 | -106.4 | 45.2 | 3 | BEARISH | -95.5 |
| NXGT Nexteligent Holdings, Inc. | — | -14.0 | 2.7 | -1.5 | 5.3 | -0.2 | 3 | BEARISH | -30.9 |
| WGS GeneDx Holdings Corp. | $1.7B | -17.8 | -40.8 | -17.2 | -15.5 | 25.4 | 4 | BEARISH | -50.5 |
| AAPG Ascentage Pharma Group International | $1.4B | -6.3 | -236.8 | -144.8 | -270.2 | 170.9 | 3 | BEARISH | -56.5 |
| SNBIF SanBio Company Limited | $1.3B | -19.7 | -55.8 | -2935.2 | — | — | 3 | BEARISH | 0.0 |
| OMDA Omada Health | $1.2B | 282.5 | 1.8 | -1.5 | 6.0 | 404.7 | 7 | BEARISH | -27.4 |
| CVSGF CVS Group plc | $1.1B | 52.9 | 5.9 | 7.3 | 2.7 | -22.7 | 6 | BEARISH | 0.7 |
| PKBFF PeakBirch Commerce Inc. | $540M | -0.0 | -16609.0 | 16544.6 | -58.8 | -69.1 | 3 | BEARISH | 0.0 |
| DCTH Delcath Systems, Inc. | $500M | 1350.9 | 0.5 | -2.7 | 9.2 | 35.8 | 6 | BEARISH | 48.8 |
| TSNLF Tristel PLC | $280M | 24.3 | 23.4 | 31.6 | 15.8 | 10.3 | 8 | BEARISH | 8.5 |
| SLGL Sol-Gel Technologies Ltd. | $230M | -12.1 | -35.9 | -228.0 | 36.4 | 282.9 | 3 | BEARISH | 71.3 |
| APLMW Apollomics, Inc. | $170M | -2.6 | -233.7 | 845.7 | 1188.0 | -75.9 | 3 | BEARISH | -64.6 |
| LPCUF Lee's Pharmaceutical Holdings Limited | $110M | 3.7 | 9.9 | 0.2 | 11.9 | 81.2 | 8 | BEARISH | 1.1 |
| TLPH Talphera, Inc. | $60M | -3.4 | -143.4 | 436.3 | — | -96.3 | 2 | BEARISH | -13.5 |
| MDAI Spectral AI, Inc. | $50M | -4.5 | 99.0 | 97.9 | -118.5 | -45.0 | 2 | BEARISH | -26.4 |
| MRKR Marker Therapeutics, Inc. | $20M | -2.1 | -76.9 | -1014.3 | — | -77.1 | 2 | BEARISH | -2.0 |
| PTKFY PT Kalbe Farma Tbk | $10M | 9.2 | 15.5 | 17.8 | 9.1 | 13.6 | 6 | BEARISH | -45.5 |
| AMS American Shared Hospital Services | $10M | -5.3 | -7.5 | -5.5 | -6.1 | 4.0 | 5 | BEARISH | -41.4 |
| VRCI Verde Science, Inc. | — | -0.0 | 72.3 | 23.0 | — | — | 5 | BEARISH | 100.0 |
| NTII Neurobiological Technologies, Inc. | — | 0.0 | 48.7 | 441.6 | 89.7 | 99.7 | 4 | BEARISH | 0.0 |
| IBOGF Universal Ibogaine Inc. | — | -0.5 | -94.8 | 5.5 | -9.4 | 208.2 | 4 | BEARISH | -98.6 |
| RGIN Regenicin, Inc. | — | -0.0 | 16.9 | 4.1 | — | — | 4 | BEARISH | 0.0 |
| OMDD Ormand Industries Inc | — | — | — | — | — | — | — | BEARISH | 0.0 |
| WLDFF Wildflower Brands Inc. | — | -0.0 | -27.7 | -4.7 | 1.9 | 319.8 | 7 | BEARISH | 0.0 |
| GLSHQ Gelesis Holdings, Inc. | — | -0.0 | 391.0 | -233.6 | -693.9 | -45.8 | 3 | BEARISH | 0.0 |
| SHOM Southern Home Medical, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| FSPM FusionPharm, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PSIQ Profile Solutions, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| LXGTF Registered Plan Private Investments Inc. | — | -0.0 | 7.6 | 5.5 | — | — | 1 | BEARISH | 0.0 |
| ROTH PharmaRoth Labs, Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| FORZ Forza Innovations Inc. | — | -0.0 | 91.9 | 0.0 | 11330.0 | 8.7 | 3 | BEARISH | 0.0 |
| PRCNF Pure Global Cannabis Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CWWBF Plant-Based Investment Corp. | — | -0.0 | -95.9 | -3827.0 | 167.3 | -218.9 | 3 | BEARISH | 0.0 |
| LRSV Link Reservations Inc. | — | -7.6 | 103.3 | 152.0 | -20.7 | 73995.4 | 5 | BEARISH | -50.0 |
| DMSI Dermisonics, Inc. | — | -0.0 | -392.2 | 1105.0 | — | — | 1 | BEARISH | 0.0 |
| HAVLF HAVN Life Sciences Inc. | — | -0.0 | -275.3 | -163.4 | 5734.1 | 876.8 | 3 | BEARISH | 0.0 |
| BNVIF Binovi Technologies Corp. | — | -0.0 | -433.7 | 182.0 | 17056.9 | -74.4 | 1 | BEARISH | 400.0 |
| CRRVF CVR Medical Corp. | — | -0.0 | 49.0 | 11.5 | — | — | 1 | BEARISH | 0.0 |
| INSD Instadose Pharma Corp. | — | -0.0 | -9.7 | -3.7 | — | — | 4 | BEARISH | -90.9 |
| TLOG TetraLogic Pharmaceuticals Corporation | — | -0.0 | 382.3 | 479.8 | — | — | 1 | BEARISH | 0.0 |
| IONM Assure Holdings Corp. | — | -0.0 | 237.0 | 462.9 | -25500.0 | -64.6 | 1 | BEARISH | -99.0 |
| PSYBF PsyBio Therapeutics Corp | — | -0.0 | 344.6 | 135.0 | — | — | 2 | BEARISH | -90.0 |
| MAJI Nextel Medical Corp. | — | 0.6 | -2.6 | 42.9 | — | — | 1 | BEARISH | — |
| IGRW Interactive Health Network | — | 0.2 | 1090.1 | 947.6 | -29882.2 | — | 2 | BEARISH | 0.0 |
| GRI GRI Bio, Inc. | — | -0.0 | -142.0 | 1227.5 | — | — | 5 | BEARISH | -97.1 |
| RGDXQ Response Genetics, Inc | — | -0.0 | 1186.4 | -243.6 | -110.9 | -8.1 | 3 | BEARISH | 0.0 |
| DSOL Drug Free Solution, Inc. | — | -16.9 | 255.8 | 197.9 | — | — | 2 | BEARISH | -63.6 |
| WCUI Wellness Center USA, Inc. | — | -0.0 | 44.8 | 1728.1 | -86.5 | 140.9 | 5 | BEARISH | 0.0 |
| CBIA Canopus Biopharma, Inc. | — | -0.0 | 1457.1 | 15327.7 | — | — | 1 | BEARISH | 0.0 |
| IMEXF Imagin Medical Inc. | — | -0.0 | 31.8 | 185.9 | — | — | 3 | BEARISH | 0.0 |
| CAAOF INDVR Brands Inc. | — | -0.0 | -111.6 | -22.0 | -159.3 | 22.0 | 4 | BEARISH | 0.0 |
| VPHIF Valeo Pharma Inc. | — | -0.0 | 65.5 | 19863.3 | -65.0 | -0.2 | 2 | BEARISH | -66.7 |
| MRZM Marizyme, Inc. | — | -0.0 | 117.5 | -190.1 | — | -69.0 | 3 | BEARISH | 0.0 |
| CYPS Cyclo3pss Corporation | — | — | — | — | — | — | — | BEARISH | 9900.0 |
| IBXG iBX Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| AVTI Avitar, Inc. | — | -0.0 | 26.0 | -62.7 | -263.1 | -47.4 | 2 | BEARISH | 0.0 |
| UPPR Upper Street Marketing Inc. | — | -0.0 | 228.5 | -53.9 | -715.0 | — | 1 | BEARISH | 42.9 |
| ALID Allied Corp. | — | -0.0 | 266.4 | 484.7 | -207842.5 | -53.9 | 2 | BEARISH | 49900.0 |
| BPMUF Basilea Pharmaceutica AG | $960M | 17.2 | 39.5 | 75.9 | 23.5 | 4.5 | 7 | BEARISH | 27.1 |
| BOIRF Boiron S.A. | $550M | 12.4 | 7.2 | 7.8 | 2.0 | 97.0 | 5 | BEARISH | 10.5 |
| IMPZY Implanet S.A. | $230M | -5.2 | 275.6 | -110.9 | -30.0 | 24.3 | 5 | BEARISH | 0.2 |
| AKBA Akebia Therapeutics, Inc. | $160M | -7.1 | -109.4 | 15.6 | -18.1 | 7.5 | 6 | BEARISH | -75.9 |
| APYX Apyx Medical Corporation | $100M | -12.6 | -96.4 | -12.3 | -23.4 | 25.6 | 5 | BEARISH | -16.6 |
| ATRA Atara Biotherapeutics, Inc. | $90M | -7.3 | 46.3 | 30.3 | -767.3 | -96.7 | 2 | BEARISH | -44.5 |
| AYTU Aytu BioPharma, Inc. | $20M | -1.4 | -52.6 | -24.3 | -0.1 | -13.3 | 4 | BEARISH | -12.2 |
| SYGGF Synairgen plc | — | -0.2 | -71.9 | -381.4 | — | — | 1 | BEARISH | -50.0 |
| ANTCF Aion Therapeutic Inc. | — | -0.2 | 365.1 | 64.7 | -53.7 | 563.3 | 3 | BEARISH | 17.6 |
| MSIU Medical Supply International USA, Inc. | — | — | — | — | — | — | — | BEARISH | 300.0 |
| PFSA Profusa, Inc. Common Stock | — | -0.0 | 158.4 | 181.7 | — | — | 2 | BEARISH | 158.6 |
| CHYPF Health Logic Interactive Inc. | — | -3.5 | 20.0 | 14.2 | — | — | 1 | BEARISH | -45.2 |
| BTAX Biostax Corp. | — | -0.0 | 7.3 | 5.8 | — | — | 2 | BEARISH | 100.0 |
| RSCF Reflect Scientific, Inc. | — | 15.0 | 12.1 | 17.0 | 15.2 | 76.0 | 6 | BEARISH | 4.0 |
| ABMT Advanced BioMedical Technologies Inc. | — | -0.1 | 6.0 | 9.6 | 3842.6 | 264.3 | 3 | BEARISH | 400.0 |
| IDYLF Imaging Dynamics Company Ltd. | — | -0.3 | 18.7 | 39.1 | -2277.3 | -65.6 | 4 | BEARISH | 152.7 |
| SYDRF Delota Corp. | — | -3.7 | -139.4 | -20.5 | -1.7 | -13.0 | 4 | BEARISH | 0.0 |
| OLMM OneLife Technologies Corp. | — | -0.0 | 454.4 | -594.1 | — | — | 3 | BEARISH | 900.0 |
| RYHTY Ryman Healthcare Limited | $1.0B | -11.1 | -4.2 | -0.3 | -30.8 | 10.6 | 7 | BEARISH | -32.6 |
| CLYM Climb Bio, Inc. | $590M | -12.2 | -27.1 | -88.6 | — | — | 2 | BEARISH | 381.9 |
| MNPR Monopar Therapeutics Inc. | $470M | -31.4 | -19.5 | 523.8 | — | — | 2 | BEARISH | -9.7 |
| ATGGF Actinogen Medical Limited | $140M | -8.8 | -77.5 | -235.8 | — | -100.0 | 1 | BEARISH | 17.2 |
| GWLL Goldenwell Biotech, Inc. | $60M | -240.7 | 31.8 | 137.0 | — | 319257.9 | 5 | BEARISH | 225.0 |
| CPHI China Pharma Holdings, Inc. | $30M | -0.6 | -21.0 | -8.7 | -153.8 | -11.0 | 4 | BEARISH | -64.6 |
| BVAXF BioVaxys Technology Corp. | — | -0.9 | 310.6 | 48.4 | — | — | 1 | BEARISH | -52.0 |
| CANQF CanaQuest Medical Corp. | — | -0.0 | 177.1 | 159.9 | -1515.1 | 102.7 | 4 | BEARISH | 0.0 |
| SQZB SQZ Biotechnologies Company | — | -0.0 | -203.4 | -410.2 | — | -44.6 | 0 | BEARISH | 4.3 |
| IGNT Ingen Technologies, Inc. | — | — | — | — | — | — | — | BEARISH | -50.0 |
| VOGX Vogenx Inc. | $260M | — | — | — | — | — | — | BEARISH | — |
| MEOBF Mesoblast Limited | $2.0B | -34.8 | -9.9 | -6.4 | -23.4 | 613.8 | 5 | BEARISH | -21.4 |
| BIOGY BioGaia AB (publ) | $1.3B | 31.4 | 31.8 | 52.6 | 27.5 | 13.1 | 5 | BEARISH | 19.9 |
| CBGL Cannabis Global Inc. | — | -0.5 | 5.4 | 17.3 | — | 520.3 | 3 | BEARISH | -90.0 |
| PCLOF PharmaCielo Ltd. | $10M | -2.7 | 39.6 | -31.4 | -103.5 | 11.2 | 4 | BEARISH | 71.2 |
| MLYS Mineralys Therapeutics, Inc. | $1.8B | -5.0 | -80.9 | 2274.6 | — | — | 2 | BEARISH | -47.3 |
| IMTX Immatics N.V. | $1.1B | -4.2 | -47.8 | -858.3 | -683.4 | -68.0 | 2 | BEARISH | -30.5 |
| LYPHF Luye Pharma Group Ltd. | $1.1B | 7.9 | 4.5 | 5.7 | 13.0 | -2.1 | 6 | BEARISH | 0.8 |
| TDVXF Dynavox Group AB (publ) | $900M | 28.7 | 39.7 | 17.2 | 12.8 | 8.8 | 8 | BEARISH | -29.1 |
| AKTS Aktis Oncology, Inc. | $850M | -16.0 | -29.9 | 276.4 | -713.5 | -36.1 | 5 | BEARISH | 365552.2 |
| ATTO Attovia Therapeutics, Inc. | $630M | -17.0 | -294.4 | -1137.2 | -4597.1 | -50.5 | 4 | BEARISH | 313.6 |
| OLMA Olema Pharmaceuticals, Inc. | $560M | -3.5 | -52.7 | 585.3 | — | — | 2 | BEARISH | -14.8 |
| BNTC Benitec Biopharma Inc. | $300M | -9.0 | -33.2 | 1840.8 | — | — | 3 | BEARISH | -34.9 |
| TARA Protara Therapeutics, Inc. | $140M | -1.8 | -45.8 | -41.3 | — | — | 2 | BEARISH | -51.4 |
| OTLK Outlook Therapeutics, Inc. | $130M | -0.5 | 256.9 | 1372.0 | -225766.7 | -169.4 | 3 | BEARISH | -59.3 |
| JYNT The Joint Corp. | $100M | 27.4 | 19.4 | -33.1 | 4.3 | 220.6 | 8 | BEARISH | -13.3 |
| ITHUF iAnthus Capital Holdings, Inc. | $30M | -0.5 | 53.1 | -9.2 | -40.8 | -9.9 | 1 | BEARISH | -37.1 |
| AKTX Akari Therapeutics, Plc | $20M | -0.0 | -139.9 | -175.8 | — | — | 3 | BEARISH | -73.2 |
| LUCY Lucyd, Inc | $10M | -0.6 | -84.6 | -209.4 | -165.3 | 72.5 | 4 | BEARISH | -52.0 |
| NCNA NuCana plc | $10M | -0.3 | -70.7 | -739.9 | — | — | 4 | BEARISH | -74.8 |
| INBS Intelligent Bio Solutions Inc. | $10M | -0.2 | -292.3 | -304.3 | -341.0 | 38.1 | 4 | BEARISH | -83.7 |
| LIFS Life Stem Genetics Inc. | — | -2.5 | -126.7 | -111.5 | — | — | 2 | BEARISH | -50.0 |
| RLFTY MindMaze Therapeutics Holding S.A. | — | -4.6 | -36.8 | -30.3 | -1182.3 | -95.8 | 2 | BEARISH | -95.4 |
| LGVN Longeveron Inc. | — | -0.2 | -203.6 | -2062.6 | -2116.0 | -42.7 | 4 | BEARISH | -80.6 |
| CBDHF Hempfusion Wellness Inc. | — | 0.0 | -82.5 | -84.6 | -190.5 | — | 1 | BEARISH | 0.0 |
| PZOO Pazoo, Inc. | — | -0.0 | 49.0 | 21.1 | -972321.6 | -100.0 | 4 | BEARISH | 0.0 |
| JAGX Jaguar Health, Inc. | — | -0.0 | -501.9 | -118.9 | -1035.3 | 135.5 | 4 | BEARISH | -99.8 |
| DRMA Dermata Therapeutics, Inc. | — | -0.2 | -183.9 | 734.5 | — | — | 2 | BEARISH | -78.5 |
| WLSI Wellstar International, Inc. | — | -0.0 | 24.2 | 35.0 | — | — | 3 | BEARISH | 0.0 |
| FLOOF Flower One Holdings Inc. | — | -0.0 | 111.5 | -21.8 | -15.4 | -19.8 | 2 | BEARISH | 0.0 |
| SSKN STRATA Skin Sciences, Inc. | — | -0.0 | -164.6 | -42.5 | 0.6 | -8.5 | 4 | BEARISH | -100.0 |
| FIORF Fiore Cannabis Ltd. | — | -0.0 | -417.3 | -33.3 | -383.4 | -6.2 | 2 | BEARISH | 0.0 |
| GBHPF Global Hemp Group Inc. | — | -0.1 | 61.0 | 8.0 | — | — | 2 | BEARISH | -99.2 |
| SRUTF Sproutly Canada Inc. | — | -0.0 | 7045.7 | -519.2 | -1194.7 | 28.2 | 4 | BEARISH | 0.0 |
| NPHC Nutra Pharma Corp. | — | -0.1 | 23.1 | 4.7 | -11458.0 | 55.8 | 3 | BEARISH | 0.0 |
| ITMC Itoco Inc. | — | -0.0 | 303.4 | 96.7 | — | — | 2 | BEARISH | 0.0 |
| GBLX GB Sciences, Inc. | — | -0.0 | 19.5 | 17.2 | -103.2 | — | 3 | BEARISH | -66.7 |
| PROF Profound Medical Corp. | $200M | -6.0 | -73.1 | -148.0 | -384.2 | 35.5 | 3 | BEARISH | 5.1 |
| LFMDP LifeMD, Inc. | $150M | -4.4 | -687.6 | 135.4 | -15.0 | -16.7 | 4 | BEARISH | -9.8 |
| GNLX Genelux Corporation | $90M | -2.5 | -168.9 | 20537.7 | — | — | 2 | BEARISH | -69.7 |
| CNVIF Conavi Medical Corp. | $10M | 13.4 | 57.4 | 363.8 | -4867.7 | — | 2 | BEARISH | — |
| BJDX Bluejay Diagnostics, Inc. | — | -0.0 | -98.9 | 5625.8 | — | — | 4 | BEARISH | -93.8 |
| ERNA Ernexa Therapeutics Inc. | — | -0.1 | -320.7 | 626.9 | — | -100.0 | 5 | BEARISH | -93.3 |
| DKSC Dakshidin Corporation | — | -34.4 | -113.2 | -9.1 | — | — | 2 | BEARISH | 200.0 |
| AAGH America Great Health | — | 2.0 | -12.2 | 22.4 | -635.8 | -5.1 | 4 | BEARISH | 33.3 |
| ALUR Allurion Technologies Inc. | — | -0.0 | 45.2 | 39.3 | -206.8 | -55.5 | 3 | BEARISH | -99.1 |
| MRES Institute of Biomedical Research Corp. | — | -2.3 | 301783.0 | -6062.7 | — | — | 1 | BEARISH | -81.2 |
| RDHL RedHill Biopharma Ltd. | — | -3.2 | 428.1 | 117.9 | -101.3 | 157.6 | 6 | BEARISH | -72.7 |
| CSPHF CStone Pharmaceuticals | $1.4B | -15.0 | -51.4 | -340.2 | -123.0 | 135.6 | 5 | BEARISH | -15.4 |
| DRTSW Alpha Tau Medical Ltd. | $1.2B | -12.8 | -141.7 | -17.1 | — | — | 3 | BEARISH | 820.5 |
| SMSZF SMS Co., Ltd. | $700M | -14.5 | -40.8 | 31.1 | 18.4 | 6.9 | 6 | BEARISH | 0.0 |
| ZRSEF DocMorris AG | $520M | -10.2 | -30.1 | -29.3 | -8.9 | 11.0 | 2 | BEARISH | 0.0 |
| BHCCF Benchmark Holdings plc | $230M | -4.1 | 16.4 | -17.9 | 377.4 | -62.6 | 6 | BEARISH | 0.0 |
| UNHLF EC Healthcare | $100M | -1.6 | -25.3 | 1.7 | -21.3 | -9.0 | 3 | BEARISH | 0.0 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $40M | 118.8 | 228.3 | 11.8 | -21.1 | 6.2 | 3 | BEARISH | 0.0 |
| WORX SCWorx Corp. | $40M | -0.4 | -38.1 | -8.2 | -17.1 | 3.1 | 6 | BEARISH | 338.1 |
| XCUR Exicure, Inc. | $10M | -0.8 | -168.4 | 779.8 | — | — | 2 | BEARISH | -78.2 |
| PRVCF PreveCeutical Medical Inc. | $10M | -16.7 | 9.9 | 96.4 | — | — | 3 | BEARISH | -49.5 |
| ADIA Adia Med Inc. | $10M | -0.1 | 32.2 | -16.3 | 8.3 | — | 1 | BEARISH | 228.9 |
| LSTA Lisata Therapeutics, Inc. | $10M | -0.6 | -99.9 | 590.1 | — | -90.7 | 2 | BEARISH | -62.1 |
| ERNAW Ernexa Therapeutics Inc. Warrants | — | — | — | — | — | — | — | BEARISH | — |
| SPDE Speedus Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PROT Proteonomix, Inc. | — | -0.0 | 77.5 | -1239.4 | — | -63.1 | 4 | BEARISH | 0.0 |
| SECI Sector 10, Inc. | — | 0.0 | 0.5 | 0.3 | — | — | 3 | BEARISH | 0.0 |
| SLNX Solanbridge Group, Inc. | — | -7.0 | 149.0 | 74.1 | — | — | 2 | BEARISH | 400.0 |
| ADLI American Medical Technologies Inc. | — | -0.0 | -34.0 | 1108.3 | -19.7 | -21.7 | 3 | BEARISH | 0.0 |
| NBIO Nascent Biotech, Inc. | — | -0.0 | 230.6 | 328.8 | — | — | 5 | BEARISH | -77.8 |
| LBLTF Lattice Biologics Ltd. | — | -0.0 | 27.4 | -482.6 | — | -28.9 | 4 | BEARISH | 0.0 |
| VIAP VIA Pharmaceuticals, Inc. | — | -0.0 | 64.7 | 103.9 | — | — | 2 | BEARISH | 0.0 |
| RNUGF ReNeuron Group plc | — | -0.0 | -106.8 | 210.1 | -1809.6 | -68.2 | 1 | BEARISH | 0.0 |
| UAHC United American Healthcare Corporation | — | 180.0 | 4.6 | -10.0 | — | -100.0 | 6 | BEARISH | -18.6 |
| GSRX GSRX Industries Inc. | — | -0.0 | -119.6 | -84.3 | -81.5 | -5.5 | 5 | BEARISH | 0.0 |
| DGEN Deltagen Inc. | — | 0.0 | 19.8 | 182.7 | -27.2 | -65.8 | 4 | BEARISH | 0.0 |
| XCRP Xcorporeal, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| BNKL Bionik Laboratories Corp. | — | -0.0 | -787.6 | -1107.0 | -282.5 | 41.7 | 3 | BEARISH | 0.0 |
| DHAI DIH Holding US, Inc. | — | -0.0 | 24.9 | 14.2 | -34.8 | 262.3 | 3 | BEARISH | -100.0 |
| PFND Pathfinder Cell Therapy, Inc. | — | -0.0 | 22.4 | 46.3 | — | — | 2 | BEARISH | 0.0 |
| CLCFF Christina Lake Cannabis Corp. | — | -1.6 | -37.8 | -14.8 | -10.0 | -18.1 | 2 | BEARISH | -43.9 |
| ARPC Arem Pacific Corporation | — | -9.0 | -104.2 | 50.1 | -12.7 | -7.6 | 5 | BEARISH | 0.0 |
| VIVXF Avivagen Inc. | — | -0.1 | 63.9 | 92.2 | -2302.1 | -7.9 | 3 | BEARISH | 0.0 |
| KONEF Wellbeing Digital Sciences Inc. | — | — | 10994.4 | -1249.0 | -349.5 | — | 2 | BEARISH | 0.0 |
| CTVEF Certive Solutions Inc. | — | -0.2 | 13.8 | 16.9 | -129.9 | 8.5 | 4 | BEARISH | 0.0 |
| CDXI Cardax, Inc. | — | -0.0 | 81.1 | 38.5 | -1740.8 | -27.3 | 2 | BEARISH | 0.0 |
| ZMSPF Zecotek Photonics Inc. | — | -0.0 | 21.5 | 53.8 | 1884.0 | 2081.2 | 3 | BEARISH | 0.0 |
| ADYX Adynxx, Inc. | — | -0.0 | 1148.3 | 259.7 | — | -95.1 | 2 | BEARISH | 0.0 |
| IYXI Inyx, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CVHIF Ventura Cannabis & Wellness Corporation | — | -0.0 | -24592.2 | -12731.6 | -112.6 | -64.0 | 4 | BEARISH | 0.0 |
| ENCW Enchanted World Inc. | — | — | — | — | — | — | — | BEARISH | 200.0 |
| PANC Panacos Pharmaceuticals, Inc. | — | -0.0 | -168.8 | -792.8 | -33966.7 | -45.9 | 1 | BEARISH | 0.0 |
| MCDA KMA Holding, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ERBB American Green, Inc. | — | 0.1 | 33.3 | -15.0 | -629.5 | 17.7 | 3 | BEARISH | 0.0 |
| SOFE SOAFEE, Inc. | — | 0.1 | 12.0 | -337.1 | 21.4 | 1539.1 | 4 | BEARISH | 45.5 |
| SYVC Synovics Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ROSGQ Rosetta Genomics Ltd. | — | -0.0 | -44.3 | -306.4 | 136.0 | — | 1 | BEARISH | 0.0 |
| GHRS GH Research PLC | $1.2B | -20.7 | -18.8 | 2015.5 | — | — | 2 | BEARISH | 44.6 |
| DSGN Design Therapeutics, Inc. | $640M | -9.4 | -34.1 | 1787.8 | — | — | 1 | BEARISH | 59.0 |
| TENX Tenax Therapeutics, Inc. | $50M | -1.3 | -59.8 | 1235.8 | — | — | 1 | BEARISH | -74.9 |
| GREH Green Rain Energy Holdings Inc. | — | 0.4 | 28.6 | -43.9 | -94.2 | — | 3 | BEARISH | 120.7 |
| OCLG Oncologix Tech Inc. | — | -0.0 | 255.0 | — | — | -20.4 | 2 | BEARISH | -0.0 |
| SDCCQ SmileDirectClub Inc Class A | — | -0.0 | -72.6 | -19.0 | -17.5 | -23.4 | 3 | BEARISH | -99.0 |
| BSPM Biostar Pharmaceuticals, Inc. | — | -0.0 | 2.7 | 1.9 | — | -91.9 | 5 | BEARISH | 0.0 |
| LFPI LifePoint, Inc. | — | -0.0 | -288.4 | -229.2 | -52133.6 | 161.6 | 3 | BEARISH | 1400.0 |
| HNSBF Hansa Biopharma AB (publ) | $330M | -4.9 | 159.8 | 1182.7 | -541.7 | -3.7 | 2 | BEARISH | -28.2 |
| CTOR Citius Oncology, Inc. | $50M | -1.2 | -126.6 | -109.8 | -597.4 | — | 3 | BEARISH | -66.2 |
| ADVB Advanced Biomed Inc. Common Stock | $10M | 6.4 | 0.4 | -42.2 | 544.5 | — | 4 | BEARISH | -66.9 |
| VICP Vicapsys Life Sciences, Inc. | $10M | -20.5 | 31.3 | 17.6 | — | — | 5 | BEARISH | -73.3 |
| CMHSF Comprehensive Healthcare Systems, Inc. | $10M | -1.8 | 78.3 | 144.6 | -37.9 | -22.6 | 3 | BEARISH | -35.0 |
| ANTH Anthera Pharmaceuticals, Inc. | — | -0.0 | -251.4 | 1107.5 | — | — | 1 | BEARISH | 9900.0 |
| SDNI Scandia, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| VYCO Vycor Medical, Inc. | — | -29.1 | 1.5 | -1.1 | -5.3 | 1.6 | 6 | BEARISH | -65.1 |
| CPMD CannaPharmaRX, Inc. | — | -0.1 | 42.4 | 22.4 | -691.1 | 24.8 | 3 | BEARISH | -58.3 |
| PLYX Polaryx Therapeutics, Inc. Common Stock | $90M | -15.5 | -35.9 | 437.3 | — | — | 2 | BEARISH | — |
| CASIF CASI Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| IDRSF Idorsia Ltd | $1.4B | -3.5 | 27.1 | -344.5 | -203.1 | -8.1 | 1 | BEARISH | 19.6 |
| VBIZF Viva Biotech Holdings | $400M | 13.9 | 4.5 | 4.2 | 8.0 | 2.9 | 7 | BEARISH | -35.1 |
| CGHC Capital Group Holdings, Inc. | — | -0.0 | -44.6 | -14.9 | -24.2 | — | 5 | BEARISH | 0.0 |
| FOXO FOXO Technologies Inc. | — | 0.0 | -62.5 | -3.2 | 172.6 | 44.0 | 3 | BEARISH | 9900.0 |
| SYRS Syros Pharmaceuticals, Inc. | — | -0.0 | -777.0 | 960.6 | — | -90.5 | 0 | BEARISH | 0.0 |
| VICA Rafina Innovations Inc. | — | -0.1 | -51.0 | -15.7 | — | 873.6 | 3 | BEARISH | 233.3 |
| BBLNF Babylon Holdings Limited | — | -0.0 | 348.4 | -1412.2 | -20.3 | 198.9 | 3 | BEARISH | 9900.0 |
| NMXS Net Medical Xpress Solutions, Inc. | — | -0.0 | -362.8 | -352.4 | -6733.3 | -89.2 | 2 | BEARISH | 600.0 |
| FPMI FluoroPharma Medical, Inc. | — | -0.0 | 22.7 | 39.7 | — | — | 2 | BEARISH | 100.0 |
| ACBM Acro Biomedical Co., Ltd. | — | -10.8 | 36.8 | 262.2 | — | 100.0 | 3 | BEARISH | 3614.3 |
| CASBF CanSino Biologics Inc. | $1.4B | 399.2 | 0.8 | -1.2 | 11.0 | 32.5 | 7 | BEARISH | -39.1 |
| CRVS Corvus Pharmaceuticals, Inc. | $890M | -16.4 | -35.4 | -415.6 | — | — | 4 | BEARISH | 33.8 |
| MRAI Marpai, Inc. | $80M | -3.7 | 47.4 | 28.0 | -110.0 | -29.7 | 3 | BEARISH | 93.9 |
| ETST Earth Science Tech, Inc. | $30M | 7.0 | 66.8 | 212.2 | 8.0 | 8.0 | 6 | BEARISH | -39.5 |
| GGBXF Green Growth Brands Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| HMPQ HempAmericana, Inc | — | -0.5 | 25.6 | 14.8 | — | 184.6 | 2 | BEARISH | 0.0 |
| ICBU iMD Companies, Inc. | — | -11.8 | 27.7 | 30.0 | — | -100.0 | 3 | BEARISH | -60.0 |
| ALHC Alignment Healthcare, Inc. | $1.7B | 41.0 | 20.0 | -54.4 | 2.7 | 37.2 | 8 | BEARISH | -54.0 |
| ANIP ANI Pharmaceuticals, Inc. | $1.7B | 14.8 | 20.0 | 20.7 | 9.3 | 30.9 | 7 | BEARISH | -22.8 |
| NKTR Nektar Therapeutics | $1.1B | -5.8 | -35.8 | -29.2 | -401.0 | -27.2 | 3 | BEARISH | -38.4 |
| RGNX REGENXBIO Inc. | $440M | -1.9 | -137.6 | -368.4 | 21.0 | 12.0 | 2 | BEARISH | -46.8 |
| BLSM BlossomHill Therapeutics, Inc. | $430M | — | — | — | — | — | — | BEARISH | — |
| TECX Tectonic Therapeutic, Inc. | $390M | -4.5 | -33.8 | -6371.3 | — | — | 1 | BEARISH | 10.4 |
| IPSC Century Therapeutics, Inc. | $260M | -1.4 | -49.7 | -60.0 | — | -100.0 | 2 | BEARISH | 150.0 |
| CPHRF Cipher Pharmaceuticals Inc. | $240M | 8.5 | 23.5 | 24.9 | 33.3 | 3.7 | 6 | BEARISH | -8.3 |
| TLSI TriSalus Life Sciences, Inc. | $220M | -3.0 | 438.3 | 453.7 | -80.5 | 25.2 | 4 | BEARISH | -21.7 |
| NAGE Niagen Bioscience Inc | $190M | 13.1 | 21.8 | 44.7 | 3.2 | 11.0 | 6 | BEARISH | -66.6 |
| NNNN Anbio Biotechnology Class A Ordinary Shares | $170M | — | — | — | — | — | — | BEARISH | -84.0 |
| LUCD Lucid Diagnostics Inc. | $80M | -0.9 | -556.3 | -1646.4 | -792.9 | 24.9 | 6 | BEARISH | -67.3 |
| MAIA MAIA Biotechnology, Inc. | $70M | -1.8 | -218.7 | 330.4 | — | — | 3 | BEARISH | -22.7 |
| NSRX Nasus Pharma Ltd. | $30M | — | — | — | — | — | — | BEARISH | -58.0 |
| ONMD OneMedNet Corporation | $30M | -2.7 | 231.2 | 252.1 | -743.8 | 216.5 | 3 | BEARISH | -80.4 |
| HMTXF Hemostemix Inc. | $10M | -2.4 | 69.9 | 190.1 | — | — | 1 | BEARISH | -44.5 |
| AVTBF Avant Brands Inc. | $10M | -0.6 | -39.8 | -15.3 | 2.7 | 5.1 | 5 | BEARISH | -19.1 |
| SCPS Scopus BioPharma Inc. | — | -0.0 | 132.3 | 53.6 | — | — | 2 | BEARISH | 33.3 |
| RSCI Redwood Scientific Technologies, Inc. | — | -0.0 | 2488.8 | 821.0 | — | — | 2 | BEARISH | -99.9 |
| LLBO Lifeline Biotechnologies, Inc. | — | — | — | — | — | — | — | BEARISH | -42.9 |
| VNRX VolitionRX Ltd | — | -0.0 | 80.1 | 66.5 | -1837.7 | 86.3 | 3 | BEARISH | -58.5 |
| BITRF Biotron Limited | — | -3.6 | -87.5 | -87.8 | -113.4 | -71.0 | 0 | BEARISH | -90.7 |
| CEVE Ceres Ventures, Inc. | — | -0.0 | 175.9 | 280.3 | — | — | 3 | BEARISH | 0.0 |
| BIIO Bionovate Technologies Corp | — | -0.0 | 47.5 | 16.6 | — | — | 3 | BEARISH | 9900.0 |
| BSPK Bespoke Extracts, Inc. | — | -0.0 | 37.1 | 45.4 | -16.7 | 284.5 | 4 | BEARISH | -99.8 |
| THER Theralink Technologies, Inc. | — | -0.0 | 6.0 | -69.7 | 5363.6 | 32.8 | 2 | BEARISH | 0.0 |
| CVKD Cadrenal Therapeutics, Inc. Common Stock | — | -0.2 | -275.2 | -540.4 | — | — | 3 | BEARISH | -92.5 |
| PNPL Pineapple, Inc. | — | -10.4 | 63.1 | -28.2 | -276.2 | 943.8 | 7 | BEARISH | -99.6 |
| CYIO CYIOS Corporation | — | 1.4 | 60.5 | 46.3 | — | -48.3 | 2 | BEARISH | -83.3 |
| MLECW Moolec Science S.A. | — | -0.0 | -174.7 | -31.5 | -91.8 | 170.4 | 3 | BEARISH | -3.8 |
| VIVS VivoSim Labs, Inc. | — | -0.0 | -343.1 | 241.9 | -7433.3 | 202.7 | 2 | BEARISH | -93.6 |
| PPTDF PeptiDream Inc. | $870M | -39.6 | -7.1 | -9.6 | -25.7 | 47.8 | 4 | BEARISH | -38.7 |
| WHTCF WELL Health Technologies Corp. | $770M | 163.6 | 0.5 | 5.4 | -2.7 | 38.6 | 6 | BEARISH | -20.2 |
| GNMLF Genomma Lab Internacional, S.A.B. de C.V. | $710M | 8.4 | 14.3 | 13.4 | 11.4 | 22.0 | 4 | BEARISH | -22.7 |
| AQST Aquestive Therapeutics, Inc. | $500M | -6.5 | 121.1 | 43.4 | -165.5 | 22.6 | 5 | BEARISH | -39.6 |
| SPHRY Starpharma Holdings Limited | $220M | -26.9 | -46.5 | -441.4 | -725.1 | 186.8 | 4 | BEARISH | 64.3 |
| BDSX Biodesix, Inc. | $170M | -7.2 | -540.0 | -31.9 | -27.1 | 34.5 | 6 | BEARISH | 243.8 |
| EUDA EUDA Health Holdings Limited | $40M | -6.8 | -50.6 | -26.7 | -22.9 | 49.4 | 5 | BEARISH | -65.2 |
| HRGN Harvard Apparatus Regenerative Technology Inc. | $30M | -4.9 | 239.0 | 256.6 | -409.4 | — | 2 | BEARISH | — |
| LPCN Lipocine Inc. | $10M | -0.8 | -60.9 | 662.3 | -1379.6 | -62.7 | 2 | BEARISH | -46.5 |
| NDRA ENDRA Life Sciences Inc. | $10M | -0.7 | -152.0 | -105.1 | — | — | 4 | BEARISH | -5.4 |
| CABR Caring Brands, Inc. | $10M | — | — | — | — | — | — | BEARISH | -68.4 |
| BRAXF Braxia Scientific Corp. | — | -0.1 | -254.6 | -2393.3 | -184.2 | 27.6 | 3 | BEARISH | 0.0 |
| PDMI Paradigm Medical Industries, Inc. | — | -0.0 | 47.4 | -40.4 | -184.3 | -30.7 | 4 | BEARISH | -90.0 |
| GPFT Grapefruit USA, Inc. | — | -0.1 | 11.4 | 5.9 | — | — | 2 | BEARISH | -66.7 |
| AEGY Alternative Energy Partners, Inc. | — | -0.0 | 190.5 | 67.0 | — | -165.0 | 4 | BEARISH | -99.0 |
| SIGY Sigyn Therapeutics, Inc. | — | -0.0 | 61.7 | 32.8 | — | -100.0 | 1 | BEARISH | -99.0 |
| CHME China Medicine Corp. | — | -145.9 | 9.7 | 9.7 | 12.7 | -4.3 | 6 | BEARISH | -16.4 |
| AZFL Amazonas Florestal, Ltd | — | 3.3 | 19.8 | 13.9 | 13.6 | — | 5 | BEARISH | 0.0 |
| VRPX Virpax Pharmaceuticals, Inc. | — | -0.0 | 2.6 | 0.4 | — | — | 1 | BEARISH | -96.2 |
| VRAX Virax Biolabs Group Limited | — | -0.0 | -110.9 | -481.7 | -40439.1 | 121.6 | 4 | BEARISH | 105.4 |
| ATXI Avenue Therapeutics, Inc. | — | -0.4 | -120.0 | 178.4 | — | -100.0 | 2 | BEARISH | -47.1 |
| CVGRF City View Green Holdings Inc. | — | -1.7 | 75.6 | 105.0 | — | — | 4 | BEARISH | -32.4 |
| SCNI Scinai Immunotherapeutics Ltd. | — | -0.0 | -19.2 | -53.3 | -435.4 | 162.7 | 2 | BEARISH | -63.4 |
| EVIO EVIO, Inc. | — | 1.7 | 65.3 | 33.5 | 8.3 | -26.9 | 4 | BEARISH | 0.0 |
| NVOS Novo Integrated Sciences, Inc. | — | -0.0 | -81.4 | -35.0 | 162.4 | 5.7 | 3 | BEARISH | -88.0 |
| UTRS Minerva Surgical, Inc. | — | -0.0 | -170.1 | -43.9 | -60.0 | 3.1 | 1 | BEARISH | 0.0 |
| SBFM Sunshine Biopharma, Inc. | — | -0.0 | -21.9 | -31.4 | -16.9 | -2.7 | 5 | BEARISH | -99.2 |
| TELA TELA Bio, Inc. | $40M | -1.3 | 1232.5 | -260.3 | -58.4 | 6.1 | 3 | BEARISH | -34.0 |
| NUGS Cannabis Strategic Ventures | — | -0.2 | 115.4 | -142.7 | -3106.7 | -29.3 | 2 | BEARISH | 4700.0 |
| CALA Calithera Biosciences, Inc. | — | -0.0 | -141.5 | 979.6 | — | -100.0 | 1 | BEARISH | -50.0 |
| EXETF Extendicare Inc. | $1.9B | 19.9 | 43.8 | 14.1 | 5.0 | 31.2 | 3 | BEARISH | 70.0 |
| ANRO Alto Neuroscience, Inc. | $860M | -9.4 | -49.2 | -201.4 | — | — | 3 | BEARISH | 90.5 |
| ABUS Arbutus Biopharma Corp | $830M | 5.5 | 89.6 | 86.7 | -507.2 | 1078.8 | 4 | BEARISH | -3.4 |
| HOPHF Hemogenyx Pharmaceuticals Plc | $20M | -3.7 | -628.5 | -474.6 | — | — | 4 | BEARISH | 0.0 |
| XAIR Beyond Air, Inc. | — | -0.0 | -429.9 | 409.7 | -448.8 | 60.7 | 6 | BEARISH | 13.5 |
| AOLS Aeolus Pharmaceuticals, Inc. | — | -0.0 | -186.4 | 1650.1 | -7300.0 | -68.7 | 1 | BEARISH | 0.0 |
| NWCI NewCardio, Inc. | — | -0.0 | 258.3 | 352.6 | -23059.8 | 40.9 | 2 | BEARISH | 0.0 |
| NUVB Nuvation Bio Inc. | $1.6B | -10.6 | -47.8 | 70.2 | -198.3 | 1083.6 | 4 | BEARISH | -8.7 |
| AUTL Autolus Therapeutics plc | $410M | -1.5 | -132.9 | 451.5 | -85.6 | 292.0 | 3 | BEARISH | -1.2 |
| AUNA Auna S.A. | $380M | -16.9 | 0.8 | 4.5 | 2.4 | 9.2 | 7 | BEARISH | -21.6 |
| SMTI Sanara MedTech Inc. | $300M | -8.8 | -147.7 | 19.8 | -1.6 | 12.9 | 5 | BEARISH | 7.8 |
| ELTP Elite Pharmaceuticals, Inc. | $270M | 4.9 | 74.3 | 43.6 | 18.3 | 33.7 | 5 | BEARISH | -60.9 |
| PLX Protalix BioTherapeutics, Inc. | $210M | 10.7 | 31.2 | 47.1 | 19.0 | 30.1 | 5 | BEARISH | 8.8 |
| RLYB Rallybio Corporation | $90M | 3.5 | 34.5 | -1198.7 | — | -35.6 | 6 | BEARISH | 2462.0 |
| VYYRF Voyageur Pharmaceuticals Ltd. | $20M | -5.5 | -527.9 | -47345.4 | -6124.5 | — | 3 | BEARISH | -79.0 |
| ALZN Alzamend Neuro Inc | $10M | -0.5 | -163.2 | 401.5 | — | — | 1 | BEARISH | -51.4 |
| IGEX Indo Global Exchange(s) PTE, Ltd. | — | -18.1 | -12.1 | -3.5 | — | -100.0 | 5 | BEARISH | -10.0 |
| AFFY Affymax, Inc. | — | -0.0 | 98.1 | -302.0 | 17164.3 | -99.9 | 5 | BEARISH | -11.1 |
| RMRK Rimrock Gold Corp. | — | 204.0 | 8.6 | 6.4 | — | -100.0 | 2 | BEARISH | 0.0 |
| TRLV Trulieve Cannabis Corp. | $1.8B | — | — | — | — | — | — | BEARISH | — |
| OCUL Ocular Therapeutix, Inc. | $1.4B | -5.1 | -73.0 | -31671.3 | -584.5 | -8.1 | 3 | BEARISH | -36.9 |
| LRMR Larimar Therapeutics, Inc. | $240M | -1.3 | -139.6 | 590.9 | — | — | 2 | BEARISH | -41.5 |
| LXEO Lexeo Therapeutics, Inc. Common Stock | $230M | -2.7 | -46.8 | -249.1 | — | — | 3 | BEARISH | -68.2 |
| OGI Organigram Global Inc. | $130M | 2.1 | 18.4 | -1.3 | 99.8 | 38.1 | 5 | BEARISH | -44.1 |
| MENS Jyong Biotech Ltd. Ordinary Shares | $130M | — | — | — | — | — | — | BEARISH | -95.9 |
| ADAG Adagene Inc. | $90M | -5.7 | -28.6 | 111.8 | -1011.1 | 8927.0 | 5 | BEARISH | 44.3 |
| MEDIF MediPharm Labs Corp. | $20M | -5.6 | -13.2 | -15.4 | 0.0 | -6.7 | 4 | BEARISH | -9.0 |
| PUMD ProUroCare Medical Inc. | — | — | — | — | — | — | — | BEARISH | -50.0 |
| WINT Windtree Therapeutics, Inc. | — | -0.0 | 1111.0 | -2375.5 | — | — | 3 | BEARISH | -99.7 |
| LTHO Legacy Technology Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SILO Silo Pharma, Inc. | — | -0.3 | -91.2 | 645.1 | — | -25.0 | 3 | BEARISH | 135.4 |
| USAQ QHSLab, Inc. | — | 6.3 | 114.6 | 6.2 | 4.5 | 24.6 | 6 | BEARISH | 36.4 |
| OMER Omeros Corporation | $1.2B | 9.4 | -89.2 | 71.8 | 46.4 | — | 5 | BEARISH | 131.9 |
| AVBP ArriVent BioPharma, Inc. | $1.0B | -4.3 | -53.1 | 2345.1 | — | — | 3 | BEARISH | -19.3 |
| IRWD Ironwood Pharmaceuticals, Inc. | $570M | 4.5 | -55.3 | 93.9 | 45.4 | 26.2 | 7 | BEARISH | 121.5 |
| EPRX Eupraxia Pharmaceuticals Inc. | $450M | -7.2 | -68.6 | 8742.2 | — | — | 3 | BEARISH | 33.5 |
| VRNO Verano Holdings Corp | $370M | -1.4 | -4.5 | 1.5 | -6.2 | — | 3 | BEARISH | — |
| CABA Cabaletta Bio, Inc. | $250M | -1.0 | -93.2 | -1308.0 | — | — | 3 | BEARISH | -45.5 |
| ELMD Electromed, Inc. | $220M | 19.9 | 23.3 | 32.5 | 17.5 | 15.3 | 8 | BEARISH | 10.7 |
| CYBQF CYBERDYNE Inc. | $200M | 155.4 | 0.7 | -1.4 | 36.4 | -8.1 | 3 | BEARISH | 0.0 |
| MFCSF Medical Facilities Corporation | $170M | 8.2 | 46.9 | 50.2 | 2.5 | 3.2 | 7 | BEARISH | -2.7 |
| ARMP Armata Pharmaceuticals, Inc. | $140M | -0.6 | 127.8 | -54.7 | 2953.8 | -35.1 | 2 | BEARISH | -37.6 |
| VRXA Veraxa Biotech Holding AG | $140M | — | — | — | — | — | — | BEARISH | — |
| UNCY Unicycive Therapeutics, Inc. | $110M | -2.2 | -101.1 | 349.9 | — | — | 4 | BEARISH | -28.2 |
| INO Inovio Pharmaceuticals, Inc. | $60M | -0.8 | -409.9 | 257.7 | — | -100.0 | 1 | BEARISH | -62.7 |
| VERU Veru Inc. | $40M | -3.8 | -62.3 | -211.2 | — | -100.0 | 3 | BEARISH | -40.3 |
| ANVS Annovis Bio, Inc. | $40M | -0.6 | -703.7 | 170.2 | — | — | 1 | BEARISH | -52.6 |
| SEOVF Sernova Corp. | $30M | -3.7 | 57.0 | 76.3 | — | — | 3 | BEARISH | -35.6 |
| DVHGF Devonian Health Group, Inc. | $20M | — | -76.1 | -75.1 | -1098.1 | -91.5 | 1 | BEARISH | 37.7 |
| DYAI Dyadic International, Inc. | $20M | -1.8 | 522.6 | 1288.0 | -221.0 | 1.5 | 3 | BEARISH | -66.6 |
| NMTC NeuroOne Medical Technologies Corporation | $10M | -0.9 | -119.7 | -335.0 | -101.7 | 50.8 | 5 | BEARISH | 2.8 |
| MODD Modular Medical, Inc. | $10M | -0.2 | -247.9 | -302.8 | — | — | 2 | BEARISH | -88.3 |
| CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | — | — | — | — | — | — | — | BEARISH | -76.0 |
| MDIT Medite Cancer Diagnostics, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PTLF Petlife Pharmaceuticals, Inc. | — | -0.0 | 257.0 | 178.4 | — | — | 2 | BEARISH | 0.0 |
| AKAN Akanda Corp. | — | -0.0 | 855.2 | -259.9 | -1532.3 | 84.2 | 3 | BEARISH | -97.5 |
| TTOO T2 Biosystems, Inc. | — | -0.0 | 277.6 | -638.9 | -509.7 | -30.2 | 3 | BEARISH | -95.0 |
| IVRO InVitro International | — | 17.1 | 3.7 | 4.6 | 4.8 | -14.0 | 5 | BEARISH | -25.0 |
| MDCN Medican Enterprises, Inc. | — | -3.4 | 40.4 | -2.1 | — | -38.5 | 3 | BEARISH | -99.0 |
| BIORQ Biora Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| EMGE Emergent Health Corp | — | -0.0 | 23.7 | 51.7 | — | -80.0 | 1 | BEARISH | 0.0 |
| ATRX Adhera Therapeutics Inc | — | -0.0 | 18.6 | 6.5 | — | — | 1 | BEARISH | 0.0 |
| PLWY Peoplesway.com Inc. | — | -0.0 | -6.5 | -4001.9 | -1.4 | -22.7 | 5 | BEARISH | 0.0 |
| SXTP 60 Degrees Pharmaceuticals, Inc. | — | -0.1 | -321.8 | -390.2 | -1089.2 | 68.0 | 3 | BEARISH | -43.8 |
| NXEN Nexien BioPharma, Inc. | — | -0.0 | 48.5 | 112.0 | — | — | 2 | BEARISH | -99.2 |
| AOXG Aoxing Pharmaceutical Company, Inc. | — | -37.5 | -0.2 | -13.9 | -405.2 | -99.8 | 1 | BEARISH | -69.7 |
| FUNI Hypha Labs, Inc. | — | -0.2 | 26.8 | 31.4 | — | — | 2 | BEARISH | — |
| PRFX PRF Technologies Ltd. | — | -0.1 | -57.8 | -88.3 | -19978.6 | 137249010644668.4 | 6 | BEARISH | -40.9 |
| EVGN Evogene Ltd. | — | -0.4 | 265.3 | 101.3 | -509.5 | -80.4 | 3 | BEARISH | -70.5 |
| BLEG Branded Legacy, Inc. | — | -0.0 | 2011.7 | 147.0 | — | -29.4 | 2 | BEARISH | -98.7 |
| MNZO Manzo Pharmaceuticals, Inc. | — | -9.8 | 4.6 | 4.1 | — | — | 2 | BEARISH | -99.0 |
| EVAHF EGF Theramed Health Corp. | — | -0.2 | 102.2 | 4.7 | — | — | 2 | BEARISH | -71.0 |
| CRIS Curis, Inc. | — | -0.0 | 455.3 | -23281.0 | — | -62.2 | 3 | BEARISH | -98.5 |
| AMPE Ampio Pharmaceuticals, Inc. | — | -0.0 | -114.0 | 1652.6 | -838.4 | — | 4 | BEARISH | 5806.4 |
| PBFFF Planet Based Foods Global Inc. | — | -0.7 | 69.6 | 63.1 | — | 100.0 | 2 | BEARISH | -80.8 |
| ORIC ORIC Pharmaceuticals, Inc. | $1.4B | -6.9 | -39.8 | -102.9 | — | — | 3 | BEARISH | -30.6 |
| KSPHF Kissei Pharmaceutical Co., Ltd. | $1.0B | 11.1 | 6.5 | -1.9 | 20.2 | 10.7 | 6 | BEARISH | -2.4 |
| LOVFF Cannara Biotech Inc. | $140M | 17.8 | 11.4 | 12.2 | 15.2 | 15.4 | 7 | BEARISH | 17.2 |
| CPIX Cumberland Pharmaceuticals Inc. | $130M | -6.8 | -46.7 | -41.6 | -2472.5 | -25.7 | 3 | BEARISH | 52.7 |
| POCI Precision Optics Corporation, Inc. | $50M | -9.4 | -22.3 | -19.0 | -1.2 | 65.2 | 5 | BEARISH | 2.8 |
| INBP Integrated BioPharma, Inc. | $10M | -1.8 | -15.0 | -13.1 | -13.9 | -19.3 | 2 | BEARISH | -46.0 |
| KPRX Kiora Pharmaceuticals, Inc. | $10M | -0.9 | -56.4 | -2884.1 | — | — | 2 | BEARISH | -6.7 |
| TRUFF Rhelion Life Sciences Corp. | $10M | -2.1 | -37.0 | -58.5 | -804.7 | -34.3 | 3 | BEARISH | -27.1 |
| BDPT BioAdaptives Inc. | — | -0.0 | 80.2 | 56.3 | 3009.0 | 169.7 | 3 | BEARISH | -93.6 |
| MDRM Modern Mobility Aids, Inc. | — | -63.9 | 146.1 | 120.5 | — | — | 2 | BEARISH | -47.1 |
| TNON Tenon Medical, Inc. | — | -0.0 | -549.9 | -452.2 | -316.7 | 80.9 | 4 | BEARISH | 85.2 |
| BCTXZ BriaCell Therapeutics Corp. Warrant | — | -0.3 | -168.1 | -2016.9 | — | — | 1 | BEARISH | -69.3 |
| RAPP Rapport Therapeutics, Inc. Common Stock | $1.2B | -7.4 | -40.0 | 3981.5 | — | — | 4 | BEARISH | -15.0 |
| DRTS Alpha Tau Medical Ltd | $1.2B | -12.8 | -141.7 | -17.1 | — | — | 3 | BEARISH | 220.9 |
| MGTX MeiraGTx Holdings plc | $880M | 12.8 | 72.3 | 96.7 | 50.0 | 948.3 | 7 | BEARISH | 9.9 |
| ORMP Oramed Pharmaceuticals Inc. | $170M | 1.0 | 74.1 | -4.3 | — | -100.0 | 4 | BEARISH | 75.5 |
| BRIBF Brii Biosciences Limited | $90M | -3.5 | -10.3 | -62.6 | — | 22.5 | 4 | BEARISH | -46.0 |
| ECOR electroCore, Inc. | $60M | -5.0 | 1761.5 | 336.0 | -32.4 | 33.5 | 3 | BEARISH | 71.8 |
| ELOX Eloxx Pharmaceuticals, Inc. | $40M | -8.6 | -107.5 | 81.5 | — | — | 4 | BEARISH | 1311999900.0 |
| SYBX Synlogic, Inc. | $10M | -19.6 | -5.3 | 306.3 | — | — | 2 | BEARISH | -40.7 |
| BFRI Biofrontera Inc. | $10M | -1.5 | -988.4 | -39.2 | -5.0 | 17.8 | 4 | BEARISH | -13.1 |
| SGIPF Sugi Holdings Co.,Ltd. | $1.8B | 15.9 | 10.0 | 11.6 | 2.2 | 46.6 | 7 | BEARISH | 0.9 |
| FBIOP Fortress Biotech, Inc. | $130M | 0.6 | 107.5 | -87.8 | -2.5 | 15.5 | 6 | BEARISH | 118.1 |
| STSN Stemsation International, Inc. | $10M | -4.8 | -2.8 | -1.6 | — | — | 3 | BEARISH | 8.7 |
| ORGS Orgenesis Inc. | — | -0.0 | 764.3 | 1083.0 | 2628.2 | -192.0 | 1 | BEARISH | -74.1 |
| HBRM Herborium Group, Inc. | — | -2.3 | 0.6 | 0.6 | 0.7 | -2.7 | 5 | BEARISH | -50.0 |
| AVLN Avalyn Pharma Inc. Common Stock | $1.1B | — | — | — | — | — | — | BEARISH | — |
| APMD Apnimed, Inc. | $790M | — | — | — | — | — | — | BEARISH | — |
| CBIO Crescent Biopharma, Inc. | $480M | -1.8 | -107.7 | 1928.6 | — | — | 5 | BEARISH | 3.9 |
| NPCE NeuroPace, Inc. | $440M | -22.6 | -122.1 | -39.6 | -27.2 | 11.6 | 4 | BEARISH | 22.0 |
| KYTX Kyverna Therapeutics, Inc. | $330M | -2.0 | -87.2 | 14267.8 | — | — | 2 | BEARISH | -24.6 |
| RXST RxSight, Inc. | $210M | -4.3 | -17.3 | -66.9 | -35.9 | -18.8 | 3 | BEARISH | -43.4 |
| TSNDF TerrAscend Corp. | $170M | -3.9 | -22.6 | -28.1 | -13.6 | — | 3 | BEARISH | — |
| IMDX Insight Molecular Diagnostics Inc. | $90M | -2.1 | 488.7 | 92.7 | -4711.3 | -60.8 | 2 | BEARISH | -51.1 |
| MIST Milestone Pharmaceuticals Inc. | $80M | -1.1 | -35522.6 | 587.8 | -5118.8 | — | 5 | BEARISH | -62.3 |
| RECEF Recce Pharmaceuticals Ltd | $70M | -6.3 | 151.4 | 200.5 | — | -100.0 | 2 | BEARISH | -56.0 |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | $70M | -0.7 | -213.1 | 3515.1 | — | — | 4 | BEARISH | -35.7 |
| NMRA Neumora Therapeutics, Inc. Common Stock | $70M | -0.3 | -187.1 | 231.9 | — | — | 2 | BEARISH | -77.6 |
| CNTB Connect Biopharma Holdings Limited | $50M | -1.0 | -105.5 | 1034.1 | -1249.0 | 49.8 | 2 | BEARISH | -47.2 |
| CVM CEL-SCI Corporation | $30M | -0.6 | -252.5 | -142.9 | — | -100.0 | 4 | BEARISH | -82.3 |
| ARTL Artelo Biosciences, Inc. | $10M | -0.0 | -705.7 | -1031.2 | — | — | 5 | BEARISH | -92.2 |
| NSCIF Nanalysis Scientific Corp. | $10M | -3.5 | -33.5 | -6.2 | -6.9 | -6.2 | 5 | BEARISH | -36.3 |
| FNAM Evolutionary Genomics, Inc. | — | -0.0 | 62.2 | -99.6 | — | — | 2 | BEARISH | 0.0 |
| RBOT Vicarious Surgical Inc. | — | -0.0 | -223.8 | -476.5 | — | — | 1 | BEARISH | -99.7 |
| SCNX Scienture Holdings, Inc. | — | -0.1 | -53.5 | -15.4 | -821.3 | 540.6 | 4 | BEARISH | -87.8 |
| SYBE SYBLEU Inc | — | -3.1 | 71.5 | -202.2 | -685.7 | — | 2 | BEARISH | 0.0 |
| RGRX RegeneRx Biopharmaceuticals, Inc. | — | -0.0 | 53.5 | 45.8 | -2006.3 | -0.0 | 3 | BEARISH | 450.0 |
| LNDZF Evome Medical Technologies Inc. | — | -2.2 | -294.8 | -10.4 | -11.5 | -15.9 | 4 | BEARISH | -98.3 |
| TRGM Targeted Medical Pharma, Inc. | — | -0.0 | 26.6 | 20.9 | -45.1 | -26.0 | 4 | BEARISH | -90.0 |
| BICTF Biocure Technology Inc. | — | -0.1 | -889.9 | 60.0 | — | — | 1 | BEARISH | 0.0 |
| CPYT CarePayment Technologies, Inc. | — | -0.0 | 1607.0 | -66.2 | -585.5 | — | 2 | BEARISH | 0.0 |
| OHCS Optimus Healthcare Services, Inc. | — | -0.0 | 99.2 | 130.3 | -469.4 | 43.7 | 4 | BEARISH | -99.4 |
| NVCR Novocure Ltd | $1.7B | -10.9 | -43.2 | -93.1 | -8.5 | 11.0 | 6 | BEARISH | 4.3 |
| GERN Geron Corporation | $720M | -9.7 | -29.2 | -74.1 | -29.0 | 24.4 | 2 | BEARISH | -24.3 |
| MTLZF Metall Zug AG | $680M | -34.1 | -2.8 | -1.4 | -5.6 | -0.3 | 6 | BEARISH | 0.0 |
| HELP Helus Pharma Inc. | $630M | -2.6 | -56.3 | -143.0 | — | — | 2 | BEARISH | — |
| ZVRA Zevra Therapeutics, Inc. | $580M | 10.7 | 34.8 | -1356.4 | 22.1 | 119.4 | 6 | BEARISH | -7.0 |
| PHAT Phathom Pharmaceuticals, Inc. | $460M | -4.9 | 26.4 | 8.9 | -23.7 | 110.2 | 4 | BEARISH | -54.5 |
| FTH Faeth Therapeutics, Inc. | $440M | — | — | — | — | — | — | BEARISH | — |
| CLVLF Clinuvel Pharmaceuticals Limited | $250M | 10.7 | 13.2 | 126.7 | 41.1 | -1.1 | 6 | BEARISH | -32.0 |
| CELG-RI Bristol-Myers Squibb Company Ce | $250M | 0.0 | 46.7 | 22.0 | 25.6 | 3.1 | 8 | BEARISH | 232.3 |
| ETRA Electra Therapeutics Inc. | $180M | — | — | — | — | — | — | BEARISH | — |
| UPB Upstream Bio, Inc. | $150M | -1.0 | -46.0 | -1266.4 | -5136.1 | 49.2 | 3 | BEARISH | -82.1 |
| CUE Cue Biopharma, Inc. | $140M | -0.8 | -1603.5 | 1241.9 | -1943.2 | 354.4 | 3 | BEARISH | -8.4 |
| LENZ LENZ Therapeutics, Inc. | $100M | -0.8 | -59.2 | 17313.3 | -581.8 | 329.5 | 3 | BEARISH | -89.7 |
| SHIEF Shield Therapeutics plc | $80M | -7.4 | 65.2 | 698.4 | -7.4 | 152.4 | 3 | BEARISH | -24.5 |
| ACRV Acrivon Therapeutics, Inc. Common Stock | $70M | -1.0 | -64.6 | 5251.5 | — | — | 1 | BEARISH | -14.3 |
| SOMNF SomnoMed Limited | $50M | -24.8 | -5.6 | 2.2 | -6.4 | 2.6 | 6 | BEARISH | -60.7 |
| NDTP NDT Pharmaceuticals Inc. | $50M | -29.4 | -3.8 | -1.5 | -458.3 | — | 4 | BEARISH | -87.3 |
| INNMF Amplia Therapeutics Limited | $30M | -5.1 | -24.9 | -86.9 | — | -100.0 | 2 | BEARISH | 10.2 |
| RVXCF Resverlogix Corp. | $20M | -1.5 | 11.5 | 25.3 | — | — | 4 | BEARISH | -30.1 |
| SCYX SCYNEXIS, Inc. | $20M | -2.1 | -18.4 | -120.7 | 3147.7 | 489.8 | 5 | BEARISH | 424.6 |
| NSPR InspireMD, Inc. | $20M | -0.9 | -148.8 | -1383.2 | -808.8 | 53.4 | 4 | BEARISH | -80.0 |
| DTCFF Defence Therapeutics Inc. | $20M | -3.1 | -237.8 | -86.8 | — | — | 4 | BEARISH | -56.4 |
| RVVTF Revive Therapeutics Ltd. | $10M | -0.8 | -1114.6 | 25.7 | — | — | 2 | BEARISH | 57.3 |
| OTLC Oncotelic Therapeutics, Inc. | $10M | 0.0 | 181.4 | -1.4 | 155.3 | — | 5 | BEARISH | -82.1 |
| RHEPB Regional Health Properties, Inc. | $10M | 0.5 | -328.8 | -0.6 | -3.2 | 200.4 | 6 | BEARISH | -3.2 |
| ICU SeaStar Medical Holding Corporation | $10M | -0.6 | -356.9 | 415.0 | -606.5 | 123.6 | 4 | BEARISH | -58.3 |
| BICX BioCorRx Inc. | $10M | -1.7 | 25.4 | 84.3 | -1096.7 | 151.2 | 3 | BEARISH | -47.2 |
| INTS Intensity Therapeutics, Inc. | $10M | -0.7 | -195.9 | 4123.4 | — | — | 5 | BEARISH | -44.7 |
| PLRZ Polyrizon Ltd. | $10M | -1.9 | -21.4 | -68.2 | — | — | 0 | BEARISH | 31.6 |
| PHIO Phio Pharmaceuticals Corp. | $10M | -0.7 | -113.7 | 2701.6 | — | — | 2 | BEARISH | -57.6 |
| APPB Applied Biosciences Corp. | — | -0.0 | -297.6 | -188.8 | -798.1 | 75.3 | 4 | BEARISH | 0.0 |
| CDT CDT Equity Inc. | — | -0.0 | 13.1 | 5.4 | 9.1 | — | 7 | BEARISH | -97.5 |
| APUS Apimeds Pharmaceuticals US, Inc | — | -0.1 | -100.1 | -12.6 | — | — | 2 | BEARISH | -84.5 |
| ADTX Aditxt, Inc. | — | -0.0 | 622.6 | 49.4 | -131159.8 | -74.1 | 1 | BEARISH | -100.0 |
| LTUS Lotus Pharmaceuticals, Inc. | — | -355.3 | 14.7 | -340.1 | — | — | 3 | BEARISH | 9.5 |
| PASO Patient Access Solutions, Inc. | — | -0.0 | 540.4 | 691.6 | 0.6 | — | 2 | BEARISH | 0.0 |
| AMBS Amarantus BioScience Holdings, Inc. | — | -0.0 | 7.3 | 3.8 | -4080.5 | — | 3 | BEARISH | -66.7 |
| LVRLF CordovaCann Corp. | — | -1.0 | 47.4 | -18.4 | -6.5 | -2.8 | 4 | BEARISH | 14.1 |
| BRGX BioRegenx, Inc. | — | -0.2 | 0.6 | 1.6 | -6.2 | — | 3 | BEARISH | — |
| IHGP Jun An Kang Group Inc. | — | 2.0 | 0.5 | 0.5 | 1.0 | 64.0 | 6 | BEARISH | -98.7 |
| YECO EV Biologics, Inc. | — | -0.0 | 16.2 | 18.1 | 18.6 | 264.7 | 5 | BEARISH | -99.9 |
| BRTX BioRestorative Therapies, Inc. | — | -0.1 | -241.1 | 2112.9 | -9298.3 | -8.5 | 3 | BEARISH | -95.5 |
| STJO St. Joseph, Inc. | — | 0.6 | 9.1 | 6.7 | 89.6 | -23.9 | 7 | BEARISH | -87.3 |
| ICCO InterCare DX, Inc. | — | -0.0 | 16.1 | 3053.3 | — | — | 5 | BEARISH | 0.0 |
| AFMDQ Affimed N.V. | — | — | — | — | — | — | — | BEARISH | — |
| CLABF Core One Labs Inc. | — | -0.3 | -233.7 | -70.3 | -897.6 | -69.3 | 3 | BEARISH | -90.0 |
| LMLLF Pharmadrug Inc. | — | -0.9 | 37.6 | 446.5 | — | — | 2 | BEARISH | -45.6 |
| LVVV LiveWire Ergogenics, Inc. | — | -0.4 | -188.5 | -4.0 | -2585.3 | -89.5 | 3 | BEARISH | -84.6 |
| POAS Phaos Technology Holdings (Caym | — | — | — | — | — | — | — | BEARISH | — |
| SPRC SciSparc Ltd. | — | -0.0 | -519.9 | -161.9 | -1891.2 | -26.8 | 5 | BEARISH | -78.1 |
| GXXY Galexxy Holdings, Inc. | — | -0.0 | 370.1 | 271.5 | -385.0 | -88.8 | 2 | BEARISH | -98.5 |
| SYUP Anbc, Inc. | — | — | — | — | — | — | — | BEARISH | 50.0 |
| YOURF YourWay Cannabis Brands Inc. | — | -0.0 | 19.0 | 18.4 | 3.3 | 253.3 | 8 | BEARISH | 0.0 |
| MTNB Matinas BioPharma Holdings, Inc. | — | -0.1 | -154.3 | -504.1 | — | — | 4 | BEARISH | -91.7 |
| UDOCF Unidoc Health Corp. | — | -1.6 | 392.6 | 140.6 | -352.4 | 606.8 | 3 | BEARISH | -72.2 |
| AGNPF Grey Matters Health Inc. | — | — | -140.9 | -64.7 | — | — | 3 | BEARISH | -51.7 |
| CSTF CuraScientific Corp | — | -0.0 | -72.1 | 17.4 | -2482.5 | 954.6 | 5 | BEARISH | -99.0 |
| CENBF CEN Biotech, Inc. | — | -0.0 | 32.0 | -64.0 | 569.4 | -54.9 | 5 | BEARISH | 900.0 |
| ENMI DH Enchantment Inc. | — | -0.5 | 52.9 | -49.5 | -32.2 | 26.9 | 5 | BEARISH | -66.7 |
| AYRWF Ayr Wellness Inc. | — | -0.0 | -65.7 | -16.1 | -53.2 | -2.4 | 3 | BEARISH | -100.0 |
| VBIO Valion Bio, Inc. | — | -0.0 | -240.8 | -48.0 | — | -281.4 | 2 | BEARISH | — |
| SKVI Skinvisible, Inc. | — | -0.8 | 10.0 | 7.2 | -5110.7 | 0.0 | 2 | BEARISH | -59.7 |
| HIGR Hi-Great Group Holding Company | — | -14.0 | 30.7 | 30.8 | -177.4 | -40.3 | 1 | BEARISH | -91.8 |
| NVNO enVVeno Medical Corporation | — | -0.0 | -58.5 | 4255.8 | — | — | 4 | BEARISH | 883.2 |
| BMMJ Body and Mind Inc. | — | -0.1 | 267.1 | 411.6 | -58.9 | -48.9 | 2 | BEARISH | -98.0 |
| MCIC Multicorp International, Inc. | — | -15.7 | -1.1 | -0.2 | — | — | 3 | BEARISH | 0.0 |
| HLTHQ Cue Health Inc. | — | -0.0 | -90.3 | -100.6 | -789.6 | -85.3 | 1 | BEARISH | 0.0 |
| RGBPP Regen BioPharma, Inc. | — | -0.0 | 20.3 | 12.8 | -1079.8 | 0.0 | 4 | BEARISH | -98.5 |
| SHMN SOHM, Inc. | — | 7.0 | -15.3 | -2.9 | -130.8 | -3.6 | 4 | BEARISH | -29.2 |
| NPRRF Nipro Corporation | $1.4B | — | — | — | — | — | — | BEARISH | 5.8 |
| CURLF Curaleaf Holdings, Inc. | $1.8B | -61.8 | -4.2 | 0.5 | 3.7 | 2.7 | 7 | BEARISH | -1.5 |
| NVAX Novavax, Inc. | $1.6B | -6.8 | 323.7 | 29.2 | -94.2 | -61.6 | 2 | BEARISH | 18.6 |
| PRQR ProQR Therapeutics N.V. | $180M | -3.2 | -57.9 | 139.7 | -99.6 | 12.7 | 2 | BEARISH | -50.7 |
| CRDL Cardiol Therapeutics Inc. | $140M | -4.9 | -204.6 | 1592.3 | — | — | 4 | BEARISH | -4.1 |
| AMGXF AnGes, Inc. | $140M | -3.0 | -160.6 | -111.8 | -531.3 | -16.1 | 4 | BEARISH | 0.0 |
| BBIXF Bonus BioGroup Ltd. | $50M | -17.2 | 3245.0 | 2543.1 | — | — | 2 | BEARISH | 13233.3 |
| INTI Inhibitor Therapeutics, Inc. | $10M | -4.2 | 358.8 | 88.0 | — | — | 1 | BEARISH | 59.8 |
| IHTI Integrative Health Technologies, Inc. | — | 0.0 | -13.8 | -11.8 | 53.8 | 263.8 | 4 | BEARISH | -95.0 |
| SLHPF Skylight Health Group Inc. | — | -0.0 | -109.3 | -44.8 | -21.4 | — | 2 | BEARISH | -90.0 |
| IRME IR-Med Inc. | — | -0.1 | 1793.9 | 264.1 | — | -23.5 | 2 | BEARISH | -93.8 |
| MYMX Mymetics Corporation | — | -0.0 | 16.6 | 357.9 | -3012.0 | -62.8 | 2 | BEARISH | 0.0 |
| NWPHF Newron Pharmaceuticals S.p.A. | $410M | -6.6 | 83.9 | -32.1 | -513.4 | — | 1 | BEARISH | — |
| VRXAW Veraxa Biotech AG | — | — | — | — | — | — | — | BEARISH | — |
| BLEVF Beleave Inc. | — | -0.0 | -105.9 | -25.1 | -653.1 | 117.7 | 4 | BEARISH | -99.0 |
| KKUR ChromoCure, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SRNE Sorrento Therapeutics, Inc. | — | -0.0 | 1502.8 | 468.4 | -633.7 | 16.9 | 2 | BEARISH | -98.3 |
| GTBIF Green Thumb Industries Inc. | $1.4B | 11.7 | 7.0 | 2.5 | 1.6 | 4.8 | 7 | BEARISH | -13.5 |
| SNDX Syndax Pharmaceuticals, Inc. | $1.2B | -5.7 | -255.9 | -270.9 | -67.8 | 222.3 | 4 | BEARISH | 9.2 |
| CTMX CytomX Therapeutics, Inc. | $510M | -5.2 | -37.8 | 305.9 | -1457.4 | -87.0 | 2 | BEARISH | -29.8 |
| ASMB Assembly Biosciences, Inc. | $400M | 37.4 | -0.0 | 56.2 | -28.8 | 125.1 | 4 | BEARISH | -31.0 |
| MPLT MapLight Therapeutics, Inc. | $340M | -1.5 | -57.5 | -366.6 | — | — | 2 | BEARISH | -56.5 |
| CTNM Contineum Therapeutics, Inc. | $270M | -5.3 | -28.0 | -541.6 | — | — | 4 | BEARISH | -18.4 |
| ABEO Abeona Therapeutics Inc. | $250M | -4.0 | -43.1 | -5983.3 | -177.4 | 6280.0 | 2 | BEARISH | -17.9 |
| CRLBF Cresco Labs Inc. | $210M | -2.0 | -25.8 | 5.5 | 9.7 | -4.5 | 2 | BEARISH | -50.6 |
| HWAIF Healwell AI Inc. | $150M | -5.4 | -21.9 | -10.8 | 19.4 | 54.1 | 5 | BEARISH | -54.1 |
| AIRS AirSculpt Technologies, Inc. | $90M | -7.9 | -12.0 | -6.0 | -2.6 | -8.7 | 5 | BEARISH | -87.6 |
| CRBU Caribou Biosciences, Inc. | $60M | -0.5 | -78.3 | -695.0 | -1619.9 | 10.0 | 3 | BEARISH | -80.0 |
| IBIO iBio, Inc. | $50M | -2.5 | -65.7 | 21688.6 | — | -75.0 | 4 | BEARISH | -37.2 |
| CVRX CVRx, Inc. | $40M | -0.7 | -133.4 | -260.4 | -89.4 | 12.0 | 3 | BEARISH | -86.5 |
| ORXOY Orexo AB (publ) | $20M | -0.4 | 3924.8 | -872.8 | -12050.0 | -97.8 | 4 | BEARISH | -83.4 |
| CLRB Cellectar Biosciences, Inc. | $10M | -0.3 | -119.6 | 717.6 | — | — | 3 | BEARISH | -65.5 |
| AVCNF Avicanna Inc. | $10M | -3.2 | -109.4 | -64.5 | -18.1 | -0.2 | 3 | BEARISH | -60.5 |
| AIM AIM ImmunoTech Inc. | $10M | -0.0 | -2382.3 | -513.5 | -14569.2 | -21.5 | 5 | BEARISH | -93.3 |
| PLSM Pulsenmore Ltd. Ordinary Shares | $10M | — | — | — | — | — | — | BEARISH | — |
| BTAIQ BioXcel Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| CATV Opus Holdings, Inc. | — | -16.9 | -0.8 | -1.4 | 91.7 | 47.8 | 5 | BEARISH | -99.6 |
| FITY Fifty 1 Labs, Inc. | — | -1.0 | 132.4 | 345.2 | -58137.6 | -75.6 | 4 | BEARISH | -87.5 |
| YCBD cbdMD, Inc. | — | -1.2 | -40.3 | -27.6 | -20.3 | 10.0 | 2 | BEARISH | -64.5 |
| ACNV Accelera Innovations, Inc | — | -0.0 | 197.1 | 28.9 | — | -97.0 | 1 | BEARISH | 0.0 |
| AQSZF Aequus Pharmaceuticals Inc. | — | 3.1 | 10.0 | 17.6 | 147.2 | 122.3 | 5 | BEARISH | -85.7 |
| ASCLF Ascletis Pharma Inc. | $770M | -7.8 | -28.4 | -7144.0 | — | -60.6 | 2 | BEARISH | -40.0 |
| ACHV Achieve Life Sciences, Inc. | $670M | -4.4 | -845.0 | 24.6 | — | — | 2 | BEARISH | 46.4 |
| NVCT Nuvectis Pharma, Inc. | $650M | -14.0 | -214.6 | 174.4 | — | — | 1 | BEARISH | 180.3 |
| NIKA Nika Pharmaceuticals Inc. | $370M | -4711.6 | 26.8 | 18.5 | — | 100.0 | 3 | BEARISH | 8.5 |
| IRD Opus Genetics, Inc. | $290M | -2.9 | -4796.5 | 59.8 | -1072.6 | -36.1 | 3 | BEARISH | 84.0 |
| PALI Palisade Bio, Inc. | $230M | -2.2 | -51.4 | 815.6 | -2114.8 | — | 5 | BEARISH | -28.3 |
| GALT Galectin Therapeutics Inc. | $210M | -8.3 | 21.9 | 99.4 | — | — | 2 | BEARISH | -30.6 |
| EDTXF Spectral Medical Inc. | $210M | -6.8 | 64.9 | 19.4 | 53.3 | 1.5 | 2 | BEARISH | -42.1 |
| MGNX MacroGenics, Inc. | $140M | -11.2 | -32.6 | 33.8 | 59.4 | 2.3 | 2 | BEARISH | 29.3 |
| SEER Seer, Inc. | $110M | -1.6 | -26.4 | -58.8 | -544.8 | -13.3 | 3 | BEARISH | -16.0 |
| COYA Coya Therapeutics, Inc. | $90M | -3.8 | -60.5 | -18820.6 | -2723.4 | 1793.8 | 4 | BEARISH | -37.2 |
| PXMBF Paxman AB (publ) | $80M | -308.0 | -1.2 | -1.7 | 2.4 | 33.5 | 3 | BEARISH | 0.0 |
| MNOV MediciNova, Inc. | $70M | -6.8 | -25.6 | -78.2 | -504.8 | 583.9 | 3 | BEARISH | 21.5 |
| SKIN SkinHealth Systems Inc. | $70M | -2.3 | -43.8 | -1.6 | -3.7 | -6.5 | 4 | BEARISH | -64.1 |
| OSTX OS Therapies Incorporated | $60M | -1.1 | 1924.5 | 268.9 | — | — | 1 | BEARISH | -35.2 |
| HRTX Heron Therapeutics, Inc. | $60M | -1.7 | 334.6 | -7.6 | -14.6 | 1.0 | 3 | BEARISH | -73.8 |
| XLO Xilio Therapeutics, Inc. | $50M | -5.4 | -55.0 | 43.1 | -34.1 | 327.3 | 6 | BEARISH | 864.5 |
| GANX Gain Therapeutics, Inc. | $50M | -2.4 | -268.3 | 1288.8 | — | — | 4 | BEARISH | -38.5 |
| ALPS Alps Group Inc | $50M | — | — | — | — | — | — | BEARISH | — |
| MYO Myomo, Inc. | $50M | -3.7 | -123.8 | -74.2 | -34.4 | 6.1 | 3 | BEARISH | 14.9 |
| MREO Mereo BioPharma Group plc | $40M | -1.6 | -67.8 | 6194.3 | — | -100.0 | 2 | BEARISH | -85.2 |
| DWTX Dogwood Therapeutics, Inc. | $40M | -0.1 | -47.8 | -39.7 | — | — | 2 | BEARISH | -79.9 |
| INIS Radnostix, Inc. | $30M | -0.0 | -29489557.0 | -23.1 | -33.0 | -23.7 | 1 | BEARISH | -30.0 |
| DGNOF DIAGNOS Inc. | $30M | -8.8 | -988.8 | -2061.6 | -7539.8 | -36.9 | 3 | BEARISH | 11.5 |
| BIAF bioAffinity Technologies, Inc. | $20M | -0.0 | -1860.2 | -352.6 | -222.8 | -23.2 | 4 | BEARISH | -91.9 |
| ROMJF Rubicon Organics Inc. | $20M | -15.7 | -4.1 | -24.0 | 2.2 | 16.7 | 1 | BEARISH | -27.7 |
| PVCT Provectus Biopharmaceuticals, Inc. | $20M | -3.9 | 78.1 | 83.4 | — | -100.0 | 5 | BEARISH | -37.8 |
| COCP Cocrystal Pharma, Inc. | $20M | -1.2 | -311.7 | -3697.6 | -3013.3 | — | 2 | BEARISH | -18.7 |
| CRVW CareView Communications, Inc. | $20M | -6.4 | 6.4 | -1.4 | -10.0 | 8.5 | 7 | BEARISH | -7.4 |
| IMRN Immuron Limited | $10M | -2.5 | -40.2 | -187.8 | -54.4 | -29.7 | 5 | BEARISH | -59.1 |
| INNPF InnoCan Pharma Corporation | $10M | -6.5 | -21.0 | -13488.5 | -0.6 | -19.2 | 3 | BEARISH | -86.2 |
| PHYOF IXICO plc | $10M | -6.0 | -15.8 | -23.6 | -28.5 | 13.2 | 2 | BEARISH | 0.0 |
| BNGO Bionano Genomics, Inc. | $10M | -0.3 | -83.6 | -89.6 | -90.8 | 10.0 | 6 | BEARISH | -33.5 |
| GTHP Guided Therapeutics, Inc. | $10M | -3.7 | 66.3 | 57.9 | — | 450.8 | 3 | BEARISH | -47.4 |
| PASG Passage Bio, Inc. | $10M | -0.3 | -169.1 | 159.0 | — | — | 3 | BEARISH | -53.2 |
| UEEC United Health Products, Inc. | $10M | -6.2 | 37.4 | 34.4 | — | — | 4 | BEARISH | -55.3 |
| GLWLF Glow Lifetech Corp. | $10M | -50.0 | -11.1 | -21.1 | -26.6 | 59.2 | 5 | BEARISH | -16.1 |
| HLYK HealthLynked Corp. | $10M | -1.4 | 63.5 | -580.7 | -328.1 | -46.7 | 3 | BEARISH | 11.6 |
| SINT Sintx Technologies, Inc. | $10M | -0.3 | -408.3 | -216.8 | -598.7 | 0.2 | 3 | BEARISH | -50.7 |
| SNOA Sonoma Pharmaceuticals, Inc. | $10M | -0.9 | -41.1 | -55.7 | -5.2 | 47.0 | 4 | BEARISH | -71.5 |
| RVLWF Revitalist Lifestyle and Wellness Ltd. | $10M | -0.1 | 613.5 | -129.3 | -263.6 | — | 2 | BEARISH | 0.0 |
| EWLL eWellness Healthcare Corp. | — | -0.2 | 69.3 | 46.3 | — | -99.2 | 1 | BEARISH | 0.0 |
| AMBD American Mobile Dental Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HTPRF HTC Purenergy Inc. | — | -0.0 | 13.4 | -6.6 | — | 100.0 | 5 | BEARISH | -99.9 |
| WPHM Winston Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | -66.7 |
| EVLO Evelo Biosciences, Inc. | — | -0.0 | 948.0 | 605.0 | — | — | 2 | BEARISH | -80.0 |
| ISCO International Stem Cell Corporation | — | -2.7 | 30.4 | -10.8 | -2.7 | 3.4 | 6 | BEARISH | 16.0 |
| BBAL New York Health Care, Inc. | — | -0.0 | -9.2 | -21.4 | -1.7 | 3.5 | 6 | BEARISH | 0.0 |
| PHMB PharmaCom BioVet, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HMGN Hemagen Diagnostics, Inc. | — | -0.0 | 29.1 | -24.6 | -18.6 | -21.4 | 2 | BEARISH | 100.0 |
| BIGG Big Tree Group, Inc. | — | 0.0 | 0.4 | -0.6 | -0.6 | 55.4 | 5 | BEARISH | 0.0 |
| VSMD Vasamed, Inc. | — | -0.0 | 54566.1 | 395.4 | -334.5 | 70.0 | 4 | BEARISH | 0.0 |
| RCAR RenovaCare, Inc. | — | -0.0 | -436.6 | 812.3 | — | — | 2 | BEARISH | -99.0 |
| ELAB PMGC Holdings Inc. | — | -0.0 | -73.0 | -66.6 | -225.1 | 408.6 | 3 | BEARISH | -100.0 |
| FCHS First Choice Healthcare Solutions, Inc. | — | -0.0 | 61.1 | 51.6 | — | 140.3 | 4 | BEARISH | -33.3 |
| IMCC IM Cannabis Corp. | — | -0.0 | 1556.1 | -129.3 | -57.5 | -21.1 | 1 | BEARISH | -98.0 |
| OXIHF Oxford Investments Holdings Inc. | — | -0.2 | 19.5 | 9.8 | 6887.8 | -90.6 | 2 | BEARISH | 0.0 |
| ZCMD Zhongchao Inc. | — | -0.0 | -32.0 | -103.3 | -92.6 | -28.3 | 4 | BEARISH | -99.9 |
| OILFF Nextleaf Solutions Ltd. | — | -1.8 | -41.0 | -53.4 | -19.9 | -18.2 | 3 | BEARISH | -68.9 |
| SIGO Sunset Island Group, Inc. | — | -0.0 | 185.8 | 85.4 | — | — | 4 | BEARISH | 0.0 |
| HEMP Hemp, Inc | — | -0.2 | -38.7 | -6.0 | -4131.8 | 333.7 | 4 | BEARISH | 0.0 |
| PTPI Petros Pharmaceuticals, Inc. | — | 0.0 | -124.4 | 96.3 | — | -100.0 | 1 | BEARISH | -90.5 |
| CHMMF Chimeric Therapeutics Limited | — | -0.0 | 655.2 | 80.8 | — | -100.0 | 2 | BEARISH | 0.0 |
| ABTI Alterola Biotech, Inc. | — | -0.1 | -27.4 | 216.7 | — | — | 3 | BEARISH | 0.0 |
| NHEL Natural Health Farm Holdings Inc. | — | -0.0 | -37.2 | -15.8 | 9.3 | 6892.6 | 4 | BEARISH | 0.0 |
| LIANY LianMedical | — | 1.0 | 74.7 | -612.1 | — | — | 6 | BEARISH | -35.6 |
| VCNX Vaccinex, Inc. | — | -0.4 | 776.6 | 414.6 | -1584.0 | 226.6 | 3 | BEARISH | 4.2 |
| AXIM AXIM Biotechnologies, Inc. | — | -1.6 | 3.0 | 24.9 | -90.9 | 2142.6 | 5 | BEARISH | -62.7 |
| AIMLF AI/ML Innovations Inc. | — | -1.5 | 1433.6 | -1620.8 | -92486.4 | -73.9 | 1 | BEARISH | -30.0 |
| LNAI Lunai Bioworks Inc. | — | -0.3 | -21.6 | 30.2 | — | — | 2 | BEARISH | -97.2 |
| NXL Nexalin Technology, Inc. | — | -0.1 | -240.3 | -1401.4 | -18412.7 | 24.2 | 4 | BEARISH | 10.1 |
| ARSUF Fagron N.V. | $2.0B | 19.1 | 16.7 | 10.8 | 8.4 | 11.8 | 4 | BEARISH | 9.8 |
| SNDA Sonida Senior Living, Inc. | $1.6B | -5.4 | -25.2 | -2.9 | -11.8 | 49.4 | 4 | BEARISH | 28.5 |
| MEDOF Medios AG | $1.3B | 23.8 | 2.1 | 2.8 | 0.6 | 10.0 | 6 | BEARISH | 0.0 |
| CSBTF Kuros Biosciences AG | $950M | 115.7 | 9.6 | 9.2 | 4.8 | 29.1 | 4 | BEARISH | -39.6 |
| IART Integra LifeSciences Holdings Corporation | $930M | 72.9 | 1.2 | 13.4 | 3.6 | 0.8 | 6 | BEARISH | -23.2 |
| IMMX Immix Biopharma, Inc. | $680M | -9.2 | -34.2 | 1509.2 | — | — | 4 | BEARISH | 139.8 |
| LXRX Lexicon Pharmaceuticals, Inc. | $630M | -9.9 | -40.2 | -99.7 | -4591.8 | -29.0 | 3 | BEARISH | 28.4 |
| CADL Candel Therapeutics, Inc. | $610M | -6.1 | -81.8 | 219.4 | — | — | 2 | BEARISH | 60.6 |
| AVR Anteris Technologies Global Corp. | $570M | -2.2 | -75.1 | 3136.2 | -2884.3 | 31.1 | 5 | BEARISH | 16.6 |
| MDXG MiMedx Group, Inc. | $570M | -30.4 | 2.9 | 5.8 | -23.1 | -2.4 | 6 | BEARISH | -41.3 |
| AVIR Atea Pharmaceuticals, Inc. | $320M | -2.1 | -58.1 | 974.6 | — | — | 3 | BEARISH | 31.4 |
| SY So-Young International Inc. | $280M | -7.6 | -15.7 | -22.3 | -11.4 | 14.1 | 4 | BEARISH | -32.7 |
| IKT Inhibikase Therapeutics, Inc. | $220M | -3.4 | -52.0 | 920.5 | — | — | 3 | BEARISH | 3.9 |
| PFGTF Pacific Edge Limited | $170M | -6.1 | -194.5 | -709.2 | -299.7 | -49.4 | 2 | BEARISH | 36.9 |
| RTGN RetinalGenix Technologies Inc. | $80M | -36.0 | 90.4 | -10.3 | — | -100.0 | 4 | BEARISH | 12.7 |
| INMB INmune Bio, Inc. | $40M | -2.2 | -74.8 | -475.4 | — | -100.0 | 2 | BEARISH | -16.9 |
| BMEA Biomea Fusion, Inc. | $40M | -1.3 | -164.1 | 210.3 | — | — | 2 | BEARISH | -54.4 |
| CELU Celularity Inc. | $30M | -0.5 | 150.9 | 40592.8 | 13.0 | -58.1 | 4 | BEARISH | -55.0 |
| RMTI Rockwell Medical, Inc. | $30M | -5.3 | -15.5 | -14.8 | -6.6 | -21.1 | 6 | BEARISH | 541.2 |
| MLSS Milestone Scientific Inc. | $30M | -6.6 | -121.7 | -160.5 | -37.3 | 3.7 | 4 | BEARISH | -30.4 |
| AVEFF Avecho Biotechnology Limited | $20M | -9.3 | -268.2 | 103.4 | -3227.5 | -46.6 | 3 | BEARISH | 0.0 |
| SER Serina Therapeutics, Inc. | $20M | -0.9 | -206.3 | 1868.6 | — | -100.0 | 3 | BEARISH | -67.7 |
| BMRA Biomerica, Inc. | $10M | -1.1 | -113.8 | -132.4 | -97.4 | -11.2 | 1 | BEARISH | -40.9 |
| CMPD CompuMed, Inc. | $10M | -28.3 | -8.7 | -11.2 | 1.1 | 22.4 | 6 | BEARISH | 90.0 |
| CMMB Chemomab Therapeutics Ltd. | $10M | -1.1 | -82.7 | -314.7 | — | — | 1 | BEARISH | -63.9 |
| CPMV Mosaic ImmunoEngineering Inc. | — | -2.8 | 9.2 | 7.5 | — | — | 2 | BEARISH | -73.2 |
| XRTX XORTX Therapeutics Inc. | — | -0.4 | -99.1 | -68.5 | — | — | 3 | BEARISH | 63.0 |
| PRMD PrimeMD Inc | — | -0.0 | 42.8 | 34.3 | 159.9 | — | 3 | BEARISH | 200.0 |
| PAVS Paranovus Entertainment Technology Ltd. | — | -0.0 | -25.4 | -20.6 | -5.5 | 3788.4 | 3 | BEARISH | -95.5 |
| OZYMF Strategic Partners A/S | — | 20.1 | 0.8 | -117.5 | 1019.0 | — | 6 | BEARISH | 0.0 |
| GNLKQ GeneLink, Inc. | — | -0.0 | 73.0 | 82.1 | -183.0 | -33.6 | 3 | BEARISH | 0.0 |
| GLABF Gemina Laboratories Ltd. | — | -3.0 | 42.7 | 32.4 | -7838.5 | — | 5 | BEARISH | -78.3 |
| IVIXF Invion Limited | — | -0.6 | -83.6 | -69.7 | -537.3 | — | 3 | BEARISH | 0.0 |
| RXEI RxElite, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PBM Psyence Biomedical Ltd. | — | — | — | — | — | — | — | BEARISH | 4.3 |
| PAIOF Paion AG | — | -0.6 | -385.3 | -130.5 | -98.8 | -18.0 | 1 | BEARISH | 0.0 |
| HXBM Helix BioMedix, Inc. | — | — | — | — | — | — | — | BEARISH | -6.0 |
| KRSA Korsana Biosciences, Inc. | $150M | — | — | — | — | — | — | BEARISH | — |
| HBMHF HBM Holdings Limited | $1.3B | 12.7 | 24.1 | 53.0 | 53.0 | 54.6 | 4 | BEARISH | -38.1 |
| GPCR Structure Therapeutics Inc. | $1.2B | -7.1 | -20.2 | -1134.3 | — | — | 3 | BEARISH | -25.0 |
| RAFLF Raffles Medical Group Ltd | $1.2B | 22.4 | 5.8 | 7.3 | 8.2 | -2.8 | 7 | BEARISH | -20.0 |
| MCRPF MicroPort Scientific Corp. | $1.1B | 31.2 | 6.1 | -1.7 | 21.3 | -3.5 | 5 | BEARISH | -63.2 |
| ARDX Ardelyx, Inc. | $770M | -13.7 | -38.6 | -22.7 | -13.8 | 16.8 | 4 | BEARISH | -39.2 |
| XVIPY Xvivo Perfusion AB (publ) | $690M | 50.1 | 5.9 | 4.6 | 17.7 | 17.5 | 6 | BEARISH | — |
| SLBT SL Science Holding Ltd | $640M | — | — | — | — | — | — | BEARISH | — |
| PROK ProKidney Corp. | $470M | -2.7 | 9.2 | 13.2 | -18948.0 | 55.2 | 1 | BEARISH | -52.8 |
| SSII SS Innovations International, Inc. | $450M | -37.4 | -26.1 | -15.6 | -19.1 | 108.5 | 3 | BEARISH | -71.6 |
| BWAY BrainsWay Ltd. | $440M | 46.8 | 13.0 | 31.1 | 15.8 | 32.3 | 5 | BEARISH | 33.6 |
| CALZF PolyNovo Limited | $430M | 83.2 | 8.4 | 9.3 | 10.0 | 12.8 | 7 | BEARISH | -27.9 |
| SWDCF Swedencare AB (publ) | $370M | 35.2 | 1.2 | 1.7 | 3.9 | 1.4 | 7 | BEARISH | -46.5 |
| ACIU AC Immune S.A. | $250M | -4.6 | -78.5 | 96.7 | 12.4 | -39.5 | 2 | BEARISH | -34.0 |
| CUVL Clinuvel Pharmaceuticals Ltd. | $250M | — | — | — | — | — | — | BEARISH | — |
| BOVNF BioInvent International AB (publ) | $220M | -2.7 | -88.2 | 19958.5 | -964.0 | -87.2 | 1 | BEARISH | 0.0 |
| BBOT BridgeBio Oncology Therapeutics Inc. | $210M | -0.0 | -56.4 | -157.3 | — | — | 1 | BEARISH | -75.2 |
| IVVD Invivyd, Inc. | $180M | -1.6 | -95.9 | -302.5 | -310.8 | 26.3 | 2 | BEARISH | -71.3 |
| SION Sionna Therapeutics, Inc. | $160M | -1.9 | -32.3 | -137.7 | — | — | 0 | BEARISH | -89.5 |
| ONVVF Oneview Healthcare PLC | $130M | -6.4 | -147.3 | -2982.0 | -100.1 | -2.9 | 3 | BEARISH | -6.2 |
| CBUS Cibus, Inc. | $110M | -0.9 | -225.9 | -157.2 | -2227.9 | -10.3 | 2 | BEARISH | -14.6 |
| VYGR Voyager Therapeutics, Inc. | $110M | -1.0 | -54.1 | -131.1 | -773.2 | -19.1 | 2 | BEARISH | -61.8 |
| VXRT Vaxart, Inc. | $100M | 2.7 | 67.0 | 149.6 | -49.6 | 201.1 | 6 | BEARISH | 13.3 |
| FRNM Freenome, Inc. | $100M | — | — | — | — | — | — | BEARISH | — |
| ENGN enGene Holdings Inc. | $100M | -5.6 | -2.3 | 134.1 | — | -100.0 | 2 | BEARISH | -80.2 |
| TNYA Tenaya Therapeutics, Inc. | $90M | -0.8 | -121.9 | 1769.3 | -3909.3 | — | 3 | BEARISH | -75.7 |
| CCLD CareCloud, Inc. | $80M | 25.4 | 21.8 | 15.7 | 3.5 | 15.1 | 4 | BEARISH | -43.1 |
| HBPCF Helix BioPharma Corp. | $60M | -22.5 | -50.8 | -21.5 | — | — | 3 | BEARISH | -55.5 |
| PLRX Pliant Therapeutics, Inc. | $50M | -0.6 | -50.3 | -438.3 | — | — | 3 | BEARISH | -50.6 |
| RPID Rapid Micro Biosystems, Inc. | $40M | -0.7 | -141.6 | -183.2 | -160.5 | 16.1 | 2 | BEARISH | -72.9 |
| XTNT Xtant Medical Holdings, Inc. | $40M | -3.5 | -25.2 | -14.8 | -40.9 | -14.3 | 4 | BEARISH | -67.0 |
| KLRS Kalaris Therapeutics Inc | $40M | -1.0 | -79.9 | 109.5 | — | — | 0 | BEARISH | -58.6 |
| ALGS Aligos Therapeutics, Inc. | $30M | -0.7 | -113.6 | -1246.4 | -5.4 | 893.0 | 2 | BEARISH | -47.1 |
| AIRDF Rocket Doctor AI Inc. | $30M | -1.7 | -6105.0 | -2497.4 | -909.1 | — | 2 | BEARISH | -46.3 |
| DCGO DocGo Inc. | $30M | -0.1 | -92.4 | -73.3 | -21.5 | -32.4 | 3 | BEARISH | -75.5 |
| COSM Cosmos Health Inc. | $30M | -0.4 | -104.0 | -41.2 | -32.1 | 33.8 | 4 | BEARISH | -72.5 |
| RDGL Vivos Inc. | $20M | -5.9 | -132.5 | -427.2 | -2280.7 | 91.5 | 3 | BEARISH | -38.2 |
| BYSI BeyondSpring Inc. | $20M | -3.2 | 20.3 | 15.7 | — | 100.0 | 2 | BEARISH | -70.7 |
| LDDD Longduoduo Company Limited | $20M | -26.6 | 47.5 | -421.7 | -13.8 | -36.8 | 5 | BEARISH | -45.4 |
| NEUP Neuphoria Therapeutics Inc. | $20M | -0.5 | -0.2 | -0.2 | -417.7 | -91.9 | 4 | BEARISH | -25.8 |
| PRRUF Immutep Limited | $20M | -0.5 | -77.3 | 1092.5 | -328.8 | 255.0 | 3 | BEARISH | -89.5 |
| QNRX Quoin Pharmaceuticals, Ltd. | $10M | -0.3 | -578.6 | 221.3 | — | — | 1 | BEARISH | -68.9 |
| ALRTF ALR Technologies Inc. | $10M | -0.4 | 54.2 | 8.3 | -151734.7 | — | 2 | BEARISH | -11.1 |
| MSLE Satellos Bioscience Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| ANEB Anebulo Pharmaceuticals, Inc. | $10M | -1.8 | -69.7 | 650.7 | — | — | 1 | BEARISH | -89.8 |
| JMPHF Leveljump Healthcare Corp. | $10M | -1.5 | -21.1 | 0.7 | -9.7 | 5.4 | 3 | BEARISH | 677.3 |
| TCRX TScan Therapeutics, Inc. | $10M | -0.2 | -95.8 | -159.4 | -2888.6 | 2.2 | 2 | BEARISH | -91.3 |
| FBLG FibroBiologics, Inc. Common Stock | $10M | -0.2 | -660.1 | -511.6 | — | — | 4 | BEARISH | -88.8 |
| CDIO Cardio Diagnostics Holdings, Inc. | $10M | -0.6 | -75.4 | -230.9 | -28012.5 | -25.9 | 3 | BEARISH | -56.5 |
| APRE Aprea Therapeutics, Inc. | $10M | -0.5 | -47.4 | 378.1 | — | -99.8 | 2 | BEARISH | -59.7 |
| BCDA BioCardia, Inc. | $10M | -1.2 | -1803.2 | 519.4 | — | — | 3 | BEARISH | -27.5 |
| ACON Aclarion, Inc. | $10M | -0.3 | -59.0 | -1069.5 | -10899.5 | 33.1 | 3 | BEARISH | -73.7 |
| VYND Vynleads, Inc. | $10M | -27.0 | 74.2 | 89.5 | — | — | 4 | BEARISH | 62.6 |
| AIXN AiXin Life International, Inc. | $10M | -4.9 | 37.6 | 39.5 | -191.9 | -61.1 | 4 | BEARISH | 42.9 |
| HCWB HCW Biologics Inc. | — | -0.0 | -133.5 | -36.8 | -3849.9 | 707.0 | 3 | BEARISH | -94.7 |
| RSHN RushNet, Inc. | — | -1.0 | -1202.9 | -22.5 | — | -43.0 | 2 | BEARISH | -98.0 |
| WLSS Welsis Corp. | — | -51.7 | 6.2 | 3.3 | — | — | 1 | BEARISH | -82.9 |
| TSTTF TripSitter Clinic Ltd. | — | -19.2 | -0.1 | 30.7 | — | 100.0 | 4 | BEARISH | -56.2 |
| LUDG Ludwig Enterprises, Inc. | — | -0.4 | 43.5 | 103.5 | — | 100.0 | 4 | BEARISH | -93.9 |
| USRM U.S. Stem Cell, Inc. | — | -0.0 | 20.8 | 23.4 | -2836.8 | -59.1 | 5 | BEARISH | -99.0 |
| AYURF Ayurcann Holdings Corp. | — | -0.5 | 315.5 | 53.8 | -13.0 | 47.1 | 4 | BEARISH | -98.8 |
| ARNI Arno Therapeutics, Inc. | — | -0.0 | 250.7 | 111.6 | — | — | 3 | BEARISH | 0.0 |
| CHALF Chalice Brands Ltd | — | -0.0 | -51.3 | -9.0 | 9.4 | 36.2 | 5 | BEARISH | -90.0 |
| ENZC Enzolytics Inc. | — | -14.9 | 105.9 | 1.4 | — | — | 7 | BEARISH | 0.0 |
| EVFM Evofem Biosciences, Inc. | — | -0.1 | 20.1 | 26.0 | -419.1 | 4.5 | 2 | BEARISH | -45.6 |
| BBLG Bone Biologics Corporation | — | -0.2 | -47.5 | 1744.6 | — | — | 2 | BEARISH | -81.8 |
| RSLT Resilient Healthcare Corp | — | — | — | — | — | — | — | BEARISH | — |
| MBIO Mustang Bio, Inc. | — | -0.8 | -58.1 | 36.6 | — | — | 2 | BEARISH | -76.4 |
| LIMN Liminatus Pharma, Inc. Class A Common Stock | — | -0.1 | 294.4 | 252.1 | — | — | 4 | BEARISH | -95.4 |
| BIOAF Bioasis Technologies Inc. | — | -0.1 | 135.1 | 538.8 | -661.8 | 614.1 | 2 | BEARISH | -50.0 |
| NCEL NewcelX Ltd. | — | 8.2 | -48.0 | -39.1 | — | — | 2 | BEARISH | -79.0 |
| SEPSF Asep Medical Holdings Inc | — | -0.3 | -36.4 | -75.5 | -844.8 | 208.8 | 5 | BEARISH | -97.2 |
| IPAH Interpharm Holdings, Inc. | — | -0.0 | -342.5 | -47.0 | -67.2 | -5.1 | 1 | BEARISH | -99.8 |
| ENLV Enlivex Therapeutics Ltd. | — | 0.0 | 209.7 | -0.4 | — | — | 5 | BEARISH | -99.0 |
| ICCM IceCure Medical Ltd | — | -0.1 | -228.3 | 36140.9 | -496.3 | 41.6 | 7 | BEARISH | -95.9 |
| MDXL Medixall Group, Inc. | — | -0.1 | 48.8 | 48.2 | 678.9 | 29.4 | 6 | BEARISH | 3200.0 |
| ENDV Endonovo Therapeutics, Inc. | — | -0.1 | 9.2 | 4.5 | — | -100.0 | 3 | BEARISH | -50.0 |
| ARUXF Acrux Limited | — | -7.1 | -48.5 | -74.2 | -26.5 | 289.9 | 7 | BEARISH | -90.0 |
| MYNDF MYND Life Sciences Inc. | — | -2.2 | 9.5 | 34.0 | — | — | 5 | BEARISH | -41.3 |
| INBX Inhibrx Biosciences Inc. | $1.4B | -8.3 | -1773.6 | 55.8 | — | -100.0 | 4 | BEARISH | 24.5 |
| IRMD IRadimed Corporation | $1.1B | 46.1 | 23.5 | 50.1 | 25.5 | 11.2 | 6 | BEARISH | 8.8 |
| UTMD Utah Medical Products, Inc. | $240M | 20.6 | 8.8 | 22.4 | 32.3 | -9.6 | 6 | BEARISH | 16.9 |
| AAWH Ascend Wellness Holdings, Inc. | $80M | -0.7 | 388.6 | 3.1 | -7.8 | -8.4 | 3 | BEARISH | -51.8 |
| INCR InterCure Ltd. | $50M | -3.9 | -15.9 | -10.2 | -1.3 | -10.8 | 2 | BEARISH | -42.6 |
| NEPH Nephros, Inc. | $40M | 19.7 | 16.1 | 20.0 | 19.9 | 24.2 | 5 | BEARISH | -41.5 |
| LEEEF Leef Brands Inc. | $30M | -1.6 | 222.4 | -39.5 | -17.9 | 8.4 | 5 | BEARISH | -27.6 |
| ASAPF Aurora Spine Corporation | $10M | -5.6 | -35.3 | -14.8 | -22.8 | -4.5 | 5 | BEARISH | -63.9 |
| SKYE Skye Bioscience, Inc. | $10M | -0.1 | -233.9 | 389.5 | — | — | 3 | BEARISH | -3.1 |
| PTIX Protagenic Therapeutics, Inc. | — | 0.2 | -485.4 | -367.8 | — | 100.0 | 6 | BEARISH | -78.7 |
| EMMA Emmaus Life Sciences, Inc. | — | -0.4 | 9.9 | -9.3 | 21.2 | 11.0 | 4 | BEARISH | 299.0 |
| PHRRF PharmaTher Holdings Ltd. | — | -8.3 | -76.9 | 234.4 | — | — | 2 | BEARISH | -54.3 |
| ESVNF Apptly Health Technologies Corp. | — | -1.5 | -22.3 | -40.4 | — | — | 2 | BEARISH | -33.8 |
| TOMDF Todos Medical Ltd. | — | -0.0 | 89.6 | -253.6 | -355.9 | -37.1 | 3 | BEARISH | -90.0 |
| LIMNW Liminatus Pharma, Inc. Warrants | — | -0.1 | -4165.9 | 252.1 | — | — | 2 | BEARISH | -75.0 |
| UPC Universe Pharmaceuticals Inc. | — | -0.6 | -3.5 | -4.6 | -17.2 | -8.0 | 2 | BEARISH | -60.8 |
| JUVAF Juva Life Inc. | — | -0.0 | -105.0 | -21.4 | -24.6 | 43.5 | 4 | BEARISH | -90.0 |
| URGN UroGen Pharma Ltd. | $1.7B | -17.0 | 86.5 | 119.0 | -19.8 | 169.5 | 2 | BEARISH | 61.9 |
| ELEAF EL.En. S.p.A. | $1.4B | 14.0 | 13.2 | 29.1 | 6.0 | 25.8 | 8 | BEARISH | 37.9 |
| MDCLF MedinCell S.A. | $1.1B | -29.2 | 472.2 | 81.6 | -152.1 | -14.8 | 3 | BEARISH | 333.5 |
| INMD InMode Ltd. | $800M | 10.7 | 12.3 | 44.5 | 17.9 | -6.7 | 5 | BEARISH | -14.6 |
| ANL Adlai Nortye Ltd. | $560M | -5.2 | -22.4 | -317.5 | -36.3 | 223.4 | 4 | BEARISH | 575.5 |
| GNFTF Genfit S.A. | $470M | -5.6 | -5084.0 | -322.7 | -124.0 | 27.5 | 3 | BEARISH | 153.5 |
| VREOF Vireo Growth Inc. | $310M | -3.9 | -4.6 | -0.7 | -0.0 | — | 3 | BEARISH | — |
| ARTV Artiva Biotherapeutics, Inc. | $300M | -1.3 | -36.6 | -954.6 | — | — | 3 | BEARISH | -15.1 |
| VMTHF Venus Medtech (Hangzhou) Inc. | $180M | -0.8 | -25.6 | -18.2 | -141.2 | -40.7 | 4 | BEARISH | -57.5 |
| TRGNF Transgene S.A. | $120M | -4.4 | -64.1 | -184.9 | -5760.7 | -185.8 | 4 | BEARISH | -53.1 |
| GRUSF Grown Rogue International Inc. | $90M | -22.3 | -11.6 | -18.8 | -29.5 | 22.9 | 6 | BEARISH | -7.8 |
| PRNAF Alterity Therapeutics Limited | $50M | -2.3 | -55.0 | -401.1 | — | -100.0 | 2 | BEARISH | 8233.3 |
| VRHI Veri Medtech Holdings Inc. | $40M | — | — | — | — | — | — | BEARISH | — |
| CLIFF Cordlife Group Limited | $30M | -2.9 | -9.9 | -15.8 | -11.3 | 11.3 | 5 | BEARISH | 2.6 |
| ABDXF Abingdon Health Plc | $30M | -16.4 | -36.9 | -48.9 | 3.9 | 28.3 | 4 | BEARISH | 83.0 |
| TVGN Tevogen Bio Holdings Inc. | $30M | -1.1 | 235.3 | 244.1 | — | — | 5 | BEARISH | 860.5 |
| BMNDF Biomind Labs Inc. | $20M | -13.3 | 85.8 | 101.7 | — | — | 2 | BEARISH | 1483.5 |
| PCYN Procyon Corporation | — | 78.3 | -13.9 | -10.8 | 2.7 | 6.4 | 3 | BEARISH | 48.8 |
| RMTG Regenerative Medical Technology Group Inc. | — | -0.0 | 9.6 | -3.3 | -72.2 | — | 3 | BEARISH | — |
| ADDLF AddLife AB (publ) | $1.9B | 34.7 | 11.3 | 7.0 | 4.9 | 1.1 | 4 | BEARISH | -62.5 |
| GENSF Genus plc | $1.8B | 5.4 | 45.4 | 9.0 | 80.4 | -3.8 | 5 | BEARISH | -19.4 |
| VIMGF Vimian Group AB (publ) | $1.5B | 49.1 | 5.4 | 6.4 | 7.4 | 8.9 | 7 | BEARISH | -8.0 |
| SHPHF Sihuan Pharmaceutical Holdings Group Ltd. | $1.1B | 18.4 | 5.7 | 8.4 | 19.4 | 24.4 | 6 | BEARISH | 20.0 |
| CHIZF China Traditional Chinese Medicine Holdings Co. Limited | $820M | -4.9 | -4.9 | 0.0 | -14.3 | 5.6 | 6 | BEARISH | -40.3 |
| TGRNF Tong Ren Tang Technologies Co. Ltd. | $660M | 10.6 | 4.1 | 12.2 | 8.2 | -18.2 | 6 | BEARISH | -43.0 |
| CRWRF Craneware plc | $620M | 25.8 | 6.0 | 6.8 | 9.7 | 4.2 | 7 | BEARISH | -43.9 |
| EVOTF Evotec SE | $590M | -2.7 | -26.1 | -14.9 | -32.5 | -7.7 | 2 | BEARISH | -54.3 |
| KSRBF Kossan Rubber Industries Bhd | $480M | 17.0 | 5.0 | 8.5 | 11.3 | 1.0 | 5 | BEARISH | -43.2 |
| AGMB AgomAb Therapeutics N.V. American Depositary Shares | $450M | — | — | — | — | — | — | BEARISH | — |
| AVCTF Avacta Group Plc | $420M | -6.7 | -2083.2 | -753.6 | -33970.3 | -99.7 | 5 | BEARISH | -18.7 |
| ALT Altimmune, Inc. | $410M | -2.7 | -28.9 | -43.1 | — | 55.0 | 4 | BEARISH | -47.0 |
| CYH Community Health Systems, Inc. | $410M | -0.7 | 19.9 | -79.1 | 1.7 | 77.2 | 5 | BEARISH | -39.7 |
| AVTX Avalo Therapeutics, Inc. | $370M | -1.5 | -36.3 | -148.4 | — | -86.6 | 4 | BEARISH | -60.4 |
| CAPR Capricor Therapeutics, Inc. | $340M | -2.5 | -73.7 | -107.5 | — | -100.0 | 3 | BEARISH | 0.8 |
| TLRY Tilray Brands, Inc. | $310M | -1.9 | -8.8 | -3.4 | -16.8 | -16.9 | 3 | BEARISH | -81.7 |
| CGC Canopy Growth Corporation | $290M | -1.4 | -40.1 | -11.7 | -18.0 | 6.8 | 4 | BEARISH | -49.1 |
| SPHDF Santhera Pharmaceuticals Holding AG | $280M | -6.6 | 729.6 | 111.3 | -44.5 | 106.3 | 7 | BEARISH | 49.1 |
| ORYZF Oryzon Genomics S.A. | $250M | -79.9 | -3.0 | -7.2 | -1.6 | 12.6 | 4 | BEARISH | -14.1 |
| OCGN Ocugen, Inc. | $250M | -3.1 | 1211.7 | 190.2 | -1671.8 | -3.7 | 2 | BEARISH | -50.2 |
| SCTX Scribe Therapeutics Inc. | $250M | — | — | — | — | — | — | BEARISH | — |
| HLOSF Healios K.K. | $240M | 57.1 | 3.7 | -129.2 | 17028.6 | -47.1 | 4 | BEARISH | -48.6 |
| LAB Standard BioTools Inc. | $240M | -2.7 | -18.1 | -69.4 | -133.1 | -45.2 | 5 | BEARISH | -53.3 |
| IPHYF Innate Pharma S.A. | $210M | -2.5 | 267.9 | 125.3 | -343.8 | 32.0 | 3 | BEARISH | -24.5 |
| GLAS Glass House Brands Inc | $190M | — | — | — | — | — | — | BEARISH | — |
| CATX Perspective Therapeutics, Inc. | $180M | -0.8 | -39.5 | -108.8 | -33069.1 | -35.3 | 3 | BEARISH | -59.7 |
| NBP NovaBridge Biosciences | $160M | -2.2 | -45.7 | -617.8 | — | — | 1 | BEARISH | -73.2 |
| ZNTL Zentalis Pharmaceuticals, Inc. | $160M | -0.8 | -83.7 | -2245.4 | — | -100.0 | 2 | BEARISH | 19.8 |
| PHCUF Photocure ASA | $150M | 16.0 | 14.5 | 37.4 | -0.5 | 29.5 | 5 | BEARISH | 1.2 |
| STRO Sutro Biopharma, Inc. | $150M | -0.5 | 266.8 | 43.6 | -391.6 | -56.3 | 4 | BEARISH | -19.9 |
| NGEN NervGen Pharma Corp. Common stock | $150M | — | — | — | — | — | — | BEARISH | — |
| CMPX Compass Therapeutics, Inc. | $140M | -1.8 | -56.7 | 1526.3 | — | — | 4 | BEARISH | -81.2 |
| CDXS Codexis, Inc. | $140M | -3.8 | -69.4 | -37.8 | -80.5 | 35.9 | 3 | BEARISH | -51.5 |
| DERM Journey Medical Corporation | $140M | -22.7 | -23.8 | -7.4 | -1.7 | 20.9 | 5 | BEARISH | -36.2 |
| NKTX Nkarta, Inc. | $130M | -1.1 | -38.8 | -75.4 | — | — | 1 | BEARISH | -18.1 |
| OWLT Owlet, Inc. | $120M | -9.7 | 180.6 | -50.5 | -1.8 | 28.0 | 6 | BEARISH | -55.0 |
| AVXL Anavex Life Sciences Corp. | $120M | -5.0 | -23.6 | 411.7 | — | — | 2 | BEARISH | -84.7 |
| VTVT vTv Therapeutics Inc. | $100M | -233.8 | -11.7 | 91.2 | — | 216600.0 | 4 | BEARISH | 21.4 |
| VANI Vivani Medical, Inc. | $100M | -3.3 | -220.4 | -127.1 | — | — | 4 | BEARISH | -29.6 |
| ORPOF OSE Immunotherapeutics S.A. | $100M | — | — | — | — | — | — | BEARISH | — |
| TNXP Tonix Pharmaceuticals Holding Corp. | $90M | -0.4 | -81.8 | -276.2 | -299.4 | 196.0 | 3 | BEARISH | -73.6 |
| RVRC Revium Recovery Inc. | $90M | -6.4 | -0.0 | 0.0 | — | — | 2 | BEARISH | 175.0 |
| CNXU Conexeu Sciences Inc. | $90M | — | — | — | — | — | — | BEARISH | — |
| ABSCF AB Science S.A. | $80M | -6.7 | 21.5 | 34.7 | -1813.1 | 12.3 | 5 | BEARISH | -11.1 |
| NYXH Nyxoah S.A. | $80M | -0.4 | -125.8 | -181.3 | -429.5 | 359.2 | 2 | BEARISH | -83.0 |
| JWCTF JW (Cayman) Therapeutics Co. Ltd | $80M | -2.4 | -49.0 | -68.1 | -45.3 | 60.7 | 3 | BEARISH | -55.3 |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | $80M | -0.7 | -95.6 | 738.2 | — | — | 1 | BEARISH | -75.0 |
| THOXF BioPorto A/S | $70M | 77.4 | 12.3 | 43.6 | 520.6 | 3.4 | 4 | BEARISH | -48.3 |
| CRDF Cardiff Oncology, Inc. | $70M | -1.5 | -94.1 | 443.4 | -8876.9 | -7.0 | 3 | BEARISH | -60.8 |
| PTHS Pelthos Therapeutics Inc. | $70M | -0.4 | 4767.3 | -97.0 | -150.1 | — | 2 | BEARISH | -49.1 |
| CGTX Cognition Therapeutics, Inc. | $70M | -3.9 | -83.8 | 6061.8 | — | — | 3 | BEARISH | -55.4 |
| XBIT XBiotech Inc. | $60M | -1.3 | -29.9 | -201.2 | — | — | 2 | BEARISH | -22.6 |
| TLSA Tiziana Life Sciences Ltd | $60M | -4.6 | -780.6 | 375.0 | — | — | 1 | BEARISH | -49.7 |
| LDXHF Lumos Diagnostics Holdings Limited | $60M | -6.0 | -34.8 | -85.3 | -1.0 | 6.4 | 5 | BEARISH | -75.0 |
| SRTS Sensus Healthcare, Inc. | $50M | -3.0 | -34.8 | -47.6 | -382.1 | -53.4 | 3 | BEARISH | -13.5 |
| VTIAF FamiCord AG | $50M | -6.4 | -84.3 | -13.6 | -5.1 | 0.1 | 5 | BEARISH | -55.7 |
| HYFT MindWalk Holdings Corp. | $50M | -4.5 | -123.5 | -481.3 | -158.7 | -15.9 | 4 | BEARISH | -31.8 |
| MYCOF Noveris Health Sciences Inc. | $50M | -6.6 | 22.3 | 49.3 | — | — | 5 | BEARISH | 209.1 |
| DXR Daxor Corporation | $50M | 7.3 | 14.2 | 13.5 | -14382.9 | -78.3 | 3 | BEARISH | -21.7 |
| EXOZ eXoZymes, Inc. | $40M | -3.5 | -187.2 | 913.0 | — | — | 2 | BEARISH | -65.9 |
| IDXG Interpace Biosciences, Inc. | $40M | 0.2 | 221.9 | 123.7 | 1.7 | -20.3 | 6 | BEARISH | 5.5 |
| ACET Adicet Bio, Inc. | $40M | -0.3 | -78.1 | -553.5 | — | — | 4 | BEARISH | -73.6 |
| RANI Rani Therapeutics Holdings, Inc. | $40M | -2.3 | -179.1 | 245.5 | -432.7 | 306.4 | 5 | BEARISH | -65.4 |
| SNZZF Senzime AB (publ) | $40M | -4.0 | -35.1 | -36.2 | -86.6 | 27.1 | 3 | BEARISH | -63.8 |
| ALDX Aldeyra The | $40M | -1.8 | -49.5 | 269.3 | — | — | 4 | BEARISH | -86.9 |
| IXHL Incannex Healthcare Limited | $30M | -2.4 | -31.9 | 5284.2 | — | -100.0 | 4 | BEARISH | -74.2 |
| BIOQ Bioqual, Inc. | $30M | -6.3 | -2.8 | -4.3 | -0.8 | -16.6 | 3 | BEARISH | -22.5 |
| MIRA MIRA Pharmaceuticals, Inc. | $30M | -0.4 | -710.9 | -15187.8 | — | — | 3 | BEARISH | -66.7 |
| TDMMF Mach7 Technologies Limited | $30M | -6.8 | -22.3 | -41.4 | -22.3 | -17.5 | 3 | BEARISH | -72.0 |
| PLNH Planet 13 Holdings Inc. | $30M | -0.4 | -90.5 | -50.0 | -24.4 | -21.2 | 2 | BEARISH | -61.5 |
| AARD Aardvark Therapeutics, Inc. Common Stock | $30M | -0.5 | -66.0 | -3642.4 | — | — | 1 | BEARISH | -87.1 |
| BCTX BriaCell Therapeutics Corp. | $30M | -0.3 | -179.9 | -2435.2 | — | — | 2 | BEARISH | -73.9 |
| FLNA Filana Therapeutics, Inc. | $30M | -0.7 | -13.5 | 38.9 | — | — | 2 | BEARISH | — |
| MGX Metagenomi, Inc. Common Stock | $30M | -0.3 | -60.6 | -268.2 | 10693.4 | -59.8 | 1 | BEARISH | -70.0 |
| ITOC iTonic Holdings Ltd. | $20M | — | — | — | — | — | — | BEARISH | — |
| KYNB Kyntra Bio, Inc. | $20M | 0.1 | -115.2 | 29.6 | -812.3 | — | 2 | BEARISH | — |
| MVMDF More Life Company Corp. | $20M | -5.2 | -167.0 | -602.2 | -5006.5 | 43.0 | 4 | BEARISH | 115.8 |
| ACH Accendra Health, Inc. | $20M | -0.1 | -1.1 | 4.3 | -14.5 | -99.1 | 3 | BEARISH | -97.6 |
| ARAY Accuray Incorporated | $20M | -0.3 | -80.1 | -11.3 | -1.9 | -12.3 | 2 | BEARISH | -91.5 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $20M | -1.2 | -234.4 | -475.2 | -504.1 | 36.6 | 3 | BEARISH | -39.9 |
| TELIF Telescope Innovations Corp. | $20M | 5.5 | -229.2 | -80.7 | -116.8 | 66.3 | 2 | BEARISH | -19.4 |
| MCRB Seres Therapeutics, Inc. | $20M | -0.8 | -66.6 | -87.8 | 622.4 | — | 3 | BEARISH | -89.6 |
| YI 111, Inc. | $20M | -1.7 | 30.0 | 15.9 | -1.7 | -20.9 | 2 | BEARISH | -33.7 |
| MRMD MariMed Inc. | $20M | -1.4 | -28.4 | -0.9 | -8.6 | 4.2 | 4 | BEARISH | -62.1 |
| ATYR aTyr Pharma, Inc. | $20M | -0.2 | -98.4 | -1890.1 | — | — | 2 | BEARISH | -86.8 |
| MDXH MDxHealth S.A. | $20M | -0.3 | 193.7 | -23.4 | -42.4 | -19.1 | 2 | BEARISH | -96.0 |
| PAVM PAVmed Inc. | $20M | -0.1 | -31.9 | -43.6 | -16315.2 | -89.0 | 3 | BEARISH | 400.1 |
| SCLX Scilex Holding Company | $20M | -0.0 | 160.5 | 105.7 | -1485.2 | -28.5 | 3 | BEARISH | -89.0 |
| RVP Retractable Technologies, Inc. | $20M | -4.8 | -4.5 | -53.2 | 39.3 | -11.2 | 4 | BEARISH | -36.9 |
| TRAW Traws Pharma, Inc. | $10M | -0.7 | -711.4 | 133.9 | — | -100.0 | 1 | BEARISH | -86.2 |
| IMMVF Immunovia AB | $10M | -0.4 | -425.5 | 808.2 | -5991.9 | 31.4 | 3 | BEARISH | -80.8 |
| TOVX Theriva Biologics, Inc. | $10M | -0.3 | -101.9 | -213.5 | — | — | 2 | BEARISH | -42.0 |
| PTN Palatin Technologies, Inc. | $10M | -1.0 | -877.5 | 1176.9 | -1449.1 | — | 5 | BEARISH | -12.7 |
| GUTS Fractyl Health, Inc. | $10M | -0.1 | 1063.0 | -568.7 | — | -100.0 | 5 | BEARISH | -94.3 |
| VTGN VistaGen Therapeutics, Inc. | $10M | -0.1 | -166.5 | 851.1 | -882.8 | 287.3 | 4 | BEARISH | -95.6 |
| OPTBF OptiBiotix Health Plc | $10M | -1.4 | -102.1 | -102.1 | -231.5 | -12.9 | 4 | BEARISH | 109900.0 |
| IZOZF Izotropic Corporation | $10M | -4.3 | 40.2 | 39.2 | — | — | 3 | BEARISH | -70.5 |
| TPST Tempest Therapeutics, Inc. | $10M | -0.1 | -931.1 | -564.2 | — | — | 1 | BEARISH | -95.1 |
| INAB IN8bio, Inc. | $10M | -0.5 | -111.1 | -576.1 | — | — | 4 | BEARISH | -53.3 |
| FEMY Femasys Inc. | $10M | -0.3 | -443.7 | -188.1 | -1346.8 | 21.9 | 5 | BEARISH | -90.1 |
| QNTM Quantum BioPharma Ltd. | $10M | -0.4 | -425.3 | 175.1 | — | — | 4 | BEARISH | -82.3 |
| PDRX PD-Rx Pharmaceuticals, Inc. | $10M | — | — | — | — | — | — | BEARISH | 6.9 |
| IMNN Imunon, Inc. | $10M | -0.2 | -429.7 | -226.7 | — | — | 2 | BEARISH | -82.4 |
| RGNT Regentis Biomaterials Ltd. | $10M | — | — | — | — | — | — | BEARISH | — |
| MGRX Mangoceuticals, Inc. | $10M | -0.2 | -95.1 | -82.6 | -1909.1 | -38.9 | 4 | BEARISH | -87.7 |
| GTBP GT Biopharma, Inc. | $10M | -0.1 | -798.9 | 927.8 | — | — | 2 | BEARISH | -68.3 |
| BNR Burning Rock Biotech Limited | $10M | -1.3 | -12.8 | -41.7 | -13.7 | -6.6 | 2 | BEARISH | 4.8 |
| MDXHF Medx Health Corp. | $10M | — | 63.5 | 166.6 | -1353.4 | 19.2 | 3 | BEARISH | 150.0 |
| TVRD Tvardi Therapeutics, Inc. | $10M | -0.3 | -126.2 | 296.9 | — | — | 1 | BEARISH | -81.8 |
| VRCDF Verici Dx plc | $10M | -0.6 | -192.7 | -151.0 | -227.8 | 84.7 | 3 | BEARISH | -60.5 |
| PXXLF Poxel S.A. | $10M | -0.4 | 34.8 | 129.6 | -624.6 | 41.5 | 4 | BEARISH | -12.0 |
| DARE Dare Bioscience, Inc. | $10M | -0.9 | 165.3 | 136.8 | -1590.4 | 7816.7 | 3 | BEARISH | -66.5 |
| HIND Vyome Holdings, Inc. | $10M | -0.1 | -193.1 | 516.3 | -2543.3 | -98.0 | 4 | BEARISH | -68.8 |
| GSGTF GenSight Biologics S.A. | $10M | -1.0 | 46.5 | 47.3 | 1190.6 | -401.7 | 3 | BEARISH | -57.9 |
| AREVF AREV Life Sciences Global Corp | — | -1.9 | 23.9 | 15.1 | — | -96.1 | 2 | BEARISH | -95.0 |
| OGEN Oragenics, Inc. | — | -0.1 | -1307.1 | 4273.7 | — | — | 3 | BEARISH | -71.9 |
| RPGLF Regent Pacific Group Limited | — | -16.2 | 38.3 | 5.9 | 10.3 | 491.5 | 6 | BEARISH | -94.1 |
| ISHI Islet Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| KALY Kali, Inc. | — | -8.6 | 32.3 | 47.0 | 20.9 | 28.1 | 4 | BEARISH | -98.0 |
| GSTC GlobeStar Therapeutics Corporation | — | -0.0 | 60.9 | 49.1 | — | — | 4 | BEARISH | -99.0 |
| PMSNF Proteome Sciences plc | — | -1.9 | 25.2 | -36.8 | -74.6 | -16.5 | 4 | BEARISH | -66.7 |
| STMH Stem Holdings, Inc. | — | -0.0 | -274.8 | 873.4 | 98.5 | -100.0 | 3 | BEARISH | 900.0 |
| USMJ North American Cannabis Holdings, Inc. | — | -3.5 | 40.1 | 1.5 | — | 14.2 | 2 | BEARISH | 0.0 |
| CBDX Curative Biosciences, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| AJOY Ayujoy Herbals Ltd. | — | -1.0 | -54.8 | 142.7 | — | -100.0 | 3 | BEARISH | -53.7 |
| GENX Genex Pharmaceutical, Inc. | — | 0.0 | 7.8 | 5.1 | -8.1 | 32.8 | 5 | BEARISH | 0.0 |
| NUNZ Nunzia Pharmaceutical Company | — | -0.0 | 69398.6 | 176728.6 | — | — | 2 | BEARISH | 0.0 |
| OVATF Ovation Science Inc. | — | -1.7 | 44.0 | 34.6 | -690.6 | -27.1 | 3 | BEARISH | -74.6 |
| SUVZ Suvanza Pharma, LLC | — | — | — | — | — | — | — | BEARISH | 0.0 |
| LABT Lakewood-Amedex Biotherapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| OJSY OJsys, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| RADX Radiopharm Theranostics Limited | — | — | — | — | — | — | — | BEARISH | -82.0 |
| EDNEF Eden Empire Inc. | — | — | 64.3 | -88.8 | -1382.1 | — | 2 | BEARISH | -90.9 |
| AMIX Autonomix Medical, Inc. | — | -0.0 | -316.0 | 4343.4 | — | — | 2 | BEARISH | -90.9 |
| MBAI MBody AI Ltd. | — | — | — | — | — | — | — | BEARISH | — |
| MRDH Meridian Holdings, Inc. | — | -0.6 | 29.2 | -2410.8 | — | -100.0 | 1 | BEARISH | -21.3 |
| EFTR eFFECTOR Therapeutics, Inc. | — | -0.0 | 1737.6 | 607.9 | — | -91.9 | 4 | BEARISH | 0.0 |
| AVCRF Avricore Health Inc. | — | -2.8 | -131.4 | -548.9 | -354.9 | -93.8 | 2 | BEARISH | -97.6 |
| SMAS Somatic Systems, Inc. | — | — | — | — | — | — | — | BEARISH | -99.0 |
| AXRX Amexdrug Corporation | — | — | — | — | — | — | — | BEARISH | 0.0 |
| GRST Ethema Health Corporation | — | -1.0 | 18.3 | 0.0 | 1.2 | 171.7 | 6 | BEARISH | -99.0 |
| ACUS Acusphere, Inc. | — | -0.0 | -363.3 | -4565.0 | -3033.3 | -5.2 | 2 | BEARISH | 0.0 |
| HRTT Heart Tronics, Inc. | — | -0.0 | -1320.1 | -1322.8 | — | — | 1 | BEARISH | 0.0 |
| PPRG Patient Portal Technologies, Inc. | — | -0.0 | -4.5 | -0.3 | -3.5 | -23.2 | 2 | BEARISH | 0.0 |
| WOWU WOWI, Inc. | — | 0.0 | 51.5 | 49.7 | -38.1 | — | 4 | BEARISH | -50.0 |
| OMID OMID Holdings, Inc. | — | 25.2 | -127.5 | -314.5 | 40.6 | 57.1 | 5 | BEARISH | -61.1 |
| BUDZ WEED, Inc. | — | -1.6 | 176.9 | 220.9 | — | -100.0 | 1 | BEARISH | -66.8 |
| DCOY Decoy Therapeutics Inc. | — | — | — | — | — | — | — | BEARISH | — |
| PPII Coenzyme-A Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| NGMDF NuGen Medical Devices Inc. | — | -0.3 | 81.2 | -448.2 | -19565.6 | -86.3 | 2 | BEARISH | -70.9 |
| XTXXF Adastra Holdings Ltd. | — | -0.7 | -227.3 | -93.3 | -9.6 | -33.9 | 2 | BEARISH | -98.6 |
| RASP Actavia Life Sciences, Inc. | — | -0.1 | 20.1 | 14.5 | — | — | 2 | BEARISH | -87.5 |
| MCOA Marijuana Company of America, Inc. | — | -0.1 | 295.5 | 51.6 | — | -72.4 | 1 | BEARISH | 0.0 |
| CLDI Calidi Biotherapeutics, Inc. | — | -0.0 | -713.6 | -1404.6 | — | — | 4 | BEARISH | -97.2 |
| GNPX Genprex, Inc. | — | -0.0 | -203.9 | 3484.8 | — | — | 4 | BEARISH | -99.0 |
| BZYR Burzynski Research Institute, Inc. | — | -0.0 | 2902.9 | 1462.7 | — | — | 4 | BEARISH | -99.4 |
| KALA KALA BIO, Inc. | — | -0.0 | -345.3 | -913.5 | — | -100.0 | 4 | BEARISH | -99.5 |
| TSOI Therapeutic Solutions International, Inc. | — | -0.1 | -187.6 | -130.3 | -5123.0 | -99.7 | 4 | BEARISH | 0.0 |
| WSNAF Wesana Health Holdings Inc. | — | -0.1 | 1113.6 | 90.8 | — | — | 3 | BEARISH | -80.1 |
| HSMD Healthcare Solutions Management Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CYDX CYduct Diagnostics, Inc. | — | -11.1 | 15.8 | 13.7 | -394.2 | -16.3 | 3 | BEARISH | 148.6 |
| IBXXF Imagion Biosystems Limited | — | -0.4 | 127.1 | 360.0 | -376.2 | -50.2 | 3 | BEARISH | -86.7 |
| NLVVF New Leaf Ventures Inc | — | -0.2 | -2466.1 | -179.6 | -152.9 | -39.2 | 1 | BEARISH | -99.0 |
| ETAOF Etao International Co., Ltd. | — | -0.0 | -1369.5 | 4843.5 | -1544.0 | — | 5 | BEARISH | -66.7 |
| OVIT OncoVista Innovative Therapies, Inc. | — | -0.0 | 61.2 | 43.6 | — | — | 1 | BEARISH | 0.0 |
| NEUN Neurogenesis, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| GRPI Grupo International Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CEROW CERo Therapeutics Holdings, Inc. | — | -0.0 | 101.5 | 60.5 | — | -100.0 | 1 | BEARISH | -84.2 |
| KAYS Kaya Holdings, Inc. | — | -0.0 | 141.1 | -11929.1 | -158865.8 | -102.0 | 3 | BEARISH | -97.1 |
| NBRVF Nabriva Therapeutics plc | — | — | — | — | — | — | — | BEARISH | -0.0 |
| SZLSF StageZero Life Sciences Ltd. | — | -0.0 | 23.1 | 18.6 | -79.9 | -29.3 | 2 | BEARISH | -80.4 |
| BNIGF Beroni Group Limited | — | -0.1 | -1153.4 | -274.8 | -15945.7 | 40.9 | 5 | BEARISH | 0.0 |
| PNDHF Pond Technologies Holdings Inc. | — | -0.4 | 43.2 | 90.7 | -114.9 | -47.3 | 2 | BEARISH | -27.3 |
| SLXN Silexion Therapeutics Ltd. | — | -0.0 | -17022.0 | -931.4 | — | — | 3 | BEARISH | -95.6 |
| AMHD HLK Biotech Holding Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| UNVC Univec, Inc. | — | -3.3 | 6.9 | 5.9 | -1481.4 | 78.3 | 4 | BEARISH | -52.9 |
| ISPC iSpecimen Inc. | — | -0.0 | -968.5 | 305.3 | -896.9 | -92.1 | 4 | BEARISH | -97.4 |
| IONKF Ionic Brands Corp. | — | -0.0 | -395.1 | -29.9 | -53.6 | 179.4 | 4 | BEARISH | 0.0 |
| AQQRF Aquarius Surgical Technologies Inc. | — | -0.3 | 26.1 | -39.2 | -855.7 | 8.7 | 4 | BEARISH | 0.0 |
| JNHMF Jack Nathan Medical Corp. | — | -0.7 | -152.9 | 25.0 | -471.3 | -108.0 | 4 | BEARISH | -75.0 |
| AIDX 20/20 Biolabs Inc. | — | — | — | — | — | — | — | BEARISH | — |
| ZVSA ZyVersa Therapeutics, Inc. | — | -0.0 | 817.1 | 242.0 | — | -100.0 | 1 | BEARISH | -99.3 |
| QMDT Quick-Med Technologies, Inc. | — | -0.0 | 8.3 | 3.4 | -78.6 | -6.9 | 5 | BEARISH | 400.0 |
| UPDC UPD Holding Corp. | — | -0.0 | 198.3 | 1243.8 | -858.8 | — | 2 | BEARISH | 0.0 |
| MBGNF Many Bright Ideas Technologies Inc. | — | -2.2 | 20.4 | 126.7 | — | — | 2 | BEARISH | 0.0 |
| NIKI Niki BioSolutions, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| BIXT Bioxytran, Inc. | — | -0.7 | 92.2 | 68.7 | — | — | 4 | BEARISH | -54.0 |
| CHHE China Health Industries Holdings, Inc. | — | -0.0 | -6.9 | -35.0 | -164082.8 | 77.5 | 2 | BEARISH | 0.0 |
| NSRS Medcann Industries, Inc. | — | -0.0 | -92.1 | -21.1 | — | — | 2 | BEARISH | 0.0 |
| NNRX Nutranomics, Inc. | — | -0.1 | 58.6 | -70.9 | -150.9 | 46.4 | 4 | BEARISH | -98.0 |
| DTMXF Quanta AI Inc. | — | — | 6074.2 | 6923.2 | -413.2 | 15.3 | 3 | BEARISH | -77.7 |
| GOVX GeoVax Labs, Inc. | — | -0.0 | -891.6 | 1530.7 | — | -100.0 | 3 | BEARISH | -98.6 |
| KLYG Kelyniam Global, Inc. | — | -23.3 | -26.9 | 10.0 | -16.7 | 2.0 | 5 | BEARISH | -23.1 |
| BMCS BioTech Medics, Inc. | — | -13.9 | -0.0 | -0.0 | — | — | 5 | BEARISH | -97.7 |
| USPS Ultimate Sports, Inc. | — | -15.1 | 14.7 | 11.0 | — | — | 1 | BEARISH | -60.4 |
| IVF INVO Fertility, Inc. | — | -0.0 | -55.3 | -28.1 | 40.9 | 13.8 | 4 | BEARISH | -97.4 |
| MMTC Micro Imaging Technology, Inc. | — | -0.0 | 83.3 | 72.6 | — | — | 1 | BEARISH | 0.0 |
| TNGNQ Tengion, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| WOK WORK Medical Technology Group Ltd. Class A | — | -0.0 | -20.9 | -10.5 | -63.0 | -0.2 | 4 | BEARISH | -67.0 |
| LVCE LiveCare, Inc. | — | — | — | — | — | — | — | BEARISH | -77.2 |
| ECIA Encision Inc. | — | -0.7 | -21.1 | -7.4 | 2.0 | -8.7 | 3 | BEARISH | -94.0 |
| BBRRF Blueberries Medical Corp. | — | -7.1 | -218.7 | -2675.7 | -588.1 | -36.9 | 4 | BEARISH | -36.4 |
| WEQL WellQuest Medical & Wellness Corporation | — | -0.0 | 16.1 | -19.9 | -36.3 | 126.5 | 3 | BEARISH | 100.0 |
| XENO Xeno Transplants Corporation | — | -0.0 | -286.5 | 78.1 | — | — | 1 | BEARISH | 0.0 |
| ZHCLF Zenith Capital Corp. | — | -0.2 | 35107.2 | 37766.2 | -360.0 | — | 3 | BEARISH | 3233.3 |
| PERCF Percheron Therapeutics Limited | — | — | — | — | — | — | — | BEARISH | — |
| MDCX Medicus Pharma Ltd. Common Stock | — | -0.0 | -3904.0 | -693.1 | — | — | 3 | BEARISH | -97.9 |
| VPRO Viropro Inc. | — | -0.0 | -19.7 | -4.8 | -269.7 | 155.0 | 2 | BEARISH | 0.0 |
| DPAT Dental Patient Care America, Inc. | — | 320.0 | 117.2 | 10.7 | 26.9 | -3.7 | 5 | BEARISH | 64.1 |
| APYI Aspyra Inc. | — | -0.0 | -102.5 | 49.8 | -82.7 | -15.6 | 1 | BEARISH | 0.0 |
| ULIHF The United Laboratories International Holdings Limited | $1.9B | 21.1 | 3.3 | 4.4 | 5.6 | -16.6 | 4 | BEARISH | -49.9 |
| PHMMF Pharma Mar, S.A. | $1.6B | 21.0 | 24.9 | 35.9 | -2.0 | 15.5 | 7 | BEARISH | -16.4 |
| FDMDF 4DMedical Limited | $1.6B | -8.7 | -174.5 | 43.4 | -1194.8 | 20.5 | 3 | BEARISH | 79.9 |
| BCAX Bicara Therapeutics Inc. Common Stock | $1.1B | -3.1 | -41.0 | 583.9 | — | — | 2 | BEARISH | -42.6 |
| LFTSF LifeTech Scientific Corporation | $1.0B | 105.4 | 7.3 | 6.9 | -5.7 | 103.7 | 4 | BEARISH | -14.3 |
| TTALF Terveystalo Oyj | $910M | 13.2 | 10.3 | 6.3 | 2.1 | -8.7 | 4 | BEARISH | -44.5 |
| IVEVF Inventiva S.A. | $750M | -6.2 | -988.4 | -371.6 | -347346.6 | -99.7 | 3 | BEARISH | -22.8 |
| INRLF Valneva SE | $640M | -2.8 | -118.0 | -54.8 | -89.3 | -27.2 | 1 | BEARISH | -44.9 |
| NNCSF Nanosonics Limited | $620M | 50.8 | 8.3 | 15.6 | 8.1 | 2.4 | 4 | BEARISH | -39.9 |
| SPRY ARS Pharmaceuticals, Inc. | $400M | -1.7 | -210.3 | -424.3 | -185.2 | 4.1 | 2 | BEARISH | -61.8 |
| EIKN Eikon Therapeutics, Inc. Common Stock | $390M | — | — | — | — | — | — | BEARISH | — |
| DMTRF 3-D Matrix, Ltd. | $310M | 12.4 | 75.0 | 31.1 | 9.4 | 57.0 | 6 | BEARISH | 61.3 |
| SPOK Spok Holdings, Inc. | $220M | 11.4 | 8.4 | 10.0 | 11.8 | -3.4 | 5 | BEARISH | -36.3 |
| CHHHF CareRx Corporation | $150M | 7.8 | 27.3 | 40.1 | 0.4 | 3.0 | 6 | BEARISH | -10.8 |
| CORBF Global Cord Blood Corporation | $130M | 1.5 | 104.3 | -167.2 | 35.9 | — | 4 | BEARISH | 26.7 |
| ORGO Organogenesis Holdings Inc. | $130M | -1.0 | -27.8 | -7.7 | -227.0 | 6.4 | 3 | BEARISH | -80.2 |
| NERV Minerva Neurosciences, Inc. | $110M | -0.1 | 337.5 | 10.0 | — | — | 1 | BEARISH | -51.2 |
| STXS Stereotaxis, Inc. | $100M | -3.9 | -184.3 | -142.6 | -58.3 | -5.5 | 5 | BEARISH | -68.2 |
| LNSR LENSAR Inc | $70M | 4.7 | 1231.0 | -218.4 | 21.4 | 3.3 | 5 | BEARISH | -50.1 |
| VRCA Verrica Pharmaceuticals Inc. | $60M | -2.0 | 473.3 | 437.4 | -224.4 | 106.2 | 5 | BEARISH | -7.5 |
| ONCY Oncolytics Biotech Inc. | $50M | -1.8 | 90135.4 | 285.1 | — | — | 1 | BEARISH | -63.5 |
| DRIO DarioHealth Corp. | $40M | 4.9 | 113.8 | -93.8 | -153.1 | -22.6 | 3 | BEARISH | -77.9 |
| OTCFF Ocumetics Technology Corp. | $40M | -6.7 | 174.3 | 2137.7 | — | — | 1 | BEARISH | -66.3 |
| PRPO Precipio, Inc. | $40M | -28.7 | -9.0 | -8.1 | -3.1 | 33.5 | 6 | BEARISH | -10.4 |
| EDSA Edesa Biotech, Inc. | $30M | -1.5 | -122.9 | 759.6 | — | — | 1 | BEARISH | -2.7 |
| EYPT EyePoint Pharmaceuticals, Inc. | $30M | -0.1 | -148.7 | -3014.8 | -18633.1 | -94.6 | 2 | BEARISH | -96.9 |
| NRXBF NurExone Biologic Inc. | $30M | — | — | — | — | — | — | BEARISH | — |
| MDDVF Medical Developments International Limited | $30M | 65.2 | 1.1 | 3.6 | 4.1 | 8.9 | 7 | BEARISH | -15.1 |
| IGC IGC Pharma, Inc. | $30M | -2.9 | -129.2 | -127.6 | -1107.9 | -15.4 | 1 | BEARISH | -43.1 |
| NNOX Nano-X Imaging Ltd. | $30M | -0.2 | -99.0 | -164.5 | -1335.1 | 31.5 | 2 | BEARISH | -92.0 |
| CRVO CervoMed Inc. | $30M | -0.7 | -107.6 | 1244.8 | — | — | 2 | BEARISH | -68.5 |
| BSEM BioStem Technologies, Inc. | $30M | -0.9 | -74.7 | -84.3 | -113.6 | -119.6 | 2 | BEARISH | -67.9 |
| CNTX Context Therapeutics Inc. | $20M | -0.4 | -76.1 | 841.7 | — | — | 2 | BEARISH | -82.8 |
| QUCY Quantum Cyber N.V. | $20M | — | — | — | — | — | — | BEARISH | — |
| ACIXF Acarix AB (publ) | $20M | -5.4 | -86.1 | -207.4 | -410.8 | 65.2 | 4 | BEARISH | -33.1 |
| SYMQY SymBio Pharmaceuticals Limited | $20M | -0.5 | -334.3 | 639.4 | -515.2 | -54.2 | 1 | BEARISH | -57.1 |
| OPTH Optimi Health Corp. | $20M | — | — | — | — | — | — | BEARISH | — |
| TXMD TherapeuticsMD, Inc. | $20M | -95.2 | -0.8 | -12.9 | 17.8 | 27.8 | 6 | BEARISH | 36.6 |
| BXPHF Botanix Pharmaceuticals Limited | $20M | -0.3 | -96.3 | -131.6 | -203.1 | 495.6 | 4 | BEARISH | -92.5 |
| ORXOF Orexo AB | $20M | -0.4 | 3924.8 | -872.8 | -12050.0 | -97.8 | 4 | BEARISH | -81.0 |
| ACXP Acurx Pharmaceuticals, Inc. | $10M | -0.3 | -128.1 | 241.9 | — | — | 3 | BEARISH | -83.8 |
| RDTCF Rapid Dose Therapeutics Corp. | $10M | -4.2 | 49.3 | 80.2 | -86.2 | 4.3 | 4 | BEARISH | -58.4 |
| MDBIF TrivarX Limited | $10M | -0.0 | -61.2 | -48.7 | — | -100.0 | 4 | BEARISH | -70.8 |
| BDMD Baird Medical Investment Holdings Limited | $10M | -0.5 | -45.3 | -23.2 | 0.4 | -23.1 | 4 | BEARISH | -82.5 |
| BLRX BioLineRx Ltd. | $10M | -1.1 | -63.5 | -113.0 | -1029.3 | -94.3 | 3 | BEARISH | -46.8 |
| ANPCF CelLBxHealth plc | $10M | — | -239.7 | -609.1 | -452.4 | -32.8 | 2 | BEARISH | -60.8 |
| ACTU Actuate Therapeutics Inc | $10M | -0.4 | 2457.6 | 541.3 | — | — | 3 | BEARISH | -94.7 |
| CNTMF Fluent Corp. | $10M | -0.1 | 119.7 | -49.4 | -65.1 | -34.7 | 4 | BEARISH | -71.3 |
| AIMD Ainos, Inc. | $10M | -0.3 | -196.3 | -69.4 | -3022849.3 | -87.7 | 1 | BEARISH | -77.2 |
| KTTA Pasithea Therapeutics Corp. | $10M | -0.2 | -65.5 | -453.2 | — | — | 4 | BEARISH | -45.8 |
| IPDQF ImpediMed Limited | $10M | -0.4 | -162.3 | 295.0 | -177.9 | 14.7 | 3 | BEARISH | -67.0 |
| RVPH Reviva Pharmaceuticals Holdings, Inc. | $10M | -0.1 | -32.2 | 45.6 | — | — | 4 | BEARISH | -29.9 |
| CBSC Cardiac Biotech Solutions Inc. | $10M | -6.8 | 87.3 | 51.1 | -341.6 | 78.5 | 3 | BEARISH | -26.8 |
| MTVA MetaVia Inc. | $10M | -0.3 | -175.7 | 209.3 | — | — | 0 | BEARISH | -89.3 |
| CODX Co-Diagnostics, Inc. | — | -0.0 | -174.8 | -218.8 | -3782.4 | -28.1 | 3 | BEARISH | -98.8 |
| NAVBQ Navidea Biopharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| CVSI CV Sciences, Inc. | — | -0.8 | -118.9 | -46.0 | -26.0 | -14.9 | 1 | BEARISH | -77.4 |
| HLUN HEALTHeUNIVERSE, Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| NUMD Nu-Med Plus, Inc. | — | -24.0 | 8.1 | 29.2 | — | -100.0 | 4 | BEARISH | -76.0 |
| ACAI Safeplus International Holdings Limited | — | -0.3 | -205.0 | -617.4 | -224.7 | -94.2 | 1 | BEARISH | 100.0 |
| SCAL Stem Cell Authority, Ltd. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CLRD Clearday, Inc. | — | -0.0 | 41.6 | 33.3 | -296.5 | -39.1 | 3 | BEARISH | -90.0 |
| FAMDF Futura Medical plc | — | -0.3 | -145.8 | -370.5 | -72.8 | -70.7 | 2 | BEARISH | -86.7 |
| NASC Nascent Pharma Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| MEDD Medical Imaging Corp. | — | — | — | — | — | — | — | BEARISH | 100.0 |
| KAPA Kairos Pharma, Ltd. | — | -0.3 | -114.0 | -301.0 | — | — | 3 | BEARISH | -93.5 |
| APVO Aptevo Therapeutics Inc. | — | -0.0 | -420.3 | -4688.7 | — | — | 1 | BEARISH | -95.2 |
| NSHSF NanoSphere Health Sciences Inc. | — | 9.5 | 4.6 | 11.1 | — | — | 0 | BEARISH | 0.0 |
| CANF Can-Fite BioPharma Ltd. | — | -0.2 | -184.2 | 353.7 | -2277.7 | -40.1 | 2 | BEARISH | -82.5 |
| LUFFF Herbal Dispatch Inc. | — | -1.0 | -124.8 | -42.8 | -26.7 | 4.6 | 6 | BEARISH | 46.0 |
| PPBT Purple Biotech Ltd. | — | -0.0 | -111.3 | -99.1 | — | — | 2 | BEARISH | 60.8 |
| STLNW Starling Oncology Inc. Wt | — | — | — | — | — | — | — | BEARISH | — |
| TBRIF Therma Bright Inc. | — | -0.4 | 711.8 | 33.4 | -336.3 | 202.0 | 3 | BEARISH | -52.9 |
| HTGMQ HTG Molecular Diagnostics, Inc. | — | -0.0 | -343.2 | 734.2 | -489.6 | -28.2 | 2 | BEARISH | -99.0 |
| BXRXQ Baudax Bio, Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| EKGGF CardioComm Solutions, Inc. | — | — | 92.7 | 515.6 | -152.3 | -41.9 | 2 | BEARISH | 51.1 |
| DOSEF Doseology Sciences Inc. | — | -0.7 | -95.4 | -103.8 | -1609.9 | 161.1 | 1 | BEARISH | -90.4 |
| JRSS JRSIS Health Care Corporation | — | -6.8 | -10.1 | -10.3 | 4.5 | -94.6 | 6 | BEARISH | 80.6 |
| ATTBF Abattis Bioceuticals Corp. | — | -0.0 | -27.0 | -30.2 | -400.9 | 4163.2 | 4 | BEARISH | -96.7 |
| NRSN NeuroSense Therapeutics Ltd. | — | -0.3 | 779.3 | 571.3 | — | — | 3 | BEARISH | -89.7 |
| SNNVF Sunniva Inc. | — | -0.2 | -85.4 | -22.5 | -381.7 | 126.7 | 3 | BEARISH | -90.0 |
| SCRCQ ScripsAmerica, Inc. | — | -0.0 | 168.2 | 144.2 | -17.6 | 3510.5 | 5 | BEARISH | -99.0 |
| ISOLF Isodiol International Inc. | — | -0.0 | -220.6 | -602.3 | -73.2 | -17.7 | 4 | BEARISH | -99.0 |
| NMLSF Restart Life Sciences Corp. | — | -1.7 | -214.3 | -153.9 | -307.0 | — | 2 | BEARISH | -63.3 |
| ZLDAF Zelira Therapeutics Limited | — | -1.6 | 80.8 | 147.8 | -185107971.7 | -99.3 | 1 | BEARISH | -7.8 |
| ALST AllStar Health Brands Inc | — | -0.3 | 12.9 | 2.5 | — | — | 4 | BEARISH | -25.0 |
| EAPH Parallel Industries Inc. | — | -0.2 | 26.8 | 19.0 | — | 0.0 | 4 | BEARISH | -90.0 |
| SAGD South American Gold Corp. | — | -0.5 | 106.5 | 49.7 | — | — | 1 | BEARISH | -90.0 |
| PMCB PharmaCyte Biotech, Inc. | — | -0.1 | -44.0 | 793.8 | — | — | 2 | BEARISH | -66.1 |
| GENPF Genix Pharmaceuticals Corporation | — | -3.8 | 19.6 | 11.6 | — | -100.0 | 2 | BEARISH | -40.2 |
| MAHN Mid-Atlantic Home Health Network, Inc. | — | — | — | — | — | — | — | BEARISH | -93.0 |
| BIMI BIMI International Medical Inc. | — | -0.0 | -159.5 | -56.3 | -124.0 | -65.7 | 4 | BEARISH | 0.0 |
| IAGX Imagenetix, Inc. | — | -0.1 | -88.3 | -8.5 | -12.9 | -69.1 | 4 | BEARISH | 0.0 |
| CDIX Cardiff Lexington Corporation | — | -0.0 | -481.3 | -3.3 | -114.8 | 0.3 | 2 | BEARISH | -99.9 |
| MILC Millennium Sustainable Ventures Corp. | — | -0.0 | 763.2 | -36.7 | — | 584982.1 | 2 | BEARISH | -50.0 |
| OXBOF Oxford BioDynamics Plc | — | -0.3 | -214.9 | -155.8 | -649.8 | 33.6 | 3 | BEARISH | -81.1 |
| CELZ Creative Medical Technology Holdings, Inc. | — | -0.4 | -78.0 | 8335.2 | — | -50.0 | 2 | BEARISH | -86.0 |
| TWSI Tristar Wellness Solutions Inc. | — | -1.5 | 61.9 | 93.6 | -80.6 | -29.1 | 3 | BEARISH | -99.7 |
| BLFE BioLife Sciences Inc. | — | -0.0 | 318059.1 | -92210.0 | — | — | 2 | BEARISH | 0.0 |
| XSNX NovAccess Global Inc. | — | -0.0 | 27.7 | 18.0 | — | — | 3 | BEARISH | 0.0 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
VNDA vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F